<table>
  <tr>
    <td>Contributing Authors</td>
    <td>........... 0.0</td>
    <td></td>
    <td>ce</td>
    <td>eee</td>
    <td>eee Vil</td>
  </tr>
  <tr>
    <td>Faculty REVICWEIS</td>
    <td>ccc cece</td>
    <td></td>
    <td>eee</td>
    <td>eee.</td>
    <td>Vii</td>
  </tr>
  <tr>
    <td>do) — |</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>IX</td>
  </tr>
  <tr>
    <td>Acknowledgments............00.c</td>
    <td></td>
    <td>cee</td>
    <td>cece</td>
    <td>ee</td>
    <td>ees XI</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>How to Contribute</td>
    <td>ccc</td>
    <td>ccc</td>
    <td>cece</td>
    <td>eeeees</td>
    <td>xiii</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td colspan="2">How to Contribute... 0.2... xiii</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 1. Guide to the USMLE Step3............</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 2. Ambulatory Medicine ............... 11</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 3. Cardiology ........................... 29</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 4. Emergency Medicine ................ 51</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 5. Endocrinology ....................... 79</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 6. Ethics and Statistics.................. 99</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 7. Gastroenterology................... 109</td>
  </tr>
  <tr>
    <td>
      CHAPTER 8. Hematology......................... CHAPTER 9.
      Oncology............................
    </td>
    <td>129 147</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>CHAPTER 10. Infectious CHAPTER 11. Musculoskeletal</td>
    <td>Disease................. 169 199</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 12. Nephrology........................ 213</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 13. Neurology.......................... 229</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 14. Obstetrics.......................... 251</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 15. Gynecology........................ 271</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 16. Pediatrics .......................... 287</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 17. Psychiatry.......................... 331</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 18. Pulmonary ......................... 357</td>
  </tr>
  <tr>
    <td colspan="2">CHAPTER 19. High-Yield CCS Cases.............. 375</td>
  </tr>
  <tr>
    <td colspan="2">APPeNdIX 0.0...</td>
  </tr>
  <tr>
    <td>TX About the Authors</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>How Is Step 3 STRUCTURED?</td>
    <td></td>
  </tr>
  <tr>
    <td>Wuat Types OF Questions Are ASKED?</td>
    <td></td>
  </tr>
  <tr>
    <td>How Are THE Scores REPORTED?</td>
    <td></td>
  </tr>
  <tr>
    <td>How Do | Reaister To TAKE THE EXAM?</td>
    <td></td>
  </tr>
  <tr>
    <td>Wuart Ir | Neep To RescHEDULE THE EXAM?</td>
    <td>DAaAunnHnWhDn</td>
  </tr>
  <tr>
    <td>Wuat Asout Time?</td>
    <td></td>
  </tr>
  <tr>
    <td>le | Leave Durinc THE Exam, Wuat Happens To My Score?</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>How Lone Witt | Have to Wair Berore | Get My Scores?</td>
    <td>6</td>
  </tr>
  <tr>
    <td>USMLE/NBME Resources</td>
    <td></td>
  </tr>
  <tr>
    <td>Primum Computer-Based Case Simulations</td>
    <td>N</td>
  </tr>
  <tr>
    <td>Reviewinc A CASE</td>
    <td></td>
  </tr>
  <tr>
    <td>FINISHING THE CASE</td>
    <td>oN</td>
  </tr>
  <tr>
    <td>How Is tHe CCS GrabDeD?</td>
    <td></td>
  </tr>
  <tr>
    <td>HiGH-YieLD STRATEGIES FOR THE CCS</td>
    <td>ou 1</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CaTEGoRY</th>
    <th>PERCENT OF OveraLt CONTENT</th>
  </thead>
  <tr>
    <td>General Principles of Foundational Science?</td>
    <td>1-3%</td>
  </tr>
  <tr>
    <td>
      Biostatistics and Epidemiology/Population Health and Interpretation of the
      Medical Literature Social Science
    </td>
    <td>14-18%</td>
  </tr>
  <tr>
    <td>Immune System</td>
    <td>80-85%</td>
  </tr>
  <tr>
    <td>Blood and Lymphoreticular System</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">Behavioral Health</td>
  </tr>
  <tr>
    <td>Nervous System and Special Senses Skin and Subcutaneous</td>
    <td></td>
  </tr>
  <tr>
    <td>Musculoskeletal System</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">Cardiovascular System</td>
  </tr>
  <tr>
    <td>Respiratory System</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">Gastrointestinal System</td>
  </tr>
  <tr>
    <td colspan="2">Renal and Urinary System</td>
  </tr>
  <tr>
    <td colspan="2">Pregnancy, Childbirth, and the Puerperium</td>
  </tr>
  <tr>
    <td colspan="2">Female Reproductive System and Breast</td>
  </tr>
  <tr>
    <td colspan="2">Male Reproductive System</td>
  </tr>
  <tr>
    <td colspan="2">Endocrine System</td>
  </tr>
  <tr>
    <td>Multisystem Processes and Disorders</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CompeTENCY</th>
    <th>Day 1: FIP</th>
    <th>Day 2: ACM</th>
  </thead>
  <tr>
    <td>Medical Knowledge/Scientific Concepts</td>
    <td>18-22%</td>
    <td></td>
  </tr>
  <tr>
    <td>Patient Care: Diagnosis</td>
    <td>40-45%</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">History/PE</td>
  </tr>
  <tr>
    <td colspan="3">Laboratory/Diagnostic Studies</td>
  </tr>
  <tr>
    <td colspan="3">Diagnosis</td>
  </tr>
  <tr>
    <td>Prognosis/Outcome</td>
    <td></td>
    <td>20-25%</td>
  </tr>
  <tr>
    <td>Patient Care: Management</td>
    <td></td>
    <td>75-80%</td>
  </tr>
  <tr>
    <td colspan="3">Health Maintenance/Disease Prevention</td>
  </tr>
  <tr>
    <td colspan="3">Pharmacotherapy</td>
  </tr>
  <tr>
    <td colspan="3">Clinical Interventions</td>
  </tr>
  <tr>
    <td colspan="3">Mixed Management</td>
  </tr>
  <tr>
    <td colspan="3">Surveillance for Disease Recurrence</td>
  </tr>
  <tr>
    <td>Communication and Professionalism</td>
    <td>8-12%</td>
    <td></td>
  </tr>
  <tr>
    <td>Systems-based Practice/Patient Safety and Practice-based</td>
    <td>22-27%</td>
    <td></td>
  </tr>
  <tr>
    <td>Learning</td>
    <td></td>
    <td></td>
  </tr>
</table>
<table>
  <tr>
    <td>Autonomy</td>
  </tr>
  <tr>
    <td>INFORMED CONSENT</td>
  </tr>
  <tr>
    <td>RicHts oF Minors</td>
  </tr>
  <tr>
    <td>Competency</td>
  </tr>
  <tr>
    <td>ComPeTENcy vs CAPACITY</td>
  </tr>
  <tr>
    <td>DETENTION AND Use oF RESTRAINTS</td>
  </tr>
  <tr>
    <td>Durasle Power or ATTORNEY FOR HEALTH CARE</td>
  </tr>
  <tr>
    <td>Surrocare/PROoxy</td>
  </tr>
  <tr>
    <td>Confidentiality</td>
  </tr>
  <tr>
    <td>IMPORTANCE OF CONFIDENTIALITY (AND HIPAA)</td>
  </tr>
  <tr>
    <td>WHEN To VIOLATE CONFIDENTIALITY</td>
  </tr>
  <tr>
    <td>REPORTABLE CONDITIONS</td>
  </tr>
  <tr>
    <td>AskiNG Fottow-Up Questions</td>
  </tr>
  <tr>
    <td>End-of-Life Care</td>
  </tr>
  <tr>
    <td>Aovance Directives</td>
  </tr>
  <tr>
    <td>Do Nor Resuscitate OrDers/Cope Status</td>
  </tr>
  <tr>
    <td>PalN IN TERMINALLY ILL PATIENTS</td>
  </tr>
  <tr>
    <td>THe PRrincipLe oF “Douste Errect”</td>
  </tr>
  <tr>
    <td>PersisTENT VEGETATIVE STATE</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>00</td>
    <td>PHySICIAN-ASSISTED SUICIDE AND EUTHANASIA</td>
    <td>103</td>
  </tr>
  <tr>
    <td></td>
    <td>PALLIATION AND Hospice</td>
    <td>103</td>
  </tr>
  <tr>
    <td>00 00</td>
    <td>WITHDRAWAL OF TREATMENT</td>
    <td>103</td>
  </tr>
  <tr>
    <td>00</td>
    <td>Biostatistics</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>SENSITIVITY AND SPECIFICITY</td>
    <td>103</td>
  </tr>
  <tr>
    <td>00</td>
    <td>Prepictive VALUES</td>
    <td>104</td>
  </tr>
  <tr>
    <td>00 01</td>
    <td>INCIDENCE</td>
    <td>104</td>
  </tr>
  <tr>
    <td>01</td>
    <td>PREVALENCE</td>
    <td>104</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Assotute Risk</td>
    <td>104</td>
  </tr>
  <tr>
    <td></td>
    <td>Reative Risk</td>
    <td>104</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Opps Ratio</td>
    <td>104</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Assotute Risk REDUCTION OR ATTRIBUTABLE Risk</td>
    <td>105</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Retative Risk REDUCTION</td>
    <td>105</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Numeer NeeDeD To TREAT</td>
    <td>105</td>
  </tr>
  <tr>
    <td>01</td>
    <td>STATISTICAL SIGNIFICANCE/P VALUE</td>
    <td>105</td>
  </tr>
  <tr>
    <td>02</td>
    <td>CONFIDENCE INTERVAL</td>
    <td>105</td>
  </tr>
  <tr>
    <td>02</td>
    <td>Study Design</td>
    <td></td>
  </tr>
  <tr>
    <td>02</td>
    <td>SURVEYS</td>
    <td>106</td>
  </tr>
  <tr>
    <td>02</td>
    <td>PROSPECTIVE AND RETROSPECTIVE STUDIES</td>
    <td>106</td>
  </tr>
  <tr>
    <td>02</td>
    <td>Coxort STUDIES</td>
    <td>106</td>
  </tr>
  <tr>
    <td>02</td>
    <td>Case-ControL STUDIES</td>
    <td>106</td>
  </tr>
  <tr>
    <td>03</td>
    <td>RANDOMIZED CONTROLLED TRIALS</td>
    <td>107</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Disease PRESENT</th>
    <th>No Disease</th>
    <th></th>
  </thead>
  <tr>
    <td>Positive test</td>
    <td>a</td>
    <td>b</td>
    <td>PPV =a/(a+b</td>
  </tr>
  <tr>
    <td>Negative test</td>
    <td>c</td>
    <td>d</td>
    <td>NPV =d/(c +d</td>
  </tr>
  <tr>
    <td></td>
    <td>Sensitivity = a/(a + c)</td>
    <td>Specificity = d/(b + d)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Disease DeveLops</th>
    <th>No Disease</th>
    <th></th>
  </thead>
  <tr>
    <td>Exposure</td>
    <td>a</td>
    <td>b</td>
    <td>RR = [a/(a + b)]/[c/(c + d)]</td>
  </tr>
  <tr>
    <td>No exposure</td>
    <td>c</td>
    <td>d</td>
    <td>OR = ad/bc</td>
  </tr>
</table>
<table>
  <tr>
    <td>Gastroesophageal Reflux Disease</td>
    <td></td>
  </tr>
  <tr>
    <td>Peptic Ulcer Disease</td>
    <td></td>
  </tr>
  <tr>
    <td>Inflammatory Bowel Disease</td>
    <td></td>
  </tr>
  <tr>
    <td>Irritable Bowel Syndrome</td>
    <td></td>
  </tr>
  <tr>
    <td>Diarrhea</td>
    <td></td>
  </tr>
  <tr>
    <td>Celiac Sprue</td>
    <td></td>
  </tr>
  <tr>
    <td>Upper Gl Bleed</td>
    <td></td>
  </tr>
  <tr>
    <td>Lower Gl Bleed</td>
    <td></td>
  </tr>
  <tr>
    <td>Pancreatitis</td>
    <td></td>
  </tr>
  <tr>
    <td>Approach to Liver Function Tests</td>
    <td>20</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Anatomic location</td>
    <td>
      Anywhere from the mouth to the anus Most commonly affecting the terminal
      ileum, small bowel,
    </td>
    <td>
      Usually involves the rectum but can involve all or part of the colon
    </td>
  </tr>
  <tr>
    <td>Epidemiology</td>
    <td>and colon _ Bimodal distribution (20s and 50-70)</td>
    <td>
      Does not involve the Gl tract outside the colon and rectum Bimodal
      distribution (15-30 and 60-80)
    </td>
  </tr>
  <tr>
    <td rowspan="2">Symptoms</td>
    <td>
      More common among those of Jewish ancestry Gl: Colicky right lower
      quadrant pain; diarrhea (often with usually nonbloody); perirectal
      abscess/fistula; oral
    </td>
    <td>
      More common among those of Jewish ancestry Gl: Cramping abdominal pain,
      urgency, and bloody diarrhea Other: Weight loss, fatigue, arthritis,
      uveitis and episcle-
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      ulcers Other: Fever, weight loss, erythema nodosum, pyoderma gangrenosum
      (see Figure 7-5), iritis and episcleritis, arthritis, gallstones, kidney
      stones
    </td>
    <td>ritis, erythema nodosum, pyoderma gangrenosum (see Figure 7-5)</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Labs: Anemia: Chronic disease or iron, vitamin B,,, or folate deficiency
      Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) may be T
      Anti-Saccharamycyes cerevisiae antibody (ASCA) ® Imaging: Cobblestoning
      and fistulas on barium enema CT may show abscesses, fistulas, and
      strictures Confirmed with pathologic diagnosis via colonoscopy
    </td>
    <td>
      Labs: Anemia: Normocytic or iron deficiency T ESR or CRP Perinuclear
      antineutrophil cytoplasmic antibody (p-ANCA) ® Imaging: Lead-pipe colon
      and loss of haustra on barium enema Confirmed with pathologic diagnosis
      via colonoscopy
    </td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Mild to moderate: Oral corticosteroids +/— azathioprine, 6-mercaptopurine,
      or methotrexate; limited role of 5-ASA with poor efficacy Refractory
      disease: IV steroids +/— anti-TNF therapy Rule out perforations, fistulas,
      megacolon, or abscesses; resection may be needed
    </td>
    <td>
      Mild: 5-ASA compounds Moderate: Oral corticosteroids +/— azathioprine,
      6-mercaptopurine, or methotrexate Refractory disease: IV steroids +/—
      cyclosporine +/— anti-TNF therapy Rule out toxic megacolon; resection may
      be needed
    </td>
  </tr>
  <tr>
    <td>Other</td>
    <td>
      Surveillance colonoscopy 8 years after diagnosis to evaluate for
      colorectal cancer, and at least annually thereafter
    </td>
    <td>
      Associated with 1° sclerosing cholangitis and autoimmune liver disease
      Surveillance colonoscopy 8-10 years after diagnosis (unless limited to the
      rectum) to evaluate for colorectal cancer, at
    </td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Bacterial</td>
    <td>History may be</td>
    <td>Symptoms are often severe</td>
    <td>Obtain T Fecal WBCs</td>
    <td>Most cases of bacterial diarrhea will</td>
  </tr>
  <tr>
    <td rowspan="8"></td>
    <td>Look for a history of</td>
    <td>enterohemorrhagic E coli</td>
    <td>the case of hemorrhagic</td>
    <td>ment (fluids, electrolytes)</td>
  </tr>
  <tr>
    <td></td>
    <td>foreign travel or</td>
    <td>(EHEC)</td>
    <td>disease</td>
    <td>Avoid antibiotics if possible in light of</td>
  </tr>
  <tr>
    <td></td>
    <td>consumption of</td>
    <td>Patients may complain of</td>
    <td>Culture and sensitivity may</td>
    <td>potentially T release of endotoxin</td>
  </tr>
  <tr>
    <td></td>
    <td>or unpasteurized</td>
    <td></td>
    <td>sure to ask specifically</td>
    <td>to treat most cases of invasive</td>
  </tr>
  <tr>
    <td></td>
    <td>products</td>
    <td></td>
    <td>to test for EHEC when</td>
    <td>diarrhea</td>
  </tr>
  <tr>
    <td></td>
    <td>A history of recent anti-</td>
    <td></td>
    <td>appropriate)</td>
    <td>Antibiotics are contraindicated in</td>
  </tr>
  <tr>
    <td></td>
    <td>biotic use suggests</td>
    <td></td>
    <td>Request a C difficile toxin</td>
    <td>EHEC</td>
  </tr>
  <tr>
    <td></td>
    <td>Cdifficile</td>
    <td></td>
    <td>assay when appropriate</td>
    <td>
      Metronidazole or oral vancomycin is used to treat C difficile Avoid
      loperamide
    </td>
  </tr>
  <tr>
    <td rowspan="2">Viral Parasitic</td>
    <td>Family or friends may have similar symptoms</td>
    <td>
      Symptoms are usually milder and of shorter duration than bacterial illness
      Fever is unusual
    </td>
    <td>—_ Labs are generally nonspecific</td>
    <td>
      Supportive care with loperamide, bismuth, and probiotics may be helpful
    </td>
  </tr>
  <tr>
    <td></td>
    <td>Giardiais associated with</td>
    <td>_ Parasitic illnesses can cause</td>
    <td>Obtain T fecal WBCs</td>
    <td>Metronidazole is the treatment of</td>
  </tr>
  <tr>
    <td rowspan="2"></td>
    <td>day-care outbreaks</td>
    <td>prolonged symptoms if left</td>
    <td>Check stool O&amp;P smear</td>
    <td>choice for most parasitic illnesses</td>
  </tr>
  <tr>
    <td></td>
    <td>and foreign travel Entamoeba is associated with foreign travel</td>
    <td>untreated</td>
    <td>Consider checking HIV status</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>CHARACTERISTICS</th>
    <th>Causes</th>
    <th>Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td rowspan="4">Osmotic</td>
    <td>T Stool osmotic gap</td>
    <td>Lactose intolerance</td>
    <td>Usually made by the</td>
    <td>Stop the offending agent</td>
  </tr>
  <tr>
    <td></td>
    <td>Malabsorption associated</td>
    <td>= Magnesium supplements</td>
    <td>history</td>
    <td>Lactose enzyme tablets can</td>
  </tr>
  <tr>
    <td></td>
    <td>with bloating and gas</td>
    <td>Sorbitol, lactulose, or mannitol</td>
    <td></td>
    <td>be helpful in those with</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>ingestion</td>
    <td></td>
    <td>lactose intolerance</td>
  </tr>
  <tr>
    <td rowspan="3">Secretory</td>
    <td>Caused by mucosal oversecretion Normal stool osmotic gap</td>
    <td>
      Hormonal stimulation (gastrin, vasoactive intestinal peptide) _- Viruses
      Bacterial toxins
    </td>
    <td>
      Serum gastrin level and secretin stimulation test if a hormonal cause is
      suspected
    </td>
    <td>Varies with the cause</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">Exudative</td>
    <td>Associated with mucosal inflammation</td>
    <td>IBD or celiac disease TB Colon cancer</td>
    <td>T ESR or CRP Colonoscopy</td>
    <td>Treat the underlying cause</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="5">Rapidtransit</td>
    <td>1 Gut motility</td>
    <td>Hyperthyroidism</td>
    <td>Check TSH</td>
    <td>Treat the underlying cause</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>IBS</td>
    <td>Take a thorough history</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Laxative abuse</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Carcinoid</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Antibiotics (erythromycin)</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="3">Slow transit</td>
    <td></td>
    <td>J Gut motility</td>
    <td>Microscopic colitis</td>
    <td>Colonoscopy inaddition</td>
    <td>Treat the underlying cause</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Diabetes Radiation damage Scleroderma Small bowel bacterial overgrowth
    </td>
    <td>to history</td>
    <td>
      A short course of antibiotics can be given to patients with bacterial
      overgrowth
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type oF Virat Hepatitis</th>
    <th>@ Sero.ocy*®</th>
  </thead>
  <tr>
    <td>Acute HAV</td>
    <td>Anti-HAV IgM</td>
  </tr>
  <tr>
    <td>Previous HAV</td>
    <td>Anti-HAV IgG</td>
  </tr>
  <tr>
    <td>Acute HBV</td>
    <td>HBsAg, HBeAg, HBcAb IgM</td>
  </tr>
  <tr>
    <td>Acute HBV, window period</td>
    <td>HBcAb IgM only</td>
  </tr>
  <tr>
    <td>Chronic active HBV</td>
    <td>HBsAg, HBeAg, HBcAb IgG</td>
  </tr>
  <tr>
    <td>Recovery HBV</td>
    <td>HBsAb IgG, HBcAb IgG, normal ALT</td>
  </tr>
  <tr>
    <td>Immunized HBV</td>
    <td>HBsAb IgG</td>
  </tr>
  <tr>
    <td>Chronic HCV infection</td>
    <td>HCV RNA, anti-HCV Ab, elevated/normal ALT</td>
  </tr>
  <tr>
    <td>Recovery HCV</td>
    <td>Anti-HCV Ab and © HCV RNA</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SustyPeE</th>
    <th>TRANSMISSION</th>
    <th>Cunicat/Las Finpines</th>
    <th>TREATMENT AND Course</th>
  </thead>
  <tr>
    <td>HAV</td>
    <td>Fecal-oral transmission</td>
    <td>No chronic infection</td>
    <td>Supportive; generally no sequelae</td>
  </tr>
  <tr>
    <td>HBV</td>
    <td>
      HBV is transmitted by infected blood, through sexual contact, or
      perinatally HDV can coinfect those with HBV
    </td>
    <td>
      Prevalence is high in men who have sex with men, prostitutes, and IV drug
      users Adult acquired infection usually does not become chronic HBV is much
      more common in Asian countries and among immigrants from that region
    </td>
    <td>
      Interferon (IFN) and other nucleotide/nucleoside analogs (the goal is to J
      viral load and improve liver histology; cure is uncommon) Vaccinate
      against HAV Associated with arthritis, glomerulonephritis, and
      polyarteritis nodosa; chronic infection can result in HCC even without
      cirrhosis
    </td>
  </tr>
  <tr>
    <td>HCV</td>
    <td>
      HCV is transmitted through blood transfusion or IV drug use, tattoos, or
      body piercing
    </td>
    <td>
      Acute illness is often mild or asymp- tomatic; more than 70% of infections
      become chronic Characterized by waxing and waning aminotransferases HCV
      antibody (not protective) appears 6 weeks to 9 months after infection; if
      antibody testing is © but suspicion is high, check HCV RNA
    </td>
    <td>
      HCV is classically treated with IFN (ie, ribavirin); newer therapies
      include IFN-free direct-acting antivirals; therapies are tailored to viral
      genotype, patient characteristics Vaccinate against HAV and HBV
      Complications include cryoglobulinemia, membranoproliferative
      glomerulonephritis, and HCC in patients with cirrhosis; check for HIV
      Screen all people born in the United States between 1945 and 1965 for HCV
    </td>
  </tr>
  <tr>
    <td>HDV</td>
    <td>
      HDV requires a coexistent HBV infection Exposure is percutaneous HDV is
      usually found in IV drug users and high-risk HBsAg carriers
    </td>
    <td>
      Anti-HDV IgM is present in acute cases Immunity to HBV implies immunity to
      HDV
    </td>
    <td>
      See HBV infection for treatment If acquired as a superinfection in chronic
      HBV, there is T severity of infection Fulminant hepatitis or severe
      chronic hepatitis with rapid progression to cirrhosis can occur HDV is
      associated with an T risk of HCC
    </td>
  </tr>
  <tr>
    <td>HEV</td>
    <td>
      Fecal-oral transmission Endemic to India, Afghanistan, Mexico, and Algeria
    </td>
    <td>Will test @ on serology for HEV</td>
    <td>
      Supportive Self-limited; carries a 10-20% mortality rate in pregnant women
    </td>
  </tr>
</table>
<table>
  <tr>
    <td>4ematology Definitions</td>
  </tr>
  <tr>
    <td>Anemia</td>
  </tr>
  <tr>
    <td>Microcytic ANEMIA</td>
  </tr>
  <tr>
    <td>Normocytic NormocHRomic ANEMIA AND HEMoOLyTic ANEMIA</td>
  </tr>
  <tr>
    <td>Macrocytic ANEMIA</td>
  </tr>
  <tr>
    <td>Viyeloproliferative Disorders</td>
  </tr>
  <tr>
    <td>PoLycyTHEMIA VERA</td>
  </tr>
  <tr>
    <td>EsseENTIAL THROMBOCYTOSIS</td>
  </tr>
  <tr>
    <td>1° MYELoFIBROSIS</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Microcytic ANEMIA (MCV &lt; 80 FL)</th>
    <th>Normocytic ANEMIA (MCV 80-100 FL)</th>
    <th>Macrocytic ANEMIA (MCV &gt; 100 FL)</th>
  </thead>
  <tr>
    <td>lron-deficiency anemia</td>
    <td>Anemia of chronic disease</td>
    <td>Vitamin B,, deficiency</td>
  </tr>
  <tr>
    <td>Thalassemia</td>
    <td>Hemolytic anemia</td>
    <td>Folate deficiency</td>
  </tr>
  <tr>
    <td>Sideroblastic anemia</td>
    <td>Acute blood loss</td>
    <td>Liver disease</td>
  </tr>
  <tr>
    <td>Anemia of chronic disease</td>
    <td></td>
    <td>Thyroid disease</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Tron-Dericiency ANEMIA</th>
    <th>THALASSEMIA</th>
    <th>SIDEROBLASTIC ANEMIA</th>
    <th>Anemia oF Curonic DIsEASE (LATE)</th>
  </thead>
  <tr>
    <td>Pathology</td>
    <td>J Iron in marrow, J heme synthesis</td>
    <td>J Synthesis of a- or B-globin subunits</td>
    <td>Defective heme synthesis in RBC precursors</td>
    <td>
      J Ability to use iron and response to erythropoietin from an 7 of
      inflammatory markers
    </td>
  </tr>
  <tr>
    <td>Serum ferritin?</td>
    <td></td>
    <td>Normal to T</td>
    <td>T</td>
    <td>T</td>
  </tr>
  <tr>
    <td>Serum iron</td>
    <td>L</td>
    <td>Normal to T</td>
    <td>tT</td>
    <td>Slightly</td>
  </tr>
  <tr>
    <td>TIBC</td>
    <td>T</td>
    <td>Normal to T</td>
    <td>Normal to L</td>
    <td>Normal or L</td>
  </tr>
  <tr>
    <td rowspan="8">Other tests</td>
    <td>Wide RDW</td>
    <td>Normal RDW</td>
    <td>Smear showing normal and</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Thrombocytosis common</td>
    <td>Diagnosis confirmed</td>
    <td>dimorphic RBCs with baso-</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Peripheral blood smear shows</td>
    <td>with hemoglobin</td>
    <td>philic stippling</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>microcytic RBCs with central</td>
    <td>electrophoresis</td>
    <td>Diagnosis confirmed with</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>pallor</td>
    <td>Presence of basophilic</td>
    <td>bone marrow biopsy (shows</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>stippling; typically</td>
    <td>erythroid hyperplasia and</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>MCV &lt; 70, T MCHC</td>
    <td>tinged sideroblasts)</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Check lead levels if suspected</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="4">Myelofibrosis</th>
    <th rowspan="4">
      Myeloproliferative disorder with abnormally activated fibroblasts Leads to
      medullary fibrosis and anemia
    </th>
    <th>Idiopathic or 2° to polycythemia vera; can have</th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th>Labs: Reticulocytes, teardrop RBCs, T LDH</th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th>Dx: Bone marrow; see discussion of Myeloproliferative</th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th>Disorders</th>
  </thead>
  <tr>
    <td>Paroxysmal nocturnal</td>
    <td>Acquired disorder with intravascular hemolysis and</td>
    <td>Recurrent thrombosis and pancytopenia</td>
  </tr>
  <tr>
    <td>hemoglobinuria</td>
    <td>hemoglobinuria</td>
    <td>Dx: Flow cytometry</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CLINICAL FEATURE</th>
    <th>Piatetet DisorDERS</th>
    <th>COoAGULOPATHIES</th>
  </thead>
  <tr>
    <td>Amount of bleeding after surface cuts</td>
    <td>Excessive, prolonged bleeding</td>
    <td>Normal to slightly T bleeding</td>
  </tr>
  <tr>
    <td>Onset of bleeding after injury</td>
    <td>Immediate</td>
    <td>Delayed after surgery or trauma Spontaneous bleeding into</td>
  </tr>
  <tr>
    <td rowspan="2">Clinical presentation</td>
    <td>Superficial and mucosal bleeding</td>
    <td>Deep and excessive bleeding</td>
  </tr>
  <tr>
    <td></td>
    <td>Petechiae, ecchymosis</td>
    <td>GU tract</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ConpiTion</th>
    <th>PatHoLocy</th>
    <th>Diacnosis/Comments</th>
  </thead>
  <tr>
    <td></td>
    <td>INHERITED</td>
    <td></td>
  </tr>
  <tr>
    <td>Factor V Leiden</td>
    <td>
      Mutation disrupts activated protein C (APC), which slows the break- down
      of Va and ultimately Villa
    </td>
    <td>Most common</td>
  </tr>
  <tr>
    <td>Prothrombin G20210A mutation</td>
    <td>Mutation stabilizes and thus T prothrombin</td>
    <td>DNA testing to confirm; second most common</td>
  </tr>
  <tr>
    <td>Protein CorS deficiency</td>
    <td>
      Protein C normally inactivates Va and Villa; mutation affects protein C
      synthesis; protein S is a cofactor for protein C
    </td>
    <td>Warfarin carries a risk of skin necrosis.</td>
  </tr>
  <tr>
    <td>Anti-thrombin Ill deficiency</td>
    <td>Antithrombin typically inhibits thrombin and factor Xa</td>
    <td>Can result in heparin resistance</td>
  </tr>
  <tr>
    <td rowspan="2">Hyperhomocysteinemia</td>
    <td>Inherited or acquired</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>AcquireD*</td>
    <td></td>
  </tr>
  <tr>
    <td>Antiphospholipid syndrome</td>
    <td>
      Any thrombosis and &gt; 3 miscar- riages before 10 weeks or 1 after 10
      weeks
    </td>
    <td>@ Anticardiolipin or lupus anticoagulant antibodies</td>
  </tr>
  <tr>
    <td>Cancer</td>
    <td>
      Expresses tissue factor on surfaces and leads to a prothrombotic state
    </td>
    <td>Cancer screening</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CompLicaTion</th>
    <th>PRESENTATION</th>
    <th>PatHOoLocy</th>
    <th>Diacnosis/Lass</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Febrile reaction</td>
    <td>Fever; chills and malaise possible</td>
    <td>
      Interaction between antibodies in the recipient and cytokines from the
      donor
    </td>
    <td>
      Hemolytic reaction or infectious causes of hemolysis must be ruled out
    </td>
    <td>
      Avoid transfusion when febrile For future transfusions, use
      leukocyte-reduced RBCs
    </td>
  </tr>
  <tr>
    <td>Hemolytic reaction: Acute (&lt; 24 hours)</td>
    <td>Fever, chills, pain at site of reaction, hypotension, flushing</td>
    <td>
      ABO incompatibility between donor and recipient Complications: AKI (from
      hemoglobin- uria) and DIC
    </td>
    <td>
      @ Coombs test, agglu- tination of RBC on smear, low hapto- globin (best
      test) Urinalysis for hemoglo- binuria (@ Urine dip for hematuria in the
      setting of few RBCs on microscopy)
    </td>
    <td>
      Stop transfusion Maintain BP and urine output with IV fluids; give
      furosemide if urine output is &lt; 100 mL/hr Type and cross RBCs just
      transfused
    </td>
  </tr>
  <tr>
    <td>Hemolytic reaction: Delayed (4-14 days post-transfusion)</td>
    <td>Jaundice, anemia, hemoglobinuria, fever</td>
    <td>
      Previous exposure to erythrocyte antigen outside ABO system; can develop
      alloantibodies after transfusion
    </td>
    <td>T LDH, unconjugated hyperbilirubinemia, decreased haptoglobin</td>
    <td>
      Type and screen blood before future transactions Give acetaminophen for
      fever. Patients with sickle cell disease may have a worsening pain crisis
    </td>
  </tr>
  <tr>
    <td>Allergic reaction</td>
    <td>Urticaria, itching, hives; rarely anaphylaxis</td>
    <td></td>
    <td></td>
    <td>
      Stop transfusion and monitor for anaphylaxis Give diphenhydramine or other
      antihistamines Resume transfusion at a slower rate when symptoms resolve
      Provide ventilation (O,, intubation), diuretics, steroids
    </td>
  </tr>
  <tr>
    <td>TRALI (transfusion- related acute lung injury)</td>
    <td>
      Shortness of breath, hypoxemia, bilateral chest infiltrates Occurs 1-6
      hours post-transfusion Like acute respiratory distress syndrome Acute
      respiratory distress, cyanosis, fever, resolves within 24 hours
    </td>
    <td>
      Reaction between donor antibodies against recipient neutrophil antigens
    </td>
    <td>CXR shows bilateral pulmonary infiltrates without HF</td>
    <td>
      Stop transfusion Provide ventilation (oxygen, intubation), diuretics,
      steroids
    </td>
  </tr>
  <tr>
    <td>TACO (transfusion- associated circulatory</td>
    <td>
      Shortness of breath, edema Symptoms similar and hard to distinguish from
    </td>
    <td>Overload of fluid in patients with CV compromise</td>
    <td>Patients will exhibit signs of pulmonary edema and volume overload</td>
    <td>Give blood slowly Give furosemide with transfusion</td>
  </tr>
</table>
<table>
  <tr>
    <td>LEUKEMIA</td>
    <td>14§</td>
  </tr>
  <tr>
    <td>LymPHomaA</td>
    <td>14§</td>
  </tr>
  <tr>
    <td>Tumor Lysis SYNDROME</td>
    <td>151</td>
  </tr>
  <tr>
    <td>Muttipte MyeLoma</td>
    <td>152</td>
  </tr>
  <tr>
    <td>Amy.oiosis</td>
    <td>153</td>
  </tr>
  <tr>
    <td>Breast Cancer</td>
    <td></td>
  </tr>
  <tr>
    <td>Lung Cancer</td>
    <td></td>
  </tr>
  <tr>
    <td>Paraneoplastic Syndromes</td>
    <td></td>
  </tr>
  <tr>
    <td>Gl Tumors</td>
    <td></td>
  </tr>
  <tr>
    <td>PaNcreATIC CANCER</td>
    <td></td>
  </tr>
  <tr>
    <td>HEPATOCELLULAR CANCER</td>
    <td></td>
  </tr>
  <tr>
    <td>CotorecTAL CANCER</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>148</td>
    <td>BLappeR CANCER</td>
    <td>162</td>
  </tr>
  <tr>
    <td>148</td>
    <td>Prostate CANCER</td>
    <td>162</td>
  </tr>
  <tr>
    <td>151</td>
    <td>TESTICULAR CANCER</td>
    <td>163</td>
  </tr>
  <tr>
    <td>152</td>
    <td>Renat Cett CARCINOMA</td>
    <td>164</td>
  </tr>
  <tr>
    <td>153</td>
    <td>OvariaN CANCER</td>
    <td>165</td>
  </tr>
  <tr>
    <td></td>
    <td>Cervical CANCER</td>
    <td>165</td>
  </tr>
  <tr>
    <td></td>
    <td>CNS Tumors MeNINGIOMA</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>GulaL Tumors</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Tumor Markers</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Cancer Treatment Side Effects</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Acute LympHocytic Leukemia (ALL)</th>
    <th>Acute MyeLocenous Leukemia (AML)</th>
    <th>Curonic LympHocytic Leukemia (CLL)</th>
    <th>Curonic MyeLoGenous Leukemia (CML)</th>
  </thead>
  <tr>
    <td>Epidemiology</td>
    <td>Most common in children; T risk in Down syndrome</td>
    <td>
      Median age 65; risk T with age and with previous che- motherapy or
      radiation
    </td>
    <td>The most common adult leukemia; affects those &gt; 65 years of age</td>
    <td>Affects the middle-aged; risk T with previous radiation</td>
  </tr>
  <tr>
    <td>Symptoms</td>
    <td>Viral-like syndrome; bone pain and bruising</td>
    <td>Fever, bruising, fatigue, anemia, or frequent infections</td>
    <td>
      Often asymptomatic; may be an incidental finding on CBC; can present with
      fatigue and B symptoms (weight loss, night sweats, fever)
    </td>
    <td>
      Chronic phase: Asymp- tomatic or presents with fatigue, B symptoms, and
      splenomegaly Accelerated or blastic phase: Worsening symptoms; bone pain,
      bleeding (platelet dysfunction), infections
    </td>
  </tr>
  <tr>
    <td>Exam</td>
    <td>
      Pallor, petechiae/purpura (see Figure 9-1), bleeding Adenopathy,
      hepatomegaly, splenomegaly, testicular and CNS involvement (all rare in
      AML) T-cell ALL often presents with an anterior medias- tinal mass
    </td>
    <td>
      Petechiae/purpura (see Figure 9-1), lethargy, leu- kemia cutis (cutaneous
      infiltration of leukemic cells) Gingival hyperplasia, DIC, or tumor lysis
      syndrome
    </td>
    <td>
      Lymphadenopathy and hepatosplenomegaly in addition to leukemic cells
    </td>
    <td>Splenomegaly, early satiety, purpura</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Hopckin</th>
    <th>Non-Hopckin</th>
  </thead>
  <tr>
    <td>Reed-Sternberg cells</td>
    <td>No Reed-Sternberg cells</td>
  </tr>
  <tr>
    <td>Mediastinal mass/lymph nodes</td>
    <td>Peripheral lymph nodes</td>
  </tr>
  <tr>
    <td>B symptoms</td>
    <td>Fewer B symptoms</td>
  </tr>
  <tr>
    <td>Contiguous spread</td>
    <td>Typically noncontiguous</td>
  </tr>
  <tr>
    <td>Young (but bimodal)</td>
    <td>Old/middle-age</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Bone Lesions</th>
    <th>AssociateD CANCER</th>
  </thead>
  <tr>
    <td>OsteoLytic</td>
    <td>Myeloma, kidney, lung, breast, GI (can see on plain films)</td>
  </tr>
  <tr>
    <td rowspan="2">OsteoBlastic</td>
    <td>
      Prostate, breast (may be mixed), germ cell, ovary, uterus (less likely
    </td>
  </tr>
  <tr>
    <td></td>
    <td>to be seen on plain films)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>MGUS</th>
    <th>Smo.peRING MyeLoma</th>
    <th>Muttipte Myetoma</th>
  </thead>
  <tr>
    <td>Plasma cells in bone marrow</td>
    <td>&lt; 10% (always)</td>
    <td>&gt; 10% (sometimes)</td>
    <td>&gt; 10% (sometimes)</td>
  </tr>
  <tr>
    <td>M protein on SPEP</td>
    <td>&lt;34q/dL (always)</td>
    <td>&gt;3g/dL (sometimes)</td>
    <td>&gt; 3 g/dL (sometimes)</td>
  </tr>
  <tr>
    <td>End organ damage</td>
    <td>No CRAB (always)</td>
    <td>No CRAB (always)</td>
    <td>CRAB symptoms (often)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INFILTRATING DUCTAL CARCINOMA</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td rowspan="4">With © lymph nodes</td>
    <td>Lumpectomy, breast-conserving surgery, and radiation may</td>
  </tr>
  <tr>
    <td></td>
    <td>be considered, depending on tumor size</td>
  </tr>
  <tr>
    <td></td>
    <td>Chemotherapy to shrink large tumors preoperatively;</td>
  </tr>
  <tr>
    <td></td>
    <td>adjuvant chemotherapy if T risk of recurrence; endocrine</td>
  </tr>
  <tr>
    <td rowspan="3">With @ lymph nodes</td>
    <td>Breast-conserving surgery or modified radical mastectomy,</td>
  </tr>
  <tr>
    <td></td>
    <td>axillary dissection, radiation, adjuvant chemotherapy, and</td>
  </tr>
  <tr>
    <td></td>
    <td>endocrine therapy if ER/PR ©</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SustyPE</th>
    <th>CHARACTERISTICS</th>
  </thead>
  <tr>
    <td>Small cell lung</td>
    <td>Highly related to cigarette exposure. Usually centrally</td>
  </tr>
  <tr>
    <td>cancer (SCLC)</td>
    <td>located; often presents as disseminated disease</td>
  </tr>
  <tr>
    <td>Non-small cell lung</td>
    <td>Adenocarcinoma: The most common lung cancer; has</td>
  </tr>
  <tr>
    <td rowspan="8">cancer (NSCLC)</td>
    <td>a peripheral location. More common in women than</td>
  </tr>
  <tr>
    <td></td>
    <td>in men</td>
  </tr>
  <tr>
    <td></td>
    <td>Adenocarcinoma, bronchoalveolar subtype: Multiple</td>
  </tr>
  <tr>
    <td></td>
    <td>nodules, bilateral lung infiltrates, and metastases late</td>
  </tr>
  <tr>
    <td></td>
    <td>in the disease course</td>
  </tr>
  <tr>
    <td></td>
    <td>Squamous cell carcinoma: Presents centrally and is</td>
  </tr>
  <tr>
    <td></td>
    <td>often cavitary</td>
  </tr>
  <tr>
    <td></td>
    <td>Large cell carcinoma: Least common</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Patient AcE</th>
    <th>Persona History</th>
    <th>CoLorecTaL CANCER OR Apenomatous Potyes</th>
    <th>HerepitarY COLORECTAL CANcER SYNDROMES</th>
  </thead>
  <tr>
    <td rowspan="6">&gt; 50 years</td>
    <td>Previous colorectal</td>
    <td>One first-degree relative</td>
    <td>HNPCC (Lynch syndrome)</td>
  </tr>
  <tr>
    <td></td>
    <td>cancer</td>
    <td>&lt; 60 years of age or two</td>
    <td>Familial adenomatous</td>
  </tr>
  <tr>
    <td></td>
    <td>Adenomatous polyp</td>
    <td>first-degree relatives of</td>
    <td>polyposis</td>
  </tr>
  <tr>
    <td></td>
    <td>IBD, particularly</td>
    <td>any age</td>
    <td>Hamartomatous polyposis</td>
  </tr>
  <tr>
    <td></td>
    <td>ulcerative colitis</td>
    <td></td>
    <td>syndromes</td>
  </tr>
  <tr>
    <td></td>
    <td>Alcohol abuse</td>
    <td></td>
    <td></td>
  </tr>
</table>
<table>
  <tr>
    <td>Soft Tissue Infections Impetico</td>
  </tr>
  <tr>
    <td>ErYSIPELAS</td>
  </tr>
  <tr>
    <td>CELLULITIS.</td>
  </tr>
  <tr>
    <td>NecrotizinG Fascittis</td>
  </tr>
  <tr>
    <td>Periorbital/Orbital Infections</td>
  </tr>
  <tr>
    <td>Acute Osteomyelitis</td>
  </tr>
  <tr>
    <td>Septic Arthritis</td>
  </tr>
  <tr>
    <td>Encephalitis</td>
  </tr>
  <tr>
    <td>Herpes SIMPLEX VIRUS ENCEPHALITIS</td>
  </tr>
  <tr>
    <td>West Nive ENCEPHALITIS</td>
  </tr>
  <tr>
    <td>Bacterial Meningitis</td>
  </tr>
  <tr>
    <td>Upper Respiratory Tract Infections</td>
  </tr>
  <tr>
    <td>Acute Sinusitis</td>
  </tr>
  <tr>
    <td>Oritis Mepia</td>
  </tr>
  <tr>
    <td>Oriris EXTERNA</td>
  </tr>
  <tr>
    <td>PHARYNGITIS</td>
  </tr>
  <tr>
    <td>Pneumonia</td>
  </tr>
  <tr>
    <td>Pneumocystis JIROVEC! PNEUMONIA</td>
  </tr>
  <tr>
    <td>Bronchitis</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Genitourinary Tract Infections</td>
    <td></td>
  </tr>
  <tr>
    <td>Cystitis</td>
    <td>183</td>
  </tr>
  <tr>
    <td>PYELONEPHRITIS</td>
    <td>183</td>
  </tr>
  <tr>
    <td>ProstATITIS</td>
    <td>184</td>
  </tr>
  <tr>
    <td>Sexually Transmitted Diseases</td>
    <td></td>
  </tr>
  <tr>
    <td>SYPHILIS</td>
    <td>184</td>
  </tr>
  <tr>
    <td>GENITAL HERPES</td>
    <td>185</td>
  </tr>
  <tr>
    <td>Cervicitis/URETHRITIS</td>
    <td>185</td>
  </tr>
  <tr>
    <td>HIV Infection</td>
    <td>86</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Travel Medicine</td>
    <td>86</td>
  </tr>
  <tr>
    <td>FeVeR IN THE RETURNED TRAVELER</td>
    <td>186</td>
  </tr>
  <tr>
    <td>Ma aria PROPHYLAXIS</td>
    <td>187</td>
  </tr>
  <tr>
    <td>Infectious Diarrhea</td>
    <td>88</td>
  </tr>
  <tr>
    <td>Crosrrioium DirFicite Couitis</td>
    <td>188</td>
  </tr>
  <tr>
    <td>Tick-Borne Diseases</td>
    <td>89</td>
  </tr>
  <tr>
    <td>Neutropenic Fever</td>
    <td>90</td>
  </tr>
  <tr>
    <td>Sepsis</td>
    <td></td>
  </tr>
  <tr>
    <td>Staphylococcal Toxic Shock Syndrome</td>
    <td>92</td>
  </tr>
  <tr>
    <td>Fungal Infections</td>
    <td>93</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CSF Parameter</th>
    <th>BacTERIAL</th>
    <th>ViRAL</th>
    <th>TB</th>
  </thead>
  <tr>
    <td>Opening pressure (mm H,O)</td>
    <td>200-500</td>
    <td>&lt; 250</td>
    <td>180-300</td>
  </tr>
  <tr>
    <td>Cell type</td>
    <td>PMNs</td>
    <td>Lymphocytes</td>
    <td>Lymphocytes</td>
  </tr>
  <tr>
    <td>Glucose (mg/dL)</td>
    <td>Low</td>
    <td>Normal</td>
    <td>Low to normal</td>
  </tr>
  <tr>
    <td>Protein (mg/dL)</td>
    <td>High</td>
    <td>Normal</td>
    <td>Normal to high</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>PATHOGEN</th>
    <th>Gram STAIN</th>
    <th>Risk Factors</th>
    <th>TREATMENT OF CHOICE</th>
  </thead>
  <tr>
    <td>S pneumoniae</td>
    <td>Gram @ cocci in pairs and short chains</td>
    <td>All patients</td>
    <td>Vancomycin + third-generation cephalo- sporin + dexamethasone</td>
  </tr>
  <tr>
    <td>N meningitidis</td>
    <td>Gram © diplococci</td>
    <td>Age &lt; 50 years</td>
    <td>Ampicillin or third-generation cephalosporin</td>
  </tr>
  <tr>
    <td>L monocytogenes</td>
    <td>Gram @ rods</td>
    <td>Age &gt; 50 years or immunocompromised</td>
    <td>Ampicillin (not cephalosporins)</td>
  </tr>
  <tr>
    <td>Streptococcus agalactiae (group B strep)</td>
    <td>Gram @ cocci in pairs and short chains</td>
    <td>Neonates 0-4 weeks</td>
    <td>Ampicillin</td>
  </tr>
  <tr>
    <td>H influenzae type b</td>
    <td>Gram © coccobacilli</td>
    <td>Unvaccinated patients</td>
    <td>Third-generation cephalosporin</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>FinpiInG</th>
    <th>Points</th>
  </thead>
  <tr>
    <td>Anterior cervical</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">lymphadenopathy</td>
  </tr>
  <tr>
    <td>Tonsillar exudate</td>
    <td></td>
  </tr>
  <tr>
    <td>History of fever &gt; 38°C</td>
    <td></td>
  </tr>
  <tr>
    <td>Absence of cough</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Patient PRoFILe</th>
    <th>INcLupe Coverace For</th>
    <th>Empiric AntiBiotic CHOICE</th>
  </thead>
  <tr>
    <td>Healthy community members</td>
    <td>S pneumoniae, H influenzae, atypicals</td>
    <td>Macrolide (azithromycin)</td>
  </tr>
  <tr>
    <td>
      Community members with comorbidities (DM, alcoholism, asplenia,
      malignancies, chronic
    </td>
    <td>S pneumoniae, Klebsiella, Legionella</td>
    <td>Respiratory fluoroquinolone (levofloxacin or moxifloxacin) OR</td>
  </tr>
  <tr>
    <td>Patients at T risk for multidrug-resistant (MDR) organisms?</td>
    <td>Gram © rods, Pseudomonas, MRSA</td>
    <td>
      Vancomycin or linezolid + cefepime or imipenem or piperacillin/tazobactam
      + respiratory fluoroquinolone
    </td>
  </tr>
  <tr>
    <td>Patients with cystic fibrosis</td>
    <td>Pseudomonas</td>
    <td>Ceftazidime + respiratory fluoroquinolone + aminoglycoside</td>
  </tr>
  <tr>
    <td>Community members with suspected aspiration</td>
    <td>Anaerobes in addition to other organisms found in community members</td>
    <td>Clindamycin or metronidazole added to the above regimen</td>
  </tr>
  <tr>
    <td>Suspicion for influenza</td>
    <td></td>
    <td>
      Oseltamivir if within 48 hours of symptom onset or in those who require
      hospitalization
    </td>
  </tr>
  <tr>
    <td rowspan="3">Ventilated patients</td>
    <td></td>
    <td>Pseudomonas, Klebsiella,</td>
    <td>Vancomycin or linezolid + cefepime or imipenem or</td>
  </tr>
  <tr>
    <td>Legionella, Acinetobacter, MRSA, other GNRs</td>
    <td>piperacillin/tazobactam + respiratory fluoroquinolone or gentamicin</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>PopuLaTion</th>
    <th>@ TB Skin Test</th>
  </thead>
  <tr>
    <td>Low risk of disease—patients with no risk factors for TB</td>
    <td>=15mm</td>
  </tr>
  <tr>
    <td>Exposure risk:</td>
    <td>=10mm</td>
  </tr>
  <tr>
    <td colspan="2">Health care workers</td>
  </tr>
  <tr>
    <td colspan="2">Immigrants from endemic areas</td>
  </tr>
  <tr>
    <td colspan="2">
      Patients with chronic illness (eg, COPD, CKD, DM, posttransplant, cancer)
    </td>
  </tr>
  <tr>
    <td colspan="2">Homeless persons</td>
  </tr>
  <tr>
    <td colspan="2">Injection drug users</td>
  </tr>
  <tr>
    <td>HIV patients</td>
    <td>=5mm</td>
  </tr>
  <tr>
    <td colspan="2">Immunocompromised</td>
  </tr>
  <tr>
    <td colspan="2">Recent contact with TB</td>
  </tr>
  <tr>
    <td>CXR consistent with previous TB infection</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Nuc eosipe Zidovudine (AZT)</th>
    <th>Myopathy and bone marrow suppression</th>
  </thead>
  <tr>
    <td>Didanosine (ddl)</td>
    <td>Pancreatitis</td>
  </tr>
  <tr>
    <td>Abacavir</td>
    <td>Hypersensitivity reactions (eg, fever, chills, dyspnea)</td>
  </tr>
  <tr>
    <td>Emtricitabine (FTC)</td>
    <td>Diarrhea, nausea, and headache</td>
  </tr>
  <tr>
    <td>Lamivudine (3TC)</td>
    <td>Same as those for emtricitabine</td>
  </tr>
  <tr>
    <td>Tenofovir (TNV)</td>
    <td>Renal toxicity</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Cause</th>
    <th>HicH-Risk Areas</th>
    <th>TRANSMISSION</th>
    <th>Perio</th>
    <th>PRESENTATION</th>
    <th>Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Chikungunya</td>
    <td>
      —_—_ West Africa, Asia, Europe, Indian and Pacific Islands, Caribbean
      Islands
    </td>
    <td>Aedes mosquito bite</td>
    <td>3-7 days</td>
    <td>
      High-grade fever, bilateral polyarthralgia, maculopapular rash, headache,
      myalgia, facial edema
    </td>
    <td>
      RT-PCR (presenting 1-7 days after symptom onset) — ELISA or IFA for = 8
      days after symptom onset
    </td>
    <td>Acute: Supportive care — Chronic: DMARDs (MTX)</td>
  </tr>
  <tr>
    <td>Malaria</td>
    <td>
      Africa, South-central and Southeast Asia, Western Pacific, Caribbean
      islands, Central America, South America
    </td>
    <td>Anopheles mosquito bite</td>
    <td>7-30 days</td>
    <td>
      Malaise, head- ache, myalgias, jaundice, anemia, abnormal LFTs,
      thrombocytopenia, hypoglycemia, cyclical fevers
    </td>
    <td>
      Serial thin and thick smears, at least X 3, looking for ring forms inside
      RBCs
    </td>
    <td>
      Antibiotic treatment varies depending on local resistance patterns; blood
      products as needed for anemia
    </td>
  </tr>
  <tr>
    <td>Typhoid fever</td>
    <td>South-central and Southeast Asia, southern Africa</td>
    <td>Fecal-oral</td>
    <td>5-21 days</td>
    <td>
      Malaise, abdominal discomfort, diarrhea, hepato- splenomegaly, rose spots
    </td>
    <td>Growth on blood, urine, or stool culture</td>
    <td>Fluoroquinolones</td>
  </tr>
  <tr>
    <td>Dengue fever</td>
    <td>
      South-central and Southeast Asia, Western Pacific, Africa, Central
      America, South America, Caribbean islands
    </td>
    <td>Aedes mosquito bite</td>
    <td>3-10 days</td>
    <td>
      Severe myalgias (also known as “breakbone fever” because of associated
      pain), headache, retroorbital pain, maculopapular rash, thrombocytopenia,
      hemorrhage
    </td>
    <td>Primarily clinical; can check titers</td>
    <td>Supportive care/ blood products as needed</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Disease/Causative PATHOGEN</th>
    <th>History/PE</th>
    <th>Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Lyme disease Borrelia burgdorferi; transmitted by Ixodes deer tick</td>
    <td>
      Early localized: Erythema migrans (see Figure 10-14), fever, arthral-
      gias, myalgias, lymphadenopathy Early disseminated: Myocarditis +/— AV
      block, Bell palsy, periph- eral neuropathy, meningitis Late disseminated:
      Arthritis, chronic neurologic symptoms
    </td>
    <td>
      ELISA as initial screen followed by Western blot or PCR as a con-
      firmatory test
    </td>
    <td>
      Doxycycline (patients &gt; 9 years) or amoxicillin (children &lt; 9 years,
      preg- nant women); ceftriaxone if cardiac or neurologic symptoms are
      present Doxycycline or amoxicillin if neurologic symptoms are an isolated
      Bell palsy
    </td>
  </tr>
  <tr>
    <td>
      Rocky Mountain spotted fever Rickettsia rickettsii; transmitted by a
      variety of ticks (different from those that transmit Lyme disease)
    </td>
    <td>
      Fever, rash on palms and soles that spreads to the trunk, arthralgias,
      headache, thrombocytopenia, hyponatremia, 7 transaminases
    </td>
    <td>Serum antibody titers</td>
    <td>Doxycycline regardless of patient age</td>
  </tr>
  <tr>
    <td>
      Human monocytic ehrlichiosis, human granulocytic anaplasmosis Ehrlichia
      spp, Anaplasma phago- cytophilum; transmitted by several deer ticks; may
      be cotransmitted with Lyme disease
    </td>
    <td>
      Nonspecific (fever, chills, malaise, headache, myalgias) with no PE
      findings; patients often have thrombocytopenia, leukopenia, and T
      transaminases
    </td>
    <td>
      Serology, PCR, or peripheral blood smear to look for intracytoplasmic
      inclusions (morulae)
    </td>
    <td>Doxycycline</td>
  </tr>
  <tr>
    <td>Babesiosis Babesia spp (Babesia organisms infect RBCs)</td>
    <td>
      Fever, chills, fatigue, myalgias. Bloodwork will reflect hemolytic anemia
    </td>
    <td>
      Peripheral blood smear looking for organisms inside RBCs (in Maltese cross
      formation) or PCR
    </td>
    <td>
      Clindamycin and quinine are preferred. Atovaquone and azithromycin are
      alternatives Consider plasma exchange in those with severe infection (&gt;
      10% parasitemia, significant hemolytic anemia); if symp- toms persist,
      consider coinfection with Anaplasma/Ehrlichia or Lyme disease
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SEVERITY</th>
    <th>CRITERIA</th>
  </thead>
  <tr>
    <td>Sepsis</td>
    <td>Meets at least two of the SIRS criteria with evidence of infection</td>
  </tr>
  <tr>
    <td>Severe sepsis</td>
    <td>Meets the criteria for sepsis with evidence of end-organ damage</td>
  </tr>
  <tr>
    <td rowspan="2">Septicshock</td>
    <td>
      — Meets the criteria for sepsis with BP not responding to fluid
      resuscitation and
    </td>
  </tr>
  <tr>
    <td></td>
    <td>necessitating the initiation of pressors and/or inotropes</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="2">INFECTION</th>
    <th></th>
    <th>Location/Mobe oF</th>
    <th rowspan="2">History/Symptoms/ Exam</th>
    <th></th>
    <th></th>
  </thead>
  <thead>
    <th></th>
    <th>MorpHotocy</th>
    <th>TRANSMISSION</th>
    <th></th>
    <th>Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Cryptococcosis</td>
    <td>Encapsulated yeast (Image A)</td>
    <td>Not localized to a particular region Inhalation of pigeon droppings</td>
    <td>
      Self-limited pneu- monia in healthy patients Invasive with meningo-
      encephalitis if depressed T-cell function
    </td>
    <td>
      Antigen testing and culture of infected tissue (blood, sputum, CSF); may
      be seen with silver stain; India ink test may show a halo 2° to capsule
      (see Image A)
    </td>
    <td>
      Mild to moderate disease: Fluconazole x 6-12 months Invasive disease or
      immuno-com- promised hosts: Amphotericin + flu- cytosine for 2 weeks
      followed by long- term fluconazole
    </td>
  </tr>
  <tr>
    <td>Histoplasmosis</td>
    <td>Dimorphic fungus; narrow-based budding yeast on biopsy (Image B)</td>
    <td>
      Ohio/Mississippi River Valleys Inhalation of bat guano or bird excrement,
      typi- cally in caves or at construction sites
    </td>
    <td>
      Respiratory/flu-like illness in healthy host Disseminated disease
      inimmuno-compro- __ mised hosts, with palatal ulcerations, fever, weight
      loss, splenomegaly, and anemia/bone marrow suppression
    </td>
    <td>
      Silver staining and culture of biopsied infected tissue +/— Histoplasma
      antigen tests of urine and serum
    </td>
    <td>
      Mild to moderate disease without CNS involvement: Itraconazole
      Severe/dissemi- nated disease: Amphotericin
    </td>
  </tr>
  <tr>
    <td>Coccidioidomycosis</td>
    <td>| Dimorphic fungus; spherules with endospores on biopsy (Image C)</td>
    <td>
      Southwestern United States, particularly Arizona or the San Joaquin Valley
      in California Inhalation of spores from soil
    </td>
    <td>
      _1° disease is usually a self-limited pneu- monia with dry cough and fever
      Disseminated disease affects the CNS (meningitis), skin (erythema
      nodosum), bones, and joints
    </td>
    <td>
      Silver stains of culture or biopsy, serologic studies, or antibody
      detection in CSF if meningitis is present
    </td>
    <td>
      Fluconazole or itraconazole Amphotericin for severe pneumonia,
      disseminated infec- tion (including CNS infection), and immuno-compro-
      mised patients
    </td>
  </tr>
  <tr>
    <td>Blastomycosis</td>
    <td>Dimorphic fungus, broad- based budding yeast on biopsy (Image D)</td>
    <td>
      Ohio/Mississippi River Valleys, states bordering the Great Lakes
      Inhalation of spores from soil
    </td>
    <td>
      Most patients present wi ith pneumonia; up to 50% may have dis- seminated
      disease ith a verrucous-like WI rash/subcutaneous nodules and/or
    </td>
    <td>
      Direct visualization on wet prep and culture of infected tissues With bone
      involve- ment, lytic lesions may be seen on
    </td>
    <td>
      Mild to moderate disease without CNS involvement: Itraconazole
      Severe/dissemi- nated disease: Amphotericin
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ANTIMICROBIAL Group</th>
    <th>Common Examptes</th>
    <th>Orcanisms CoverED</th>
    <th>MeEcHANISM OF AcTION</th>
    <th>Common ApversE EFrects</th>
  </thead>
  <tr>
    <td>Natural penicillins</td>
    <td>Penicillin G, penicillin V</td>
    <td>
      Tpallidum, Enterococcus, streptococci, and rare penicillin-sensitive
      staphylococci
    </td>
    <td>Inhibit bacterial cell wall synthesis</td>
    <td>Hypersensitivity reaction</td>
  </tr>
  <tr>
    <td>B-lactamase- resistant penicillins</td>
    <td>
      Dicloxacillin, methicillin (no longer used clinically, but important
      because of methicillin-resistant staphylococci), nafcillin, oxacillin
    </td>
    <td>
      Used primarily for methicillin-sensitive staphylococci, but do cover some
      streptococci
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Aminopenicillins</td>
    <td>
      Amoxicillin, amoxi- cillin/clavulanic acid, ampicillin, ampicillin/
      sulbactam
    </td>
    <td>
      Natural penicillin coverage and E coli, Proteus, H influenzae, and
      Enterococcus. Q-Lactamase inhibitors add coverage for enteric gram ©
      organisms and anaerobes
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Extended- spectrum penicillins</td>
    <td>Piperacillin/tazobactam, ticarcillin/clavulanic acid</td>
    <td>
      Aminopenicillin/B-lactamase inhibitor coverage in addition to resistant
      gram © organisms, including Pseudomonas
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>First-generation cephalosporins</td>
    <td>Cefazolin, cephalexin</td>
    <td>
      Staphylococci, streptococci, Proteus, E coli, and Klebsiella (PEcK)
      Cephalosporins do not cover any enterococci
    </td>
    <td>
      Inhibit bacterial cell wall synthesis; less susceptible to B-lactamases
    </td>
    <td>Hypersensitivity reaction</td>
  </tr>
  <tr>
    <td>Second- generation cephalosporins</td>
    <td>Cefaclor, cefuroxime</td>
    <td>
      First-generation cephalosporin coverage and H influenzae, Enterobac-
      teriaceae, Neisseria (HEN PEcK)
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Cephamycins</td>
    <td>Cefotetan, cefoxitin</td>
    <td>
      Second-generation cephalosporin cov- erage and gram ®/gram anaerobes
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Third-generation cephalosporins</td>
    <td>Cefotaxime, ceftazidime, ceftriaxone</td>
    <td>
      Most gram © aerobes and gram © anaerobes; ceftriaxone adds strepto- coccal
      coverage and ceftazidime adds Pseudomonas coverage
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Fourth-generation cephalosporins</td>
    <td>Cefepime</td>
    <td>Gram © aerobes, streptococci, and Pseudomonas</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Second- generation quinolones</td>
    <td>Ciprofloxacin</td>
    <td>
      Gram © aerobes and atypicals such as Legionella, Mycoplasma, and
      Chlamydia; best Pseudomonas coverage of all
    </td>
    <td>Inhibit DNA synthesis</td>
    <td>Tendinopathy, QTc pro- longation, myasthenia gravis exacerbation</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ANTIMICROBIAL Group</th>
    <th>Common Examptes</th>
    <th>Orcanisms CoverRED</th>
    <th>MEcHANISM OF AcTION</th>
    <th>Common ApveERSE EFrects</th>
  </thead>
  <tr>
    <td>Third-generation quinolones</td>
    <td>Levofloxacin</td>
    <td>Gram © aerobes, streptococci, and atypicals</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Fourth-generation quinolones</td>
    <td>Moxifloxacin</td>
    <td>
      Gram © organisms, some anaerobes, weak gram © coverage, and atypicals
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Carbapenems</td>
    <td>Ertapenem, imipenem, meropenem</td>
    <td>
      Gram @ organisms (except resistant Staphylococcus and Enterococcus); gram
      © organisms, including Pseudomonas and anaerobes; ertapenem has no
      Pseudomonas or Enterococcus coverage
    </td>
    <td>
      Inhibit bacterial _cell wall synthesis; highly resistant to B-lactamases
    </td>
    <td>CNS effects including —_ seizures</td>
  </tr>
  <tr>
    <td>Macrolides</td>
    <td>Azithromycin, erythro- mycin, clarithromycin</td>
    <td>Gram @ organisms and atypicals; high S pneumoniae resistance</td>
    <td>Inhibit bacterial protein synthesis</td>
    <td>QTc prolongation, cholestasis</td>
  </tr>
  <tr>
    <td>Aminoglycosides</td>
    <td>Gentamicin, tobramycin</td>
    <td>Gram © aerobes, including Pseudomonas</td>
    <td>In hibit bacterial protein synthesis</td>
    <td>Hearing loss, renal dysfunction</td>
  </tr>
  <tr>
    <td>Monobactams</td>
    <td>Aztreonam</td>
    <td>Gram © aerobes, including Pseudomonas</td>
    <td>Inhibits bacterial cell wall synthesis</td>
    <td>Transaminitis, Gl upset, neutropenia</td>
  </tr>
  <tr>
    <td>Semisynthetic lincosamides</td>
    <td>Clindamycin</td>
    <td>Gram @ anaerobes, MRSA</td>
    <td>Inhibits bacterial protein synthesis</td>
    <td>Gl upset, rash</td>
  </tr>
  <tr>
    <td>Oxazolidinones</td>
    <td>Linezolid</td>
    <td>MRSA; vancomycin-resistant enterococcus</td>
    <td>Inhibits protein synthesis</td>
    <td>Bone marrow sup- pression, peripheral neuropathy, lactic acidosis</td>
  </tr>
  <tr>
    <td>Synthetic nitroimidazole</td>
    <td>Metronidazole</td>
    <td>Anaerobes (C difficile)</td>
    <td>Inhibits bacterial DNA synthesis</td>
    <td>
      Gl upset, peripheral neu- ropathy, disulfiram-like reaction with EtOH
    </td>
  </tr>
  <tr>
    <td>Combination</td>
    <td>TMP-SMX</td>
    <td>Gram © organisms, gram © organisms, P jiroveci</td>
    <td>Inhibits bacterial DNA synthesis</td>
    <td>Hyperkalemia, thrombocytopenia, J creatinine clearance</td>
  </tr>
  <tr>
    <td>Glycopeptides</td>
    <td>Vancomycin</td>
    <td>MRSA and C difficile (PO only)</td>
    <td>Inhibits bacterial cel | wall synthesis</td>
    <td>Red man syndrome, thrombocytopenia; rarely renal toxicity</td>
  </tr>
  <tr>
    <td>Tetracyclines</td>
    <td>Doxycycline, minocycline, tigecycline</td>
    <td>
      Tick-borne infections, atypical organ- isms, streptococcus, and MRSA
    </td>
    <td>In ibit bacterial protein synthesis</td>
    <td>
      Tooth discoloration, skin photosensitivity, drug- induced lupus, GI upset
    </td>
  </tr>
</table>
<table>
  <tr>
    <td>Systemic Lupus Erythematosus</td>
    <td>200</td>
  </tr>
  <tr>
    <td>Rheumatoid Arthritis</td>
    <td>201</td>
  </tr>
  <tr>
    <td>Osteoarthritis</td>
    <td>202</td>
  </tr>
  <tr>
    <td>Gout</td>
    <td>203</td>
  </tr>
  <tr>
    <td>Low Back Pain</td>
    <td>206</td>
  </tr>
  <tr>
    <td>Spondyloarthropathies</td>
    <td>207</td>
  </tr>
  <tr>
    <td>ANKYLOSING SPONDYLITIS</td>
    <td>208</td>
  </tr>
  <tr>
    <td>Reactive ARTHRITIS</td>
    <td>208</td>
  </tr>
  <tr>
    <td>Psoriatic ARTHRITIS</td>
    <td>208</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>00</td>
    <td>Vasculitides</td>
    <td>208</td>
  </tr>
  <tr>
    <td>01</td>
    <td>Temporal Arteritis (GIANT CeLt ARTERITIS) Potyarteritis Noposa</td>
    <td>208 209</td>
  </tr>
  <tr>
    <td>02</td>
    <td>Rheumatica</td>
    <td>209</td>
  </tr>
  <tr>
    <td>03</td>
    <td>Polymyalgia Fibromyalgia</td>
    <td>210</td>
  </tr>
  <tr>
    <td>06</td>
    <td>Polymyositis and Dermatomyositis</td>
    <td>210</td>
  </tr>
  <tr>
    <td>07</td>
    <td>Systemic Sclerosis (Scleroderma)</td>
    <td>211</td>
  </tr>
  <tr>
    <td colspan="3">208</td>
  </tr>
  <tr>
    <td>208</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">Color</td>
    <td rowspan="2">Normat Clear</td>
    <td>NoNINFLAMMATORY</td>
    <td>INFLAMMATORY</td>
    <td rowspan="2">INFEcTIous Opaque</td>
    <td rowspan="2">HEMORRHAGIC Bloody</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Xanthochromic</td>
    <td>Yellow</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Viscosity</td>
    <td>High</td>
    <td>High</td>
    <td>Low</td>
    <td>Low</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>WBCs/mm?</td>
    <td>&lt; 200</td>
    <td>200-3000</td>
    <td>3000-50,000</td>
    <td>&gt; 50,000</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>% PMNs</td>
    <td>&lt;25</td>
    <td>&lt;25</td>
    <td>&gt;50</td>
    <td>&gt;75</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>Crystals</td>
    <td></td>
    <td></td>
    <td>May be present</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">Differential</td>
    <td></td>
    <td>Osteoarthritis, SLE, trauma,</td>
    <td>Gout, pseudogout, RA, SLE, TB, scleroderma,</td>
    <td>_ Bacterial, TB</td>
    <td>Coagulopathy,</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>aseptic, necrosis, Charcot joint</td>
    <td>ankylosing spondylitis, psoriatic arthritis</td>
    <td></td>
    <td>trauma</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Cauda equina syndrome</th>
    <th>
      Bowel and bladder incontinence or retention, saddle anesthesia A medical
      emergency
    </th>
    <th>Order a stat MRI if suspected</th>
  </thead>
  <tr>
    <td>Degenerative processes</td>
    <td>
      Chronic and progressive Degeneration of disks, localized pain that can
      refer to adjacent spinal nerves (eg, pain that radiates down the thigh)
      Severe facet degeneration can lead to spinal stenosis: “Neurogenic
      claudication” &gt; LBP worsens with standing and walking but improves with
      sitting or leaning forward (patients typically find it easier to walk
      uphill than downhill)
    </td>
    <td>Order a lumbar spine x-ray to rule out other causes of LBP</td>
  </tr>
  <tr>
    <td>Neoplastic</td>
    <td>
      1° or metastatic to bone; suspect in elderly patients with unintentional
      weight loss or a history of cancer
    </td>
    <td>
      A tumor mass may be seen on lumbar spine x-ray; bone scan or MRI can
      detect disease not seen on plain film
    </td>
  </tr>
  <tr>
    <td>Traumatic</td>
    <td>
      Acute onset of LBP is temporally associated with a traumatic event Look
      for local spinal tenderness 2° to a fracture or a herniated disk (pain
      worsens with cough; L4 or L5 nerve root compression) Paraspinal tenderness
      indicates myofascial strain
    </td>
    <td>
      X-ray (first line) or CT (second line) may be necessary to confirm a
      fracture and to assess the spinal column for stability; myofascial strain
      and disk herniations cannot be seen
    </td>
  </tr>
  <tr>
    <td>Osteomyelitis</td>
    <td>Fever, chills, or IV drug use; ESR is often TT</td>
    <td>
      X-ray is not sensitive but may show disk nar- rowing and endplate
      destruction MRI may be needed to aid in diagnosis and to assess for
      epidural abscess
    </td>
  </tr>
  <tr>
    <td>Ankylosing spondylitis</td>
    <td>
      Typical patient a young man presenting with chronic LBP that is worse in
      the morning, improving with movement Associated with HLA-B27 in Caucasians
      Associated with anterior uveitis, spinal mobility
    </td>
    <td>
      X-ray may show fusing of sacroiliac joints, squaring of the lumbar
      vertebrae, devel- opment of vertical syndesmophytes; “bamboo spine” in
      long-standing disease @ HLA-B27
    </td>
  </tr>
  <tr>
    <td>2° to disease from the aorta, kidneys,</td>
    <td>Pain is referred</td>
    <td>Conduct a thorough abdominal exam</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>NERVE Roots</th>
    <th>Motor Dericits</th>
    <th>Sensory Dericit</th>
    <th>REFLEXES</th>
  </thead>
  <tr>
    <td>C5</td>
    <td>Deltoid, biceps</td>
    <td>Ant shoulder</td>
    <td>J Biceps reflex</td>
  </tr>
  <tr>
    <td>(e)</td>
    <td>Biceps, wrist extensors</td>
    <td>Brachioradialis</td>
    <td>J Biceps, triceps reflex</td>
  </tr>
  <tr>
    <td>C7</td>
    <td>Triceps, wrist flexors, finger extensors</td>
    <td>Triceps</td>
    <td>J Triceps reflex</td>
  </tr>
  <tr>
    <td>L3,L4</td>
    <td>— Problemsin rising fromachair and heel walking</td>
    <td>Over the anterior knee or the medial calf</td>
    <td>J Knee jerk</td>
  </tr>
  <tr>
    <td rowspan="2">L5</td>
    <td>Problems with heel walking,</td>
    <td>Over the medial aspect</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>extension of the big toe, or dorsiflexion of the ankle</td>
    <td>of the foot</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">S1</td>
    <td></td>
    <td>Problems with toe walking or</td>
    <td>Over the lateral aspect</td>
    <td>J Ankle jerk</td>
  </tr>
  <tr>
    <td>plantar flexing the ankle</td>
    <td>of the foot</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Acute Kidney Injury</td>
    <td>214</td>
  </tr>
  <tr>
    <td>Electrolyte Disorders</td>
    <td>215</td>
  </tr>
  <tr>
    <td>HYPONATREMIA</td>
    <td>215</td>
  </tr>
  <tr>
    <td>HYPERNATREMIA</td>
    <td>215</td>
  </tr>
  <tr>
    <td>HyPoKALemIA</td>
    <td>217</td>
  </tr>
  <tr>
    <td colspan="2">HYPERKALEMIA 217</td>
  </tr>
  <tr>
    <td>Nephrotic and Nephritic Syndromes</td>
    <td>218</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>214</td>
    <td>Nephrolithiasis</td>
    <td>221</td>
  </tr>
  <tr>
    <td>215</td>
    <td>Diuretics</td>
    <td>223</td>
  </tr>
  <tr>
    <td>215 215</td>
    <td>Acid-Base Disorders</td>
    <td>224</td>
  </tr>
  <tr>
    <td>217</td>
    <td>Renal Tubular Acidosis</td>
    <td>225</td>
  </tr>
  <tr>
    <td>217</td>
    <td>Chronic Kidney Disease</td>
    <td>227</td>
  </tr>
  <tr>
    <td>218</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Cass</th>
    <th>Cause</th>
    <th>Fena</th>
    <th>UA</th>
  </thead>
  <tr>
    <td>Prerenal</td>
    <td>
      J Renal blood flow, as in renal artery stenosis, shock, heart failure,
      hepa torenal syndrome, and NSAID or ACEI/ARB use
    </td>
    <td>&lt; 1%</td>
    <td>Usually not helpful but may see hyaline casts</td>
  </tr>
  <tr>
    <td rowspan="3">Intrinsic</td>
    <td>
      Acute glomerulonephritis (AGN): Poststreptococcal glomerulonephritis, IgA
      nephropathy
    </td>
    <td>Variable</td>
    <td>| AGN: Dysmorphic RBCs and RBC casts</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Acute interstitial nephritis (AIN): Antibiotics (penicillins,
      cephalosporins), NSAIDs, and PPIs/H,-receptor blockers
    </td>
    <td>Variable</td>
    <td>— AIN: Eosinophils and WBC casts</td>
  </tr>
  <tr>
    <td></td>
    <td>ATN: See Table 12-2</td>
    <td>&gt; 2%</td>
    <td>ATN: Pigmented granular (“muddy brown”) casts</td>
  </tr>
  <tr>
    <td>Postrenal</td>
    <td>
      — Any condition that impedes urinary excretion (prostatic hypertrophy)
    </td>
    <td>Variable</td>
    <td>Variable</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="5">Defining features</td>
    <td>Proteinuria (&gt; 3.5 g/day)</td>
    <td>Hematuria</td>
  </tr>
  <tr>
    <td></td>
    <td>Edema (loss of serum albumin)</td>
    <td>Hypertension</td>
  </tr>
  <tr>
    <td></td>
    <td>Hyperlipidemia</td>
    <td>Proteinuria (usually &lt; 3.5 g/day)</td>
  </tr>
  <tr>
    <td></td>
    <td>Hypercoagulability</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Immunodeficiency (loss of IgG)</td>
    <td></td>
  </tr>
  <tr>
    <td>Urine</td>
    <td>Fat vacuoles (Maltese cross</td>
    <td>Dysmorphic RBCs, RBC casts</td>
  </tr>
  <tr>
    <td rowspan="7">microscopy Diagnosis</td>
    <td>_ pattern)</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Order testing antibody (ANA), complement</td>
    <td>testing complement antineutrophil cytoplasmic antibody</td>
  </tr>
  <tr>
    <td></td>
    <td>levels, serum/urine free light</td>
    <td>(ANCA), anti-GBM antibodies, and anti-</td>
  </tr>
  <tr>
    <td></td>
    <td>chains, rapid plasma reagin,</td>
    <td>streptolysin O antibody</td>
  </tr>
  <tr>
    <td></td>
    <td>HBV, HCV, and HIV</td>
    <td>Arenal biopsy is often required for defini-</td>
  </tr>
  <tr>
    <td></td>
    <td>A renal biopsy is often required</td>
    <td>tive diagnosis</td>
  </tr>
  <tr>
    <td></td>
    <td>for definitive diagnosis</td>
    <td></td>
  </tr>
  <tr>
    <td>General</td>
    <td>ACEI/ARB (decrease proteinuria)</td>
    <td>Treat the underlying condition (can range</td>
  </tr>
  <tr>
    <td rowspan="3">treatment</td>
    <td></td>
    <td>Loop diuretic (decrease edema)</td>
    <td>from supportive therapy to immunosup-</td>
  </tr>
  <tr>
    <td></td>
    <td>Statin therapy (lower lipid levels)</td>
    <td>pressive therapy)</td>
  </tr>
  <tr>
    <td>Anticoagulation (if thrombosis</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Minimal change disease</th>
    <th>
      Light: Normal Electron: Diffuse podocyte epi- thelial foot process
      effacement (Image A, arrow)
    </th>
    <th>More common in children &lt; 10 years of age Idiopathic</th>
    <th>First line: Steroids Second line: Cyclophosphamide</th>
  </thead>
  <tr>
    <td>Focal segmental glomerulosclerosis</td>
    <td>
      Light: Glomerular sclerosis (Image B, arrows) Electron: Diffuse podocyte
      foot process effacement
    </td>
    <td>More common in African-American adults Idiopathic HIV Heroin use</td>
    <td>First line: Steroids Second line: Cyclosporine</td>
  </tr>
  <tr>
    <td>nephropathy</td>
    <td>
      “spike and dome” appearance of GBM (Image C, arrows) Electron:
      Subepithelial deposits
    </td>
    <td>Idiopathic HBV Malignancy</td>
    <td>
      cyclophosphamide/cyclosporine NOTE: Mild presentations can be managed with
      general treatment strategies alone (eg, ACEI, statin)
    </td>
  </tr>
  <tr>
    <td>Membranoproliferative glomerulonephritis (MPGN)</td>
    <td>
      Light/Electron: Subendothelial (Image D, arrows) or subepithelial deposits
    </td>
    <td>
      Overall a rare cause of glomerular disease in children and adults HCV
      Systemic lupus erythematosus (SLE) Idiopathic
    </td>
    <td>
      Treat the underlying condition (eg, antiviral therapy) NOTE: Some patients
      may require steroids
    </td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">PaTHOLoGy</td>
    <td>Microscopy</td>
    <td>History/PE</td>
    <td>Las FINDINGS</td>
    <td>TREATMENT</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>ANCA</td>
    <td>@®</td>
    <td></td>
  </tr>
  <tr>
    <td>Microscopic</td>
    <td>Necrotizing vasculitis</td>
    <td>Hemoptysis</td>
    <td>@ p-ANCA</td>
    <td>Steroids +</td>
  </tr>
  <tr>
    <td>polyangiitis</td>
    <td>without granuloma formation</td>
    <td>Purpura</td>
    <td>Normal complements levels</td>
    <td>cyclophosphamide/rituximab</td>
  </tr>
  <tr>
    <td>Granulomatosis</td>
    <td>Necrotizing vascu-</td>
    <td>Hemoptysis</td>
    <td>@ c-ANCA</td>
    <td>Steroids +</td>
  </tr>
  <tr>
    <td>with polyangiitis</td>
    <td>litis with granuloma</td>
    <td>Oral ulcers</td>
    <td>Normal complement levels</td>
    <td>cyclophosphamide/rituximab</td>
  </tr>
  <tr>
    <td></td>
    <td>formation</td>
    <td>Saddle nose</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Eosinophilic</td>
    <td>Necrotizing vascu-</td>
    <td>Asthma</td>
    <td>@ p-ANCA</td>
    <td>Steroids</td>
  </tr>
  <tr>
    <td>granulomatosis</td>
    <td>litis with granuloma</td>
    <td>Nasal polyps</td>
    <td>Normal complement levels</td>
    <td>NOTE: May need to add</td>
  </tr>
  <tr>
    <td>with polyangiitis</td>
    <td>formation</td>
    <td>Skin nodules</td>
    <td></td>
    <td>cyclophosphamide if lack</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>PaTHOLoGy</th>
    <th>Microscopy</th>
    <th>History/PE</th>
    <th>Las FINDINGS</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td colspan="5">Anti-GBM G@</td>
  </tr>
  <tr>
    <td>Goodpasture syndrome</td>
    <td>Linear IgG deposits along GBM Crescentic glomerulonephritis</td>
    <td>Pulmonary hemorrhage Hematuria</td>
    <td>@ anti-GBM Normal complement levels</td>
    <td>Steroids + cyclophosphamide + plasma exchange</td>
  </tr>
  <tr>
    <td colspan="5">Immune Comtex MepiateD</td>
  </tr>
  <tr>
    <td>Poststreptococcal glomerulonephritis</td>
    <td>Subepithelial deposits — Crescentic glomerulonephritis</td>
    <td>Hematuria 3 weeks following URI or skin infection with S pyogenes</td>
    <td>@ Antistreptolysin O antibody 1G</td>
    <td>Supportive therapy</td>
  </tr>
  <tr>
    <td>IgA nephropathy</td>
    <td>Mesangial IgA immune complex deposition</td>
    <td>— Hematuria 1-2 days fol- lowing URI or GI tract infection</td>
    <td>Normal complement levels</td>
    <td>Supportive therapy If proteinuria, ACEI/ARB</td>
  </tr>
  <tr>
    <td colspan="5">Genetic Mutation</td>
  </tr>
  <tr>
    <td>Alport syndrome</td>
    <td>GBM thickening Tubular foam cells</td>
    <td>Sensorineural hearing loss Ocular defects Hematuria</td>
    <td>pertinent</td>
    <td>If proteinuria, ACEI/ARB</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>Urine Microscopy</th>
    <th>RabioLocicaL Finpines</th>
    <th>PreveNTION/ TREATMENT</th>
  </thead>
  <tr>
    <td>Calcium</td>
    <td>Envelope-shaped</td>
    <td>Radiopaque</td>
    <td>Increase fluid intake (goal urinary</td>
  </tr>
  <tr>
    <td>oxalate</td>
    <td>crystals</td>
    <td></td>
    <td>output 2 L/day) Decrease dietary oxalate and dietary sodium</td>
  </tr>
  <tr>
    <td>Struvite (Mg-NH,-PO,)</td>
    <td>Coffin-lid shaped crystals</td>
    <td>Radiopaque (see Figure 12-4B)</td>
    <td>UTI prevention — Surgical removal</td>
  </tr>
  <tr>
    <td>Uric acid</td>
    <td>Diamond-shaped crystals</td>
    <td>Radiolucent, visu- alized on CT</td>
    <td>
      _ Increase fluid intake Alkalinize urine Administer xanthine oxidase
      inhibitor
    </td>
  </tr>
  <tr>
    <td rowspan="3">Cystine</td>
    <td>Hexagonal</td>
    <td>Radiopaque</td>
    <td>Increase fluid intake</td>
  </tr>
  <tr>
    <td></td>
    <td>shaped crystals</td>
    <td></td>
    <td>Alkalinize urine</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Administer penicillamine/</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Diuretic CLass</th>
    <th>Mecuanism oF AcTION</th>
    <th>Apverse Errects</th>
  </thead>
  <tr>
    <td>Osmotic agents (eg, mannitol, urea)</td>
    <td>Entire tubule</td>
    <td>T Tubular fluid osmolarity, J Nat</td>
  </tr>
  <tr>
    <td>Carbonic anhydrase inhibitors (eg, acetazolamide)</td>
    <td>Inhibition of carbonic anhydrase in the proximal tubule</td>
    <td>Metabolic acidosis, hypokalemia</td>
  </tr>
  <tr>
    <td>Loop diuretics (eg, furosemide, torsemide, ethacrynic acid)</td>
    <td>Inhibition of the Na*/K*/2Cl~ cotransporter in the loop of Henle</td>
    <td>Hypokalemia, ototoxicity</td>
  </tr>
  <tr>
    <td>Thiazides (eg,</td>
    <td>Inhibition of the Na*/Cl~</td>
    <td>Hypokalemia; hyper “GLUC”:</td>
  </tr>
  <tr>
    <td>hydrochorothiazide,</td>
    <td>cotransporter in the distal</td>
    <td>HyperGlycemia</td>
  </tr>
  <tr>
    <td>chlorthalidone,</td>
    <td>convoluted tubule</td>
    <td>HyperLipidemia</td>
  </tr>
  <tr>
    <td>metolazone)</td>
    <td></td>
    <td>HyperUricemia HyperCalcemia</td>
  </tr>
  <tr>
    <td>K* sparing diuretics</td>
    <td>
      Spironolactone/eplerenone: Inhibition of aldosterone receptor in the
      collection duct Amiloride/triamterene: Inhibition of epithelial sodium
      channel in the collecting duct
    </td>
    <td>Hyperkalemia, gynecomastia (spironolactone only)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>VARIABLE</th>
    <th>Tyee | (DisTAL)</th>
    <th>Type II (PROXIMAL)</th>
    <th>Type IV (ImpaiRED MineRALocorticoiD EFFECT)</th>
  </thead>
  <tr>
    <td>Defect</td>
    <td>H* secretion</td>
    <td>HCO,” reabsorption</td>
    <td>Aldosterone deficiency or resistance</td>
  </tr>
  <tr>
    <td>Serum K*</td>
    <td>Low</td>
    <td>Low</td>
    <td>High</td>
  </tr>
  <tr>
    <td>Urinary pH</td>
    <td>&gt;53</td>
    <td>
      5.3 or high at onset but can be &lt; 5.3 once serum is in its acidotic
      state
    </td>
    <td>Variable (not typically used to differentiate)</td>
  </tr>
  <tr>
    <td>Etiologies</td>
    <td>Autoimmune disorders, hyper-</td>
    <td>— Multiple myeloma, amyloidosis, all other</td>
    <td>Hypoaldosteronism, angiotensin II</td>
  </tr>
  <tr>
    <td>(most common)</td>
    <td>calciuria, amphotericin B, ifosfamide, genetic disorders</td>
    <td>
      causes of Fanconi syndrome (eg, genetic and acquired), aminoglycosides,
      ifosfamide, cis- platin, acetazolamide
    </td>
    <td>inhibition (ACEls/ARBs), urinary tract obstruction, heparin</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>Potassium bicarbonate supplementation</td>
    <td>
      Treat underlying cause; often needs sodium and potassium bicarbonate
      supplementation
    </td>
    <td>
      Depending on etiology may need mineralocorticoid replacement, sodium
      bicarbonate supplementation, or K wasting diuretics
    </td>
  </tr>
  <tr>
    <td>Complications</td>
    <td>Nephrolithiasis</td>
    <td>Rickets, osteomalacia</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>3rain</td>
  </tr>
  <tr>
    <td>STROKE</td>
  </tr>
  <tr>
    <td>Hematoma</td>
  </tr>
  <tr>
    <td>HEADACHE</td>
  </tr>
  <tr>
    <td>SEIZURES</td>
  </tr>
  <tr>
    <td>Brain DEATH</td>
  </tr>
  <tr>
    <td>VERTIGO</td>
  </tr>
  <tr>
    <td>spinal Cord</td>
  </tr>
  <tr>
    <td>CompRrESSION</td>
  </tr>
  <tr>
    <td>SPINAL STENOSIS</td>
  </tr>
  <tr>
    <td>TRANSVERSE MyELITIS</td>
  </tr>
  <tr>
    <td>Corp SYNDROMES</td>
  </tr>
  <tr>
    <td>Anterior Horn Cells</td>
  </tr>
  <tr>
    <td>AmyortropHic LATERAL SCLEROSIS</td>
  </tr>
  <tr>
    <td>\lerve Roots</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>230</td>
    <td>Bett Patsy</td>
    <td>243</td>
  </tr>
  <tr>
    <td>230</td>
    <td>CARPAL TUNNEL SYNDROME</td>
    <td>244</td>
  </tr>
  <tr>
    <td>233</td>
    <td>Neuromuscular Junction</td>
    <td>245</td>
  </tr>
  <tr>
    <td>234</td>
    <td>MyasTHENIA GRAVIS</td>
    <td>245</td>
  </tr>
  <tr>
    <td>235</td>
    <td>Muscle</td>
    <td></td>
  </tr>
  <tr>
    <td>237</td>
    <td>Muscutar DystroPHY</td>
    <td>246 246</td>
  </tr>
  <tr>
    <td>238</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>240</td>
    <td>Movement Disorders</td>
    <td>246</td>
  </tr>
  <tr>
    <td>240</td>
    <td>ParKINSON DISEASE</td>
    <td>246</td>
  </tr>
  <tr>
    <td>241</td>
    <td>HUNTINGTON DISEASE</td>
    <td>247</td>
  </tr>
  <tr>
    <td>241</td>
    <td>Autoimmune Disorders</td>
    <td>247</td>
  </tr>
  <tr>
    <td>242</td>
    <td>GUILLAIN-BaARRE SYNDROME</td>
    <td>247</td>
  </tr>
  <tr>
    <td>242</td>
    <td>Muttipte SCLEROSIS</td>
    <td>248</td>
  </tr>
  <tr>
    <td>242</td>
    <td>Neuropsychiatric Disorders</td>
    <td>249</td>
  </tr>
  <tr>
    <td></td>
    <td>DemeNTIA</td>
    <td>249</td>
  </tr>
  <tr>
    <td>243</td>
    <td>Wernicke-Korsakorr SYNDROME</td>
    <td>250</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>VesseL AFFECTED</th>
    <th>Dericit</th>
  </thead>
  <tr>
    <td rowspan="2">MCA stroke</td>
    <td>
      Contralateral weakness of the arm and face; contralateral sensory deficits
      Right side leads to neglect Left side leads to language deficits:
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      (expressive) aphasia: speech, comprehension Wernicke (receptive) aphasia:
      Poor comprehension, speech production intact, “word salad” nonsensical
      speech
    </td>
  </tr>
  <tr>
    <td>ACA stroke</td>
    <td>Contralateral leg weakness and sensory deficits</td>
  </tr>
  <tr>
    <td>PCA stroke</td>
    <td>Homonymous hemianopia with macular sparing</td>
  </tr>
  <tr>
    <td rowspan="3">Brainstem strokes</td>
    <td>
      Posterior inferior cerebellar artery (medulla) Wallenberg syndrome:
      Nystagmus, Horner syndrome, loss of pain and tem- perature sensation on
      the ipsilateral face and contralateral body
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      Anterior inferior cerebellar artery (pons): Ipsilateral limb ataxia and
      contralateral hemiplegia and loss of pain and tem- sensation
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      perature Posterior cerebral artery (PCA) (midbrain) Weber syndrome:
      Ipsilateral cranial nerve Ill palsy and contralateral arm and leg weakness
    </td>
  </tr>
  <tr>
    <td>Lacunar</td>
    <td>Internal capsule: Pure motor stroke</td>
  </tr>
  <tr>
    <td>stroke</td>
    <td>Thalamus: Pure sensory stroke</td>
  </tr>
  <tr>
    <td></td>
    <td>Basilar part of pons: Dysarthria (clumsy hand syndrome)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>Symptoms</th>
    <th>Exam/Diaanosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Tension</td>
    <td>Tight, bandlike pain bilaterally lasting 30 min to 7 days</td>
    <td>Normal exam; a clinical diagnosis.</td>
    <td>NSAIDs/acetaminophen; relaxation techniques</td>
  </tr>
  <tr>
    <td rowspan="6">Migraine</td>
    <td>Typically unilateral throbbing pain lasting for</td>
    <td>Normal exam; a clinical diagnosis.</td>
    <td>Elimination of triggers</td>
  </tr>
  <tr>
    <td></td>
    <td>4 hours to 3 days; can be associated with</td>
    <td>that has a familial predisposition;</td>
    <td>Prophylaxis: Amitriptyline, topiramate,</td>
  </tr>
  <tr>
    <td></td>
    <td>photophobia, phonophobia, nausea, vom-</td>
    <td>more common in women</td>
    <td>propranolol, zonisamide</td>
  </tr>
  <tr>
    <td></td>
    <td>iting, and aura</td>
    <td></td>
    <td>Abortive agents: Triptans, NSAIDs</td>
  </tr>
  <tr>
    <td></td>
    <td>Aura: Visual disturbance such as scotoma that</td>
    <td></td>
    <td>Severe requiring hospitalization: IV</td>
  </tr>
  <tr>
    <td></td>
    <td>occurs prior to onset of migraine</td>
    <td></td>
    <td>
      hydration, antiemetics, and antihis- tamine; IV steroids; ergotamine
    </td>
  </tr>
  <tr>
    <td rowspan="3">Cluster</td>
    <td>Brief, severe, unilateral, periorbital headache;</td>
    <td>Exam reveals ipsilateral lacrimation,</td>
    <td>Abortive: 100% O, or injectable triptan</td>
  </tr>
  <tr>
    <td></td>
    <td>attacks at the same hour each day</td>
    <td>
      conjunctival injection, Horner syn- drome, and nasal congestion; more
      common in men
    </td>
    <td>Prevention: Verapamil or steroids</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>Symptoms</th>
    <th>Exam/Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Idiopathic intracranial hypertension (pseudotumor cerebri)</td>
    <td>Mimics symptoms of tumor head- ache or migraine</td>
    <td>
      Young, overweight female with elevated opening pressure on LP and evidence
      of papilledema on exam, with no evidence of tumor on MRI
    </td>
    <td>
      Weight loss to reduce head- aches, acetazolamide to reduce risk of vision
      loss, and thera- peutic lumbar punctures
    </td>
  </tr>
  <tr>
    <td>Aneurysm</td>
    <td>May mimic migraine symptoms; sudden and severe pain with rupture</td>
    <td>Family history of aneurysms, CTA reveals vessel abnormality</td>
    <td>Surgical repair, BP control</td>
  </tr>
  <tr>
    <td>Tumor headache</td>
    <td>
      Progressively worsening headache; worse in the morning, refractory to
      traditional treatment
    </td>
    <td>
      May have personality changes or other neurologic sequelae such as seizures
    </td>
    <td>
      Surgery, radiation, or resection depending on the type and location of the
      tumor
    </td>
  </tr>
  <tr>
    <td>Giant cell arteritis</td>
    <td>
      Age &gt; 50, pain around the ear and associated with chewing, can have
      visual loss
    </td>
    <td>
      Temporal tenderness, jaw claudication, elevated ESR &gt; 50, temporal
      artery biopsy
    </td>
    <td>Steroids</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="4">Tonic-clonic (“grand mal”)</td>
    <td>
      Acute loss of consciousness; tonic phase (stiffening of body) followed by
    </td>
  </tr>
  <tr>
    <td></td>
    <td>clonic phase (jerking of body)</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Postictal period (deep sleep) that presents with incontinence, confusion,
      low
    </td>
  </tr>
  <tr>
    <td></td>
    <td>serum HCO;, and T serum CK and prolactin</td>
  </tr>
  <tr>
    <td>Absence (“petit mal”)</td>
    <td>
      Acute brief lapses of consciousness that begin in childhood (ages 4-8) No
      postictal period
    </td>
  </tr>
  <tr>
    <td>Atonic</td>
    <td>
      Acute brief loss of postural control resulting in a fall (1-2 seconds)
    </td>
  </tr>
  <tr>
    <td>Myoclonic</td>
    <td>Acute shock-like contraction of muscle groups (jerks)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Druc</th>
    <th>Uses</th>
    <th>Apverse Errect(s)</th>
  </thead>
  <tr>
    <td>Levetiracetam</td>
    <td>Broad spectrum: All seizure types</td>
    <td>_T Risk of suicidality and mood disturbance</td>
  </tr>
  <tr>
    <td>Lamotrigine</td>
    <td>Broad spectrum: All seizure types; also a mood stabilizer</td>
    <td>| Stevens-Johnson syndrome</td>
  </tr>
  <tr>
    <td>Valproate</td>
    <td>Broad spectrum: All seizure types</td>
    <td>— Teratogenic, weight gain, hair loss, tremor, liver failure</td>
  </tr>
  <tr>
    <td>Topiramate</td>
    <td>Broad spectrum: All seizure types; also migraine prop! ylaxis</td>
    <td>
      | Cognitive impairment (why Topamax is nicknamed “Dopamax”), weight loss,
      kidney stones
    </td>
  </tr>
  <tr>
    <td>Carbamazepine</td>
    <td>Narrow spectrum: Focal or 2° generalized; trigeminal neuralgia</td>
    <td>Hyponatremia, pancytopenia</td>
  </tr>
  <tr>
    <td>Phenytoin</td>
    <td>Narrow spectrum: Focal or 2° generalized</td>
    <td>Gingival hyperplasia, bone demineralization</td>
  </tr>
  <tr>
    <td>Ethosuximide</td>
    <td>Narrow spectrum: Absence seizures</td>
    <td>Sedation</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Assent REFLEX</th>
    <th>DEFINITION</th>
    <th>Nerves INVOLVED</th>
  </thead>
  <tr>
    <td>Pupillary light</td>
    <td>No change in pupil size in response to bright light</td>
    <td>CN II, Ill</td>
  </tr>
  <tr>
    <td>Corneal</td>
    <td>No blinking when the cornea is touched</td>
    <td>CNV, VII</td>
  </tr>
  <tr>
    <td>Oculovestibular</td>
    <td>
      No deviation of eyes to stabilize images on retina during simulated head
      movement (“doll’s eyes” reflex)
    </td>
    <td>CN III, IV, VI, VIII</td>
  </tr>
  <tr>
    <td>Gag</td>
    <td>No response when the posterior pharynx is stimulated</td>
    <td>— CN IX, X</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">Pathology</td>
    <td>PERIPHERAL</td>
    <td>CENTRAL</td>
  </tr>
  <tr>
    <td></td>
    <td>_Lesion of the vestibular apparatus of the inner ear or CN VIII</td>
    <td>Lesion of brainstem vestibular nuclei or their connections</td>
  </tr>
  <tr>
    <td rowspan="6">Symptoms</td>
    <td>Vertigo is intermittent, positional</td>
    <td>Vertigo is not positional and may have</td>
  </tr>
  <tr>
    <td></td>
    <td>and may be associated with tin-</td>
    <td>accompanying cranial nerve injuries</td>
  </tr>
  <tr>
    <td></td>
    <td>nitus, hearing loss, and postural</td>
    <td>(facial droops, dysarthria, absent</td>
  </tr>
  <tr>
    <td></td>
    <td>Nystagmus rotary, and fatigable</td>
    <td>Nystagmus changes gaze; vertical nystagmus is highly</td>
  </tr>
  <tr>
    <td></td>
    <td>Fixation of gaze or eye closure stops</td>
    <td>specific for central vertigo</td>
  </tr>
  <tr>
    <td></td>
    <td>vertigo</td>
    <td>Visual fixation does not stop vertigo</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>See Figure 13-3</td>
    <td>See Figure 13-3</td>
  </tr>
  <tr>
    <td rowspan="5">Treatment</td>
    <td>‘Treat by canalith repositioning (Epley</td>
    <td>Treat the underlying cause (brainstem</td>
  </tr>
  <tr>
    <td></td>
    <td>maneuver) for benign paroxysmal</td>
    <td>stroke, vertebral dissection, mass or</td>
  </tr>
  <tr>
    <td></td>
    <td>positional vertigo; physical therapy,</td>
    <td>aneurysm)</td>
  </tr>
  <tr>
    <td></td>
    <td>antihistamines/benzodiazepines/</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>scopolamine</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Location</th>
    <th>Spinat Tracts AFFECTED</th>
    <th>Symptoms/PRESENTATION</th>
  </thead>
  <tr>
    <td>Syrinx (central</td>
    <td>Initially spinothalamic</td>
    <td>Loss of pain and temperature sensation ina</td>
  </tr>
  <tr>
    <td rowspan="3">cord)</td>
    <td>tracts crossing at ventral</td>
    <td>“cape” distribution followed by weakness of</td>
  </tr>
  <tr>
    <td></td>
    <td>commissure followed by</td>
    <td>the arms (typically a cervical lesion)</td>
  </tr>
  <tr>
    <td></td>
    <td>corticospinal tracts</td>
    <td></td>
  </tr>
  <tr>
    <td>Brown-Sequard</td>
    <td>Unilateral posterior</td>
    <td>Ipsilateral weakness and loss of light touch,</td>
  </tr>
  <tr>
    <td>syndrome</td>
    <td>column, spinothalamic,</td>
    <td>vibration, and proprioception and contralat-</td>
  </tr>
  <tr>
    <td>Anterior cord</td>
    <td>Bilateral spinothalamic</td>
    <td>Motor paralysis and loss of pain and</td>
  </tr>
  <tr>
    <td>syndrome</td>
    <td>
      and corticospinal tracts, often due to infarction of anterior spinal
      artery
    </td>
    <td>temperature sensation below the level of the lesion</td>
  </tr>
  <tr>
    <td>Posterior cord</td>
    <td>Posterior columns</td>
    <td>Bilateral loss of light touch, vibration, and</td>
  </tr>
  <tr>
    <td>syndrome</td>
    <td></td>
    <td>proprioception; can be seen in vitamin B,,</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>MyasTHENIA Gravis</th>
    <th>LamBert-Eaton MyasTHENIc SYNDROME</th>
  </thead>
  <tr>
    <td>Antibody to postsynaptic ACh receptors</td>
    <td>Antibody to presynaptic voltage-gated calcium channel receptors</td>
  </tr>
  <tr>
    <td>Symptoms worse with physical activity</td>
    <td>Symptoms improve with physical activity</td>
  </tr>
  <tr>
    <td>Associated with thymoma</td>
    <td>Associated with small cell lung cancer producing antibodies</td>
  </tr>
  <tr>
    <td>@ Edrophonium test</td>
    <td>© Edrophonium test</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>TyPE</th>
    <th>DistINGUISHING CHARACTERISTICS</th>
  </thead>
  <tr>
    <td>Alzheimer disease</td>
    <td>
      Most common type of dementia, B-amyloid plaques and neuro- fibrillary
      tangles
    </td>
  </tr>
  <tr>
    <td>Frontotemporal dementia (Pick disease)</td>
    <td>
      Frontal disinhibition, socially inappropriate, poor decision making, Pick
      bodies found in the cortex
    </td>
  </tr>
  <tr>
    <td>Lewy body dementia</td>
    <td>
      Parkinsonian features on exam associated with visual hallucina- tions,
      daily fluctuating cognition, REM sleep behavior disorder, and mood
      disturbance
    </td>
  </tr>
  <tr>
    <td>Creutzfeldt-Jakob disease</td>
    <td>
      Acute onset of dementia associated with myoclonic jerks and periodic sharp
      waves on EEG, prion disease
    </td>
  </tr>
  <tr>
    <td rowspan="3">Vascular dementia</td>
    <td>Stepwise worsening of symptoms with evidence of lacunar</td>
  </tr>
  <tr>
    <td></td>
    <td>strokes and white matter changes on imaging, may have</td>
  </tr>
  <tr>
    <td></td>
    <td>associated focal deficits</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Determination of Gravidity and Parity Prenatal Care and Nutrition</td>
  </tr>
  <tr>
    <td>Aneuploidy Screening and Diagnostic Testing</td>
  </tr>
  <tr>
    <td>PRENATAL ANEUPLOIDY SCREENING</td>
  </tr>
  <tr>
    <td>PRENATAL DIAGNOSTIC TESTING</td>
  </tr>
  <tr>
    <td>Tests of Fetal Well-Being</td>
  </tr>
  <tr>
    <td>Nownstress Test</td>
  </tr>
  <tr>
    <td>CONTRACTION STRESS TEST</td>
  </tr>
  <tr>
    <td>BlopPHYSICAL PROFILE</td>
  </tr>
  <tr>
    <td>Fetat Heart Rate DECELERATIONS</td>
  </tr>
  <tr>
    <td>Normal Labor and Delivery</td>
  </tr>
  <tr>
    <td>DEFINITIONS</td>
  </tr>
  <tr>
    <td>StaGes OF LABOR</td>
  </tr>
  <tr>
    <td>Monirorine In LABor</td>
  </tr>
  <tr>
    <td>Teratogens in Pregnancy</td>
  </tr>
  <tr>
    <td>Abnormal Labor and Delivery</td>
  </tr>
  <tr>
    <td>Premature Rupture OF MEMBRANES</td>
  </tr>
  <tr>
    <td>Preterm LABOR</td>
  </tr>
  <tr>
    <td>Feta MALPRESENTATION</td>
  </tr>
  <tr>
    <td>SHOULDER DysTociA</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Medical Complications of Pregnancy</td>
    <td>261</td>
  </tr>
  <tr>
    <td>DiaseTes MeLLiTus</td>
    <td>261</td>
  </tr>
  <tr>
    <td>HyPeRTENSIVE DISEASE IN PREGNANCY</td>
    <td>262</td>
  </tr>
  <tr>
    <td>HYROID DISEASE IN PREGNANCY</td>
    <td>263</td>
  </tr>
  <tr>
    <td>HyPeREMESIS GRAVIDARUM</td>
    <td>264</td>
  </tr>
  <tr>
    <td>Peripartum Complications</td>
    <td>264</td>
  </tr>
  <tr>
    <td>PosTPARTUM HEMORRHAGE</td>
    <td>264</td>
  </tr>
  <tr>
    <td>SHEEHAN SYNDROME (PostpaRTUM HypopiTUITARISM)</td>
    <td>264</td>
  </tr>
  <tr>
    <td>NTRAPARTUM AND POSTPARTUM FEVERS</td>
    <td>264</td>
  </tr>
  <tr>
    <td>Mastitis</td>
    <td>264</td>
  </tr>
  <tr>
    <td>Postpartum Psychiatric Disorders</td>
    <td>265</td>
  </tr>
  <tr>
    <td>Obstetric Complications of Pregnancy</td>
    <td>265</td>
  </tr>
  <tr>
    <td>First-TRIMESTER BLEEDING</td>
    <td>265</td>
  </tr>
  <tr>
    <td>Recurrent ABORTION</td>
    <td>266</td>
  </tr>
  <tr>
    <td>INTRAUTERINE GROWTH RESTRICTION</td>
    <td>267</td>
  </tr>
  <tr>
    <td>OLIGOHYDRAMNIOS AND POLYHYDRAMNIOS</td>
    <td>267</td>
  </tr>
  <tr>
    <td>Ruesus ISOIMMUNIZATION</td>
    <td>268</td>
  </tr>
  <tr>
    <td>THIRD-TRIMESTER BLEEDING</td>
    <td>268</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Ace (GA)</th>
    <th>RECOMMENDED TESTING AND TREATMENT</th>
  </thead>
  <tr>
    <td>Initial visit</td>
    <td>
      Obtain CBC, blood type, Rh-antibody screen, UA with culture, gonorrhea and
      chlamydia testing, rubella antibody titer, hepatitis B surface antigen,
      syphilis screen, HIV Offer genetic carrier screening (ie, cystic fibrosis,
      sickle cell) to all patients Women at risk for gestational diabetes (ie,
      prior gestational diabetes, obesity, or DM in a first-degree relative)
      should get HbA,, and/or early glucose tolerance testing
    </td>
  </tr>
  <tr>
    <td>6-11 weeks</td>
    <td>Conduct ultrasound to determine GA (more accurate than later scans)</td>
  </tr>
  <tr>
    <td>10-14 weeks</td>
    <td>
      Conduct ultrasound to determine nuchal translucency Obtain first-trimester
      serum aneuploidy screening OR noninvasive prenatal testing (NIPT), also
      called cell-free fetal DNA Discuss chorionic villus sampling with
      high-risk patients (based on abnormal NIPT or risk factors)
    </td>
  </tr>
  <tr>
    <td>15-19 weeks</td>
    <td>
      Conduct second-trimester aneuploidy screening (ie, Quad screen) Offer
      amniocentesis to patients with abnormal screening
    </td>
  </tr>
  <tr>
    <td>18-21 weeks</td>
    <td>
      Conduct screening ultrasound to survey fetal anatomy, placental location,
      and amniotic fluid
    </td>
  </tr>
  <tr>
    <td>24-28 weeks</td>
    <td>
      Order a 1-hour glucose challenge test; if = 140 mg/dL, follow with a
      3-hour glucose tolerance test Repeat hemoglobin/hematocrit
    </td>
  </tr>
  <tr>
    <td>28 weeks</td>
    <td>
      Give Rho(D) immune globulin (eg, RhoGAM) injection for Rh © patients Start
      fetal kick counting (the patient should count 10 fetal movements in 2
      hours)
    </td>
  </tr>
  <tr>
    <td>35-37 weeks</td>
    <td>
      — Screen for group B Streptococcus (GBS) with a rectovaginal swab Repeat
      hemoglobin/hematocrit Repeat gonorrhea and chlamydia testing, rapid plasma
      reagin, and HIV (in at-risk patients) Assess fetal with maneuvers and
      ultrasound if needed
    </td>
  </tr>
  <tr>
    <td></td>
    <td>position Leopold</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Neural Tuse Derect</th>
    <th>Trisomy 18</th>
    <th>Trisomy 21</th>
  </thead>
  <tr>
    <td>MSAFP</td>
    <td>t</td>
    <td>L</td>
    <td></td>
  </tr>
  <tr>
    <td>Estriol</td>
    <td>© Spina bifida J Anencephaly</td>
    <td>L</td>
    <td></td>
  </tr>
  <tr>
    <td>Inhibin A</td>
    <td>eo</td>
    <td>oO</td>
    <td></td>
  </tr>
  <tr>
    <td>hCG</td>
    <td>°</td>
    <td>L</td>
    <td></td>
  </tr>
  <tr>
    <td>H-hCG</td>
    <td>Not used</td>
    <td>L</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INDICATION</th>
    <th>Sare FOR Use</th>
    <th>ConTRAINDICATED</th>
  </thead>
  <tr>
    <td>Acne</td>
    <td>Benzoyl peroxide</td>
    <td>
      Vitamin A and derivatives (eg, isotretinoin, etretinate) &gt; heart and
      great vessel defects, craniofacial dysmorphism, and deafness
    </td>
  </tr>
  <tr>
    <td>Antibiotics</td>
    <td>
      Penicillins, cephalosporins, clindamycin; macrolides, metronidazole after
      first trimester
    </td>
    <td>
      Tetracycline — tooth discoloration, | bone growth Quinolones — cartilage
      damage
    </td>
  </tr>
  <tr>
    <td>Bipolar disorder</td>
    <td>Assess risks vs benefits</td>
    <td>
      Trimethoprim (Bactrim) &gt; neural tube defects (folic acid antagonist)
      Lithium &gt; Ebstein anomaly (defect of the tricuspid valve and
      atrialization of right ventricle)
    </td>
  </tr>
  <tr>
    <td>Cancer</td>
    <td>Alkylating agents in the second and third trimesters</td>
    <td>
      Folic acid antagonists — abnormalities of the neural tube and cranium
    </td>
  </tr>
  <tr>
    <td>Contrast solution</td>
    <td>Indigo carmine</td>
    <td>Methylene blue — jejunal and ileal atresia</td>
  </tr>
  <tr>
    <td>Depression</td>
    <td>Assess risks vs benefits</td>
    <td>
      SSRIs may cause persistent pulmonary hypertension of the newborn, poor
      feeding, and/or jitteriness
    </td>
  </tr>
  <tr>
    <td>GERD</td>
    <td>Calcium carbonate, ranitidine, cimetidine, omeprazole</td>
    <td>Alka-Seltzer, bismuth subsalicylate (contains NSAID)</td>
  </tr>
  <tr>
    <td>Headache/ migraine</td>
    <td>Acetaminophen, codeine, caffeine</td>
    <td>
      NSAIDs may cause oligohydramnios and closure of the ductus arteriosus,
      especially in the third trimester Ergotamine has abortifacient potential
      and a theoretical risk of fetal
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INDICATION</th>
    <th>SAFE FOR Use</th>
    <th>ConTRAINDICATED</th>
  </thead>
  <tr>
    <td>Hypertension</td>
    <td>Labetalol, hydralazine, nifedipine, methyldopa, clonidine</td>
    <td>ACEls and ARBs =&gt; fetal renal damage and oligohydramnios</td>
  </tr>
  <tr>
    <td>Hyperthyroidism</td>
    <td>
      Propylthiouracil (PTU) during first trimester Switch to methimazole after
      first trimester due to risk of maternal liver toxicity from PTU
    </td>
    <td>Methimazole (first trimester) — aplasia cutis</td>
  </tr>
  <tr>
    <td>Hypothyroidism</td>
    <td>Levothyroxine</td>
    <td></td>
  </tr>
  <tr>
    <td>Nausea/vomiting</td>
    <td>
      Pyridoxine (B,), doxylamine, prochlorperazine, metoclopramide,
      ondansetron, granisetron, promethazine
    </td>
    <td></td>
  </tr>
  <tr>
    <td>Pain</td>
    <td>
      Acetaminophen, menthol, topical patches, morphine, hydrocodone,
      propoxyphene, meperidine—should not be used continuously
    </td>
    <td>
      NSAIDs = oligohydramnios, closure of ductus arteriosus. If needed, may use
      &lt; 48 hours — Long-term use of opioids may lead to neonatal abstinence
      syndrome
    </td>
  </tr>
  <tr>
    <td>Seizure</td>
    <td>
      Use an anticonvulsant that works best to control maternal seizures;
      monotherapy at the lowest dose is preferred Folate supplementation (4
      mg/day) should be started 3 months before conception
    </td>
    <td>
      Valproic acid should be avoided if possible — craniofacial defects and
      NTDs Phenytoin &gt; dysmorphic facies, microcephaly, intellectual
      disability, hypoplasia of the nails and distal phalanges, and NTDs
      Carbamazepine =&gt; craniofacial defects, intellectual disability, and
      NTDs Phenobarbital — cleft palate and cardiac defects Trimethadione and
      paramethadione — intellectual disability, speech difficulty, and abnormal
      facies
    </td>
  </tr>
  <tr>
    <td>Thromboembolic disease</td>
    <td>
      Heparin, low-molecular-weight heparin; warfarin may be used in cases of
      highly thrombogenic artificial heart valves
    </td>
    <td>
      Warfarin &gt; fetal nasal hypoplasia and bony defects (chondrodysplasia)
      Avoid use of direct thrombin and factor Xa inhibitors, as safety is not
      well-studied
    </td>
  </tr>
  <tr>
    <td>URI</td>
    <td>
      Guaifenesin, acetaminophen, diphenhydramine, loratadine, nasal sprays
    </td>
    <td>— Avoid OTC combination medications, as many include NSAIDs</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Maternal Factors</th>
    <th>Fetat AND MaterNat Factors</th>
    <th>Feat Factors</th>
  </thead>
  <tr>
    <td>&gt; Two prior cesarean deliveries or</td>
    <td>Cephalopelvic disproportion or</td>
    <td>Placenta previa</td>
  </tr>
  <tr>
    <td>invasive uterine surgery</td>
    <td>suspected macrosomia</td>
    <td>Fetal malposition</td>
  </tr>
  <tr>
    <td>Active genital herpes infection</td>
    <td>Placental abruption</td>
    <td>Fetal distress</td>
  </tr>
  <tr>
    <td>Cervical carcinoma</td>
    <td>Labor dystocia or failed induction</td>
    <td>Cord prolapse</td>
  </tr>
  <tr>
    <td>HIV infection with high viral load</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>0</th>
    <th>1</th>
    <th>2</th>
  </thead>
  <tr>
    <td>Appearance</td>
    <td>All blue or pale</td>
    <td>Acrocyanosis</td>
    <td>All pink</td>
  </tr>
  <tr>
    <td>Pulse</td>
    <td>Absent</td>
    <td>&lt; 100</td>
    <td>= 100</td>
  </tr>
  <tr>
    <td>Grimace (reflex)</td>
    <td>No response</td>
    <td>Grimace</td>
    <td>Cry</td>
  </tr>
  <tr>
    <td>Activity</td>
    <td></td>
    <td>Some flexion</td>
    <td>Resists extension</td>
  </tr>
  <tr>
    <td>Respiration</td>
    <td></td>
    <td>Irregular gasps</td>
    <td>Strong cry</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PREGESTATIONAL</th>
    <th>GESTATIONAL</th>
  </thead>
  <tr>
    <td>Definition</td>
    <td>DM present before pregnancy</td>
    <td>DM provoked by pregnancy</td>
  </tr>
  <tr>
    <td>Risk factors</td>
    <td>Family history, autoimmune disorders (type 1), obesity (type 2)</td>
    <td>
      Obesity, family history (in a first-degree relative), prior history of DM
      in pregnancy
    </td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      If not diagnosed prior to conception, may be diagnosed by HbA,, &gt; 6.4
      in the first trimester
    </td>
    <td>
      _ Diagnosed if the 1-hour glucose test is = 140 mg/dL and the follow-up
      3-hour glucose test has at least two T levels
    </td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Strict control of blood glucose levels with diet, exercise, and glycemic
      agents or insulin Insulin requirements increase drastically during
      pregnancy Monitor fetal well-being with NSTs and growth scans
    </td>
    <td>
      ADA diet and regular exercise. If blood sugars are T after 1 week,
      glyburide can be added __ If glyburide is not sufficient, initiate insulin
      therapy Monitor fetal well-being with NSTs and growth scans
    </td>
  </tr>
  <tr>
    <td>Postpartum</td>
    <td>
      Continue glucose monitoring and decrease insulin accord- ingly, as
      requirements quickly decrease after delivery
    </td>
    <td>
      —_No further BG or insulin required. Perform a 2-hour glucose tolerance
      test at the postpartum visit to ensure resolution of diabetes
    </td>
  </tr>
  <tr>
    <td colspan="3">Complications</td>
  </tr>
  <tr>
    <td>Fetus</td>
    <td>
      Congenital malformations, spontaneous abortion (SAB), stillbirth,
      intrauterine growth restriction (IUGR), polyhydramnios, macrosomia,
      shoulder dystocia, neonatal hypoglycemia (due to hyperinsulinemia)
    </td>
    <td>
      Polyhydramnios, macrosomia, shoulder dystocia, neonatal hypoglycemia
    </td>
  </tr>
  <tr>
    <td>Mother</td>
    <td>
      Hypoglycemia, diabetic ketoacidosis, preterm labor, worsening end-organ
      dysfunction, 7 risk of preeclampsia
    </td>
    <td>
      Perineal trauma from macrosomic infant; T lifetime risk of developing DM
    </td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">Gestational hypertension</td>
    <td>Diacnosis</td>
    <td>TREATMENT</td>
    <td>CompLicaTIONS</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Systolic BP (SBP) = 140 or diastolic BP (DBP) = 90 on = two occasions 4
      hours apart at = 20 weeks No elevated BP prior to 20 weeks’ gestation
    </td>
    <td>Deliver at 37 weeks</td>
    <td>Progression to preeclampsia</td>
  </tr>
  <tr>
    <td>Preeclampsia</td>
    <td>
      SBP = 140 or DBP = 90 on = two occasions 4 hours apart Proteinuria (= 300
      mg/24 hours)
    </td>
    <td>
      Deliver at 37 weeks Magnesium sulfate is no longer recommended for seizure
      prophylaxis
    </td>
    <td>
      Fetal growth restriction, preterm delivery, placental abruption,
      disseminated intravascular coagulation (DIC), cerebral hemorrhage,
      fetal/maternal death
    </td>
  </tr>
  <tr>
    <td></td>
    <td>Pulmonary Headache or vision changes</td>
    <td>magnesium toxicity; treat toxicity with IV calcium gluconate</td>
    <td></td>
  </tr>
  <tr>
    <td>Eclampsia</td>
    <td>Preeclampsia + seizure</td>
    <td>
      Magnesium sulfate to control seizures Monitor ABCs closely; when stable,
      deliver
    </td>
    <td>Injury from falls, maternal and fetal hypoxia</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Uterine Atony</th>
    <th>GENITAL TRACT TRAUMA</th>
    <th>RETAINED PLACENTAL TISSUE</th>
  </thead>
  <tr>
    <td>Risk factors</td>
    <td>
      Uterine overdistention (multiple gestation, polyhydramnios), prolonged
      labor/induction, uterine infection, grand multiparity
    </td>
    <td>Precipitous delivery, operative vaginal delivery, large infant</td>
    <td>
      Placenta accreta/increta/percreta, pla- centa previa, prior cesarean
      delivery or curettage, accessory placental lobe
    </td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>Palpation of a soft, enlarged, “boggy” uterus</td>
    <td>
      Inspection of the cervix, vagina, and vulva for lacerations or hematoma
    </td>
    <td>
      —_ Inspection of the placenta and bimanual exam and/or ultrasound of
      uterine cavity
    </td>
  </tr>
  <tr>
    <td rowspan="4">Treatment</td>
    <td>Vigorous bimanual massage with empty bladder</td>
    <td>— Surgical repair of the defect,</td>
    <td>Removal of remaining placental tissue</td>
  </tr>
  <tr>
    <td></td>
    <td>Oxytocin infusion</td>
    <td>which may require additional</td>
    <td>manually or surgically via curettage</td>
  </tr>
  <tr>
    <td></td>
    <td>Methylergonovine if not hypertensive; PGF, if</td>
    <td>anesthesia and OR setting</td>
    <td>For placenta accreta/increta/percreta,</td>
  </tr>
  <tr>
    <td></td>
    <td>not asthmatic; misoprostol</td>
    <td></td>
    <td>hysterectomy may be necessary</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>CHORIOAMNIONITIS</th>
    <th>Enpometritis</th>
  </thead>
  <thead>
    <th>Definition</th>
    <th>
      Infection of the chorion, amnion, and amniotic fluid, diagnosed during
      labor
    </th>
    <th>Infection of the uterus, diagnosed after delivery</th>
  </thead>
  <tr>
    <td>Risk factors</td>
    <td>Prolonged PROM, GBS, meconium</td>
    <td>Cesarean delivery, prolonged PROM, chorioamnionitis</td>
  </tr>
  <tr>
    <td>Symptoms/</td>
    <td>Intrapartum fever with no other obvious source and one of the</td>
    <td>Postpartum fever with fundal tenderness, or fever within</td>
  </tr>
  <tr>
    <td>exam</td>
    <td>
      following: Fetal tachycardia Maternal leukocytosis Purulent fluid from
      cervical os
    </td>
    <td>24 hours postpartum without an obvious source</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Treated based on clinical symptoms +/— CBC; diagnosis confirmed by
      placental pathology
    </td>
    <td>
      Pelvic exam to rule out hematoma or retained membranes CBC with
      differential, UA and urine culture, and blood cultures as indicated
    </td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Antibiotics and delivery of the fetus (not an indication for cesarean
      delivery) “Cured” by delivery of placenta, but some clinicians recommend
      additional dose of antibiotics to decrease risk of endometritis
    </td>
    <td>Antibiotics until the patient is afebrile for 24 hours</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>Exam</th>
    <th>UttrasouND</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Threatened abortion</td>
    <td>Cervix closed</td>
    <td>
      Normal ultrasound for GA (shows at least a gestational sac, and may show
      yolk sac or fetus with HR)
    </td>
    <td>Expectant management; consider pelvic rest for several weeks</td>
  </tr>
  <tr>
    <td rowspan="3">Inevitable abortion</td>
    <td>Cervix dilated, no products of concep-</td>
    <td>Normal ultrasound for GA</td>
    <td>Expectant (no intervention)</td>
  </tr>
  <tr>
    <td></td>
    <td>tion (POC) expelled</td>
    <td></td>
    <td>Medical (misoprostol)</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Surgical (D&amp;C)</td>
  </tr>
  <tr>
    <td>Missed abortion</td>
    <td>Cervix closed</td>
    <td>Absent HR</td>
    <td>Expectant Medical (misoprostol) Surgical (D&amp;C)</td>
  </tr>
  <tr>
    <td rowspan="4">Incomplete abortion</td>
    <td></td>
    <td>Cervix open, some POC expelled or</td>
    <td>No viable pregnancy, but POC visual-</td>
    <td>— Expectant</td>
  </tr>
  <tr>
    <td></td>
    <td>visible in cervical canal</td>
    <td>ized in endometrial cavity</td>
    <td>Medical (misoprostol) Surgical (D&amp;C)</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Complete abortion</td>
    <td>Cervix may be closed or slightly dilated</td>
    <td>Empty endometrial cavity</td>
    <td></td>
  </tr>
  <tr>
    <td>Septic abortion</td>
    <td>
      Fever, severe abdominal and cervical tenderness, purulent and malodorous
      discharge on speculum exam
    </td>
    <td>No viable pregnancy, but POC visual- ized in endometrial cavity</td>
    <td>
      D&amp;C and IV antibiotics, hospital monitoring, and supportive care until
      afebrile
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Feta</th>
    <th>MaterNa</th>
  </thead>
  <tr>
    <td>Chromosomal abnormalities: Trisomy 21</td>
    <td>Hypertension or preeclampsia</td>
  </tr>
  <tr>
    <td>most common, followed by trisomies</td>
    <td>Drugs: Cigarette smoking most common;</td>
  </tr>
  <tr>
    <td>18 and 13</td>
    <td>alcohol, heroin, methamphetamines, cocaine</td>
  </tr>
  <tr>
    <td>Infection: CMV most common; toxoplas-</td>
    <td>SLE</td>
  </tr>
  <tr>
    <td>mosis, syphilis, rubella</td>
    <td>Pregestational diabetes</td>
  </tr>
  <tr>
    <td>Multiple gestation</td>
    <td>Antiphospholipid syndrome</td>
  </tr>
  <tr>
    <td>Placental or umbilical cord abnormalities</td>
    <td>Ethnic/genetic variation</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>OLIGOHYDRAMNIOS</th>
    <th>PoLyHYDRAMNIOS</th>
  </thead>
  <tr>
    <td>Definition</td>
    <td>Amniotic fluid index (AFI) = 5 cm on ultrasound</td>
    <td>AFI = 25 cm on ultrasound</td>
  </tr>
  <tr>
    <td rowspan="3">Causes</td>
    <td>Fetal urinary tract abnormalities (renal agenesis, polycystic |</td>
    <td>Uncontrolled maternal DM, multiple gestations, fetal pulmo-</td>
  </tr>
  <tr>
    <td></td>
    <td>kidneys, GU obstruction)</td>
    <td>nary or GI anomalies (duodenal atresia, tracheoesophageal</td>
  </tr>
  <tr>
    <td></td>
    <td>Use of NSAIDs or ACEls</td>
    <td></td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Ultrasound for anomalies Ferning test and Nitrazine paper to rule out PROM
    </td>
    <td>Ultrasound for fetal anomalies; glucose testing for DM</td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Hydration; consider amnioinfusion during labor to prevent cord compression
    </td>
    <td>— Consider therapeutic amniocentesis</td>
  </tr>
  <tr>
    <td rowspan="3">Complications</td>
    <td></td>
    <td>Cord compression &gt; fetal hypoxia</td>
    <td>Preterm labor, placental abruption, fetal malpresentation,</td>
  </tr>
  <tr>
    <td>Musculoskeletal abnormalities (facial distortion, clubfoot)</td>
    <td>cord prolapse on PROM, postpartum hemorrhage due to</td>
  </tr>
  <tr>
    <td></td>
    <td>Pulmonary hypoplasia, IUGR</td>
    <td>uterine atony</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PLACENTAL ABRUPTION</th>
    <th>PLacenta PREVvIA</th>
    <th>Uterine Rupture</th>
  </thead>
  <tr>
    <td>Definition</td>
    <td>
      Placental separation from the site of uterine implantation before delivery
      of the fetus
    </td>
    <td>
      Abnormal placental implantation covering all of part of the cervical os
    </td>
    <td>Atear in the myometrium, often at the site of a previous scar</td>
  </tr>
  <tr>
    <td>Risk factors</td>
    <td>
      Hypertension, abdominal/pelvic trauma, tobacco or cocaine use, uterine
      distention
    </td>
    <td>
      Prior Cesarean delivery, grand multiparity, multiple gestations, prior
      placenta previa
    </td>
    <td>
      Prior uterine scar from cesarean delivery or myomectomy, uterine
      anomalies, grand multiparity
    </td>
  </tr>
  <tr>
    <td>Symptoms</td>
    <td>
      Abdominal pain; persistent vaginal bleeding Prolonged or frequent uterine
      contrac- tions and sudden cervical dilation Fetal distress
    </td>
    <td>
      Painless vaginal bleeding with or without uterine contractions, which may
      spontaneously resolve Occurs in the second or third trimester Usually no
      fetal distress
    </td>
    <td>
      Severe abdominal pain, usually during labor Change in the shape of the
      abdomen Loss of fetal station Fetal distress
    </td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Primarily clinical Ultrasound for retroplacental hemor- rhage (low
      sensitivity) KB fetal-maternal hemorrhage test, coagulation tests to
      assess for DIC
    </td>
    <td>Ultrasound for placental position</td>
    <td>Primarily clinical; diagnosis confirmed on cesarean delivery</td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Mild/chronic abruption prior to term: Hospitalization, fetal monitoring,
      type and cross, bed rest Severe abruption: Stabilization (ABCs), type and
      cross, immediate delivery
    </td>
    <td>
      No cervical exam, no vaginal delivery Cesarean at term or with fetal
      distress or persistent heavy bleeding Pelvic rest Serial ultrasound to
      assess fetal growth and resolution of previa
    </td>
    <td>Immediate cesarean delivery and repair of the rupture</td>
  </tr>
  <tr>
    <td>Complications</td>
    <td>Hemorrhagic shock; DIC; fetal death with severe abruption</td>
    <td>
      7 Risk of placenta accreta Persistent hemorrhage requiring hyster- ectomy
      to prevent maternal death
    </td>
    <td>Fetal and maternal death</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Review of the Menstrual Cycle</td>
    <td>272</td>
  </tr>
  <tr>
    <td>Abnormal Uterine Bleeding</td>
    <td>272</td>
  </tr>
  <tr>
    <td>Amenorrhea</td>
    <td>274</td>
  </tr>
  <tr>
    <td>Dysmenorrhea</td>
    <td>275</td>
  </tr>
  <tr>
    <td>Polycystic Ovarian Syndrome</td>
    <td>275</td>
  </tr>
  <tr>
    <td>Endometriosis</td>
    <td>276</td>
  </tr>
  <tr>
    <td>Gestational Trophoblastic Disease</td>
    <td>277</td>
  </tr>
  <tr>
    <td colspan="2">Vulvovaginitis 278</td>
  </tr>
  <tr>
    <td>Pelvic Inflammatory Disease</td>
    <td>278</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>272</td>
    <td>Contraception Orat CONTRACEPTIVES</td>
    <td>281 281</td>
  </tr>
  <tr>
    <td>274</td>
    <td>OTHER CONTRACEPTIVES</td>
    <td>281</td>
  </tr>
  <tr>
    <td>275</td>
    <td>INTRAUTERINE DEVICES</td>
    <td>282</td>
  </tr>
  <tr>
    <td></td>
    <td>EMERGENCY CONTRACEPTION</td>
    <td>283</td>
  </tr>
  <tr>
    <td>275</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>276</td>
    <td>Infertility</td>
    <td>283</td>
  </tr>
  <tr>
    <td>277</td>
    <td>Menopause</td>
    <td>284</td>
  </tr>
  <tr>
    <td>278</td>
    <td>Urinary Incontinence</td>
    <td>284</td>
  </tr>
  <tr>
    <td>278</td>
    <td>Benign Breast Disorders</td>
    <td>285</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>‘STRUCTURAL</th>
    <th>NonstRUCTURAL</th>
  </thead>
  <thead>
    <th>Causes (PALM)</th>
    <th>Causes (COEIN)</th>
  </thead>
  <tr>
    <td>Polyps</td>
    <td>Coagulopathy</td>
  </tr>
  <tr>
    <td>Adenomyosis</td>
    <td>Ovulatory</td>
  </tr>
  <tr>
    <td>Leiomyomas</td>
    <td>dysfunction</td>
  </tr>
  <tr>
    <td rowspan="3">Malignancies</td>
    <td>Endometrial</td>
  </tr>
  <tr>
    <td></td>
    <td>Iatrogenic</td>
  </tr>
  <tr>
    <td></td>
    <td>Not yet classified</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>FeaTuRE</th>
    <th>Partiat Mote</th>
    <th>Comptete Mote</th>
  </thead>
  <tr>
    <td>Karyotype</td>
    <td>Most commonly 69, XXX or 69, XXY</td>
    <td>= Most commonly 46, XX or 46, XY</td>
  </tr>
  <tr>
    <td>Fetal parts</td>
    <td>Usually present</td>
    <td>Absent</td>
  </tr>
  <tr>
    <td>B-hCG level</td>
    <td>&lt; 100,000</td>
    <td>&gt; 100,000</td>
  </tr>
  <tr>
    <td>Theca lutein cysts</td>
    <td>Rare</td>
    <td>15-25%</td>
  </tr>
  <tr>
    <td>Malignancy</td>
    <td>&lt;5%</td>
    <td>6-32%</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th colspan="2">HormonaL</th>
  </thead>
  <tr>
    <td>Progesterone-only contraceptives</td>
    <td>
      Indicated in woman for whom combined OCPs are contraindicated; less
      effective than combined agents and generally reserved for breastfeeding
      mothers who have lactational amenorrhea
    </td>
  </tr>
  <tr>
    <td>Injectable</td>
    <td>
      Administered intramuscularly every 3 months; associated with irregular
      spotting and weight gain, hair thin- ning, and transient J in bone mineral
      density
    </td>
  </tr>
  <tr>
    <td>Subdermal progesterone implant</td>
    <td>
      Most effective method; approved for 3 years of use Can be associated with
      irregular spotting or local irritation at insertion site (erythema,
      swelling)
    </td>
  </tr>
  <tr>
    <td>Transdermal patch</td>
    <td>
      Applied weekly for 3 weeks followed by a 1-week patch-free interval during
      which menses occurs Similar indications, contraindications, and side
      effect profile as combined OCPs May be less effective in obese patients
      (weight &gt; 90 kg [198 Ib])
    </td>
  </tr>
  <tr>
    <td>Vaginal ring</td>
    <td>
      Kept in place for 3 weeks, followed by a 1-week holiday during which
      menses occurs Contains estrogen and must be used in appropriate candidates
      Similar indications, contraindications, and side effect profile as
      combined OCPs
    </td>
  </tr>
  <tr>
    <td>Intrauterine devices</td>
    <td>See below</td>
  </tr>
  <tr>
    <td></td>
    <td>NonHoRMONAL</td>
  </tr>
  <tr>
    <td>Condoms, male or female</td>
    <td>Provide protection against STIs</td>
  </tr>
  <tr>
    <td>Cervical diaphragm</td>
    <td>
      Placed intravaginally over the cervix immediately before intercourse and
      removed within 3 hours afterward
    </td>
  </tr>
  <tr>
    <td>Spermicidal gel</td>
    <td>
      Can be used in combination with condoms or diaphragm; when used alone, it
      is unreliable
    </td>
  </tr>
  <tr>
    <td>Copper IUD</td>
    <td>See below</td>
  </tr>
  <tr>
    <td>Fertility awareness method</td>
    <td>
      The “rhythm method”; relies on avoidance of intercourse during the
      ovulatory period
    </td>
  </tr>
  <tr>
    <td>Male or female sterilization</td>
    <td>
      Either fallopian tube interruption in women (tubal ligation or permanently
      implanted birth control device) or ligation of the vas deferens in men
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>FemaLe</th>
    <th>Mate</th>
  </thead>
  <tr>
    <td>Ovulatory dysfunction: Ovarian failure,</td>
    <td>Congenital disorders: Include Klinefelter</td>
  </tr>
  <tr>
    <td>prolactinoma</td>
    <td>syndrome, androgen insensitivity,</td>
  </tr>
  <tr>
    <td>Uterine/tubal factors: Tubal occlusion 2° to</td>
    <td>5a-reductase deficiency, Kallmann</td>
  </tr>
  <tr>
    <td>endometriosis or PID, myomas that distort</td>
    <td>syndrome, and Prader-Willi syndrome</td>
  </tr>
  <tr>
    <td>the endometrium or fallopian tubes,</td>
    <td>Systemic disorders: Obesity, chronic illness</td>
  </tr>
  <tr>
    <td>congenital genital tract abnormalities</td>
    <td>Disorders of sperm production and transport:</td>
  </tr>
  <tr>
    <td>Endocrine dysfunction: Thyroid/adrenal</td>
    <td>Ejaculatory dysfunction, J sperm count,</td>
  </tr>
  <tr>
    <td>disease, PCOS</td>
    <td>abnormal morphology, or J motility</td>
  </tr>
  <tr>
    <td>Unexplained infertility or rare problems</td>
    <td>Unexplained infertility or rare problems</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Stress INCONTINENCE</th>
    <th>Uree Incontinence/ Overactive BLADDER (Detrusor INsTaBILITY)</th>
    <th>Mixep INCONTINENCE</th>
  </thead>
  <tr>
    <td>History</td>
    <td>
      Loss of urine with 7 intra-abdominal pressure (eg, running, coughing,
      laughing, sneezing)
    </td>
    <td>
      Urge incontinence: Loss of urine with urge to void Overactive bladder
      syndrome: Urgency to void with or without urge incontinence and often with
      nocturia and frequency
    </td>
    <td>Stress and urge incontinence presenting simultaneously</td>
  </tr>
  <tr>
    <td>Mechanism</td>
    <td>Poor support or poor function of the urethral sphincter</td>
    <td>Involuntary detrusor muscle contractions</td>
    <td>A combination of both mechanisms</td>
  </tr>
  <tr>
    <td>Etiology</td>
    <td>
      7 Elasticity of the vagina; loss of muscle mass of vagina, urethral
      hypermobility Risk factors: Age, genetics, childbirth, obesity, COPD,
      menopause
    </td>
    <td>Idiopathic, neurologic (Alzheimer disease, diabetes, MS)</td>
    <td>As for both conditions</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Patient history Demonstrable leakage with stress (cough) = @ stress test
    </td>
    <td>
      Patient history Urodynamics/cystometry reveals involuntary detrusor muscle
      contraction associated with urinary leakage
    </td>
    <td>As for both conditions</td>
  </tr>
  <tr>
    <td>Treatment</td>
    <td>
      Pelvic floor strengthening exercises (Kegel exercises) weight loss,
      biofeed- back, pessaries, surgery (suburethral sling) to restore bladder
      neck support
    </td>
    <td>
      Behavior modification (eg, limiting fluid intake; avoiding caffeinated or
      alcoholic beverages) Bladder training Medical therapy (anticholinergic)
      Surgical therapy (sacral neurostimulators,
    </td>
    <td>
      — Treat urge incontinence first Geared towards the patient's worst
      symptom; some treat- ments overlap (eg, Kegel exercises)
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Disease TYPE</th>
    <th>History/PE</th>
    <th>TREATMENT</th>
    <th>AsSOCIATED WITH CARCINOMA</th>
  </thead>
  <tr>
    <td>Fibrocystic changes</td>
    <td>
      Mild to moderate pain in the breasts +/— lumps premenstrually; multifocal,
      bilateral nodularity Most common in women 20-50 years of age
    </td>
    <td>OCPs</td>
    <td>
      Patients are at 7 risk for breast cancer only in the presence of cellular
      atypia Cancer must be excluded in high-risk groups
    </td>
  </tr>
  <tr>
    <td>Fibroadenoma</td>
    <td>
      It is the most common tumor in menstruating women &lt; 25 years of age It
      presents as a small, firm, unilateral, nontender mass that is freely
      movable and slow growing Ultrasound can be used to differentiate from a
      cyst
    </td>
    <td>
      Thirty percent will spontaneously disappear Removal is not necessary, but
      surgical excision is both diagnostic and curative; biopsy if the patient
      is ina high-risk group Recurrence is common
    </td>
    <td>Risk is twice as high as that of control patients</td>
  </tr>
  <tr>
    <td>Intraductal papilloma</td>
    <td>
      Clear, bloody, or discolored fluid from a single duct opening Milking of
      the breast shows drainage from one duct opening
    </td>
    <td>
      Drainage and surgical exploration of the duct A malignant process must
      always be excluded
    </td>
    <td>Risk is twice as high as that of control patients</td>
  </tr>
  <tr>
    <td>Mastitis</td>
    <td>
      Seen mainly in breastfeeding women; presents as a hard, red, tender,
      swollen area of breast accompanied by fever, myalgias, and general malaise
    </td>
    <td>
      Continued breastfeeding; NSAIDs and antibiotics to cover common etiologies
      (Staphylococcus, Streptococcus, E coli)
    </td>
    <td></td>
  </tr>
  <tr>
    <td>Abscess</td>
    <td>
      Can develop if mastitis is inadequately treated Exam reveals a fluctuant
      mass accompanied by systemic symptoms similar to those of mastitis
    </td>
    <td>Needle aspiration or surgical drainage in addition to antibiotics</td>
    <td></td>
  </tr>
  <tr>
    <td>Fat necrosis</td>
    <td>
      Firm, tender, and ill-defined with surrounding erythema; related to
      trauma/ischemia
    </td>
    <td>Analgesia An excisional biopsy may be done to rule out malignancy</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Vell-Child Care/Routine Health Screening</td>
  </tr>
  <tr>
    <td>SCREENING Basics</td>
  </tr>
  <tr>
    <td>Nutrition</td>
  </tr>
  <tr>
    <td>Norma GROWTH PaTTERNS</td>
  </tr>
  <tr>
    <td>ABNORMAL GROWTH PATTERNS</td>
  </tr>
  <tr>
    <td>DEVELOPMENTAL MILESTONES</td>
  </tr>
  <tr>
    <td>IMMUNIZATIONS</td>
  </tr>
  <tr>
    <td>AnticipatorY GUIDANCE</td>
  </tr>
  <tr>
    <td>Cuitp Asuse</td>
  </tr>
  <tr>
    <td>he Newborn</td>
  </tr>
  <tr>
    <td>NEONATAL RASHES</td>
  </tr>
  <tr>
    <td>Respiratory Distress</td>
  </tr>
  <tr>
    <td>NEONATAL Sepsis</td>
  </tr>
  <tr>
    <td>CONGENITAL TORCHES INFECTIONS</td>
  </tr>
  <tr>
    <td>CONGENITAL ANOMALIES</td>
  </tr>
  <tr>
    <td>JAUNDICE</td>
  </tr>
  <tr>
    <td>ermatology</td>
  </tr>
  <tr>
    <td>Diaper Dermatitis (“DiAPER RASH”)</td>
  </tr>
  <tr>
    <td>ViraL EXANTHEMS</td>
  </tr>
  <tr>
    <td>ndocrinology</td>
  </tr>
  <tr>
    <td>CONGENITAL ADRENAL HYPERPLASIA</td>
  </tr>
  <tr>
    <td>PuserTy AND ABNORMAL PuserTAL DEVELOPMENT</td>
  </tr>
  <tr>
    <td>nfectious Disease</td>
    <td></td>
  </tr>
  <tr>
    <td>Fever WitHour A Source</td>
  </tr>
  <tr>
    <td>MeniNaITIS</td>
  </tr>
  <tr>
    <td>mmunology</td>
  </tr>
  <tr>
    <td>IMMUNODEFICIENCY SYNDROMES</td>
  </tr>
  <tr>
    <td>Kawasak! Disease (Mucocutaneous LympH Nope SYNDROME)</td>
  </tr>
  <tr>
    <td>heumatology</td>
  </tr>
  <tr>
    <td>JUVENILE IDIOPATHIC ARTHRITIS</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>288</td>
    <td>Cardiology</td>
    <td>314</td>
  </tr>
  <tr>
    <td>288</td>
    <td>VENTRICULAR SEPTAL DEFECT</td>
    <td>314</td>
  </tr>
  <tr>
    <td>288</td>
    <td>ATRIAL SePTAL DEFECT</td>
    <td>315</td>
  </tr>
  <tr>
    <td>288</td>
    <td>Patent Ductus ARTERIOSUS</td>
    <td>315</td>
  </tr>
  <tr>
    <td>289</td>
    <td>TETRALOGY OF FALLOT</td>
    <td>316</td>
  </tr>
  <tr>
    <td>289</td>
    <td>TRANSPOSITION OF THE GREAT ARTERIES</td>
    <td>316</td>
  </tr>
  <tr>
    <td>290</td>
    <td>COARCTATION OF THE AORTA</td>
    <td>317</td>
  </tr>
  <tr>
    <td>291</td>
    <td>Gastroenterology</td>
    <td>317</td>
  </tr>
  <tr>
    <td>292</td>
    <td>Pytoric STENOSIS</td>
    <td>317</td>
  </tr>
  <tr>
    <td>293</td>
    <td>INTUSSUSCEPTION</td>
    <td>318</td>
  </tr>
  <tr>
    <td>293</td>
    <td>Matroration/VoLvuLus</td>
    <td>318</td>
  </tr>
  <tr>
    <td>293</td>
    <td>Mecket DiverTICULUM</td>
    <td>320</td>
  </tr>
  <tr>
    <td>293</td>
    <td>NecROTIZING ENTEROCOLOTIS</td>
    <td>320</td>
  </tr>
  <tr>
    <td>296</td>
    <td>Ma assorrTION</td>
    <td>321</td>
  </tr>
  <tr>
    <td>296</td>
    <td>Pulmonology</td>
    <td>321</td>
  </tr>
  <tr>
    <td>299</td>
    <td>Croup (LARYNGOTRACHEOBRONCHITIS)</td>
    <td>321</td>
  </tr>
  <tr>
    <td>301</td>
    <td>EpiGLortitis</td>
    <td>323</td>
  </tr>
  <tr>
    <td>301</td>
    <td>Pertussis</td>
    <td>323</td>
  </tr>
  <tr>
    <td>302</td>
    <td>BRONCHIOLITIS</td>
    <td>324</td>
  </tr>
  <tr>
    <td>303</td>
    <td>PNEUMONIA</td>
    <td>324</td>
  </tr>
  <tr>
    <td>303</td>
    <td>Cystic Fiprosis</td>
    <td>325</td>
  </tr>
  <tr>
    <td>305</td>
    <td>Neurology</td>
    <td>325</td>
  </tr>
  <tr>
    <td></td>
    <td>FesriLe SEIZURES</td>
    <td>325</td>
  </tr>
  <tr>
    <td>306 306</td>
    <td>Epitepsy SYNDROMES.</td>
    <td>326</td>
  </tr>
  <tr>
    <td>306</td>
    <td>Oncology</td>
    <td>326</td>
  </tr>
  <tr>
    <td>310</td>
    <td>Witms Tumor</td>
    <td>326</td>
  </tr>
  <tr>
    <td>310</td>
    <td>NEUROBLASTOMA</td>
    <td>327</td>
  </tr>
  <tr>
    <td>310</td>
    <td>RETINOBLASTOMA</td>
    <td>328</td>
  </tr>
  <tr>
    <td>312</td>
    <td>Genetics</td>
    <td>328</td>
  </tr>
  <tr>
    <td>219</td>
    <td>Common Genetic DisorDERS</td>
    <td>328</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Ace?</th>
    <th>Gross Motor</th>
    <th>Fine Motor</th>
    <th></th>
    <th>LanGuaGe</th>
    <th>Sociat/Coenitive</th>
  </thead>
  <tr>
    <td>2 months</td>
    <td>Lifts head/chest when prone</td>
    <td>Tracks past midline</td>
    <td></td>
    <td>Alerts to sound; coos</td>
    <td>Recognizes parent; exhibits social smile</td>
  </tr>
  <tr>
    <td>4-5 months</td>
    <td>Rolls front to back and back to front (4 months)</td>
    <td>Grasps rattle</td>
    <td></td>
    <td>
      Laughs and squeals; orients to voice; begins to make consonant sounds
    </td>
    <td>Enjoys looking around; laughs</td>
  </tr>
  <tr>
    <td>6 months</td>
    <td>Sits unassisted</td>
    <td>Transfers objects; dem- onstrates raking grasp</td>
    <td></td>
    <td>Babbles</td>
    <td>Demonstrates stranger anxiety</td>
  </tr>
  <tr>
    <td>9-10 months</td>
    <td>Crawls; pulls to stand</td>
    <td>Uses three-finger (immature) pincer grasp</td>
    <td></td>
    <td>Says “mama/dada” (non- specific); says first word at 11 months</td>
    <td>Waves “bye-bye”; plays pat-a-cake</td>
  </tr>
  <tr>
    <td>12 months</td>
    <td>Walks alone; throws object</td>
    <td>Uses two-finger (mature) pincer grasp</td>
    <td></td>
    <td>Uses one to three words</td>
    <td>
      Imitates actions; exhibits separation anxiety Follows one-step commands
    </td>
  </tr>
  <tr>
    <td>2 years</td>
    <td>Walks up/down steps with help; jumps</td>
    <td>—_ Builds tower of six cubes</td>
    <td></td>
    <td>— Uses two-word phrases</td>
    <td>Follows two-step commands; removes clothes</td>
  </tr>
  <tr>
    <td>3 years</td>
    <td>Rides a tricycle; climbs stairs with alternating feet (3-4 years)</td>
    <td>Copies a circle; uses —_ utensils</td>
    <td></td>
    <td>Uses three-word sentences</td>
    <td>—_ Brushes teeth with help; washes/dries hands</td>
  </tr>
  <tr>
    <td>A years</td>
    <td>Hops</td>
    <td>Copies a cross (square at 4.5 years)</td>
    <td></td>
    <td>| Knows colors and some numbers</td>
    <td>Exhibits cooperative play; plays board games</td>
  </tr>
  <tr>
    <td>5 years</td>
    <td>Skips; walks backward for long distances</td>
    <td>
      Copies a triangle; ties shoelaces; knows left and right; prints letters
    </td>
    <td></td>
    <td>Uses five-word sentences</td>
    <td>Exhibits domestic role playing; plays dress-up</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ABNORMALITY</th>
    <th>PREsENTATION/ TREATMENT</th>
  </thead>
  <thead>
    <th>Erythema toxicum neonatorum</th>
    <th>
      Erythematous macules and papules that progress to pustules (Image A)
      Lesions usually within 24-48 hours after birth and resolve spontaneously
      in 5-7 days
    </th>
  </thead>
  <tr>
    <td>Transient neonatal pustular melanosis</td>
    <td>
      appear May present as pustules with a nonerythematous base or erythematous
      macules with a surrounding scaly area, with hyperpigmented macules Lesions
      present at birth and resolve spontaneously within weeks to months
    </td>
  </tr>
  <tr>
    <td>Neonatal acne</td>
    <td>
      Papules and pustules appearing on the face and/or scalp (Image B) at 3
      weeks of age; generally resolves by 4 months of age Tx: Gentle cleansing
      with soap and water; avoidance of oils and lotions
    </td>
  </tr>
  <tr>
    <td>Milia</td>
    <td>
      White papules composed of retained keratin and sebaceous material Present
      at birth; usually found on the cheeks and nose; resolves spontaneously
      within the first weeks of life
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      greasy on (Image C); to Tx: Application of emollient overnight followed by
      massage and shampooing with baby shampoo to loosen scales; use of a soft
      brush to remove scales
    </td>
  </tr>
  <tr>
    <td>Seborrheic dermatitis</td>
    <td>
      Erythema and scales, usually the face and scalp resolves within weeks
      months Medication: Ketoconazole, selenium sulfide, or hydrocortisone may
      be tried for persistent scales
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Congenital dermal melano-</td>
    <td>
      Dark blue to black birth marks generally present in lumbosacral area,
      particularly in patients of African or Asian
    </td>
  </tr>
  <tr>
    <td>cytosis (Mongolian spots)</td>
    <td>
      descent patients; can fade by 2 years of age but can persist to adulthood
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>DisorDeR</th>
    <th>DescrIPTION</th>
    <th>History</th>
    <th>Exam/CXR Finpines</th>
    <th>TREATMENT</th>
    <th>CompLications</th>
  </thead>
  <tr>
    <td>Respiratory distress syndrome/ hyaline membrane disease</td>
    <td>
      Surfactant defi- ciency leading to poor lung compliance and respiratory
      failure
    </td>
    <td>Usually occurs in premature infants</td>
    <td>
      Hypoxemia, J air movement; CXR J lung volumes and “ground-glass”
      appearance (see Figure 16-2A)
    </td>
    <td>
      Maternal antenatal steroids for prevention; O, and CPAP; surfactant
      administration; respira- tory support
    </td>
    <td>
      Chronic lung disease (BPD), retinopathy of prematurity, intraven- tricular
      hemorrhage
    </td>
  </tr>
  <tr>
    <td>Transient tachypnea of the newborn</td>
    <td>
      Retained fetal lung fluid leading to brief, self-resolving, mild
      respiratory distress; diagnosis of exclusion
    </td>
    <td>
      Term or near-term infants; nonasphyxi- ated; born following short labor or
      via Cesarean delivery without labor
    </td>
    <td>CXR shows perihilar streaking and fluid in interlobar fissures</td>
    <td>
      Usually only a mild to moderate O, require- ment for support; typically
      resolves over time
    </td>
    <td></td>
  </tr>
  <tr>
    <td>Meconium aspiration syndrome</td>
    <td>
      Inhalation of meconium at or near the time of birth leading to aspiration
      pneumonitis
    </td>
    <td>Term infants; meco- nium present at the time of delivery</td>
    <td>
      Hypoxia; coarse breath sounds; CXR shows coarse, irregular infiltrates,
      hyperexpansion (seen by diaphragmatic flattening), and lobar consolidation
    </td>
    <td>
      Nasopharyngeal suc- tioning at perineum if vigorous; tracheal suctioning
      at birth if _ not vigorous; venti- latory support and antibiotics; nitric
      oxide if severe pulmonary hypertension
    </td>
    <td>
      Pulmonary hyperten- sion, pneumothorax, pneumomediastinum; patients can be
      critically ill, with some even requiring extra- corporeal membrane
      oxygenation (ECMO) support
    </td>
  </tr>
  <tr>
    <td>Congenital diaphragmatic hernia</td>
    <td>
      A defect in the diaphragm leading to herniation of abdominal con- tents
      into the chest cavity; limitation of lung growth leading to pulmo- nary
      hypoplasia
    </td>
    <td>
      Severe respiratory distress at birth; may be diagnosed by prenatal
      ultrasound
    </td>
    <td>
      Scaphoid abdomen; CXR may show bowel loops in the chest (see Figure 16-2B)
    </td>
    <td>
      Immediate intubation, placement of NG tube to suction, ventilatory
      support, and surgical correction after stabi- lization; patients may
      require ECMO
    </td>
    <td>Severe pulmonary hypertension; mortality 25-40%</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INFECTION</th>
    <th>DescRrIPTION</th>
    <th>TREATMENT</th>
    <th>PREVENTION</th>
  </thead>
  <tr>
    <td>Toxoplasmosis</td>
    <td>
      Hydrocephalus, seizures, chorioretinitis, intra- cranial calcifications,
      and ring-enhancing lesions on head CT
    </td>
    <td>Pyrimethamine, _ sulfadiazine, spiramycin</td>
    <td>
      Avoid exposure to cats and cat feces during pregnancy; avoid
      raw/undercooked meat; treat women with 1° infection
    </td>
  </tr>
  <tr>
    <td>Rubella</td>
    <td>
      “Blueberry muffin” rash, cataracts, hearing loss, patent ductus arteriosus
      (PDA) and other cardiac defects, encephalitis
    </td>
    <td></td>
    <td>Immunize mothers prior to pregnancy</td>
  </tr>
  <tr>
    <td>Cytomegalovirus (CMV)</td>
    <td>
      —_ Petechial rash, periventricular calcifications, microcephaly,
      chorioretinitis
    </td>
    <td>Ganciclovir</td>
    <td>Avoid exposure</td>
  </tr>
  <tr>
    <td>Herpes simplex (HSV)</td>
    <td>
      Skin, eye, and mouth vesicles; can progress to severe CNS/systemic
      infection
    </td>
    <td>Acyclovir</td>
    <td>
      Perform Cesarean delivery if birthing mother has active lesions The
      highest risk is from mothers with 1° infection
    </td>
  </tr>
  <tr>
    <td>Syphilis</td>
    <td>
      Maculopapular skin rash on the palms and soles, lymphadenopathy,
      “snuffles,’ osteitis
    </td>
    <td>— Penicillin</td>
    <td>Treat seropositive mothers with penicillin</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Lesion</th>
    <th>DescrIPTION</th>
    <th>History/PE</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Cleft lip/palate</td>
    <td>Abnormal ridge/division of the lip and/ or palate (Image A)</td>
    <td>
      Presents at birth Poor feeding; aspiration; severe, recurrent otitis media
      May be associated with other anomalies
    </td>
    <td>Surgical repair of the lip/palate</td>
  </tr>
  <tr>
    <td>Tracheoesophageal fistula</td>
    <td>
      Five types; a blind esophageal pouch with a fistula between the distal
      esoph- agus and trachea the most common (Image B)
    </td>
    <td>
      Apparent within first hours of life or presents later in infancy Copious
      secretions, choking/ coughing with feeds, cyanosis, respiratory
      distress/aspiration “Can't pass NG tube”
    </td>
    <td>
      Suctioning of the pouch with an NG tube; reflux precautions; sup- portive
      care; surgical repair
    </td>
  </tr>
  <tr>
    <td>Abdominal wall defects</td>
    <td>
      Omphalocele (Image C, a membrane- covered herniation of abdominal
      contents) Gastroschisis (Image D, extrusion of the intestine through the
      defect)
    </td>
    <td>
      A visible defect seen antenatally or at birth Associated anomalies are
      common with omphalocele but are rare in gastroschisis
    </td>
    <td>
      Coverage of abdominal contents with moist sterile dressing NG
      decompressions, antibiotics, supportive care, and stabiliza- tion followed
      by 1° or staged closure
    </td>
  </tr>
  <tr>
    <td>Intestinal atresias</td>
    <td>
      Intestinal obstruction With Down syndrome, “double bubble” appearance of
      the duodenal bulb (1) and stomach (2) in duodenal atresia (Image E)
    </td>
    <td>
      Present antenatally or at birth Abdominal distention, bilious vom- iting,
      obstipation/failure to pass meconium, polyhydramnios
    </td>
    <td>Surgical resection</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Hirschsprung disease</th>
    <th>
      Absence of ganglion cells in the colon (on rectal suction biopsy) leading
      to nar- rowing of the aganglionic segment with dilation of the proximal
      normal colon; can be a short (75%) or long segment
    </th>
    <th>
      Usually presents within first 2 years of life Failure to pass meconium,
      vomiting, abdominal distention, chronic constipation Region of marked
      dilation superior to the aganglionic segment shown via barium enema
    </th>
    <th>
      Rectal irrigation for decompression A staged procedure with an initial
      diverting colostomy fol- lowed by resection when the infant is &gt; 6
      months of age
    </th>
  </thead>
  <tr>
    <td>Neural tube defects</td>
    <td>
      Include anencephaly (incompatible with life) and spina bifida (eg,
      myelomenin- gocele) (Image F, arrowheads indicate nerve roots within the
      anechoic herni- ated sac. The arrow shows overlying skin visible above the
      level of the spinal defect but abruptly stops at the defect)
    </td>
    <td>
      May be detected prenatally Associated with T maternal age and amniotic
      fluid a-fetoprotein Varies depending on the type of defect Associated with
      an T risk of latex allergy
    </td>
    <td>
      Risk J with folate ingestion during the first trimester Surgical repair
    </td>
  </tr>
  <tr>
    <td>Branchial cleft cysts</td>
    <td>Most common congenital neck mass</td>
    <td>
      Presents in late childhood/early adult- hood when it becomes infected
      (often with fistula formation and drainage)
    </td>
    <td>Surgical excision</td>
  </tr>
  <tr>
    <td>Thyroglossal duct cysts</td>
    <td>Midline lesion of the anterior neck that moves with swallowing</td>
    <td>Most present during childhood with acute viral infection</td>
    <td>
      Complete excision, which usually requires part of the hyoid bone; can
      recur with incomplete excision
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>CHARACTERISTICS</th>
    <th>History/PE</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Gilbert syndrome</td>
    <td>
      The most common inherited disorder of bilirubin glucuronidation (see
      Figure 16-3); due to a defect in UGT1A1 Presentation in adolescence due to
      hormonal changes; rarely diagnosed before puberty
    </td>
    <td>
      Repeated episodes of jaundice with stressors such as illness, fever,
      dehydration, and fasting Asymptomatic
    </td>
    <td></td>
  </tr>
  <tr>
    <td>Crigler-Najjar</td>
    <td>Abnormal functioning of the bilirubin-UGT</td>
    <td>T Unconjugated bilirubin; normal hepatic enzymes</td>
    <td>Liver transplantation</td>
  </tr>
  <tr>
    <td rowspan="3">syndrome</td>
    <td>enzyme</td>
    <td>Patients typically have persistent hyperbilirubi-</td>
    <td>is the only curative</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>nemia despite treatment with phototherapy and plasmapheresis</td>
    <td>therapy</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ExaNTHEM</th>
    <th>PRESENTATION</th>
    <th>EpipemioLocy/Comptications</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Varicella-zoster virus (VZV)</td>
    <td>
      Typically appear as pruritic vesicles on an erythematous base in multiple
      stages of eruption and healing (Image A)
    </td>
    <td>
      VZV is uncommon owing to vaccination; it most often occurs in immunosup-
      pressed and unvaccinated patients Complications: Systemic viremia or
      bacterial superinfection can occur
    </td>
    <td>
      Consider VZIG for immuno- compromised patients who are exposed Prevent
      with vaccination
    </td>
  </tr>
  <tr>
    <td>Pityriasis rosea</td>
    <td>
      Often begins with a “herald patch,’a large, salmon-colored, scaly lesion
      (Image B), followed 5-10 days later by lesions, espe- cially on the trunk
      running along Blaschko lines in a“Christmas tree” distribution
    </td>
    <td></td>
    <td>
      Supportive care; may improve more rapidly with UV light Resolves in weeks
      to months
    </td>
  </tr>
  <tr>
    <td>Rubeola (measles virus)</td>
    <td>
      Fever with the 3 C’s—Cough, Coryza, and Conjunctivitis—and Koplik spots
      (Image C) Erythematous papules start 2-4 days later on the face and spread
      downward
    </td>
    <td>
      Complications: Pneumonia, gastroen- teritis, myocarditis, and encephalitis
    </td>
    <td>
      Consider vitamin A supple- mentation in patients with malnutrition or
      malabsorp- tive states as measles can increase risk of deficiency Prevent
      with vaccination
    </td>
  </tr>
  <tr>
    <td>Erythema infectiosum, also called fifth disease (Parvovirus B19)</td>
    <td>
      Presents with fever, chills, and headache followed 2-3 days later by the
      develop- ment of a “slapped cheek” appearance with a flat, erythematous
      rash on the cheeks (Image D); evolves to a lacy rash on the trunk and legs
      lasting 2-3 weeks
    </td>
    <td></td>
    <td>Provide supportive care</td>
  </tr>
  <tr>
    <td>Roseola (HHV-6 or -7)</td>
    <td>
      Begins as poorly defined erythematous macules and papules on the chest and
      spreads outward Classic presentation includes high, spiking fevers lasting
      3-5 days, followed by a rash developing after fever has resolved or is
      resolving
    </td>
    <td>
      Complications: The first febrile seizures may be associated with
      infection; encephalitis
    </td>
    <td>Provide supportive care</td>
  </tr>
  <tr>
    <td>Mumps (Mumps virus)</td>
    <td>
      Fever, malaise, headache, and anorexia; affects glands and neural tissue
      Commonly recognized by parotid swelling
    </td>
    <td>May result in orchitis or meningoencephalitis</td>
    <td>Provide supportive care Prevent with vaccination</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>CSF</th>
    <th>Initial Pressure (mm H,O)</th>
    <th>APPEARANCE</th>
    <th>Cetts/L</th>
    <th>Protein (MG/DL)</th>
  </thead>
  <tr>
    <td>Normal</td>
    <td>&lt; 160</td>
    <td>Clear</td>
    <td>
      0-5 lymphocytes; first 3 months, 1-3 polymorphonuclear leukocytes (PMNs);
      neonates, up to 30lympho- cytes, rare RBCs
    </td>
    <td>
      15-35 (lumbar), 5-15 (ven- tricular); up to 150 (lumbar) _ for a short
      time after birth; to 6 months up to 65
    </td>
  </tr>
  <tr>
    <td>Bloody tap</td>
    <td>Normal or L</td>
    <td>Bloody (sometimes with clot)</td>
    <td>One additional WBC/700 RBCs”</td>
    <td>One additional milligram per 800 RBCs?</td>
  </tr>
  <tr>
    <td>Bacterial meningitis, acute</td>
    <td>200-750+</td>
    <td>Opalescent to purulent</td>
    <td>Up to thousands, mostly PMNs; early, few cells</td>
    <td>Up to hundreds</td>
  </tr>
  <tr>
    <td>Bacterial meningitis, partially treated</td>
    <td>Usually T</td>
    <td>Clear or opalescent</td>
    <td>Usually T; PMNs usually predominate</td>
    <td>T</td>
  </tr>
  <tr>
    <td>Tuberculous meningitis</td>
    <td>| 150-750+</td>
    <td>Opalescent; fibrin web or pellicle</td>
    <td>250-500, mostly lymphocytes; early, T PMNs</td>
    <td>45-500; parallels cell count; T over time</td>
  </tr>
  <tr>
    <td>Fungal meningitis</td>
    <td>tT</td>
    <td>Variable; often clear</td>
    <td>10-500; early, T PMNs; then mostly lymphocytes</td>
    <td>Elevated and increasing</td>
  </tr>
  <tr>
    <td>Aseptic meningoencephalitis</td>
    <td>Normal or slightly T</td>
    <td>Clear unless cell count &gt; 300/uL</td>
    <td>to a few hundred, mostly lym- phocytes; PMNs predominate early</td>
    <td>— 20-125</td>
  </tr>
  <tr>
    <td>Parainfectious encephalomyelitis</td>
    <td>80-450, usually T</td>
    <td>Usually clear</td>
    <td>0-50+, mostly lymphocytes; lower numbers, even 0, in MS</td>
    <td>15-75</td>
  </tr>
  <tr>
    <td>Polyneuritis</td>
    <td>Normal and occasionally T</td>
    <td>Early: normal; late: xantho- chromic if protein T</td>
    <td>Normal; occasionally slight T</td>
    <td>Early: normal; late: 45-1500</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Guucose (mG/pL)</th>
    <th>Otuer Tests</th>
    <th>Comments</th>
  </thead>
  <tr>
    <td>50-80 (two-thirds of blood glucose); may be 7 after seizure</td>
    <td>CSF-IgG index &lt; 0.7%; LDH 2-27 U/L</td>
    <td>
      CSF protein in the first month may be up to 170 mg/dL in small-for-date or
      premature infants; no T in WBCs due to seizure
    </td>
  </tr>
  <tr>
    <td>Normal</td>
    <td>
      RBC number should J between the first and third tubes; wait 5 minutes
      between tubes
    </td>
    <td>Spin down fluid; supernatant will be clear and colorless‘</td>
  </tr>
  <tr>
    <td>J; May be none</td>
    <td>
      Smear and culture are mandatory; LDH &gt; 24 U/L; lactate, IL-8, TNF 7,
      correlate with prognosis
    </td>
    <td>
      Very early, glucose may be normal; PCR meningococci and pneumococci in
      plasma; CSF may aid diagnosis
    </td>
  </tr>
  <tr>
    <td>Normal or L</td>
    <td>LDH usually &gt; 24 U/L; PCR may still be ©</td>
    <td>Smear and culture may be © if antibiotics have been used</td>
  </tr>
  <tr>
    <td>J; May be none</td>
    <td>Smear for acid-fast organisms; CSF culture and inoculation; PCR</td>
    <td>Consider AIDS, a common comorbidity of TB</td>
  </tr>
  <tr>
    <td></td>
    <td>
      India ink preparations, cryptococcal antigen, PCR, culture, inoculations,
      immunofluores- cence tests
    </td>
    <td>
      Often superimposed in patients who are debilitated or on immunosuppressive
      therapy
    </td>
  </tr>
  <tr>
    <td>Normal; may be J in mumps, HSV, or other viral infections</td>
    <td>
      CSF, stool, blood, throat washings for viral cultures; LDH &lt; 28 U/L;
      PCR for HSV, CMV, EBV, enterovirus, etc
    </td>
    <td>
      Acute and convalescent antibody titers for some viruses; in mumps, up to
      1000 lymphocytes; serum amylase often T; up to 1000 cells present in
      enteroviral infection
    </td>
  </tr>
  <tr>
    <td>Normal</td>
    <td>CSF-IgG index, oligoclonal bands variable; in MS, moderate T</td>
    <td>No organisms; fulminant cases resemble bacterial meningitis</td>
  </tr>
  <tr>
    <td>Normal</td>
    <td>CSF-IgG index may be T; oligoclonal bands variable</td>
    <td>Try to find cause (eg, viral infections, toxins, lupus, diabetes)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>B-Ceut</th>
    <th>Disorpers</th>
    <th></th>
  </thead>
  <tr>
    <td>Bruton agammaglobulinemia</td>
    <td>
      An X-linked recessive B-cell deficiency found only in boys Symptoms
      beginning after 6 months of age, when maternal IgG (transferred
      transplacentally) is no longer active
    </td>
    <td>
      Life-threatening; characterized by encapsulated Pseudomonas, S pneumoniae,
      and Haemophilus infections after 6 months of age
    </td>
    <td>
      Quantitative Ig levels: if low, confirm with B- and T-cell subsets (B
      cells are absent; T cells are often high) Absent tonsils and other
      lymphoid tissue may provide
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>aclue Treat with prophylactic antibi- otics and IVIG</td>
  </tr>
  <tr>
    <td>Common variable immunodeficiency (CVID)</td>
    <td>
      Usually a combined B- and T-cell defect All Ig levels low (in the 20s and
      30s) Normal B-cell numbers; J plasma cells Symptoms usually present later
      in life (15-35 years of age)
    </td>
    <td>
      T Pyogenic upper and lower respiratory infections 7 Risk of lymphoma and
      auto- immune disease
    </td>
    <td>
      Quantitative Ig levels; confirm with B- and T-cell subsets Treat with IVIG
    </td>
  </tr>
  <tr>
    <td>IgA deficiency</td>
    <td>Mild; the most common immunodeficiency J IgA levels only</td>
    <td>
      Usually asymptomatic; patients may develop recurrent respiratory or Gl
      infections (Giardia) Anaphylactic transfusion reaction due to anti-IgA
      antibodies is a common
    </td>
    <td>
      Quantitative IgA levels; treat infections Be careful giving IVIG, as it
      can lead to the production of anti-IgA antibodies and cause severe
      allergic reactions; if IVIG is necessary, give IgA-depleted
    </td>
  </tr>
  <tr>
    <td rowspan="2">Hyper-IgM Syndrome</td>
    <td>Absence of CD40 ligand that allows class-</td>
    <td>presentation Severe, recurrent sinopul-</td>
    <td>IVI</td>
  </tr>
  <tr>
    <td></td>
    <td>
      switching from IgM to other Ig classes T IgM levels, low levels of all
      other Ig, and
    </td>
    <td>monary infections due to impaired Ig</td>
    <td>Treat with antibiotic prophylaxis</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Thymic aplasia</td>
    <td>See the mnemonic CATCH 22</td>
    <td>Variable risk of infection</td>
    <td>Absolute T-lymphocyte count;</td>
  </tr>
  <tr>
    <td rowspan="9">(DiGeorge syndrome)</td>
    <td>Presents with tetany (2° to hypocalcemia)</td>
    <td>TTT Infections with viruses,</td>
    <td>mitogen stimulation response;</td>
  </tr>
  <tr>
    <td></td>
    <td>in the first days of life</td>
    <td>fungi, and PCP pneumonia</td>
    <td>delayed hypersensitivity skin</td>
  </tr>
  <tr>
    <td></td>
    <td>Autosomal dominant</td>
    <td>X-ray film may show absent</td>
    <td>testing</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>thymic shadow</td>
    <td>Treat with bone marrow</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>transplantation and IVIG for</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>antibody deficiency; give PCP</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>prophylaxis.</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Thymus transplantation is an</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>alternative</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>DisorDeR</th>
    <th>DescriPTION</th>
    <th>Inrection Risk/TyPE</th>
    <th>Diacnosis/TREATMENT</th>
  </thead>
  <tr>
    <td colspan="4">Comeinep DisorDeRS</td>
  </tr>
  <tr>
    <td>Ataxia-telangiectasia</td>
    <td>
      Progressive cerebellar ataxia and oculocu- taneous telangiectasias Caused
      by an autosomal recessive mutation in gene responsible for repair of dsDNA
      breaks
    </td>
    <td>
      T Incidence of malignancies, including non-Hodgkin lym- phoma, leukemia,
      and gastric carcinoma
    </td>
    <td>
      No specific treatment; may require IVIG depending on the severity of the
      Ig deficiency
    </td>
  </tr>
  <tr>
    <td>Severe combined immunodeficiency (SCID)</td>
    <td>
      Most commonly X-linked recessive Severe lack of B andT cells due to a
      defect in stem cell maturation and J adenosine deaminase Referred to as
      “bubble boy disease,’ because children are confined to an
    </td>
    <td>
      Severe, frequent bacterial infections; chronic candidiasis; opportunistic
      organisms
    </td>
    <td>
      Bone marrow or stem cell transplantation and IVIG for antibody deficiency
      Requires PCP prophylaxis
    </td>
  </tr>
  <tr>
    <td>Wiskott-Aldrich</td>
    <td>
      isolated, sterile environment An X-linked recessive disorder seen only in
    </td>
    <td>17 Risk of atopic disorders,</td>
    <td>Treatment is supportive (IVIG</td>
  </tr>
  <tr>
    <td>syndrome</td>
    <td>
      male patients Symptoms usually present at birth T IgE/IgA, J IgM, and
      thrombocytopenia The classic presentation involves bleeding, eczema, and
      recurrent otitis media Remember the mnemonic WIPE: Wiskott-Aldrich
      Infections Purpura (thrombocytopenic) Eczema
    </td>
    <td>
      lymphoma/leukemia, and infection from S pneumoniae, S aureus, and H
      influenzae type b (encapsulated organisms; think back to how IgM
      functions)
    </td>
    <td>
      and antibiotics) Patients are at higher risk for developing autoimmune
      diseases and malignancies Patients rarely survive to adulthood Patients
      with severe infections may be treated with bone marrow transplantation
    </td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">Age group</td>
    <td>TRACHEITIS</td>
    <td>Croup</td>
    <td>EpicLottitis</td>
  </tr>
  <tr>
    <td></td>
    <td>3 months to 2 years</td>
    <td>3 months to 3 years</td>
    <td>3-7 years</td>
  </tr>
  <tr>
    <td>Incidence in children presenting with stridor</td>
    <td>2%</td>
    <td>88%</td>
    <td>8%</td>
  </tr>
  <tr>
    <td>Pathogen</td>
    <td>Often S aureus</td>
    <td>PIV</td>
    <td>Formerly H influenzae; now S pneumoniae and S aureus</td>
  </tr>
  <tr>
    <td>Onset</td>
    <td>Prodrome (3 days) leading to acute decompensation (within 24 hours)</td>
    <td>Prodrome (1-7 days)</td>
    <td>Rapid (4-12 hours)</td>
  </tr>
  <tr>
    <td>Fever severity</td>
    <td>Intermediate grade</td>
    <td>Low grade</td>
    <td>High grade</td>
  </tr>
  <tr>
    <td>Associated symptoms</td>
    <td>Variable respiratory distress</td>
    <td>Barking cough, inspiratory stridor, hoarseness</td>
    <td>
      Respiratory distress, acute decompensation, toxic appearance, inspiratory
      stridor, muffled voice, drooling
    </td>
  </tr>
  <tr>
    <td>Position preference</td>
    <td></td>
    <td></td>
    <td>Seated, neck extended</td>
  </tr>
  <tr>
    <td>Response to racemic epinephrine</td>
    <td></td>
    <td>J in stridor</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR findings</td>
    <td>May see subglottic narrowing on lateral film</td>
    <td>“Steeple sign” on AP film</td>
    <td>“Thumbprint sign” on lateral film</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SYNDROME</th>
    <th>History/PE</th>
    <th>Diacnosis</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Absence seizures</td>
    <td>Multiple, brief staring episodes</td>
    <td>A generalized 3-Hz spike-and-wave pattern on EEG</td>
    <td>Ethosuximide; valproic acid</td>
  </tr>
  <tr>
    <td>Infantile spasms (West syndrome)</td>
    <td>
      Affects infants &lt; 1 year of age, pre- senting with “jackknife” spasms
      and psychomotor arrest/developmental regression
    </td>
    <td>Hypsarrhythmia on EEG Associated with tuberous sclerosis</td>
    <td>
      ACTH; vigabatrin Treatment resistant: Topiramate, zonisamide, valproic
      acid, lamotrigine, ketogenic diet
    </td>
  </tr>
  <tr>
    <td>Lennox-Gastaut syndrome</td>
    <td>
      First seizure between 1 and 7 years of age Presents with multiple,
      progressive, difficult-to-treat seizure types, including generalized
      tonic-clonic seizures (GTCS) and drop attacks
    </td>
    <td>
      An atypical spike-and-wave pattern, primarily in the frontal region, on
      EEG Progressive intellectual disability Associated with refractory
      infantile spasms and tuberous sclerosis
    </td>
    <td>
      Difficult to treat Topiramate, ethosuximide, felbamate, levetiracetam,
      zonisamide, val- proate, clonazepam, rufinamide, clobazam, ketogenic diet,
      vagus nerve stimulation
    </td>
  </tr>
  <tr>
    <td>Juvenile myoclonic epilepsy</td>
    <td>
      Affects healthy adolescents, pre- senting with myoclonic jerks or
      generalized tonic-clonic seizures (GTCS) in the early morning hours/ upon
      awakening
    </td>
    <td>
      May have a genetic basis; patients often have a @ family history
      Spike-and-wave sequences or multispike-and-wave complexes on EEG
    </td>
    <td>
      Antiepileptic medications such as lamotrigine, valproic acid, topiramate,
      levetiracetam, zonisamide
    </td>
  </tr>
  <tr>
    <td>Benign partial epilepsy</td>
    <td>
      Affects healthy children, presenting with partial seizures during wakeful-
      ness (oral, vocal, upper extremity symptoms); may spread to GTCS during
      sleep
    </td>
    <td>Spikes or sharp waves from the centrotemporal (rolandic) region</td>
    <td>
      Seizures usually disappear by ado- lescence; often no medication is
      necessary
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SYNDROME</th>
    <th>PRESENTATION</th>
    <th>AssociateD CONDITIONS</th>
    <th>Diacnosis</th>
    <th>Proanosis</th>
  </thead>
  <tr>
    <td rowspan="10">Trisomy 21 (incidence 1:700)</td>
    <td>Hypotonia, brachycephalic</td>
    <td>Cognitive delay, cardiac</td>
    <td>Karyotype, baseline</td>
    <td>One-third to one-half of</td>
  </tr>
  <tr>
    <td></td>
    <td>head, slanted palpebral fissures,</td>
    <td>defects, thyroid disease,</td>
    <td>echocardiogram, TFTs,</td>
    <td>children have congenital</td>
  </tr>
  <tr>
    <td></td>
    <td>dysplasia of the midphalanx of</td>
    <td>Gl atresias, atlantoaxial</td>
    <td>LFTs, CBC</td>
    <td>heart defects; thyroid</td>
  </tr>
  <tr>
    <td></td>
    <td>the fifth finger, single transverse</td>
    <td>instability, leukemia</td>
    <td></td>
    <td>dysfunction, visual issues,</td>
  </tr>
  <tr>
    <td></td>
    <td>palmar crease</td>
    <td></td>
    <td></td>
    <td>hearing loss, obstruc-</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>tive sleep apnea, celiac</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>disease, atlanto-occipital</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>instability, and autism</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>may develop; leukemia is</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>common</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SYNDROME</th>
    <th>PRESENTATION</th>
    <th>AssociateD CONDITIONS</th>
    <th>Diacnosis</th>
    <th>Proenosis</th>
  </thead>
  <tr>
    <td>
      Trisomy 18 (Edwards syndrome) (incidence 1:4000; 3:1 female predominance)
    </td>
    <td>
      Clenched hand/overlapping fingers, intrauterine growth retardation,
      cardiac defects, rocker-bottom feet
    </td>
    <td>Profound cognitive delay</td>
    <td>Karyotype with fluorescence in situ hybridization (FISH) analysis</td>
    <td>
      Death often from HF or pneumonia generally occurs in infancy or early
      childhood
    </td>
  </tr>
  <tr>
    <td>Trisomy 13 (Patau syndrome) (incidence 1:12,000)</td>
    <td>
      CNS malformations, polydac- tyly, seizures, deafness, sloping forehead,
      aplasia cutis, cleft lip/ cleft palate, microphthalmia/eye defects,
      cardiac defects
    </td>
    <td>Profound cognitive delay</td>
    <td>Karyotype with FISH analysis</td>
    <td>
      Death typically from HF or infection generally occurs between 3 months and
      24 months of life
    </td>
  </tr>
  <tr>
    <td>
      22q11 syndrome (DiGeorge syndrome, velocardiofacial syndrome) (incidence
      1:4000)
    </td>
    <td>
      a ‘ongenital heart disease, palatal i) bnormalities, prominent/ rr quared
      nose, thymic ypoplasia/immune deficiency, bsent parathyroid glands/ zeus
      ypocalcemia
    </td>
    <td>
      Mild to moderate cog- nitive delay (mostly speech and language), learning
      disabilities, and feeding difficulties; psychotic symptoms are common
    </td>
    <td>
      FISH analysis for 22q11.2 deletion Serum calcium, abso- lute lymphocyte
      count, renal ultra- sound, baseline echocardiogram
    </td>
    <td>Parents should be tested for being carriers of the deletion</td>
  </tr>
  <tr>
    <td>Turner syndrome (45,XO) (incidence 1:10,000)</td>
    <td>
      Short female with shield chest, widely spaced nipples, a webbed neck, and
      congenital lymphedema
    </td>
    <td>
      Cognitive delay, gonadal dysgenesis, renal anomalies, cardiac defects
      (coarctation of the aorta), hearing loss
    </td>
    <td>
      Karyotype for diagnosis Baseline echocar- diogram, renal ultrasound, BP,
      hearing screen
    </td>
    <td>Infertility; normal life span</td>
  </tr>
  <tr>
    <td>Fragile X syndrome (incidence 1:1500 males)</td>
    <td>
      Boys present with macrocephaly, large ears, macroorchidism, and tall
      stature Girls may present only with learning disabilities
    </td>
    <td>Mild to profound cogni- tive delay, autism</td>
    <td>
      DNA analysis shows expansion of a CGG nucleotide repeat in the FMR1 gene;
      the size of the repeat correlates with disease severity
    </td>
    <td>Normal life span</td>
  </tr>
  <tr>
    <td>Klinefelter syndrome (47, XXY) (1:1000)</td>
    <td>Hypogonadism, additional X chromosome inactivated (Barr body)</td>
    <td>Testicular atrophy, gynecomastia, tall with long extremities</td>
    <td>Karyotype for diagnosis</td>
    <td>
      T Risk of breast cancer; males require testosterone replacement therapy
    </td>
  </tr>
  <tr>
    <td>Marfan syndrome (incidence 1:10,000)</td>
    <td>
      Tall stature, low upper-to-lower- segment ratio, arachnodactyly, joint
      laxity, scoliosis, pectus excavatum or carinatum, lens dislocation,
      retinal detachment, dilation of the aortic root, mitral valve prolapse,
      lumbosacral dural ectasia, high-arched palate
    </td>
    <td>Normal intelligence</td>
    <td>
      Slit-lamp examination, echocardiography, genetic evaluation Clinical
      diagnosis
    </td>
    <td>
      Normal life span with treatment/corrective surgery of aortic root dilation
    </td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Pharmacotherapy</td>
    <td>332</td>
    <td>Conversion Disorder</td>
    <td>345</td>
  </tr>
  <tr>
    <td>ANXIOLYTICS AND SeDATIVe-Hypnorics</td>
    <td>332</td>
    <td>Factitious DisorDER</td>
    <td>345</td>
  </tr>
  <tr>
    <td>ANTIDEPRESSANTS</td>
    <td>332</td>
    <td>MALINGERING</td>
    <td>345</td>
  </tr>
  <tr>
    <td>ANTIPSYCHOTICS</td>
    <td>334</td>
    <td>Feeding and Eating Disorders</td>
    <td>346</td>
  </tr>
  <tr>
    <td>Moon StasiLizers</td>
    <td>335</td>
    <td>Pica</td>
    <td>346</td>
  </tr>
  <tr>
    <td>Diagnostic and Statistical Manual of Mental Disorders</td>
    <td>336</td>
    <td>Anorexia Nervosa</td>
    <td>346</td>
  </tr>
  <tr>
    <td>Disorders</td>
    <td>336</td>
    <td>Butimia Nervosa</td>
    <td>346</td>
  </tr>
  <tr>
    <td>Neurodevelopmental Autism SPECTRUM DISORDERS</td>
    <td>336</td>
    <td>Bince-Earinc DisorDER</td>
    <td>347</td>
  </tr>
  <tr>
    <td>Attention-Dericit/Hyperactivity DisoRDER</td>
    <td>337</td>
    <td>Elimination Disorders</td>
    <td>347</td>
  </tr>
  <tr>
    <td>Tic DisorDERS</td>
    <td>337</td>
    <td>Enuresis</td>
    <td>347</td>
  </tr>
  <tr>
    <td>Psychotic Disorders</td>
    <td>337</td>
    <td>Sleep-Wake Disorders</td>
    <td>348</td>
  </tr>
  <tr>
    <td>SCHIZOPHRENIA</td>
    <td>337</td>
    <td>Insomnia DisorDER</td>
    <td>348</td>
  </tr>
  <tr>
    <td>Mood (Affective) Disorders</td>
    <td>338</td>
    <td>NarcOLersy</td>
    <td>348</td>
  </tr>
  <tr>
    <td>Maior Depressive DisorDER</td>
    <td>338</td>
    <td>CircADIAN RHYTHM SLeeP-Wake DisorDER</td>
    <td>348</td>
  </tr>
  <tr>
    <td>Bipotar DisorDER</td>
    <td>340</td>
    <td>PaRASOMNIAS</td>
    <td>348</td>
  </tr>
  <tr>
    <td>Anxiety Disorders</td>
    <td>341</td>
    <td>Disruptive, Impulse Control, and Conduct Disorders</td>
    <td>349</td>
  </tr>
  <tr>
    <td>PHoBiA</td>
    <td>341</td>
    <td>Substance-Related and Addictive Disorders</td>
    <td>349</td>
  </tr>
  <tr>
    <td>Panic DisorDeR</td>
    <td>341</td>
    <td>SussTance Use DisorDeR</td>
    <td>349</td>
  </tr>
  <tr>
    <td>GENERALIZED ANxieTy DisoRDER</td>
    <td>342</td>
    <td>Opiate Use Disorder</td>
    <td>349</td>
  </tr>
  <tr>
    <td>and Related Disorders</td>
    <td>342</td>
    <td>AtcoHoL Use DisorDer</td>
    <td>351</td>
  </tr>
  <tr>
    <td>Obsessive-Compulsive</td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Ossessive-CompuLsive DISORDER</td>
    <td>342</td>
    <td>Neurocognitive Disorders</td>
    <td>351</td>
  </tr>
  <tr>
    <td>Bopy Dysmorpuic Disorder</td>
    <td>343</td>
    <td>DELIRIUM</td>
    <td>351</td>
  </tr>
  <tr>
    <td>HoarbING</td>
    <td>343</td>
    <td>DemeNTIA</td>
    <td>352</td>
  </tr>
  <tr>
    <td>Trauma- and Stressor-Related Disorders</td>
    <td>343</td>
    <td>DEPRESSION AND ANXIETY Due To A GeNeRAL MeDIcAL CONDITION</td>
    <td>353</td>
  </tr>
  <tr>
    <td>PostTrAUMATIC Stress DisORDER</td>
    <td>343</td>
    <td>Personality Disorders</td>
    <td>353</td>
  </tr>
  <tr>
    <td>AbJusTMENT DIsoRDER</td>
    <td>344</td>
    <td>Psychiatric Emergencies</td>
    <td>354</td>
  </tr>
  <tr>
    <td>Dissociative Disorders</td>
    <td>344</td>
    <td>Suicipe Risk AssesSMENT</td>
    <td>354</td>
  </tr>
  <tr>
    <td>Dissociative Ipentity DisorDER</td>
    <td>344</td>
    <td>Neurotertic MALIGNANT SYNDROME</td>
    <td>354</td>
  </tr>
  <tr>
    <td>Dissociative AMNESIA</td>
    <td>344</td>
    <td>SEROTONIN SYNDROME</td>
    <td>355</td>
  </tr>
  <tr>
    <td>Somatic Symptoms and Related Disorders</td>
    <td>344</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Symptom</th>
    <th>DescriPTION</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Acute dystonia</td>
    <td>
      Involuntary muscle contraction or spasm (eg, torti- collis, oculogyric
      crisis); more likely in young men; occurs acutely (often days to weeks
      after initiation)
    </td>
    <td>
      Give an anticholinergic (benztropine) or diphenhydramine To prevent, give
      prophylactic benztropine with an antipsychotic
    </td>
  </tr>
  <tr>
    <td>Dyskinesia</td>
    <td>
      Parkinsonism (eg, shuffling gait, cogwheel rigidity, bradykinesia); onset
      within weeks of therapy initiation
    </td>
    <td>
      Give an anticholinergic (benztropine) or a dopamine agonist (amantadine) J
      The dose of neuroleptic or discontinue (if tolerated) Older adults are at
      increased risk
    </td>
  </tr>
  <tr>
    <td>Akathisia</td>
    <td>Subjective/objective restlessness</td>
    <td>
      J Neuroleptic and try B-blockers (propranolol) Benzodiazepines or
      anticholinergics may help
    </td>
  </tr>
  <tr>
    <td>Tardive dyskinesia</td>
    <td>
      Stereotypic oral-facial movements; likely from dopa- mine receptor
      sensitization; often irreversible (50%); more common in older women;
      generally occurs after long-term use
    </td>
    <td>
      Discontinue or J the dose of neuroleptic; consider changing neuroleptic
      (eg, to clozapine or quetiapine) Giving anticholinergics or decreasing
      neuroleptics may initially worsen tardive dyskinesia
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Alcohol</th>
    <th>
      Disinhibition/impaired judgment, emotional lability, slurred speech,
      ataxia, aggression, hypoglycemia, blackouts (retro- grade amnesia), coma
    </th>
    <th>
      Tremor, tachycardia, diaphoresis, hypertension, malaise, nausea, seizures,
      delirium tremens (DTs), agitation, hallucinations; may be life-threatening
      and require hospitalization
    </th>
  </thead>
  <tr>
    <td>Opioids</td>
    <td>
      Euphoria leading to apathy, CNS depression, nausea, vomiting,
      constipation, pupillary constriction (miosis), respiratory depression
      (life-threatening in overdose) Naloxone/naltrexone will block opioid
      receptors and reverse effects (beware of the antagonist clearing before
      the opioid, particularly with long-acting opioids such as methadone)
    </td>
    <td>
      Anxiety, insomnia, anorexia, diaphoresis, dilated pupils (mydriasis),
      fever, rhinorrhea, piloerection, nausea, stomach cramps, diarrhea,
      yawning, myalgias; extremely uncomfortable, but rarely life-threatening
    </td>
  </tr>
  <tr>
    <td>Amphetamines, cocaine</td>
    <td>
      Psychomotor agitation, impaired judgment, tachycardia, pupillary dilation,
      fever, diaphoresis, hypertension, paranoia, angina, arrhythmias, seizures,
      hallucinations, sudden death. Treat with sedatives and benzodiazepines for
      severe agitation and with symptom-targeted medications
    </td>
    <td>
      Post-use “crash” with hypersomnolence, dysphoria/ nightmares, depression,
      malaise, severe craving, suicidality
    </td>
  </tr>
  <tr>
    <td>Phencyclidine hydrochloride (PCP)</td>
    <td>
      Belligerence, psychosis, violence, impulsiveness, psychomotor agitation,
      fever, tachycardia, vertical/horizontal nystagmus, ataxia, seizures,
      delirium Give benzodiazepines or haloperidol for severe symptoms;
      otherwise, provide low sensory surroundings &amp; reassurance
    </td>
    <td>
      Recurrence of intoxication symptoms due to reab- sorption in the Gl tract;
      sudden onset of severe, random violence
    </td>
  </tr>
  <tr>
    <td>LSD</td>
    <td>
      Marked anxiety or depression, delusions, visual hallucinations, pupillary
      dilation. Flashbacks a possible long-term consequence Treat by providing
      reassurance and a low-stimulation environ- ment. Give benzodiazepines for
      severe symptoms
    </td>
    <td></td>
  </tr>
  <tr>
    <td>Marijuana (THC)</td>
    <td>
      Euphoria, slowed sense of time, impaired judgment, “heightened senses,’
      social withdrawal, T appetite, dry mouth, diaphoresis, conjunctival
      injection, hallucinations, anxiety, paranoia, tachycardia, hypertension,
      amotivation
    </td>
    <td>
      Rare but can occur in long-time heavy users; irritability,
      nausea/vomiting, depression, insomnia
    </td>
  </tr>
  <tr>
    <td>Barbiturates</td>
    <td>Low safety margin; respiratory depression</td>
    <td>
      Anxiety, seizures, delirium, life-threatening cardio- vascular collapse
    </td>
  </tr>
  <tr>
    <td>Benzodiazepines</td>
    <td>
      Interactions with alcohol, amnesia, ataxia, somnolence, mild respiratory
      depression
    </td>
    <td>
      Rebound anxiety, seizures, tremor, insomnia, hypertension, tachycardia.
      Some similarities with alcohol withdrawal
    </td>
  </tr>
  <tr>
    <td>Caffeine</td>
    <td>
      Restlessness, insomnia, diuresis, muscle twitching, arrhythmias,
      psychomotor agitation
    </td>
    <td>Headache, lethargy, depression, weight gain, irritability, craving</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="3">Course</th>
    <th>Detirium</th>
    <th>DEMENTIA</th>
  </thead>
  <thead>
    <th></th>
    <th>Acute (abrupt onset); lasting hours to days; usually reversible</th>
    <th>Chronic (progressive degradation); lasting months</th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th>to years; usually irreversible</th>
  </thead>
  <tr>
    <td>Functionality</td>
    <td>
      Fluctuating ability to focus and shift attention; clouded consciousness
    </td>
    <td>Alert; intact consciousness</td>
  </tr>
  <tr>
    <td>Cognition</td>
    <td>
      Like dementia, but more likely to include perceptual disturbances
      (hallucinations) and paranoia
    </td>
    <td>
      Disrupted memory, orientation, and language; hallucinations present in ~
      30% of those with advanced disease
    </td>
  </tr>
  <tr>
    <td rowspan="4">Causes</td>
    <td></td>
    <td>
      Evidence of a general medical condition causing the problem (seizures,
    </td>
    <td>_ Insidious processes such as Alzheimer disease,</td>
  </tr>
  <tr>
    <td></td>
    <td>
      postictal state, infections, thyroid disorders, urinary tract infection
    </td>
    <td>Huntington disease, vascular dementia, AIDS</td>
  </tr>
  <tr>
    <td></td>
    <td>
      (UTI), vitamin deficiencies); substances (eg, cocaine, opioids, PCP); head
    </td>
    <td>dementia, and MDD in elderly patients</td>
  </tr>
  <tr>
    <td>trauma, kidney disease, sleep deprivation</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>DisorDeR</th>
    <th>CHARACTERISTICS</th>
    <th>Cuinicat Ditemma/StRATEGIES</th>
  </thead>
  <tr>
    <td colspan="3">Custer A:“WeiRD”</td>
  </tr>
  <tr>
    <td>Paranoid</td>
    <td>
      Distrustful and suspicious; interprets others’ motives as malevolent;
      litigious
    </td>
    <td>
      Patients are suspicious and distrustful of doctors and rarely seek medical
      attention Be clear, honest, noncontrolling, and nondefensive.
    </td>
  </tr>
  <tr>
    <td>Schizoid</td>
    <td>
      Think “D’ for distant. Isolated, detached “loners”; have restricted
      emotional expression
    </td>
    <td>Avoid humor. Maintain emotional distance</td>
  </tr>
  <tr>
    <td>Schizotypal</td>
    <td>Think “T” for thoughts. Odd behavior/appearance; exhibit cognitive</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>
      or perceptual distortions (eg, magical thinking, ideas of reference)
    </td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Cuuster B:“WiLb”</td>
    <td></td>
  </tr>
  <tr>
    <td>Borderline</td>
    <td>
      Unstable mood/relationships and feelings of emptiness; impulsive; high
      risk of suicidal ideation or self-harm
    </td>
    <td>
      Patients change the rules, demand attention, and feel that they are
      special
    </td>
  </tr>
  <tr>
    <td>Histrionic</td>
    <td>Excessively emotional and attention seeking; sexually provocative</td>
    <td>
      Patient will manipulate staff and doctor (“splitting”) Be firm: Stick to
      the treatment plan
    </td>
  </tr>
  <tr>
    <td>pafich Narcissistic</td>
    <td>
      F on - Grandiose; need admiration; have sense of entitlement; lack empathy
    </td>
    <td>
      Be fair: Do not be punitive or derogator Pr 9 y Be consistent: Do not
      change the rules
    </td>
  </tr>
  <tr>
    <td>Antisocial</td>
    <td>Violate the rights of others, social norms, and laws; impulsive;</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>lack remorse; may have a criminal history; begins in childhood as</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>conduct disorder</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Pulmonary Function Testing</td>
    <td>358</td>
  </tr>
  <tr>
    <td>Asthma</td>
    <td>359</td>
  </tr>
  <tr>
    <td>Chronic Obstructive Pulmonary Disease</td>
    <td>360</td>
  </tr>
  <tr>
    <td>Hypoxia and Hypoxemia</td>
    <td>362</td>
  </tr>
  <tr>
    <td>Pleural Effusion</td>
    <td>363</td>
  </tr>
  <tr>
    <td>Pneumothorax</td>
    <td>364</td>
  </tr>
  <tr>
    <td>TENSION PNEUMOTHORAX</td>
    <td>365</td>
  </tr>
  <tr>
    <td>Pulmonary Embolism</td>
    <td>365</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SETTING</th>
    <th>FEV,/FVC</th>
    <th>TLC</th>
    <th>DLco</th>
  </thead>
  <tr>
    <td>Asthma</td>
    <td>Normal/L</td>
    <td>Normal/T</td>
    <td>Normal/T</td>
  </tr>
  <tr>
    <td>COPD</td>
    <td>L</td>
    <td>tT</td>
    <td>L</td>
  </tr>
  <tr>
    <td>Fibrotic disease</td>
    <td>Normal/T</td>
    <td>L</td>
    <td>Lj</td>
  </tr>
  <tr>
    <td>Extrathoracic restriction</td>
    <td>Normal</td>
    <td>L</td>
    <td>Normal</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>Symptoms (Day/NicHT)</th>
    <th>FEV,</th>
    <th>MepicaTions</th>
  </thead>
  <tr>
    <td rowspan="3">Mild intermittent</td>
    <td>= 2 days/week</td>
    <td>= 80%</td>
    <td>Step 1:</td>
  </tr>
  <tr>
    <td></td>
    <td>|= 2nights/month</td>
    <td></td>
    <td>No daily medications</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>SABA (albuterol) PRN</td>
  </tr>
  <tr>
    <td>Mild</td>
    <td>&gt; 2 times/week but</td>
    <td>= 80%</td>
    <td>Step 2:</td>
  </tr>
  <tr>
    <td rowspan="2">persistent</td>
    <td>&lt;1 time/day</td>
    <td></td>
    <td>Daily low-dose ICS</td>
  </tr>
  <tr>
    <td></td>
    <td>&gt; 2 nights/month</td>
    <td></td>
    <td>SABA (albuterol) PRN</td>
  </tr>
  <tr>
    <td>Moderate</td>
    <td>Daily</td>
    <td>60-80%</td>
    <td>Step 3:</td>
  </tr>
  <tr>
    <td rowspan="3">persistent</td>
    <td>&gt; 1 night/week</td>
    <td></td>
    <td>Low-dose ICS + LABA or</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Medium-dose ICS</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>SABA (albuterol) PRN</td>
  </tr>
  <tr>
    <td>Severe</td>
    <td>Continual, frequent</td>
    <td>= 60%</td>
    <td>Step 4: Medium dose ICS + LABA</td>
  </tr>
  <tr>
    <td rowspan="6">persistent</td>
    <td></td>
    <td></td>
    <td></td>
    <td>Step 5 (if unable to control symptoms):</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>High-dose ICS + LABA</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Step 6 (if still unable to control</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>symptoms): High-dose ICS + LABA</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>+ PO SABA (albuterol)</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>PRN for all steps</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Transudative</td>
    <td>&lt;0.5</td>
    <td></td>
  </tr>
  <tr>
    <td>Exudative</td>
    <td>&gt;05</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Transudative</td>
    <td>&lt;0.6</td>
    <td></td>
  </tr>
  <tr>
    <td>Exudative</td>
    <td>&gt;06</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Transudative</td>
    <td>&lt;% upper limit of</td>
  </tr>
  <tr>
    <td></td>
    <td>normal (ULN) for</td>
  </tr>
  <tr>
    <td></td>
    <td>reference laboratory</td>
  </tr>
  <tr>
    <td colspan="2">Exudative &gt; 4 ULN for refer-</td>
  </tr>
  <tr>
    <td></td>
    <td>ence laboratory</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Preurat Assay</th>
    <th>VaLuE</th>
    <th>DIFFERENTIAL</th>
  </thead>
  <tr>
    <td>Glucose</td>
    <td>&lt;60</td>
    <td>Empyema, parapneumonic, TB, rheumatologic, malignancy</td>
  </tr>
  <tr>
    <td>WBCs</td>
    <td>&gt; 10,000</td>
    <td>Empyema, parapneumonic, rheumatoid arthritis, malignancy</td>
  </tr>
  <tr>
    <td>RBCs</td>
    <td>&gt; 100,000</td>
    <td>Traumatic tap, hemothorax, PE, malignancy</td>
  </tr>
  <tr>
    <td colspan="3">Cellular differential</td>
  </tr>
  <tr>
    <td>Lymphocytes</td>
    <td>85—95% of total nucleated cells</td>
    <td>TB, sarcoid, malignancy, chylothorax</td>
  </tr>
  <tr>
    <td>Polymorphonuclear leukocytes</td>
    <td>Nonspecific</td>
    <td>Empyema, PE</td>
  </tr>
  <tr>
    <td>Eosinophils</td>
    <td>&gt;10% total nucleated cells</td>
    <td>Bleeding, pneumothorax</td>
  </tr>
  <tr>
    <td>pH</td>
    <td>&lt;7.20</td>
    <td>Complicated effusion, empyema, rheumatologic</td>
  </tr>
  <tr>
    <td>Triglycerides</td>
    <td>&gt;110</td>
    <td>Diagnostic of chylothorax</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="2">Nobute Size</th>
    <th colspan="2">Fo.tow-up</th>
  </thead>
  <thead>
    <th></th>
    <th>Low Risk</th>
    <th>Hicu Risk</th>
  </thead>
  <tr>
    <td>&lt;6mm</td>
    <td>No routine follow-up</td>
    <td>Optional CT at 12 months</td>
  </tr>
  <tr>
    <td>6-8 mm</td>
    <td>CT at 6-12 months</td>
    <td>CT at 6-12 and 18-24 months</td>
  </tr>
  <tr>
    <td>&gt;8mm</td>
    <td>Serial CT, PET scan, or excision</td>
    <td>based on radiographic characteristics</td>
  </tr>
</table>
<table>
  <tr>
    <td>GLaucomaA</td>
  </tr>
  <tr>
    <td>Diasetic RETINOPATHY</td>
  </tr>
  <tr>
    <td>Herpes ZOSTER OPHTHALMICUS</td>
  </tr>
  <tr>
    <td>ar, Nose, and Throat</td>
  </tr>
  <tr>
    <td>INFLUENZA</td>
  </tr>
  <tr>
    <td>Hearine Loss</td>
  </tr>
  <tr>
    <td>AtterGic RHINITIS</td>
  </tr>
  <tr>
    <td>EpisTaxis</td>
  </tr>
  <tr>
    <td>ermatology</td>
  </tr>
  <tr>
    <td>“DerM TERMS”</td>
  </tr>
  <tr>
    <td>Atopic Dermatitis (ECZEMA)</td>
  </tr>
  <tr>
    <td>Contact Dermatitis</td>
  </tr>
  <tr>
    <td>Psoriasis</td>
  </tr>
  <tr>
    <td>ErytHema Noposum</td>
  </tr>
  <tr>
    <td>Rosacea</td>
  </tr>
  <tr>
    <td>EryTHEMA MULTIFORME</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>12</td>
    <td>Buttous PEMPHIGOID</td>
    <td>21</td>
  </tr>
  <tr>
    <td>13</td>
    <td>Acne Vutearis (Common Acne)</td>
    <td>21</td>
  </tr>
  <tr>
    <td>13</td>
    <td>Herpes Zoster (SHINGLES)</td>
    <td>21</td>
  </tr>
  <tr>
    <td>14</td>
    <td>DeRMATOPHYTOSES</td>
    <td>22</td>
  </tr>
  <tr>
    <td></td>
    <td>Basa Cett CarcINOMA</td>
    <td>22</td>
  </tr>
  <tr>
    <td>14</td>
    <td>Sauamous CeLt CARCINOMA</td>
    <td>23</td>
  </tr>
  <tr>
    <td>15 15</td>
    <td>MELANOMA</td>
    <td>24</td>
  </tr>
  <tr>
    <td>15</td>
    <td>Genitourinary Disorders</td>
    <td>24</td>
  </tr>
  <tr>
    <td></td>
    <td>ErectiLe DysFUNCTION</td>
    <td>24</td>
  </tr>
  <tr>
    <td></td>
    <td>BeniGN Prostatic HYPERPLASIA</td>
    <td>25</td>
  </tr>
  <tr>
    <td></td>
    <td>TESTICULAR Masses/Groin Pain IN Men</td>
    <td>26</td>
  </tr>
  <tr>
    <td></td>
    <td>Health Care Maintenance</td>
    <td>26</td>
  </tr>
  <tr>
    <td></td>
    <td>CANCER SCREENING</td>
    <td>26</td>
  </tr>
  <tr>
    <td></td>
    <td>OrHeR ROuTINE SCREENING</td>
    <td>26</td>
  </tr>
  <tr>
    <td></td>
    <td>IMMUNIZATIONS</td>
    <td>28</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Conbuctive</th>
    <th>SENSORINEURAL</th>
  </thead>
  <tr>
    <td>Location of damage</td>
    <td>Outer and middle ear</td>
    <td>Inner ear</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>
      Weber test: A vibrating tuning fork in the middle of the patient's
      forehead will sound louder in the affected ear Rinne test: Place a
      vibrating tuning fork against the patient's mastoid bone and replace
      immediately near the external meatus once it is no longer audible; bone
      conduction will be audible longer than air conduction
    </td>
    <td>
      Weber test: A vibrating tuning fork in the middle of the patient's
      forehead will sound louder in the normal ear Rinne test: Same maneuver;
      air conduction will be audible longer than bone conduction
    </td>
  </tr>
  <tr>
    <td rowspan="8">Examples</td>
    <td>Cerumen impaction</td>
    <td>Presbycusis (age-related)</td>
  </tr>
  <tr>
    <td></td>
    <td>Otitis media</td>
    <td>Drug-induced (eg, aspirin, aminoglycosides)</td>
  </tr>
  <tr>
    <td></td>
    <td>Otitis externa</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Tumor/mass</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Otosclerosis (progressive fixation of stapes)</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Foreign bodies</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Barotrauma</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Perforation of tympanic membrane</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>DescrIPTION</th>
    <th>ExampLe</th>
  </thead>
  <tr>
    <td>Macule</td>
    <td>Flat, circumscribed, &lt; 0.5 cm in diameter</td>
    <td>Lentigo, café-au-lait spot, nevi (Image A)</td>
  </tr>
  <tr>
    <td>Patch</td>
    <td>Flat, &gt; 0.5 cm in diameter</td>
    <td>Café-au-lait spot, vitiligo (Image B)</td>
  </tr>
  <tr>
    <td>Papule</td>
    <td>Elevated, palpable, &lt; 0.5 cm in diameter</td>
    <td>Nevi, molluscum contagiosum (Image C)</td>
  </tr>
  <tr>
    <td>Plaque</td>
    <td>Elevated, palpable, &gt; 0.5 cm in diameter</td>
    <td>Psoriasis, lichen simplex chronicus, oral leukoplakia (Image D)</td>
  </tr>
  <tr>
    <td>Nodule</td>
    <td>
      Circumscribed, elevated, solid, 0.5-2.0 cm in diameter; located in the
      epidermis or deeper
    </td>
    <td>Rheumatoid nodules, xanthomas (Image E)</td>
  </tr>
  <tr>
    <td>Tumor</td>
    <td>Large, circumscribed, solid; located deep in tissue</td>
    <td>Neoplasms (Image F)</td>
  </tr>
  <tr>
    <td>Vesicle</td>
    <td>Circumscribed, elevated, fluid-filled, &lt; 0.5 cm in diameter</td>
    <td>Herpes lesions (Image G), varicella-zoster lesions</td>
  </tr>
  <tr>
    <td>Bullae</td>
    <td>Circumscribed, elevated, fluid-filled, &gt; 0.5 cm in diameter</td>
    <td>Coma blisters, pemphigus (Image H), epidermolysis bullosa</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Cervical</td>
    <td>
      A Pap smear is recommended starting at age 21 until age 75 regardless of
      sexual activity; (stop at age 65 if patient has three consecutive ©
      screenings)
    </td>
  </tr>
  <tr>
    <td></td>
    <td>Screen every 3 years if patient has had a normal Pap</td>
  </tr>
  <tr>
    <td>Breast</td>
    <td>
      Those &gt; 30 years of age may 7 the screening interval to 5 years if the
      Pap is performed with HPV PCR testing Mammography should be conducted 2
      after 50 (earlier if there is @ family history at age)
    </td>
  </tr>
  <tr>
    <td>cancer</td>
    <td>
      When mammographic screening should begin is controversial. The USPSTF
      recommends: Biennial screening mammography for women 50-74 years of age
      For patients in their 40s, the decision to begin screening should be
      thoroughly discussed with their doctors
    </td>
  </tr>
  <tr>
    <td rowspan="4">Colorectal cancer</td>
    <td>
      In patients without a family history of colorectal cancer, screening
      should start at 50 years of age. A colonoscopy every 10 years
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      is recommended, but other accepted screening tools include flexible
      sigmoidoscopy every 3-5 years or an annual hemoccult If a first-degree
      relative has colon cancer, begin screening at age 40 or when the patient
      is 10 years younger than the age at which that relative was diagnosed,
      whichever comes first American College of Gastroenterology recommends that
      African-Americans be screened at age 40-45 for colon cancer
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Prostate</td>
    <td>Controversial. USPSTF 2017 Guidelines recommend:</td>
  </tr>
  <tr>
    <td>cancer</td>
    <td>
      Men 55-69 years of age: Decision to initiate screening should be
      individualized based on risk factors (eg, family history,
    </td>
  </tr>
  <tr>
    <td></td>
    <td>African-American, or urinary changes)</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Men &gt; 69 years: Recommend against PSA-based screening for prostate
      cancer
    </td>
  </tr>
  <tr>
    <td>Lung</td>
    <td>
      Controversial. The USPSTF recommends annual screening for lung cancer with
      a low-dose CT scan at 55-80 years of age if the
    </td>
  </tr>
  <tr>
    <td>cancer</td>
    <td>
      patient has a 30-pack-year smoking history and is currently smoking or
      quit within the past 15 years
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Immunization</th>
    <th>Inpication/RECOMMENDATION</th>
  </thead>
  <thead>
    <th>Tetanus</th>
    <th>
      Give 1° series in childhood followed by boosters every 10 years (see
      Chapter 4)
    </th>
  </thead>
  <tr>
    <td>Hepatitis B</td>
    <td>
      Administer to all infants and to patients at 7 risk (eg, IV drug users,
      health care providers, those with chronic liver disease)
    </td>
  </tr>
  <tr>
    <td>Pneumococcal _</td>
    <td>
      Give to those = 65 years of age or to any patient at T risk (eg, patients
      with splenectomy, chronic obstructive pulmonary disease, or diabetes;
      alcoholics; or immunocompromised patients such as those on chemo- therapy,
      posttransplant, or HIV @)
    </td>
  </tr>
  <tr>
    <td>Influenza</td>
    <td>Give annually to all patients &gt; 6 months of age</td>
  </tr>
  <tr>
    <td>Hepatitis A</td>
    <td>
      Give to those traveling to endemic areas, those with chronic liver disease
      (HBV or HCV), and IV drug abusers:
    </td>
  </tr>
  <tr>
    <td>Zoster</td>
    <td>
      Recommended for all patients = 60 years of age who have no contraindi-
      cations, including those who report a previous episode of zoster or who
      have chronic medical conditions
    </td>
  </tr>
  <tr>
    <td>Smallpox</td>
    <td>
      Currently recommended only for those working in laboratories in which they
      are exposed to the virus
    </td>
  </tr>
  <tr>
    <td>Meningococcal</td>
    <td>
      The CDC recommends that all children 11-12 years of age be vaccinated and
      that a booster dose be given at age 16
    </td>
  </tr>
</table>
<table>
  <tr>
    <td>tow to Use This Section</td>
    <td>377</td>
    <td>Case 31</td>
    <td>404</td>
  </tr>
  <tr>
    <td>Jeadache</td>
    <td>378</td>
    <td>Case 32</td>
    <td>406</td>
  </tr>
  <tr>
    <td>Case 1</td>
    <td>378</td>
    <td>Case 33</td>
    <td>406</td>
  </tr>
  <tr>
    <td>Case 2</td>
    <td>378</td>
    <td>Case 34</td>
    <td>408</td>
  </tr>
  <tr>
    <td>Case 3</td>
    <td>378</td>
    <td>Case 35</td>
    <td>408</td>
  </tr>
  <tr>
    <td>Case 4</td>
    <td>380</td>
    <td>Abdominal Pain</td>
    <td>410</td>
  </tr>
  <tr>
    <td>Case 5</td>
    <td>380</td>
    <td>Case 36</td>
    <td>410</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Case 37</td>
    <td>410</td>
  </tr>
  <tr>
    <td>\ltered Mental Status/Loss of Consciousness</td>
    <td>382</td>
    <td>Case 38</td>
    <td>410</td>
  </tr>
  <tr>
    <td>Case 6</td>
    <td>382</td>
    <td>Case 39</td>
    <td>412</td>
  </tr>
  <tr>
    <td>Case 7</td>
    <td>382</td>
    <td>Case 40</td>
    <td>412</td>
  </tr>
  <tr>
    <td>Case 8</td>
    <td>384</td>
    <td>Case 41</td>
    <td>414</td>
  </tr>
  <tr>
    <td>Case 9</td>
    <td>384</td>
    <td>Case 42</td>
    <td>414</td>
  </tr>
  <tr>
    <td>Case 10</td>
    <td>386</td>
    <td>Case 43</td>
    <td>416</td>
  </tr>
  <tr>
    <td>Case 11</td>
    <td>386</td>
    <td>Case 44</td>
    <td>416</td>
  </tr>
  <tr>
    <td>Case 12</td>
    <td>388</td>
    <td>Case 45</td>
    <td>416</td>
  </tr>
  <tr>
    <td>‘atigue/Weakness</td>
    <td>388</td>
    <td>Case 46</td>
    <td>418</td>
  </tr>
  <tr>
    <td>Case 13</td>
    <td>388</td>
    <td>Case 47</td>
    <td>418</td>
  </tr>
  <tr>
    <td>Case 14</td>
    <td>390</td>
    <td>Case 48</td>
    <td>418</td>
  </tr>
  <tr>
    <td>Case 15</td>
    <td>390</td>
    <td>Case 49</td>
    <td>420</td>
  </tr>
  <tr>
    <td>Case 16</td>
    <td>390</td>
    <td>Case 50</td>
    <td>420</td>
  </tr>
  <tr>
    <td>Case 17</td>
    <td>392</td>
    <td>Case 51</td>
    <td>422</td>
  </tr>
  <tr>
    <td>“ough/Shortness of Breath</td>
    <td>392</td>
    <td>Case 52</td>
    <td>422</td>
  </tr>
  <tr>
    <td>Case 18</td>
    <td>392</td>
    <td>Constipation/Diarrhea</td>
    <td>424</td>
  </tr>
  <tr>
    <td>Case 19</td>
    <td>392</td>
    <td>Case 53</td>
    <td>424</td>
  </tr>
  <tr>
    <td>Case 20</td>
    <td>394</td>
    <td>Case 54</td>
    <td>424</td>
  </tr>
  <tr>
    <td>Case 21</td>
    <td>394</td>
    <td>Case 55</td>
    <td>426</td>
  </tr>
  <tr>
    <td>Case 22</td>
    <td>396</td>
    <td>Case 56</td>
    <td>426</td>
  </tr>
  <tr>
    <td>Case 23</td>
    <td>396</td>
    <td>Case 57</td>
    <td>428</td>
  </tr>
  <tr>
    <td>Case 24</td>
    <td>398</td>
    <td>Case 58</td>
    <td>428</td>
  </tr>
  <tr>
    <td>Case 25</td>
    <td>398</td>
    <td>Case 59</td>
    <td>428</td>
  </tr>
  <tr>
    <td>Case 26</td>
    <td>400</td>
    <td>Gl Bleeding</td>
    <td>430</td>
  </tr>
  <tr>
    <td>Case 27</td>
    <td>400</td>
    <td>Case 60</td>
    <td>430</td>
  </tr>
  <tr>
    <td>“hest Pain</td>
    <td>402</td>
    <td>Case 61</td>
    <td>432</td>
  </tr>
  <tr>
    <td>Case 28</td>
    <td>402</td>
    <td>Case 62</td>
    <td>432</td>
  </tr>
  <tr>
    <td>Case 29</td>
    <td>402</td>
    <td>Case 63</td>
    <td>434</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Hematuria</td>
    <td>434</td>
    <td>Case 82</td>
    <td>448</td>
  </tr>
  <tr>
    <td>Case 64</td>
    <td>434</td>
    <td>Case 83</td>
    <td>450</td>
  </tr>
  <tr>
    <td>Case 65</td>
    <td>434</td>
    <td>Case 84</td>
    <td>450</td>
  </tr>
  <tr>
    <td>Case 66</td>
    <td>436</td>
    <td>Case 85</td>
    <td>452</td>
  </tr>
  <tr>
    <td>Other Urinary Symptoms</td>
    <td>436</td>
    <td>Case 86</td>
    <td>452</td>
  </tr>
  <tr>
    <td>Case 67</td>
    <td>436</td>
    <td>Child with Fever</td>
    <td>454</td>
  </tr>
  <tr>
    <td>Case 68</td>
    <td>436</td>
    <td>Case 87</td>
    <td>454</td>
  </tr>
  <tr>
    <td>Case 69</td>
    <td>438</td>
    <td>Case 88</td>
    <td>454</td>
  </tr>
  <tr>
    <td>Case 70</td>
    <td>438</td>
    <td>Case 89</td>
    <td>456</td>
  </tr>
  <tr>
    <td>Amenorrhea</td>
    <td>440</td>
    <td>Case 90</td>
    <td>456</td>
  </tr>
  <tr>
    <td>Case 71</td>
    <td>440</td>
    <td>Fever</td>
    <td>458</td>
  </tr>
  <tr>
    <td>Case 72</td>
    <td>440</td>
    <td>Case 91</td>
    <td>458</td>
  </tr>
  <tr>
    <td>Case 73</td>
    <td>442</td>
    <td>Case 92</td>
    <td>458</td>
  </tr>
  <tr>
    <td>Vaginal Bleeding</td>
    <td>442</td>
    <td>Case 93 Case 94</td>
    <td>460 460</td>
  </tr>
  <tr>
    <td>Case 74</td>
    <td>442</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Case 75</td>
    <td>444</td>
    <td>Outpatient Potpourri</td>
    <td>462</td>
  </tr>
  <tr>
    <td>Case 76</td>
    <td>444</td>
    <td>Case 95</td>
    <td>462</td>
  </tr>
  <tr>
    <td>Case 77</td>
    <td>444</td>
    <td>Case 96</td>
    <td>462</td>
  </tr>
  <tr>
    <td>Musculoskeletal Pain</td>
    <td>446</td>
    <td>Case 97</td>
    <td>462</td>
  </tr>
  <tr>
    <td>Case 78</td>
    <td>446</td>
    <td>Case 98</td>
    <td>464</td>
  </tr>
  <tr>
    <td>Case 79</td>
    <td>446</td>
    <td>Case 99</td>
    <td>464</td>
  </tr>
  <tr>
    <td>Case 80</td>
    <td>448</td>
    <td>Case 100</td>
    <td>464</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>When ReapiNnG...</th>
    <th>Ask YourseLF ...</th>
  </thead>
  <tr>
    <td rowspan="2">History</td>
    <td>
      What should | be looking for on vital signs (VS) and physical examination
      (PE)?
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      Do | need to stabilize the patient or perform an emergency procedure
      before conducting a PE?
    </td>
  </tr>
  <tr>
    <td>Physical exam</td>
    <td>
      What are the most likely diagnoses that explain the patient’s
      presentation?
    </td>
  </tr>
  <tr>
    <td rowspan="3">Differential</td>
    <td>
      What are the initial diagnostic tests and treatments that should be done?
    </td>
  </tr>
  <tr>
    <td></td>
    <td>
      Does the patient need to be transferred to another location (eg, from the
      ED to the ICU)?
    </td>
  </tr>
  <tr>
    <td></td>
    <td>Does the clock need to be advanced?</td>
  </tr>
  <tr>
    <td rowspan="2">Initial management</td>
    <td></td>
    <td>What additional workup and management should occur?</td>
  </tr>
  <tr>
    <td>Can the patient be discharged or transferred to another setting?</td>
  </tr>
  <tr>
    <td rowspan="2">Continuing management</td>
    <td>
      What should be done in follow-up, including long-term disease management,
      health maintenance, and patient counseling?
    </td>
  </tr>
  <tr>
    <td></td>
    <td>Should any treatment or monitoring be stopped?</td>
  </tr>
  <tr>
    <td>Follow-up</td>
    <td>What is the final diagnosis?</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>21 yo F presents with a severe headache.</td>
    <td>VS:T 37°C (99.2°F), P 70, BP 120/80, RR 15,</td>
    <td>Migraine (hemiplegic)</td>
  </tr>
  <tr>
    <td>She has a history of throbbing left temporal</td>
    <td>O, sat 100% room air</td>
    <td>Migraine (complicated)</td>
  </tr>
  <tr>
    <td>pain that lasts for 2-3 hours. Before these</td>
    <td>Gen: NAD</td>
    <td>Cluster headache</td>
  </tr>
  <tr>
    <td>episodes start, she sees flashes of light in</td>
    <td>Lungs: WNL</td>
    <td>Intracranial neoplasm</td>
  </tr>
  <tr>
    <td>her right visual field and feels weakness</td>
    <td>CV: WNL</td>
    <td>Partial seizure</td>
  </tr>
  <tr>
    <td>and numbness on the right side of her body</td>
    <td>Abd: WNL</td>
    <td>Pseudotumor cerebri</td>
  </tr>
  <tr>
    <td>for a few minutes. The headaches are often</td>
    <td>Ext: WNL</td>
    <td>Tension headache</td>
  </tr>
  <tr>
    <td>associated with nausea and vomiting. She</td>
    <td>Neuro: WNL</td>
    <td>Trigeminal neuralgia</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>29 yo F presents with daily episodes of</td>
    <td>VS: Afebrile, P 70, BP 120/80, RR 15</td>
    <td>Tension-type headache</td>
  </tr>
  <tr>
    <td>bilateral band-like throbbing pain in her</td>
    <td>Gen: NAD</td>
    <td>Cluster headache</td>
  </tr>
  <tr>
    <td>frontal-occipital region that last between</td>
    <td>Lungs: WNL</td>
    <td>Intracranial neoplasm</td>
  </tr>
  <tr>
    <td>30 minutes and a few hours. She usually</td>
    <td>CV: WNL</td>
    <td>Meningitis</td>
  </tr>
  <tr>
    <td>experiences these episodes when she is</td>
    <td>Abd: WNL</td>
    <td>Migraine</td>
  </tr>
  <tr>
    <td>either tired or under stress. She denies any</td>
    <td>Ext: WNL</td>
    <td>Pseudotumor cerebri</td>
  </tr>
  <tr>
    <td>associated nausea, vomiting, phonophobia,</td>
    <td>Neuro: WNL, vision normal</td>
    <td>Sinusitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>65 yo F presents with a severe intermittent</td>
    <td>VS:T 37°C (99°F), P 85, BP 140/85, RR 18, O,</td>
    <td>Cluster headache</td>
  </tr>
  <tr>
    <td>headache in the right temporal lobe together</td>
    <td>sat 100% room air</td>
    <td>Glaucoma</td>
  </tr>
  <tr>
    <td>with blurred vision in her right eye and pain</td>
    <td>Gen: NAD</td>
    <td>Intracranial neoplasm</td>
  </tr>
  <tr>
    <td rowspan="8">in her jaw during mastication.</td>
    <td>HEENT: Tenderness on temporal artery</td>
    <td>Meningitis</td>
  </tr>
  <tr>
    <td></td>
    <td>palpation</td>
    <td>Migraine</td>
  </tr>
  <tr>
    <td></td>
    <td>Neck: No rigidity</td>
    <td>Temporal (giant cell) arteritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Tension-type headache</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Trigeminal neuralgia</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Follow up in 1 month</td>
  </tr>
  <tr>
    <td>CT-head</td>
    <td>Prophylactic therapy if patient experiences</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>four or more migraines per month—</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>8-blockers (propranolol), calcium-channel</td>
  </tr>
  <tr>
    <td>ESR</td>
    <td>blockers, TCAs, SSRIs, valproic acid,</td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>topiramate, or gabapentin</td>
  </tr>
  <tr>
    <td colspan="2">IV normal saline</td>
  </tr>
  <tr>
    <td colspan="2">IV promethazine, prochlorperazine, or</td>
  </tr>
  <tr>
    <td colspan="2">metoclopramide</td>
  </tr>
  <tr>
    <td colspan="2">Aspirin, NSAIDs, or acetaminophen</td>
  </tr>
  <tr>
    <td colspan="2">Caffeine</td>
  </tr>
  <tr>
    <td colspan="2">IM sumatriptan or ergotamine (if the</td>
  </tr>
  <tr>
    <td>patient does not improve)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Follow up in 1 month</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td></td>
    <td>Nonpharmacologic therapies</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td></td>
    <td>(acupuncture, biofeedback, relaxation</td>
  </tr>
  <tr>
    <td>ESR</td>
    <td></td>
    <td>exercises)</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Cold compresses</td>
  </tr>
  <tr>
    <td colspan="3">Acetaminophen +/— caffeine (preferred in</td>
  </tr>
  <tr>
    <td colspan="3">pregnancy)</td>
  </tr>
  <tr>
    <td colspan="3">Aspirin +/— caffeine</td>
  </tr>
  <tr>
    <td>NSAIDs +/— caffeine</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Emergency room STAT</td>
    <td>Ward W/U</td>
    <td>Discharge home</td>
  </tr>
  <tr>
    <td>IV normal saline</td>
    <td>Ophthalmology consult</td>
    <td>Continue low-dose maintenance</td>
  </tr>
  <tr>
    <td>Prednisone</td>
    <td>Temporal artery biopsy: @ for temporal</td>
    <td>prednisone with slow taper</td>
  </tr>
  <tr>
    <td>Emergency room W/U</td>
    <td>arteritis</td>
    <td>ESR in 2 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>ESR every morning</td>
    <td>Adequate dietary calcium and vitamin D if</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Screen for polymyalgia rheumatica</td>
    <td>glucocorticoids are to be used chronically</td>
  </tr>
  <tr>
    <td>MRI/MRA—brain: ©</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR:</td>
    <td>Continue high-dose glucocorticoid for</td>
    <td></td>
  </tr>
  <tr>
    <td>ESR: TT</td>
    <td>2-4 weeks and then taper</td>
    <td></td>
  </tr>
  <tr>
    <td>cep: TT</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>sents with a high fever, severe</td>
    <td>VS:T 39°C (103°F), P 95, BP 150/85, RR 18,</td>
    <td>Encephalitis</td>
  </tr>
  <tr>
    <td rowspan="8">and photophobia; lives in college</td>
    <td>O, sat 100% room air</td>
    <td>Intracranial or epidural abscess</td>
  </tr>
  <tr>
    <td></td>
    <td>Gen: Moderate distress</td>
    <td>Meningitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Neck: Nuchal rigidity</td>
    <td>Migraine</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Sinusitis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Subarachnoid hemorrhage</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: @ Kernig and Brudzinski signs</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>history of</td>
    <td>VS:T 37°C (99.3°F), P 100, BP 220/120, RR 20,</td>
    <td>Cluster headache</td>
  </tr>
  <tr>
    <td>vith severe headache,</td>
    <td>O, sat 95% room air</td>
    <td>Hypertensive emergency</td>
  </tr>
  <tr>
    <td>he patient states that</td>
    <td>Gen: Severe distress</td>
    <td>hypertension)</td>
  </tr>
  <tr>
    <td>vetoprolol because he</td>
    <td>HEENT: Fundoscopy reveals papilledema</td>
    <td>Intracranial hemorrhage</td>
  </tr>
  <tr>
    <td rowspan="5">need it anymore.</td>
    <td>Lungs: WNL</td>
    <td>Intracranial neoplasm</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Migraine</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>ICU W/U</td>
    <td>Transfer to the floor</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Continuous cardiac monitoring</td>
    <td>Counsel patient re: medication compliance</td>
  </tr>
  <tr>
    <td>IV B-blocker (labetalol)</td>
    <td>Lipid profile</td>
    <td>Discharge home</td>
  </tr>
  <tr>
    <td>BP in both arms</td>
    <td>Echocardiography: EF &lt; 45%</td>
    <td>Follow up in 1 week</td>
  </tr>
  <tr>
    <td>CT—head: White matter changes.</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>consistent with hypertension</td>
    <td>Switch to oral agents after first 24 hours;</td>
    <td></td>
  </tr>
  <tr>
    <td>ECG: Left ventricular hypertrophy</td>
    <td>labetalol or metoprolol if good control</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>previously</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>ACEIs (low EF)</td>
    <td></td>
  </tr>
  <tr>
    <td>Cardiac/BP monitoring</td>
    <td>HCTZ</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CPK-MB, troponin X 3:©</td>
  </tr>
  <tr>
    <td colspan="3">CBC</td>
  </tr>
  <tr>
    <td colspan="3">Chem 8</td>
  </tr>
  <tr>
    <td colspan="3">UA</td>
  </tr>
  <tr>
    <td>UTOX</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>9 yo Mis brought in by his family</td>
    <td>VS: Afebrile, P 92, BP 144/86, RR 14</td>
    <td>Alzheimer disease</td>
  </tr>
  <tr>
    <td>omplaining of a 7-week history of difficulty</td>
    <td>Gen: NAD</td>
    <td>Chronic subdural hematoma</td>
  </tr>
  <tr>
    <td>alking accompanied by memory loss and</td>
    <td>Lungs: WNL</td>
    <td>Cobalamin (vitamin B,,) deficiency</td>
  </tr>
  <tr>
    <td>rinary incontinence. Since then, he has had</td>
    <td>CV: WNL</td>
    <td>Frontal lobe syndromes</td>
  </tr>
  <tr>
    <td>creased difficulty with memory and more</td>
    <td>Abd: WNL</td>
    <td>Huntington disease</td>
  </tr>
  <tr>
    <td rowspan="6">equent episodes of incontinence.</td>
    <td>Ext: WNL</td>
    <td>Intracranial tumor</td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: Difficulty with both recent and imme-</td>
    <td>Meningitis</td>
  </tr>
  <tr>
    <td></td>
    <td>diate recall on mini-mental status exam;</td>
    <td>Normal pressure hydrocephalus</td>
  </tr>
  <tr>
    <td></td>
    <td>spasticity and hyperreflexia in upper and</td>
    <td>Parkinson disease</td>
  </tr>
  <tr>
    <td></td>
    <td>lower extremities; problem initiating gait</td>
    <td>Vascular dementia</td>
  </tr>
  <tr>
    <td></td>
    <td>(gait is shuffling, broad-based, and slow)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Patient counseling—adequate nutrition, limit</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>alcohol use, safety (eg, driving)</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Consider referral to cognitive rehabilitation</td>
  </tr>
  <tr>
    <td>TSH</td>
    <td>Support group</td>
  </tr>
  <tr>
    <td>Serum vitamin B,, level</td>
    <td>Advance directives</td>
  </tr>
  <tr>
    <td>Serum folic acid level</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td colspan="2">VDRL/RPR</td>
  </tr>
  <tr>
    <td>CT—head: Diffuse symmetrical atrophy</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Cholinesterase inhibitor (donepezil,</td>
  </tr>
  <tr>
    <td colspan="2">rivastigmine, and galantamine) or</td>
  </tr>
  <tr>
    <td>memantine (NMDA antagonist)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Advance directives</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Neurosurgery consult</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Neurology consult</td>
    <td>Supportive care</td>
  </tr>
  <tr>
    <td>LFTs</td>
    <td>Ventriculoperitoneal shunt</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">TSH</td>
  </tr>
  <tr>
    <td colspan="3">CT—head: Enlarged lateral ventricles</td>
  </tr>
  <tr>
    <td colspan="3">with no prominence of cortical sulci (out</td>
  </tr>
  <tr>
    <td colspan="3">of proportion to sulcal enlargement)</td>
  </tr>
  <tr>
    <td colspan="3">LP</td>
  </tr>
  <tr>
    <td colspan="3">Serum vitamin B,, level</td>
  </tr>
  <tr>
    <td>Serum folic acid level</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Gen: NAD, evidence of tongue biting</td>
  </tr>
  <tr>
    <td>Lungs: WNL</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
  </tr>
  <tr>
    <td>Abd: WNL</td>
  </tr>
  <tr>
    <td>Ext: WNL</td>
  </tr>
  <tr>
    <td>GU: wet underpants from bladder</td>
  </tr>
  <tr>
    <td>incontinence</td>
  </tr>
  <tr>
    <td>Neuro: Oriented, but in a state of confusior</td>
  </tr>
  <tr>
    <td>no focal neurologic deficits</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Rx</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Neurology consult</td>
    <td>Patient education—seizure precautions:</td>
  </tr>
  <tr>
    <td>Chem 7</td>
    <td></td>
    <td>avoid unsupervised activities that may be</td>
  </tr>
  <tr>
    <td>Calcium, magnesium, phosphate</td>
    <td></td>
    <td>dangerous with seizure or sudden loss of</td>
  </tr>
  <tr>
    <td>LFTs</td>
    <td></td>
    <td>consciousness</td>
  </tr>
  <tr>
    <td>ABG</td>
    <td></td>
    <td>Driving restriction—avoid driving until</td>
  </tr>
  <tr>
    <td>ECG</td>
    <td></td>
    <td>follow-up</td>
  </tr>
  <tr>
    <td>EEG</td>
    <td></td>
    <td>Consider anti-seizure drug therapy</td>
  </tr>
  <tr>
    <td colspan="3">CT—head</td>
  </tr>
  <tr>
    <td colspan="3">MRI—brain</td>
  </tr>
  <tr>
    <td colspan="3">UA</td>
  </tr>
  <tr>
    <td>UTOX</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>complaining</td>
    <td>VS:T 37°C (98.1°F), P 35, BP 114/54, RR 15</td>
    <td>Aortic stenosis</td>
  </tr>
  <tr>
    <td>coronary artery</td>
    <td>Gen: NAD</td>
    <td>Asystole</td>
  </tr>
  <tr>
    <td>igo. He reports</td>
    <td>Lungs: WNL</td>
    <td>Atrial fibrillation</td>
  </tr>
  <tr>
    <td>e past 5 days.</td>
    <td>CV: Bradycardia, irregular S, and S,</td>
    <td>Dilated cardiomyopathy</td>
  </tr>
  <tr>
    <td>by his wife,</td>
    <td>Abd: WNL</td>
    <td>Heart block</td>
  </tr>
  <tr>
    <td>id trauma. His</td>
    <td>Ext: WNL</td>
    <td>MI</td>
  </tr>
  <tr>
    <td>sness for about</td>
    <td>Neuro: Alert and oriented; CN II-XIl intact;</td>
    <td>Myocarditis</td>
  </tr>
  <tr>
    <td>le, the patient</td>
    <td>5/5 motor strength in all extremities</td>
    <td>Myopathy</td>
  </tr>
  <tr>
    <td>adedness. His</td>
    <td></td>
    <td>Restrictive cardiomyopathy</td>
  </tr>
  <tr>
    <td rowspan="3">olol, digoxin,</td>
    <td></td>
    <td>Vasodepressor/vasovagal res|</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>VI/VF</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Medication related (8-blocke</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>ICU W/U</td>
    <td>Cardiac rehabilitation program</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>ECG</td>
    <td>Counsel patient to limit alcohol intake</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Lipid profile</td>
    <td>Counsel patient not to drive</td>
  </tr>
  <tr>
    <td>LFTs</td>
    <td>Echocardiography</td>
    <td>Low-fat, low-sodium diet</td>
  </tr>
  <tr>
    <td>ECG: Third-degree AV block</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Cardiac enzymes</td>
    <td>Lipid-lowering agents</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum calcium, magnesium, phosphate,</td>
    <td>Cardiology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>digoxin level</td>
    <td>Cardiac catheterization, angiocardiography</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>Permanent cardiac pacemaker</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">UA</td>
  </tr>
  <tr>
    <td colspan="3">Supplemental O,</td>
  </tr>
  <tr>
    <td colspan="3">Continuous cardiac/BP monitoring</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>Temporary transvenous cardiac pacemaker</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ED STAT</th>
    <th>ICU W/U</th>
    <th>Monitor for at least 24 hours</th>
  </thead>
  <tr>
    <td>Airway protection</td>
    <td>Gastric lavage: Pill fragments</td>
    <td>Transfer to inpatient psychiatry upon</td>
  </tr>
  <tr>
    <td>IV thiamine</td>
    <td>Continuous monitoring: Patient started to</td>
    <td>medical clearance</td>
  </tr>
  <tr>
    <td>Fingerstick blood glucose</td>
    <td>become drowsy again (monitor events)</td>
    <td></td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>IV naloxone: Patient responded</td>
    <td>IV naloxone: Patient responded</td>
    <td></td>
  </tr>
  <tr>
    <td>ABG</td>
    <td>Suicide precautions</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Psychiatry consult</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Collateral information from patient's family</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 7</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3" rowspan="2">Calcium, magnesium, and phosphorus levels</td>
  </tr>
  <tr>
    <td colspan="3"></td>
  </tr>
  <tr>
    <td colspan="3">Acetaminophen and salicylate levels</td>
  </tr>
  <tr>
    <td colspan="3">Lactate level</td>
  </tr>
  <tr>
    <td colspan="3">PT/PTT or INR</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td>UA</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>UTOX, EtOH level UPREG</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>Ward W/U</td>
    <td>Counsel patient—smoking cessation, diet</td>
  </tr>
  <tr>
    <td>Assess ABCs</td>
    <td>Interval neurologic exam</td>
    <td>(low-fat, low-sodium, diabetic), exercise;</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Continuous cardiac/BP monitoring</td>
    <td>diabetic teaching</td>
  </tr>
  <tr>
    <td>Fingerstick glucose</td>
    <td>Telemetry</td>
    <td>Discharge on aspirin and statin for</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Lipid panel, Hb,).</td>
    <td>secondary prevention</td>
  </tr>
  <tr>
    <td>CT—head</td>
    <td>Echocardiography: EF 60%</td>
    <td>Pharmacologic management as</td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Carotid duplex: &gt; 75% stenosis in left</td>
    <td>indicated for hypertension, diabetes, and</td>
  </tr>
  <tr>
    <td>Continuous cardiac/BP monitoring</td>
    <td>carotid artery</td>
    <td>hyperlipidemia</td>
  </tr>
  <tr>
    <td>ECG</td>
    <td>Brain MRI</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Vascular surgery consult</td>
    <td></td>
  </tr>
  <tr>
    <td>PT/PTT or INR</td>
    <td>Patient is scheduled for elective carotid</td>
    <td></td>
  </tr>
  <tr>
    <td>Neurology consult</td>
    <td>endarterectomy</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Holter (cardiac) monitoring on discharge</td>
    <td></td>
  </tr>
  <tr>
    <td>Aspirin</td>
    <td>for 30 days</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>VS: Afebrile, P 115, BP 130/80 with orthostatic</td>
    <td>Functional n</td>
  </tr>
  <tr>
    <td>changes, RR 16</td>
    <td>(conversion</td>
  </tr>
  <tr>
    <td>Gen: NAD</td>
    <td>Guillain-Bari</td>
  </tr>
  <tr>
    <td>Lungs: WNL</td>
    <td>Myasthenia</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
    <td>Paraneoplas</td>
  </tr>
  <tr>
    <td>Ext: WNL</td>
    <td>Poliomyeliti</td>
  </tr>
  <tr>
    <td>Neuro: Loss of motor strength in lower limbs;</td>
    <td>Polymyositis</td>
  </tr>
  <tr>
    <td>absent DTRs in patella and Achilles tendon;</td>
    <td>Multiple scle</td>
  </tr>
  <tr>
    <td>sensation intact</td>
    <td>Transverse n</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>Dresents with fatigue, weight gain,</td>
    <td>VS:T 36°C (97°F), BP 100/60, HR 60</td>
    <td>Anemia</td>
  </tr>
  <tr>
    <td>somnolence, cold intolerance,</td>
    <td>Gen: Obese</td>
    <td>Diabetes mellitus</td>
  </tr>
  <tr>
    <td rowspan="6">ition, and dry skin.</td>
    <td>Skin: Dry</td>
    <td>Hypothyroidism</td>
  </tr>
  <tr>
    <td></td>
    <td>HEENT: Scar on neck from previous</td>
    <td>Major depressive disorder</td>
  </tr>
  <tr>
    <td></td>
    <td>thyroidectomy</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: Delayed relaxation of DTRs</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward Rx</td>
    <td>Follow up in 3-4 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Immunoglobulins</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Plasmapheresis</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>TSH</td>
    <td>Rehabilitative medicine consult</td>
    <td>Advise patient to use seat belts</td>
  </tr>
  <tr>
    <td>ESR</td>
    <td>Neurology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>CRP</td>
    <td>Immunology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>RF</td>
    <td>Measure forced vital capacity or negative</td>
    <td></td>
  </tr>
  <tr>
    <td>VDRL</td>
    <td>inspiratory force</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum B,&gt;</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Serum folic acid</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td>Serum CPK</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">LP: T CSF protein</td>
  </tr>
  <tr>
    <td>HIV testing, ELISA</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Check TSH with reflex T4 after 1 month</td>
  </tr>
  <tr>
    <td colspan="2">CBC</td>
  </tr>
  <tr>
    <td colspan="2">Chem 14</td>
  </tr>
  <tr>
    <td colspan="2">TSH: T</td>
  </tr>
  <tr>
    <td colspan="2">FTV</td>
  </tr>
  <tr>
    <td colspan="2">ECG</td>
  </tr>
  <tr>
    <td colspan="2">Lipid profile</td>
  </tr>
  <tr>
    <td colspan="2">PHQ-2 depression screen</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td>Levothyroxine</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 2 weeks with CBC</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>Advise patient to avoid contact sports for</td>
  </tr>
  <tr>
    <td>Peripheral smear: Atypical lymphocytes</td>
    <td>at least 4 weeks from acute illness</td>
  </tr>
  <tr>
    <td colspan="2">Chem 14: T AST and T ALT</td>
  </tr>
  <tr>
    <td colspan="2">ESR</td>
  </tr>
  <tr>
    <td colspan="2">CRP</td>
  </tr>
  <tr>
    <td colspan="2">Monospot test: ®</td>
  </tr>
  <tr>
    <td colspan="2">Serum EBV titer: T</td>
  </tr>
  <tr>
    <td colspan="2">Rapid strep</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Acetaminophen or NSAIDs</td>
  </tr>
  <tr>
    <td>Encourage adequate hydration</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th></th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>with pleuritic chest pain and</td>
    <td>VS: Afebrile, BP 120/75, HR 100, RR 24</td>
    <td>CHF</td>
    <td></td>
  </tr>
  <tr>
    <td>ath. She reports having fallen</td>
    <td>Gen: Respiratory distress</td>
    <td>Fat embolism</td>
    <td></td>
  </tr>
  <tr>
    <td>uffered a femoral fracture.</td>
    <td>HEENT: WNL</td>
    <td>Lung cancer</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="4">ast in place on her right leg.</td>
    <td>Lungs: Rales, wheezing, J breath sounds in</td>
    <td>MI</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>left lower base</td>
    <td>Pericarditis</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Loud P, and splitting of S,</td>
    <td>Pneumothorax</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Pulmonary</td>
    <td>embolism</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Follow up in 1 week</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td></td>
    <td>Supportive psychotherapy</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td></td>
    <td>Encourage healthy lifestyle (sleep hygiene,</td>
  </tr>
  <tr>
    <td>TSH</td>
    <td></td>
    <td>exercise)</td>
  </tr>
  <tr>
    <td colspan="3">UTOX</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Antidepressant (eg, SSRI)</td>
  </tr>
  <tr>
    <td colspan="3">Referral for psychotherapy</td>
  </tr>
  <tr>
    <td colspan="3">Counsel patient on safety precautions,</td>
  </tr>
  <tr>
    <td colspan="3">specifically if starting to feel suicidal</td>
  </tr>
  <tr>
    <td>present to nearest ED or call 911</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 2 weeks with PT/INR</td>
  </tr>
  <tr>
    <td>IV normal saline</td>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Chest physical therapy</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>Pulmonary medicine consult</td>
    <td>Warfarin</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>PT/PTT, INR</td>
    <td>Rehabilitative medicine consult</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>ABG: Hypoxia and hypocapnia</td>
    <td>Discontinue heparin 2 days after INR is</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Left lower lobe atelectasis, Hampton</td>
    <td>therapeutic</td>
    <td></td>
  </tr>
  <tr>
    <td>humps</td>
    <td>Warfarin</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CT—chest: Pulmonary embolism</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">DVT U/S: Venous DVT</td>
  </tr>
  <tr>
    <td>IV heparin, bridge to warfarin</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>VS:T 38°C (101°F), BP 110/65, HR 100, RR 22,</td>
    <td>Bacteric</td>
  </tr>
  <tr>
    <td>O, sat 100% room air Gen: Pallor and mild distress with</td>
    <td>Diphth</td>
  </tr>
  <tr>
    <td>respiratory intercostal retraction and nasal flaring</td>
    <td>Epiglot Foreign</td>
  </tr>
  <tr>
    <td>HEENT: WNL</td>
    <td>Laryngi</td>
  </tr>
  <tr>
    <td>Lungs: Stridor, hoarseness, barking cough</td>
    <td>Laryng«</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
    <td>Measle:</td>
  </tr>
  <tr>
    <td>Abd: WNL</td>
    <td>Periton</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th></th>
  </thead>
  <tr>
    <td>th</td>
    <td>VS: Afebrile, BP 130/85, HR 90, RR 15</td>
    <td>Lung cancer</td>
  </tr>
  <tr>
    <td></td>
    <td>Gen: WNL</td>
    <td>Lymphoma</td>
  </tr>
  <tr>
    <td></td>
    <td>Chest: Barrel-shaped chest, gynecomastia</td>
    <td>Leukemia</td>
  </tr>
  <tr>
    <td>oss of</td>
    <td>Lungs: Rales, wheezing, J breath sounds,</td>
    <td>Sarcoidosis</td>
  </tr>
  <tr>
    <td rowspan="6">5a 40</td>
    <td>dullness to percussion in left upper lobe</td>
    <td>Tuberculosis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Mild RUQ tenderness with mild</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>hepatomegaly</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: Finger clubbing; dark-colored, pruritic</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>rash on both forearms</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward Rx</td>
    <td>Follow up in 1 month</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Humidified air</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Nebulized epinephrine</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Systemic corticosteroids (eg, IM, IV, or oral</td>
    <td></td>
  </tr>
  <tr>
    <td>Throat culture</td>
    <td>dexamethasone)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>CBC: J hemoglobin</td>
    <td>PFTs</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Oncology consult</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>LFTs: T AST, T ALT</td>
    <td>Surgery consult</td>
    <td>Follow up in 3-4 weeks with CXR and CBC</td>
  </tr>
  <tr>
    <td>ABG</td>
    <td>Dietary consult</td>
    <td>Counsel patient to limit alcohol intake</td>
  </tr>
  <tr>
    <td>ESR: T</td>
    <td>Bronchoscopy with biopsy</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Infiltrate and nodules in left upper</td>
    <td>CT—abdomen and pelvis</td>
    <td></td>
  </tr>
  <tr>
    <td>lobe</td>
    <td>CT—head</td>
    <td></td>
  </tr>
  <tr>
    <td>Sputum cytology: Adenocarcinoma</td>
    <td>Antiemetic medication</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Sputum culture: Negative</td>
  </tr>
  <tr>
    <td colspan="3">PPD: ©</td>
  </tr>
  <tr>
    <td>CT—chest: Left upper lobe mass</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>PE</th>
    <th></th>
  </thead>
  <tr>
    <td>VS:T 38°C (100.6°F), P 90, BP 130/70, RR 28,</td>
    <td>Bronchitis</td>
  </tr>
  <tr>
    <td>O, sat 92% on 2L NC</td>
    <td>CHF</td>
  </tr>
  <tr>
    <td>Gen: Moderate respiratory distress</td>
    <td>COPD exacerbation</td>
  </tr>
  <tr>
    <td>Lungs: Rhonchi at left lower base; diffuse</td>
    <td>Lung cancer</td>
  </tr>
  <tr>
    <td>wheezing, prolonged expiratory phase</td>
    <td>Pneumonia</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
    <td>URI</td>
  </tr>
  <tr>
    <td colspan="2">Abd: WNL</td>
  </tr>
  <tr>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>0 yo M, Mexican immigrant, presents with</td>
    <td>VS:T 38°C (100°F), BP 130/85, HR 90, RR 22,</td>
    <td>Bronchiectasis</td>
  </tr>
  <tr>
    <td>roductive cough with bloody sputum</td>
    <td>O, sat 99% room air</td>
    <td>Fungal lung infection</td>
  </tr>
  <tr>
    <td>ccompanied by night sweats, weight loss,</td>
    <td>Gen: Pallor</td>
    <td>Lung cancer</td>
  </tr>
  <tr>
    <td rowspan="4">nd fatigue for the last 3 months.</td>
    <td>Lungs: J breath sounds in upper lobes of</td>
    <td>Lymphoma</td>
  </tr>
  <tr>
    <td></td>
    <td>both lungs</td>
    <td>Sarcoidosis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>TB</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Vasculitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>Ward W/U</td>
    <td>PO prednisone</td>
  </tr>
  <tr>
    <td>Supplemental O, with target SpO, 88-92%</td>
    <td>Peak flow: 300 L/min</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>FEV,;:2L</td>
    <td>Consider pneumococcal vaccine and flu</td>
  </tr>
  <tr>
    <td>IV corticosteroids</td>
    <td>Sputum culture: ® for S pneumoniae</td>
    <td>shot</td>
  </tr>
  <tr>
    <td>Inhaled short-acting B-agonist (albuterol)</td>
    <td>sensitive to levofloxacin</td>
    <td></td>
  </tr>
  <tr>
    <td>by nebulizer</td>
    <td>Blood culture: O</td>
    <td></td>
  </tr>
  <tr>
    <td>Inhaled short-acting anticholinergic agent</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>(ipratropium) by nebulizer</td>
    <td>Change to PO levofloxacin</td>
    <td></td>
  </tr>
  <tr>
    <td>Sputum Gram stain and culture</td>
    <td>Change to PO prednisone</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood culture</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">EDW/U</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Left lower lobe infiltrate</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>ECG</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">ABG</td>
  </tr>
  <tr>
    <td colspan="3">Peak flow: &lt; 200 L/min</td>
  </tr>
  <tr>
    <td colspan="3">Sputum Gram stain: Gram ® cocci</td>
  </tr>
  <tr>
    <td colspan="3">Chem 8</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Third-generation cephalosporin + azithro-</td>
  </tr>
  <tr>
    <td>mycin vs levofloxacin or gatifloxacin IV</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Sputum culture and smear at 3 months</td>
  </tr>
  <tr>
    <td>CXR: Infiltrate/nodules in upper lobes</td>
    <td>Social worker consult</td>
    <td>LFTs</td>
  </tr>
  <tr>
    <td>AFB sputum/culture x 3 days: ® stain</td>
    <td>Rx</td>
    <td>Ophthalmology consult</td>
  </tr>
  <tr>
    <td>Sputum Gram stain and culture</td>
    <td>INH + rifampin + pyrazinamide +</td>
    <td>Family education</td>
  </tr>
  <tr>
    <td>PPD: 16 mm</td>
    <td>ethambutol</td>
    <td>Family PPD placement</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Vitamin Be</td>
    <td>Report case to the local public health</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td></td>
    <td>department</td>
  </tr>
  <tr>
    <td colspan="3">HIV testing</td>
  </tr>
  <tr>
    <td colspan="3">CT—chest: Infiltrates and cavity consistent</td>
  </tr>
  <tr>
    <td colspan="3">with TB</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Respiratory isolation</td>
  </tr>
  <tr>
    <td>Transfer to the ward</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th colspan="4">PE</th>
  </thead>
  <thead>
    <th>of</th>
    <th>VS: Afebrile, P 70, BP 120/70, RR 28, O, sat</th>
    <th></th>
    <th>CHF</th>
  </thead>
  <tr>
    <td></td>
    <td>86% room air</td>
    <td></td>
    <td>COPD exacerbatic</td>
  </tr>
  <tr>
    <td>en</td>
    <td>Gen: Moderate respiratory distress</td>
    <td></td>
    <td>MI</td>
  </tr>
  <tr>
    <td></td>
    <td>Neck: JVD</td>
    <td></td>
    <td>Pericardial tampo</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: Bibasilar crackles</td>
    <td></td>
    <td>Pulmonary embol</td>
  </tr>
  <tr>
    <td>r the</td>
    <td>CV: S1/S2/S3, RRR, 3/6 systolic murmur at</td>
    <td></td>
    <td>Pulmonary fibrosi</td>
  </tr>
  <tr>
    <td>rest.</td>
    <td>apex</td>
    <td></td>
    <td>Renal failure</td>
  </tr>
  <tr>
    <td rowspan="2">t of</td>
    <td>Abd: WNL</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: +2 bilateral pitting edema</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>ED STAT</th>
    <th>Ward W/U</th>
    <th>Cardiac rehabilitation</th>
  </thead>
  <tr>
    <td>Supplemental O,</td>
    <td>TSH</td>
    <td>Counsel patient re: smoking cessation,</td>
  </tr>
  <tr>
    <td>IV furosemide</td>
    <td>Lipid profile</td>
    <td>hypertension, exercise, relaxation, and</td>
  </tr>
  <tr>
    <td>CXR: Pulmonary edema</td>
    <td>HbA,,</td>
    <td>lipids</td>
  </tr>
  <tr>
    <td>ECG: Old Q wave in anterior leads</td>
    <td>Echocardiography: Hypokinesia in anterior</td>
    <td>Follow up in 1 week</td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>wall; EF 20%</td>
    <td>Repeat echocardiogram at 3-6 months</td>
  </tr>
  <tr>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Chem 8: K 3.7</td>
    <td>Refer to cardiology; with ischemic</td>
  </tr>
  <tr>
    <td>CPK-MB, troponin every 8 hours</td>
    <td>Rx</td>
    <td>cardiomyopathy and EF &lt; 30%,</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Fluid restriction</td>
    <td>patients may benefit from an automatic</td>
  </tr>
  <tr>
    <td>Chem 8: K 3.4</td>
    <td>Lisinopril</td>
    <td>implantable cardiac defibrillator</td>
  </tr>
  <tr>
    <td>Serum magnesium, phosphorous</td>
    <td>Atorvastatin</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Aspirin</td>
    <td></td>
  </tr>
  <tr>
    <td>lV KCl</td>
    <td>Digoxin</td>
    <td></td>
  </tr>
  <tr>
    <td>Daily weight</td>
    <td>Spironolactone</td>
    <td></td>
  </tr>
  <tr>
    <td>SQ heparin</td>
    <td>Change IV furosemide</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED W/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 2 months</td>
  </tr>
  <tr>
    <td>CBC: J hemoglobin</td>
    <td>PFTs</td>
    <td>Chest physical therapy</td>
  </tr>
  <tr>
    <td>Chem 14: T glucose, J albumin</td>
    <td>Sweat chloride test: ®</td>
    <td>Regular multiple vitamins</td>
  </tr>
  <tr>
    <td>ABG: Hypoxia</td>
    <td>Pancreatic enzymes</td>
    <td>Influenza vaccine</td>
  </tr>
  <tr>
    <td>CXR: Hyperinflation</td>
    <td>24-hour fecal fat</td>
    <td>Pneumococcal vaccine</td>
  </tr>
  <tr>
    <td>Sputum Gram stain and culture</td>
    <td>Dietary consult</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td rowspan="8">Supplemental O,</td>
    <td>Genetics consult</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Cystic fibrosis specialist</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pulmonary medicine, pediatrics consults</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>IV fluids (NS)</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Supplemental O,</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>IV piperacillin</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Inhaled albuterol</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>F with a history of hypertension and</td>
    <td>VS:T 38°C (101°F), P 105, BP 130/75, RR 22,</td>
    <td>Bronchitis</td>
  </tr>
  <tr>
    <td>‘tes mellitus presents with LUQ pain</td>
    <td>O, sat 95% room air</td>
    <td>Infectious mononucleosis</td>
  </tr>
  <tr>
    <td>npanied by fever and a productive</td>
    <td>Gen: NAD</td>
    <td>Lung abscess</td>
  </tr>
  <tr>
    <td rowspan="5">h with purulent yellow sputum.</td>
    <td>Neck: WNL</td>
    <td>Lung cancer</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: left-sided |. breath sounds and</td>
    <td>Pneumonia</td>
  </tr>
  <tr>
    <td></td>
    <td>rhonchi</td>
    <td>Pleural/Parapneumonic effusion</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Tachycardia</td>
    <td>Pyelonephritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Tenderness to palpation in LUQ</td>
    <td>Splenic abscess</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo HIV-® M presents with shortness of</td>
    <td>VS:T 38°C (101°F), BP 110/65, HR 110, RR 24</td>
    <td>Cytomegalovirus (CMV)</td>
  </tr>
  <tr>
    <td rowspan="8">sath, malaise, dry cough, fatigue, and fever.</td>
    <td>Gen: Pallor, mild respiratory distress, general-</td>
    <td>Interstitial pneumonia</td>
  </tr>
  <tr>
    <td></td>
    <td>ized lymphadenopathy</td>
    <td>Kaposi sarcoma</td>
  </tr>
  <tr>
    <td></td>
    <td>HEENT: Oral thrush</td>
    <td>Legionella pneumonia</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: Intercostal retraction; rales and</td>
    <td>Mycobacterium avium complex lung</td>
  </tr>
  <tr>
    <td></td>
    <td>J breath sounds bilaterally</td>
    <td>infection</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Pneumocystis jiroveci pneumonia</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Soft, nontender; hepatosplenomegaly</td>
    <td>TB</td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: Reddish maculopapular rash</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td>Discharge home</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>Sputum culture: ® for S$ pneumoniae</td>
    <td>Continue PO levofloxacin x 14 days</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>UA</td>
    <td>IV fluids (NS)</td>
    <td></td>
  </tr>
  <tr>
    <td>Sputum Gram stain: Gram-@ cocci</td>
    <td>PO levofloxacin</td>
    <td></td>
  </tr>
  <tr>
    <td>Sputum culture: Pending</td>
    <td>Chest physiotherapy</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Left lower lobe infiltrate</td>
    <td>SQ heparin</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th></th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td></td>
    <td>Regular follow-up visits</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>LFTs</td>
    <td></td>
    <td>LFTs</td>
  </tr>
  <tr>
    <td>CD4: 200</td>
    <td>VDRL</td>
    <td></td>
    <td>Influenza vaccine</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Anti-HCV</td>
    <td></td>
    <td>Pneumococcal vaccine after acute event</td>
  </tr>
  <tr>
    <td>ABG: Hypoxia</td>
    <td>HBsAg</td>
    <td></td>
    <td>Counsel patient re: safe sex practices</td>
  </tr>
  <tr>
    <td>Sputum Gram stain and culture</td>
    <td>Anti-HBc</td>
    <td></td>
    <td>HIV support group</td>
  </tr>
  <tr>
    <td>Sputum AFB smear</td>
    <td>Serum Toxoplasma serology</td>
    <td></td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Bronchial washings—Pneumocystis stain</td>
    <td>HIV viral load</td>
    <td></td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>(bronchoscopy is a prerequisite along with</td>
    <td>Rx</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>thoracic surgery consult): ©</td>
    <td>TMP-SMX or pentamidine (if patient</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Bilateral interstitial infiltrate</td>
    <td>cannot tolerate TMP-SMX)</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="3">PPD: ©</td>
    <td>Prednisone (If PaO, &lt; 70 mm Hg or A-a</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>gradient &gt; 35 mm Hg on room air)</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Begin antiretroviral therapy within 2</td>
    <td>weeks</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>VS: Afebrile, P 123, BP 101/64, RR 28, O,</td>
  </tr>
  <tr>
    <td>91% room air</td>
  </tr>
  <tr>
    <td>Gen: Cyanotic, severe respiratory distress</td>
  </tr>
  <tr>
    <td>Trachea: Deviated to left</td>
  </tr>
  <tr>
    <td>Lungs: No breath sounds on right side</td>
  </tr>
  <tr>
    <td>hyperresonance on percussion</td>
  </tr>
  <tr>
    <td>CV: Tachycardia; apical impulse displaced</td>
  </tr>
  <tr>
    <td>the left Abd:</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>ICU W/U</td>
    <td>Cardiac rehabilitation</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>ECG</td>
    <td>Counsel patient re: smoking cessation,</td>
  </tr>
  <tr>
    <td>Chewable aspirin</td>
    <td>Lipid panel</td>
    <td>hypertension, exercise, relaxation, and</td>
  </tr>
  <tr>
    <td>Sublingual nitroglycerin</td>
    <td>TSH</td>
    <td>lipids</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Echocardiography: 60%</td>
    <td>Advise patient to rest at home</td>
  </tr>
  <tr>
    <td>IV morphine</td>
    <td>Cardiac catheterization</td>
    <td>Low-fat, low-sodium diet</td>
  </tr>
  <tr>
    <td>ECG: T-wave inversions</td>
    <td>Stress test (if cardiac catheterization is</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>unavailable)</td>
    <td></td>
  </tr>
  <tr>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CPK-MB, troponin: ©</td>
    <td>Enoxaparin</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Aspirin</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Clopidogrel</td>
    <td></td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td>B-blocker</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>ACEI (enalapril)</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">Cardiac catheterization</td>
    <td></td>
    <td>Statin (eg, atorvastatin)</td>
    <td></td>
  </tr>
  <tr>
    <td>Cardiology consult</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>Ward W/U</td>
    <td>Pleurodesis if indicated</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Thoracic surgery consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>CXR: Inflated right lung</td>
    <td></td>
  </tr>
  <tr>
    <td>Needle thoracostomy</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Chest tube</td>
    <td>Morphine</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Collapsed right lung, mediastinal shift</td>
    <td>Chest tube to water seal and vacuum</td>
    <td></td>
  </tr>
  <tr>
    <td>to left</td>
    <td>device</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">IV morphine</td>
  </tr>
  <tr>
    <td colspan="3">EDW/U</td>
  </tr>
  <tr>
    <td colspan="3">Continuous cardiac/BP monitoring</td>
  </tr>
  <tr>
    <td colspan="3">ECG: Sinus tachycardia</td>
  </tr>
  <tr>
    <td colspan="3">CBC</td>
  </tr>
  <tr>
    <td colspan="3">Chem 14</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Discharge home</td>
  </tr>
  <tr>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Follow up in 2 weeks</td>
  </tr>
  <tr>
    <td>Stat ECG: Diffuse ST elevation, PR</td>
    <td>Restrict physical activity until symptoms</td>
  </tr>
  <tr>
    <td>depression</td>
    <td>have resolved</td>
  </tr>
  <tr>
    <td>CPK-MB, troponin x 3</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="2">CXR: No cardiomegaly</td>
  </tr>
  <tr>
    <td colspan="2">ESR</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">IV access</td>
  </tr>
  <tr>
    <td colspan="2">Supplemental O,</td>
  </tr>
  <tr>
    <td>NSAIDs</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Check thyroid studies in 1 month</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Endocrinology consult</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td colspan="3">BMP</td>
  </tr>
  <tr>
    <td colspan="3">Thyroid studies (T,, T;RU, T3, TSH): T T./T,,</td>
  </tr>
  <tr>
    <td colspan="3">LTSH</td>
  </tr>
  <tr>
    <td colspan="3">Serum thyroid autoantibodies: ®</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">Nuclear scan—thyroid: T uptake</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Propranolol</td>
  </tr>
  <tr>
    <td>Methimazole or PTU (if pregnant)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>VS:T 36°C (97°F), BP 195/110 right arm,</th>
    <th>Aortic dissec</th>
  </thead>
  <tr>
    <td>160/80 left arm, HR 100, RR 30, O, sat 98%</td>
    <td>MI</td>
  </tr>
  <tr>
    <td>room air</td>
    <td>Pericarditis</td>
  </tr>
  <tr>
    <td>Gen: Acute distress</td>
    <td>Pulmonary e</td>
  </tr>
  <tr>
    <td>Lungs: WNL</td>
    <td>Pneumothor</td>
  </tr>
  <tr>
    <td colspan="2">CV: Tachycardia, $4, diastolic decrescendo</td>
  </tr>
  <tr>
    <td colspan="2">heard best at left sternal border</td>
  </tr>
  <tr>
    <td colspan="2">Abd: WNL</td>
  </tr>
  <tr>
    <td colspan="2">Ext: Asymmetric radial pulses</td>
  </tr>
  <tr>
    <td>Limited PE</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>ight to the ED after a car acci-</td>
    <td>VS: Afebrile, BP 100/50, HR 115, RR 22, pulsus</td>
    <td>Aortic dissection</td>
  </tr>
  <tr>
    <td>asping for air and complains of</td>
    <td>paradoxus</td>
    <td>Cardiogenic shock</td>
  </tr>
  <tr>
    <td rowspan="7">2st pain, and dizziness.</td>
    <td>Gen: Confusion, cyanosis, respiratory distress</td>
    <td>MI</td>
  </tr>
  <tr>
    <td></td>
    <td>Neck: T JVP, engorged neck veins, Kussmaul</td>
    <td>Pericardial tamponade</td>
  </tr>
  <tr>
    <td></td>
    <td>sign</td>
    <td>Pericarditis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Pneumothorax</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Muffled heart sounds, | PMI</td>
    <td>Pulmonary embolism</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>ICU W/U</td>
    <td>CXR</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Continuous cardiac/BP monitoring</td>
    <td>Echocardiography</td>
  </tr>
  <tr>
    <td>IV fluids</td>
    <td>ECG</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>Echocardiography</td>
    <td></td>
  </tr>
  <tr>
    <td>Pulse oximetry</td>
    <td>CXR</td>
    <td></td>
  </tr>
  <tr>
    <td>ECG: Tachycardia, low voltage, nonspecific</td>
    <td>Cardiac surgery consult</td>
    <td></td>
  </tr>
  <tr>
    <td>ST- and T-wave changes</td>
    <td>ABG</td>
    <td></td>
  </tr>
  <tr>
    <td>CPK-MB</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Advance diet from NPO to liquids as</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td>ABG</td>
    <td>Continue supplemental O,</td>
    <td></td>
  </tr>
  <tr>
    <td>Coagulation profile</td>
    <td>Follow up in 2 weeks</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood type and crossmatch</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>et chest pain,</th>
    <th>VS: P 90-200 (variable), BP 125/75, RR 20</th>
    <th>Anxiety disc</th>
  </thead>
  <tr>
    <td>r symptoms</td>
    <td>Gen: Mild cyanosis</td>
    <td>Atrial fibrilla</td>
  </tr>
  <tr>
    <td>times a day.</td>
    <td>HEENT: WNL</td>
    <td>rate</td>
  </tr>
  <tr>
    <td>reath and</td>
    <td>Lungs: Bibasilar crackles</td>
    <td>Hyperthyroi</td>
  </tr>
  <tr>
    <td rowspan="3">\cks.</td>
    <td>CV: Irregularly irregular, tachycardia</td>
    <td>Hyperventil</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Mitral valve</td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td>Panic attack</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Outpatient follow-up in 4 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td></td>
    <td>Psychiatry consult</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td></td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>UA</td>
    <td></td>
    <td>Behavioral modification program</td>
  </tr>
  <tr>
    <td>UTOX: ©</td>
    <td></td>
    <td>Relaxation exercises</td>
  </tr>
  <tr>
    <td colspan="3">Thyroid studies</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Reassure patient</td>
  </tr>
  <tr>
    <td colspan="3">First-line treatment: SSRI</td>
  </tr>
  <tr>
    <td colspan="3">May consider short-course of</td>
  </tr>
  <tr>
    <td>benzodiazepines</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>EDW/U</th>
    <th>ICU W/U</th>
    <th>Follow in 2 weeks</th>
  </thead>
  <tr>
    <td>Supplemental O,</td>
    <td>ECG</td>
    <td>up PT/PTT, INR and warfarin dose adjustment</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Continuous cardiac/BP monitoring</td>
    <td>as necessary to target INR 2-3</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Aspirin</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Warfarin</td>
    <td></td>
  </tr>
  <tr>
    <td>Thyroid studies</td>
    <td>Discontinue heparin after therapeutic INR</td>
    <td></td>
  </tr>
  <tr>
    <td>ECG: Atrial fibrillation</td>
    <td>for 2 days</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CXR: Pulmonary vascular congestion</td>
  </tr>
  <tr>
    <td colspan="3">Echocardiography: Enlarged left atrium</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Synchronous cardioversion</td>
  </tr>
  <tr>
    <td colspan="3">Propranolol</td>
  </tr>
  <tr>
    <td colspan="3">Heparin with bridge to warfarin</td>
  </tr>
  <tr>
    <td>Alternate other oral anticoagulant</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>abdominal pain</td>
    <td>VS:T 36°C (96°F), BP 130/85, HR 110, RR 22</td>
    <td>Gastroenteritis</td>
  </tr>
  <tr>
    <td>in radiates to his</td>
    <td>Gen: Acute distress</td>
    <td>Nephrolithiasis</td>
  </tr>
  <tr>
    <td>1 comes in waves</td>
    <td>Lungs: WNL</td>
    <td>Pancreatitis</td>
  </tr>
  <tr>
    <td>vent him from</td>
    <td>CV: Tachycardia</td>
    <td>Perforated duodenal ulce</td>
  </tr>
  <tr>
    <td rowspan="6">1g position.</td>
    <td>Abd: Soft, nontender, non-distended, tender-</td>
    <td>Retrocecal appendicitis</td>
  </tr>
  <tr>
    <td></td>
    <td>ness in right flank, no peritoneal signs,</td>
    <td>Testicular torsion</td>
  </tr>
  <tr>
    <td></td>
    <td>normal BS</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>GU: No scrotal swelling, symmetric cremas-</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>teric reflexes</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: WNL, guaiac ©)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>50 yo M presents with generalized weakness,</td>
    <td>VS:T 37°C (99.2°F), P 90, BP 120/60, RR 18</td>
    <td>Colorectal cancer</td>
  </tr>
  <tr>
    <td>eft flank discomfort, nausea, and constipa-</td>
    <td>Gen: NAD</td>
    <td>Recurrent small bowel obstruction</td>
  </tr>
  <tr>
    <td>‘ion for the last 2 weeks. He has lost 20 Ib</td>
    <td>Lungs: WNL</td>
    <td>Renal abscess</td>
  </tr>
  <tr>
    <td rowspan="6">over the past 4 months.</td>
    <td>CV: WNL</td>
    <td>Renal mass/cancer</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: J BS, left flank tenderness with deep</td>
    <td>Adrenal mass</td>
  </tr>
  <tr>
    <td></td>
    <td>palpation</td>
    <td>Splenic mass</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: WNL</td>
    <td>Lymphoma</td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>'s with 2 days of progressively</td>
    <td>VS:T 38.1°C (100.6°F), BP 130/85, HR 86, RR 18</td>
    <td>Acute cervicitis</td>
  </tr>
  <tr>
    <td>k pain, urinary frequency, and</td>
    <td>Gen: Mild discomfort with exam</td>
    <td>Acute cystitis</td>
  </tr>
  <tr>
    <td>ation during urination. She</td>
    <td>Lungs: WNL</td>
    <td>Acute pelvic inflammatory di</td>
  </tr>
  <tr>
    <td rowspan="6">ubjective fever and chills.</td>
    <td>CV: WNL</td>
    <td>Acute pyelonephritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: @ BS, mild suprapubic tenderness, no</td>
    <td>Acute urethritis</td>
  </tr>
  <tr>
    <td></td>
    <td>peritoneal signs</td>
    <td>Ectopic pregnancy</td>
  </tr>
  <tr>
    <td></td>
    <td>Back: Mild CVA tenderness on the left</td>
    <td>Nephrolithiasis</td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: WNL, guaiac O</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Serum calcium, magnesium, phosphate</td>
    <td>T fluid intake</td>
  </tr>
  <tr>
    <td>CBC: Normal WBC count</td>
    <td>Serum uric acid</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Urine strain</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Serum amylase, lipase</td>
    <td>Stone analysis: Calcium oxalate</td>
    <td>Counsel patient re: smoking cessation and</td>
  </tr>
  <tr>
    <td>UA: Microscopic hematuria</td>
    <td></td>
    <td>limiting alcohol and caffeine intake</td>
  </tr>
  <tr>
    <td colspan="3">Urine culture</td>
  </tr>
  <tr>
    <td colspan="3">KUB: Radiopaque 3-mm stone</td>
  </tr>
  <tr>
    <td colspan="3">CT—kidney: Stone visualized in distal</td>
  </tr>
  <tr>
    <td colspan="3">ureter</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>Analgesia: Opioids and NSAIDs</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC: Hemoglobin 9.0</td>
    <td>Intact PTH: 1</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14: Ca 15, BUN 40, creatinine 2.0</td>
    <td>Chem 7: Ca 10, BUN 20, creatinine 1.5</td>
    <td></td>
  </tr>
  <tr>
    <td>UA: @ for RBCs</td>
    <td>CT—abdomen and chest: Left renal mass</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>Renal mass biopsy</td>
    <td></td>
  </tr>
  <tr>
    <td>U/S—complete abdominal: Left renal mass</td>
    <td>Bone scan</td>
    <td></td>
  </tr>
  <tr>
    <td>Admit to ward</td>
    <td>CT—head</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Ferritin, TIBC, serum iron</td>
    <td></td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">Bisphosphonate (pamidronate)</td>
    <td>Oncology consult</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Surgery consult</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 3-5 days</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>Urine culture: @ for E coli</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td></td>
    <td>Counsel patient re: medication compliance</td>
  </tr>
  <tr>
    <td>UA: WBC, bacteria, nitrite ®</td>
    <td></td>
    <td>Counsel patient to limit alcohol intake</td>
  </tr>
  <tr>
    <td colspan="3">Urine culture: Pending</td>
  </tr>
  <tr>
    <td colspan="3">Urinary B-hCG:</td>
  </tr>
  <tr>
    <td colspan="3">U/S—renal</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Ciprofloxacin (fluoroquinolone)</td>
  </tr>
  <tr>
    <td>Encourage oral rehydration</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td>Discharge home</td>
  </tr>
  <tr>
    <td>CBC stat and q 12 h: WY hemoglobin,</td>
    <td>Reticulocyte count: T</td>
    <td>Follow up in 2 months</td>
  </tr>
  <tr>
    <td>Jw hematocrit</td>
    <td>LDH: T</td>
    <td>Educate patient/family (including</td>
  </tr>
  <tr>
    <td>Peripheral smear: Bite cells, fragment cells</td>
    <td>Haptoglobin: 1</td>
    <td>consideration of genetic counseling)</td>
  </tr>
  <tr>
    <td>Chem 14: T indirect bilirubin</td>
    <td>UA: Hemoglobinuria</td>
    <td></td>
  </tr>
  <tr>
    <td>PT/PTT, INR</td>
    <td>G6PD assay: Consistent with G6PD</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>deficiency</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="5">Discontinue TMP-SMX</td>
    <td>Type and cross</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Start IV</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>IV fluids (NS)</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Transfuse 2 units of packed RBCs</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>EDW/U</th>
    <th>Ward W/U</th>
    <th>Follow up in 7 days</th>
  </thead>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Continuous BP monitoring</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>Continue NPO</td>
    <td>Counsel patient re: abstinence from</td>
  </tr>
  <tr>
    <td>Continuous BP monitoring</td>
    <td>U/S—liver, gallbladder and bile duct,</td>
    <td>alcohol</td>
  </tr>
  <tr>
    <td>NG tube placement, set to suction</td>
    <td>pancreas</td>
    <td>Social work consult for alcohol abuse</td>
  </tr>
  <tr>
    <td>ECG: No evidence of ischemia</td>
    <td>PT/PTT</td>
    <td>Referral to inpatient detoxification or</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>CT—abdomen</td>
    <td>outpatient group therapy (eg, Alcoholics</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Surgery consult (should patient become</td>
    <td>Anonymous) if amenable</td>
  </tr>
  <tr>
    <td>Serum amylase, lipase: T</td>
    <td>unstable)</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>ABG</td>
    <td>Gl consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Advance diet as tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td>Pulse oximetry</td>
    <td>Patient needs pharmacologic and</td>
    <td></td>
  </tr>
  <tr>
    <td>X-ray—abdomen, upright</td>
    <td>mechanical DVT prophylaxis due to high</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>risk for DVT with pancreatitis</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Watch magnesium and phosphorus level</td>
    <td></td>
  </tr>
  <tr>
    <td>NG tube</td>
    <td>as patients with EtOH abuse have high risk</td>
    <td></td>
  </tr>
  <tr>
    <td>IV meperidine for pain control</td>
    <td>for electrolyte abnormality and refeeding</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>)at home is brought to the</td>
    <td>VS:T 38°C (100°F), P 170, BP 69/44, RR 43,</td>
    <td>Duodenal web</td>
  </tr>
  <tr>
    <td>ious vomiting, irritability,</td>
    <td>O, sat 89% room air</td>
    <td>Intestinal atresia</td>
  </tr>
  <tr>
    <td>largy, and an acute episode</td>
    <td>Skin: Evidence of poor perfusion</td>
    <td>Intussusception</td>
  </tr>
  <tr>
    <td rowspan="4">J.</td>
    <td>Chest: WNL</td>
    <td>Malrotation with volvulus</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Meconium plug/ileus</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Distention; evidence of intestinal</td>
    <td>Necrotizing enterocolitis</td>
  </tr>
  <tr>
    <td></td>
    <td>obstruction</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>O, sat 93% room air</td>
  </tr>
  <tr>
    <td>Skin: No evidence of purpura</td>
  </tr>
  <tr>
    <td>Chest: WNL</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
  </tr>
  <tr>
    <td>Abd: Soft, mildly tender; examination of</td>
  </tr>
  <tr>
    <td>RUQ fails to identify presence of bowel;</td>
  </tr>
  <tr>
    <td>ill-defined mass in the RUQ</td>
  </tr>
  <tr>
    <td>Limited PE</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>Ward W/U</td>
    <td>Follow up in 48 hours</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>AXR: Gastric bubble; no air-fluid levels</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>ABG: Metabolic derangements resolved</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>D/C NG tube</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>IV fluids (NS)</td>
    <td></td>
  </tr>
  <tr>
    <td>ABG: Metabolic acidosis</td>
    <td>Advance diet as tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">AXR: Distended bowel with air-fluid levels;</td>
  </tr>
  <tr>
    <td>mass in right abdomen</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">U/S—abdomen: Compatible with</td>
  </tr>
  <tr>
    <td colspan="3">intussusception</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">NG tube placement, set to suction</td>
  </tr>
  <tr>
    <td colspan="3">Barium enema: Coiled-spring appearance;</td>
  </tr>
  <tr>
    <td colspan="3">disorder is relieved by air insufflation</td>
  </tr>
  <tr>
    <td>Pediatric surgery consult</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 7 days</td>
  </tr>
  <tr>
    <td>CBC: WNL, smear WNL</td>
    <td>Breastfeeding suppression test: Bilirubin</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>Direct Coombs test: Noncontributory</td>
    <td>levels J on cessation of breastfeeding;</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum bilirubin: 7 indirect bilirubin</td>
    <td>levels T again when breastfeeding</td>
    <td></td>
  </tr>
  <tr>
    <td>TSH: WNL</td>
    <td>restarted</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Continue breastfeeding</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Consider phototherapy (if bilirubin levels</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>do not J)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 4 weeks; patient reports that</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>he is feeling better (if symptoms persist or</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>if H pyloriis still present, may proceed to</td>
  </tr>
  <tr>
    <td>Serum amylase, lipase</td>
    <td>endoscopy)</td>
  </tr>
  <tr>
    <td>Serum H pylori antibody: ©</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Stool H pylori antibody: ®</td>
    <td>Counsel patient to limit alcohol intake</td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Counsel patient to avoid NSAID</td>
  </tr>
  <tr>
    <td>Proton pump inhibitor</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td colspan="2">Clarithromycin</td>
  </tr>
  <tr>
    <td>Metronidazole</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th></th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>presents with a 2-month history</td>
    <td>VS:T 36°C (97°F), BP 140/60, HR 90, RR 23</td>
    <td>CHF</td>
    <td></td>
  </tr>
  <tr>
    <td>ninal girth, J appetite, and early</td>
    <td>Gen: Pallor</td>
    <td>Colon cancer</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="8">» also has mild shortness of breath.</td>
    <td>Breast: WNL</td>
    <td>Liver cirrhosis</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Ovarian cancer</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Ovarian cyst</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Distended, nontender, normal BS, no</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>palpable hepatosplenomegaly</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Solid right adnexal mass</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Solid right adnexal mass; no</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>involvement of rectovaginal septum</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th></th>
  </thead>
  <tr>
    <td>of left</td>
    <td>VS:T 37°C (99°F), P 90, BP 120/50, RR 14</td>
    <td>Ectopic p</td>
  </tr>
  <tr>
    <td>o the</td>
    <td>Gen: Moderate distress</td>
    <td>Ovarian t</td>
  </tr>
  <tr>
    <td>fith</td>
    <td>Lungs: WNL</td>
    <td>Pelvic inf</td>
  </tr>
  <tr>
    <td>period</td>
    <td>CV: WNL</td>
    <td>Rupturec</td>
  </tr>
  <tr>
    <td>f pelvic</td>
    <td>Abd: RLQ tenderness with rebound and</td>
    <td>Fitz-Hug}</td>
  </tr>
  <tr>
    <td rowspan="4">ed</td>
    <td></td>
    <td>guarding</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>GU: Slightly enlarged uterus with small</td>
    <td></td>
  </tr>
  <tr>
    <td>amount of dark bloody discharge from</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>cervix; right adnexal tenderness</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Medical oncology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Palliative care consult</td>
    <td></td>
  </tr>
  <tr>
    <td>CT—abdomen: Large necrotic mass in</td>
    <td>Surgery is not an option owing to</td>
    <td></td>
  </tr>
  <tr>
    <td>head of pancreas with evidence of vascular</td>
    <td>advanced disease</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">involvement</td>
  </tr>
  <tr>
    <td>ERCP/EUS: Biopsy to obtain histology</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td>Carboplatin</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Blood type and crossmatch</td>
    <td>CA-125</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>PT/PTT, INR</td>
    <td>CBC</td>
  </tr>
  <tr>
    <td>CA-125: 900</td>
    <td>Rx</td>
    <td>Chem 14</td>
  </tr>
  <tr>
    <td>CT—abdomen and pelvis: 10- X 12-cm</td>
    <td>Exploratory laparotomy with TAH-BSO</td>
    <td></td>
  </tr>
  <tr>
    <td>right complex ovarian cyst; severe ascites</td>
    <td>and staging (includes ascites collection for</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Right moderate pleural effusion</td>
    <td>peritoneal cytology)</td>
    <td></td>
  </tr>
  <tr>
    <td>ECG</td>
    <td>Paracentesis for ascites collection</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Pap smear</td>
  </tr>
  <tr>
    <td colspan="3">Mammogram</td>
  </tr>
  <tr>
    <td>Colonoscopy</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Blood type and crossmatch</td>
    <td>Counsel patient re: safe sex practices and</td>
  </tr>
  <tr>
    <td>Urinary B-hCG: ®</td>
    <td>PT/PTT, INR</td>
    <td>contraception</td>
  </tr>
  <tr>
    <td>Quantitative serum B-hCG: 2500</td>
    <td>Gynecology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Laparoscopy</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Rh IgG (RhoGAM) if Rh-O</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Cervical Gram stain and G&amp;C culture</td>
  </tr>
  <tr>
    <td colspan="3">U/S—transvaginal: 2-cm right adnexal</td>
  </tr>
  <tr>
    <td colspan="3">mass, no intrauterine pregnancy, free fluid</td>
  </tr>
  <tr>
    <td colspan="3">in cul-de-sac</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>IV fluid (NS)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>ver, and</td>
    <td>VS:T 38°C (101°F), BP 130/85, HR 100, RR 22</td>
    <td>Clostridium difficile colitis</td>
  </tr>
  <tr>
    <td>ports</td>
    <td>Gen: Pallor, diaphoresis</td>
    <td>Colon cancer</td>
  </tr>
  <tr>
    <td>“a and</td>
    <td>Lungs: WNL</td>
    <td>Crohn disease</td>
  </tr>
  <tr>
    <td rowspan="4">iber,</td>
    <td>CV: Tachycardia</td>
    <td>Diverticular abscess</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: LLQ tenderness, no peritoneal signs,</td>
    <td>Diverticulitis</td>
  </tr>
  <tr>
    <td></td>
    <td>sluggish BS</td>
    <td>Gastroenteritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Guaiac OQ</td>
    <td>Ulcerative colitis</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>High-fiber diet</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>Urine culture: Pending</td>
    <td>Colonoscopy 4 weeks after recovery</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Blood culture: Pending</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum amylase, lipase</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>UA</td>
    <td>Gl consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Urine culture: Pending</td>
    <td>NPO, advance to clear liquid diet as</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood culture: Pending</td>
    <td>tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool culture and sensitivity</td>
    <td>Metronidazole + ciprofloxacin x 7-10 days</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool for ova and parasites</td>
    <td>Discharge home in 3-4 days</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Cdifficile toxin</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">KUB</td>
  </tr>
  <tr>
    <td colspan="3">CT—abdomen: Diverticulitis</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">NPO</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 2 weeks</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Blood type and crossmatch</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>PT/PTT, INR</td>
    <td>Counsel patient to limit alcohol intake</td>
  </tr>
  <tr>
    <td>Continuous BP monitoring</td>
    <td>Surgery consult for cholecystectomy</td>
    <td></td>
  </tr>
  <tr>
    <td>ECG</td>
    <td>Vitals q 4h</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>CBC next day</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Chem 8 next day</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum amylase, lipase</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood/urine cultures</td>
    <td>NPO, advance diet as tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td>X-ray—abdomen</td>
    <td>Continue antibiotic therapy</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Urine pregnancy test</td>
  </tr>
  <tr>
    <td colspan="3">U/S—abdomen: Gallstones with</td>
  </tr>
  <tr>
    <td colspan="3">gallbladder edema</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">IM prochlorperazine</td>
  </tr>
  <tr>
    <td colspan="3">IV hydromorphone</td>
  </tr>
  <tr>
    <td>IV cefuroxime</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>day</td>
    <td>VS:T 38°C (100.4°F), P 90, BP 110/50, RR 14 Gen: Moderate distress</td>
    <td>Cervicitis Dysmeno!</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Endometr</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Pelvic infl</td>
  </tr>
  <tr>
    <td rowspan="8">d</td>
    <td>Abd: Diffuse tenderness (greatest in the</td>
    <td>Pyelonep!</td>
  </tr>
  <tr>
    <td></td>
    <td>lower quadrants), no distention, no</td>
    <td>Vaginitis</td>
  </tr>
  <tr>
    <td></td>
    <td>rebound or guarding, J BS</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Purulent, bloody discharge from</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>cervix; cervical motion and bilateral</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>adnexal tenderness</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yht to the ED because of</td>
    <td>VS:T 37°C (98°F), P 120, BP 100/60, RR 25</td>
    <td>Acute intestinal obstruction</td>
  </tr>
  <tr>
    <td>and J appetite for 4 days.</td>
    <td>Gen: Moderate distress</td>
    <td>Alcoholic ketoacidosis</td>
  </tr>
  <tr>
    <td>s preceded by nausea,</td>
    <td>Skin: Poor skin turgor</td>
    <td>Appendicitis</td>
  </tr>
  <tr>
    <td rowspan="8">urinary frequency.</td>
    <td>HEENT: Dry mucous membranes, sweet-</td>
    <td>Diabetic ketoacidosis</td>
  </tr>
  <tr>
    <td></td>
    <td>smelling breath</td>
    <td>Drug intoxication</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Gastroenteritis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Tachycardia</td>
    <td>Pancreatitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Generalized tenderness</td>
    <td>Pyelonephritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Limited PE</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>ICU W/U</td>
    <td>Diabetic diet</td>
  </tr>
  <tr>
    <td>Glucometer: 480 mg/dL</td>
    <td>Continuous monitoring</td>
    <td>Diabetic teaching</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Random glucose q 1h</td>
    <td>Hb, q 3 months</td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Chem 8 q 4h: JK, glucose &lt; 250</td>
    <td>Follow up in 2 weeks in the office</td>
  </tr>
  <tr>
    <td>Continuous monitoring</td>
    <td>Rx</td>
    <td>Diabetic foot care</td>
  </tr>
  <tr>
    <td>Chem 14: Normal K, normal Na, T anion gap</td>
    <td>Switch IV NS to DW</td>
    <td>Ophthalmology consult</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>IV potassium</td>
    <td>Lipid profile</td>
  </tr>
  <tr>
    <td>Serum amylase, lipase</td>
    <td>SQ insulin NPH</td>
    <td>Instruct patient in home glucose</td>
  </tr>
  <tr>
    <td>UA and urine culture: @ glucose,</td>
    <td>SQ insulin regular</td>
    <td>monitoring</td>
  </tr>
  <tr>
    <td>@ ketones</td>
    <td>Discontinue IV insulin 2 hours after starting</td>
    <td>Home glucose monitoring, glucometer</td>
  </tr>
  <tr>
    <td>Urine/serum toxicology</td>
    <td>long-acting insulin (NPH or insulin glargine</td>
    <td></td>
  </tr>
  <tr>
    <td>Phosphate: 1</td>
    <td>injection)</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">ABG: Metabolic acidosis (pH = 7.1)</td>
  </tr>
  <tr>
    <td colspan="3">Quantitative serum ketones: T</td>
  </tr>
  <tr>
    <td colspan="3">Serum osmolality: Normal</td>
  </tr>
  <tr>
    <td colspan="3">X-ray—abdomen</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">IV regular insulin, continue</td>
  </tr>
  <tr>
    <td>Phosphate therapy as needed</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>fice W/U</td>
    <td>Office W/U</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC: J hematocrit, / MCV</td>
    <td>Gl consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 8: Normal</td>
    <td>Colonoscopy: Polyp with adenocarcinoma</td>
    <td></td>
  </tr>
  <tr>
    <td>Ferritin: |</td>
    <td>CT—abdomen and pelvis with contrast</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum iron:</td>
    <td>CEA</td>
    <td></td>
  </tr>
  <tr>
    <td>TIBC: T</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>TSH: Normal</td>
    <td>Iron sulfate</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool for ova and parasites</td>
    <td>General surgery consult</td>
    <td></td>
  </tr>
  <tr>
    <td>ESR: Normal</td>
    <td>Plan partial colectomy</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool guaiac: ®</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 2 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Counsel patient re: smoking cessation,</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>NSAID avoidance, medication compliance</td>
  </tr>
  <tr>
    <td>Iron studies</td>
    <td>and adherence</td>
  </tr>
  <tr>
    <td>Serum folate</td>
    <td>Gastroenterology consult</td>
  </tr>
  <tr>
    <td colspan="2">Serum vitamin D</td>
  </tr>
  <tr>
    <td colspan="2">Serum amylase, lipase</td>
  </tr>
  <tr>
    <td colspan="2">Stool for ova and parasites</td>
  </tr>
  <tr>
    <td colspan="2">Stool C difficile</td>
  </tr>
  <tr>
    <td colspan="2">X-ray—abdomen</td>
  </tr>
  <tr>
    <td colspan="2">Colonoscopy: Crohn disease</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Oral steroids</td>
  </tr>
  <tr>
    <td colspan="2">Immunomodulator therapy</td>
  </tr>
  <tr>
    <td>(eg azathioprine) or biologic therapy</td>
    <td></td>
  </tr>
  <tr>
    <td>(eg anti-TNF such as infliximab)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Call with questions</td>
  </tr>
  <tr>
    <td colspan="2">Chem 14</td>
  </tr>
  <tr>
    <td colspan="2">TSH</td>
  </tr>
  <tr>
    <td colspan="2">Stool for ova and parasites</td>
  </tr>
  <tr>
    <td colspan="2">Stool for WBCs</td>
  </tr>
  <tr>
    <td colspan="2">Stool culture and sensitivity</td>
  </tr>
  <tr>
    <td colspan="2">Transglutaminase antibody</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Educate patient</td>
  </tr>
  <tr>
    <td colspan="2">Reassurance</td>
  </tr>
  <tr>
    <td colspan="2">High-fiber diet</td>
  </tr>
  <tr>
    <td>Consider antidepressant therapy (TCA)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 1 week</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>CXR: Normal</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>KUB: Normal</td>
    <td>Pneumococcal vaccine</td>
  </tr>
  <tr>
    <td>UA</td>
    <td>p-xylose tolerance test: Carbohydrate</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool for ova and parasites</td>
    <td>malabsorption</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool occult blood</td>
    <td>Peroral duodenal biopsy: Villi are atrophic</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool Gram stain</td>
    <td>or absent</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool fat stain</td>
    <td>Dietary consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Barium enema</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CT—abdomen</td>
    <td>Gluten-free diet</td>
    <td></td>
  </tr>
  <tr>
    <td>Iron studies</td>
    <td>Vitamin D supplementation</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum folate</td>
    <td>Calcium supplementation</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum B,,</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>40 yo F presents with fever, anorexia, nausea,</td>
    <td>VS:T 38°C (100.4°F), BP 100/50, HR 100, RR 22,</td>
    <td>Amebiasis</td>
  </tr>
  <tr>
    <td>profuse and watery diarrhea, and diffuse</td>
    <td>orthostatic hypotension</td>
    <td>Food poisoning</td>
  </tr>
  <tr>
    <td>abdominal pain. Last week she was on</td>
    <td>Gen: WNL</td>
    <td>Gastroenteritis</td>
  </tr>
  <tr>
    <td rowspan="6">antibiotics for a UTI.</td>
    <td>Lungs: WNL</td>
    <td>Giardiasis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Tachycardia</td>
    <td>Hepatitis A</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Diffuse tenderness, no peritoneal signs,</td>
    <td>Infectious diarrhea (bacterial, viral,</td>
  </tr>
  <tr>
    <td></td>
    <td>@ Bs</td>
    <td>parasitic, protozoal)</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Guaiac ®</td>
    <td>Inflammatory bowel disease</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Pseudomembranous (C difficile) colitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th></th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>ul-smelling, watery</td>
    <td>VS:T 37°C (98°F), BP 110/50, HR 85, RR 22, no</td>
    <td>Amebiasis</td>
  </tr>
  <tr>
    <td>iffuse abdominal</td>
    <td>orthostatic hypotension</td>
    <td>Food poisoning</td>
  </tr>
  <tr>
    <td>t began yesterday.</td>
    <td>Gen: WNL</td>
    <td>Gastroenteritis</td>
  </tr>
  <tr>
    <td rowspan="5">e was recently in</td>
    <td>Lungs: WNL</td>
    <td>Giardiasis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Hepatitis A</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: No tenderness, no peritoneal signs,</td>
    <td>Infectious diarrhea (bacte</td>
  </tr>
  <tr>
    <td></td>
    <td>active BS</td>
    <td>parasitic, protozoal)</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Guaiac OQ</td>
    <td>Inflammatory bowel disez</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Counsel patient re: oral hydration</td>
  </tr>
  <tr>
    <td>Stool culture</td>
    <td>No orthostatic hypotension</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool Giardia antigen</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool for ova and parasites</td>
    <td>Send home on metronidazole (when</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool WBCs: ®</td>
    <td>diarrhea improves); no diphenoxylate and</td>
    <td></td>
  </tr>
  <tr>
    <td>Stool for C difficile: ©</td>
    <td>atropine/loperamide</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CBC: T WBC count</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">IV fluids (NS)</td>
  </tr>
  <tr>
    <td>Metronidazole</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Counsel patient re: oral hydration</td>
  </tr>
  <tr>
    <td colspan="3">Stool culture</td>
  </tr>
  <tr>
    <td colspan="3">Stool Giardia antigen: ®</td>
  </tr>
  <tr>
    <td colspan="3">Stool for ova and parasites</td>
  </tr>
  <tr>
    <td colspan="3">Stool WBCs</td>
  </tr>
  <tr>
    <td colspan="3">Stool for C difficile</td>
  </tr>
  <tr>
    <td colspan="3">CBC</td>
  </tr>
  <tr>
    <td colspan="3">Chem 8</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>Metronidazole</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>ICU W/U</td>
    <td>Follow up in 1 week</td>
  </tr>
  <tr>
    <td>Placement of two large bore IV</td>
    <td>CBC q 4h until hematocrit is stable; then</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>frequency can be L</td>
    <td>Counsel patient to cease alcohol intake</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Rx</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>Gl consult</td>
    <td>Dietary consult</td>
  </tr>
  <tr>
    <td>Orthostatic vitals: Drop on standing</td>
    <td>Combination therapy with epinephrine</td>
    <td>Counsel re: avoidance of NSAID</td>
  </tr>
  <tr>
    <td>Type and screen, crossmatch</td>
    <td>injection followed by thermal coagulation</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>(or endoscopic clipping)</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC: Hematocrit 24</td>
    <td>Octreotide for varices</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Advance diet as tolerated</td>
    <td></td>
  </tr>
  <tr>
    <td>KUB: No evidence of free air</td>
    <td>Pantoprazole</td>
    <td></td>
  </tr>
  <tr>
    <td>STAT GI consult/endoscopy: Gastric antral</td>
    <td>Transfer to wards if patient remains stable</td>
    <td></td>
  </tr>
  <tr>
    <td>lesion with adherent clot</td>
    <td>H pylori serology and eradication if ©</td>
    <td></td>
  </tr>
  <tr>
    <td>PT/PTT, INR</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>ECG</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">NPO</td>
  </tr>
  <tr>
    <td colspan="3">Blood transfusion if hemoglobin &lt; 7 or</td>
  </tr>
  <tr>
    <td colspan="3">active ongoing bleeding</td>
  </tr>
  <tr>
    <td>NG tube with low intermittent suction to</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>avoid aspiration</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>IV pantoprazole</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>VS:T 37°C (98.9°F), BP 90/65, HR 100, RR 24</td>
    <td>Colon cancer</td>
  </tr>
  <tr>
    <td>Gen: Mild dehydration</td>
    <td>Crohn disease</td>
  </tr>
  <tr>
    <td>Lungs: WNL</td>
    <td>Diverticular bleed</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
    <td>Infectious colitis</td>
  </tr>
  <tr>
    <td>Abd: Tender and mildly distended; no rigidity</td>
    <td>Ischemic colitis</td>
  </tr>
  <tr>
    <td>or rebound tenderness</td>
    <td>Peptic ulcer disease</td>
  </tr>
  <tr>
    <td>Rectal exam: WNL, guaiac @</td>
    <td>Small bowel malignancy)</td>
  </tr>
  <tr>
    <td>Limited PE</td>
    <td>Ulcerative colitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>Ward W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Hemoglobin and hematocrit q 4h</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Rx</td>
    <td>Counsel patient to cease alcohol intake</td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Advance diet as tolerated</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Monitor carefully for persistent fever,</td>
    <td>Dietary consult</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>leukocytosis, peritoneal irritation, diarrhea,</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum amylase</td>
    <td>and/or bleeding</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Serum lipase</td>
  </tr>
  <tr>
    <td colspan="3">LDH: T</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td colspan="3">ECG</td>
  </tr>
  <tr>
    <td colspan="3">AXR</td>
  </tr>
  <tr>
    <td colspan="3">CT—abdomen: Pneumatosis coli</td>
  </tr>
  <tr>
    <td colspan="3">Blood type and crossmatch</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">NPO</td>
  </tr>
  <tr>
    <td colspan="3">Surgery consult (for bowel resection)</td>
  </tr>
  <tr>
    <td>Broad-spectrum antibiotics</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 2 weeks</td>
  </tr>
  <tr>
    <td>CBC: Mild anemia</td>
    <td>Counsel patient re: medication compliance</td>
  </tr>
  <tr>
    <td>Iron studies</td>
    <td>and adherence</td>
  </tr>
  <tr>
    <td>Serum folate</td>
    <td>Gastroenterology referral</td>
  </tr>
  <tr>
    <td colspan="2">Serum vitamin D</td>
  </tr>
  <tr>
    <td colspan="2">Chem 14</td>
  </tr>
  <tr>
    <td colspan="2">Serum amylase, lipase</td>
  </tr>
  <tr>
    <td colspan="2">Stool culture</td>
  </tr>
  <tr>
    <td colspan="2">Stool for ova and parasites</td>
  </tr>
  <tr>
    <td colspan="2">Stool WBCs</td>
  </tr>
  <tr>
    <td colspan="2">PT/PTT</td>
  </tr>
  <tr>
    <td colspan="2">Colonoscopy and rectal biopsy: Consistent</td>
  </tr>
  <tr>
    <td colspan="2">with ulcerative colitis involving rectum and</td>
  </tr>
  <tr>
    <td colspan="2">distal sigmoid colon</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">IV steroids (for attack)</td>
  </tr>
  <tr>
    <td colspan="2">5-ASA enema/suppositories</td>
  </tr>
  <tr>
    <td colspan="2">Sulfasalazine</td>
  </tr>
  <tr>
    <td colspan="2">Immunomodulator therapy</td>
  </tr>
  <tr>
    <td colspan="2">(eg, azathioprine) or biologic therapy</td>
  </tr>
  <tr>
    <td>(eg, anti-TNF such as infliximab)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo M presents with painless bright red</td>
    <td>VS:T 37°C (98°F), BP 130/85, HR 90, RR 20</td>
    <td>Angiodysplasia</td>
  </tr>
  <tr>
    <td>0d in his stool. He reports that his diet is</td>
    <td>Gen: Pallor, diaphoresis</td>
    <td>Colon cancer</td>
  </tr>
  <tr>
    <td rowspan="5">v in fiber.</td>
    <td>Lungs: WNL</td>
    <td>Crohn disease</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Diverticulitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Soft, nontender, no peritoneal signs,</td>
    <td>Diverticulosis</td>
  </tr>
  <tr>
    <td></td>
    <td>@® Bs</td>
    <td>Ischemic colitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Bloody stool</td>
    <td>Ulcerative colitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>71 yo Asian M with a history of BPH presents</td>
    <td>VS:T 37°C (98.5°F), P 76, BP 140/75, RR 14</td>
    <td>Disk herniation</td>
  </tr>
  <tr>
    <td>vith a 3-month history of persistent low back</td>
    <td>Gen: NAD</td>
    <td>Lumbar muscle strain</td>
  </tr>
  <tr>
    <td>ain that is 3/6 in severity with no radiation.</td>
    <td>Neck: WNL</td>
    <td>Muscular spasm</td>
  </tr>
  <tr>
    <td rowspan="8">Je denies any history of trauma.</td>
    <td>Back: Tenderness along lumbar spine (L4, L5)</td>
    <td>Osteoporosis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Prostate cancer</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Sciatic irritation</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Spinal stenosis</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Irregular, enlarged prostate;</td>
    <td>Tumor in the vertebral canal</td>
  </tr>
  <tr>
    <td></td>
    <td>guaiac ©</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>40 yo M complains of a slow-onset dull pain</td>
    <td>VS:T 37°C (98°F), P 98, BP 150/95, RR 18</td>
    <td>Polycystic kidney disease</td>
  </tr>
  <tr>
    <td>in his left flank and blood in his urine. His</td>
    <td>Gen: WD/WN</td>
    <td>Renal cell carcinoma</td>
  </tr>
  <tr>
    <td rowspan="6">father died of a stroke.</td>
    <td>HEENT: WNL</td>
    <td>Renal dysplasia</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Simple renal cyst</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL (no pericardial rub)</td>
    <td>Tuberous sclerosis</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Palpable, nontender mass on both</td>
    <td>Wilms tumor</td>
  </tr>
  <tr>
    <td></td>
    <td>flanks</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>Colonoscopy: Diverticulosis, no other</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>source</td>
    <td>Counsel patient to cease alcohol intake</td>
  </tr>
  <tr>
    <td>CBC: J hemoglobin</td>
    <td>Rx</td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Advance diet as tolerated</td>
    <td>Dietary consult</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td>Gl consult</td>
    <td>High-fiber diet</td>
  </tr>
  <tr>
    <td colspan="3">Serum amylase, lipase</td>
  </tr>
  <tr>
    <td colspan="3">UA</td>
  </tr>
  <tr>
    <td colspan="3">CXR</td>
  </tr>
  <tr>
    <td>CT—abdomen: Diverticulosis</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Bone scan: Diffuse metastases</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Prostate biopsy: Adenocarcinoma</td>
    <td></td>
  </tr>
  <tr>
    <td>UA: Hematuria</td>
    <td>CT—abdomen and pelvis: @ for lymphatic</td>
    <td></td>
  </tr>
  <tr>
    <td>ESR: T</td>
    <td>involvement above aortic bifurcation</td>
    <td></td>
  </tr>
  <tr>
    <td>PSA: TT</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>X-ray—spine: Metastatic lesions in L4 and LS</td>
    <td>Androgen deprivation therapy</td>
    <td></td>
  </tr>
  <tr>
    <td>CT—lumbar spine: Mets to L4 and L5</td>
    <td>Urology consult</td>
    <td></td>
  </tr>
  <tr>
    <td>Transrectal US with biopsy: Multinodular</td>
    <td>Radiation oncology consult</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">enlarged prostate, biopsy pending</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Acetaminophen</td>
  </tr>
  <tr>
    <td>Morphine or codeine if pain persists</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>olored urine and</th>
    <th>VS:T 36°C (97.5°F), BP 140/85, HR 88, RR 18</th>
    <th>Cryoglobulinemia</th>
  </thead>
  <tr>
    <td>| fever and sore</td>
    <td>Gen: Periorbital edema, pallor</td>
    <td>IgA nephropathy</td>
  </tr>
  <tr>
    <td>‘complains of</td>
    <td>Lungs: WNL</td>
    <td>Membranoproliferative glo</td>
  </tr>
  <tr>
    <td rowspan="3">rexia.</td>
    <td>CV: WNL</td>
    <td>Poststreptococcal glomerul</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: Edema around ankles</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>70 yo M complains of waking up four to five</td>
    <td>VS:T 37°C (98.5°F), P 78, BP 140/85, RR 14</td>
    <td>BPH</td>
  </tr>
  <tr>
    <td>times per night to urinate. He also has urinary</td>
    <td>Gen: NAD</td>
    <td>Bladder cancer</td>
  </tr>
  <tr>
    <td>Urgency, a weak stream, and dribbling, and</td>
    <td>Neck: WNL</td>
    <td>Bladder stones</td>
  </tr>
  <tr>
    <td>ne needs to strain to initiate urination. He</td>
    <td>Lungs: WNL</td>
    <td>Bladder trauma</td>
  </tr>
  <tr>
    <td>denies any weight loss, fatigue, or bone</td>
    <td>CV: WNL</td>
    <td>Chronic pelvic pain</td>
  </tr>
  <tr>
    <td>pain. He also has a sensation of incomplete</td>
    <td>Abd: WNL</td>
    <td>Cystitis</td>
  </tr>
  <tr>
    <td rowspan="5">2vacuation of urine from the bladder.</td>
    <td>Rectal exam: Enlarged, nodular, non-tender,</td>
    <td>Neurogenic bladder</td>
  </tr>
  <tr>
    <td></td>
    <td>rubbery prostate gland</td>
    <td>Prostate cancer</td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td>Prostatitis</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Urethral strictures</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>UTI</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>‘complains of sudden-onset fever</td>
    <td>VS:T 37.3°C (99°F), P 65, BP 101/64, RR 16</td>
    <td>Acute cystitis</td>
  </tr>
  <tr>
    <td>, urgency and burning on urination,</td>
    <td>Gen: No acute distress</td>
    <td>Anal fistulas and fissures</td>
  </tr>
  <tr>
    <td>eal pain. His symptoms started after</td>
    <td>Lungs: WNL</td>
    <td>Epididymitis</td>
  </tr>
  <tr>
    <td rowspan="4">went urethral dilation for stricture.</td>
    <td>CV: WNL</td>
    <td>Obstructive calculus</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Suprapubic tenderness</td>
    <td>Orchitis</td>
  </tr>
  <tr>
    <td></td>
    <td>GU: Genitalia WNL</td>
    <td>Prostatitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Rectal exam: Asymmetrically swollen, firm,</td>
    <td>Pyelonephritis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Office W/U</td>
    <td>Follow up in 3 weeks with UA and periodic</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>U/S—renal</td>
    <td>BP and BUN/Cr monitoring</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td>Throat culture: ©</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>UA: Hematuria, proteinuria, RBC casts</td>
    <td>Rx</td>
    <td>Dietary consult</td>
  </tr>
  <tr>
    <td>24-hour urine protein: Proteinuria</td>
    <td>Furosemide</td>
    <td>Low-sodium diet</td>
  </tr>
  <tr>
    <td>ASO titer: Normal</td>
    <td>ACEI (captopril)</td>
    <td>Restrict fluid intake</td>
  </tr>
  <tr>
    <td>Throat culture: Pending</td>
    <td>Nephrology consult</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Total serum complement: J</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Furosemide</td>
  </tr>
  <tr>
    <td colspan="3">Captopril</td>
  </tr>
  <tr>
    <td>Penicillin</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 6 months with digital rectal</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Urology consult if refractory to treatment</td>
    <td>examination and PSA</td>
  </tr>
  <tr>
    <td>BMP: Elevated creatinine</td>
    <td>Urodynamic studies</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>UA and urine culture</td>
    <td></td>
    <td>Dietary consult</td>
  </tr>
  <tr>
    <td colspan="3">U/S—prostate</td>
  </tr>
  <tr>
    <td colspan="3">ESR</td>
  </tr>
  <tr>
    <td colspan="3">Total serum PSA</td>
  </tr>
  <tr>
    <td colspan="3">Residual urinary volume</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Finasteride</td>
  </tr>
  <tr>
    <td>Prazosin (selective short-acting a-blockers)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>UA</td>
    <td>Urology consult</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Urine Gram stain and culture</td>
    <td>Cystoscopy</td>
    <td>Counsel patient to cease alcohol intake</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td></td>
    <td>Smoking cessation</td>
  </tr>
  <tr>
    <td>Chem 8</td>
    <td></td>
    <td>Counsel patient re: safe sex practices</td>
  </tr>
  <tr>
    <td>VDRL, G/C testing</td>
    <td></td>
    <td>Treat sexual partner(s)</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>TMP-SMX or fluoroquinolone</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>sation</td>
    <td>VS:T 37.3°C (98.9°F), P 65, BP 101/64, RR 14</td>
    <td>Chemical irritation</td>
  </tr>
  <tr>
    <td>arge. He</td>
    <td>Gen: NAD</td>
    <td>Cystitis</td>
  </tr>
  <tr>
    <td>sex with</td>
    <td>Lungs: WNL</td>
    <td>Epididymitis</td>
  </tr>
  <tr>
    <td>quency,</td>
    <td>CV: WNL</td>
    <td>Orchitis</td>
  </tr>
  <tr>
    <td rowspan="3">sea.</td>
    <td>Abd: Mild suprapubic tenderness</td>
    <td>Prostatitis</td>
  </tr>
  <tr>
    <td></td>
    <td>GU: Erythema of urethral meatus, no penile</td>
    <td>Reiter syndrome</td>
  </tr>
  <tr>
    <td></td>
    <td>lesions, pus expressed from urethra</td>
    <td>Urethritis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo F presents with a 2-day history of</td>
    <td>VS: Afebrile, P 65, BP 101/64, RR 16</td>
    <td>Acute cystitis</td>
  </tr>
  <tr>
    <td>suria, T urinary frequency, and suprapubic</td>
    <td>Gen: NAD</td>
    <td>Nephrolithiasis</td>
  </tr>
  <tr>
    <td>in. She is sexually active only with her</td>
    <td>Lungs: WNL</td>
    <td>Pelvic inflammatory disease</td>
  </tr>
  <tr>
    <td>sband. She has no flank pain, fever, or</td>
    <td>CV: WNL</td>
    <td>Pyelonephritis</td>
  </tr>
  <tr>
    <td rowspan="2">usea.</td>
    <td>Abd: Mild suprapubic tenderness</td>
    <td>Urethritis</td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: WNL</td>
    <td>Vaginitis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>UA and urine culture</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Urethral Gram stain: Many WBCs/hpf</td>
    <td>Treat partner</td>
  </tr>
  <tr>
    <td>without bacteria</td>
    <td>Counsel patient re: safe sex practices</td>
  </tr>
  <tr>
    <td>Urethral G&amp;C culture (for Neisseria</td>
    <td>Repeat testing with nucleic acid</td>
  </tr>
  <tr>
    <td>gonorrhoeae and Chlamydia trachomatis)</td>
    <td>amplification testing in 3-6 months</td>
  </tr>
  <tr>
    <td colspan="2">CBC</td>
  </tr>
  <tr>
    <td colspan="2">VDRL</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">PO azithromycin (single dose)</td>
  </tr>
  <tr>
    <td>IM ceftriaxone (single dose)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td colspan="3">Office W/U Office W/U</td>
  </tr>
  <tr>
    <td>UA: TT WBCs, +4 bacteria, ® nitrites,</td>
    <td>Urine culture: @ for E coli sensitive to</td>
    <td></td>
  </tr>
  <tr>
    <td>@ leukocyte esterase</td>
    <td>TMP-SMX</td>
    <td></td>
  </tr>
  <tr>
    <td>Urine culture</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>TMP-SMX</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Chem 8</td>
  </tr>
  <tr>
    <td colspan="3">Urine pregnancy test</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td>TMP-SMX X 3 days</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>ual</td>
    <td>Adrenal tumor</td>
  </tr>
  <tr>
    <td>arche</td>
    <td>Cushing syndrorr</td>
  </tr>
  <tr>
    <td>I hair,</td>
    <td>Idiopathic hirsuti</td>
  </tr>
  <tr>
    <td rowspan="5">the skin</td>
    <td>Late-onset conge</td>
  </tr>
  <tr>
    <td></td>
    <td>Ovarian neoplasr</td>
  </tr>
  <tr>
    <td></td>
    <td>Polycystic ovariar</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>0 yo F presents with hot flashes and</td>
    <td>VS:T 36°C (97°F), BP 120/60, HR 70, RR 13</td>
    <td>Hyperthyroidism</td>
  </tr>
  <tr>
    <td>yspareunia. Her last menstrual period was</td>
    <td>Gen: NAD</td>
    <td>Hypothyroidism</td>
  </tr>
  <tr>
    <td rowspan="6">months ago.</td>
    <td>HEENT: WNL</td>
    <td>Menopause</td>
  </tr>
  <tr>
    <td></td>
    <td>Breast: WNL</td>
    <td>Pregnancy</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Prolactinoma</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Atrophy of vaginal mucosa</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Follow up in 6 months</td>
  </tr>
  <tr>
    <td colspan="3">DHEAS</td>
  </tr>
  <tr>
    <td colspan="3">Testosterone: T</td>
  </tr>
  <tr>
    <td colspan="3">Serum 17-hydroxyprogesterone</td>
  </tr>
  <tr>
    <td colspan="3">LH/FSH: T</td>
  </tr>
  <tr>
    <td colspan="3">Prolactin</td>
  </tr>
  <tr>
    <td colspan="3">TSH/free T,</td>
  </tr>
  <tr>
    <td colspan="3">Insulin/fasting glucose</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Weight loss</td>
  </tr>
  <tr>
    <td colspan="3">Exercise program</td>
  </tr>
  <tr>
    <td colspan="3">OCPs</td>
  </tr>
  <tr>
    <td colspan="3">Spironolactone</td>
  </tr>
  <tr>
    <td>Smoking cessation</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>MGMT F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Follow up in 12 months</td>
  </tr>
  <tr>
    <td>Urine pregnancy test</td>
    <td>Counsel patient re: HRT—not</td>
  </tr>
  <tr>
    <td>Prolactin</td>
    <td>recommended unless only short-term</td>
  </tr>
  <tr>
    <td>TSH</td>
    <td>treatment is planned and if the patient has</td>
  </tr>
  <tr>
    <td>FSH: T</td>
    <td>no CAD, breast cancer, or thromboembolic</td>
  </tr>
  <tr>
    <td>Wet mount</td>
    <td>risk factors</td>
  </tr>
  <tr>
    <td>Pap smear</td>
    <td>Counsel patient re: increased risk of</td>
  </tr>
  <tr>
    <td>Mammogram</td>
    <td>mood symptoms and depression in</td>
  </tr>
  <tr>
    <td>DEXA scan</td>
    <td>postmenopausal women</td>
  </tr>
  <tr>
    <td colspan="2">PHQ-2 depression screen</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Calcium supplementation</td>
  </tr>
  <tr>
    <td colspan="2">Vitamin D supplementation</td>
  </tr>
  <tr>
    <td colspan="2">Hormone therapy for vasomotor</td>
  </tr>
  <tr>
    <td colspan="2">symptoms</td>
  </tr>
  <tr>
    <td colspan="2">Vaginal estrogen cream</td>
  </tr>
  <tr>
    <td>Vaginal jelly for lubrication</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>9 F complains of prolonged and</td>
    <td>VS:T 36°C (97°F), P 65, BP 120/60, RR 14</td>
    <td>Adenomyosis</td>
  </tr>
  <tr>
    <td>ssive menstrual bleeding and increased</td>
    <td>Gen: NAD</td>
    <td>Bleeding disorder/coagulopathy</td>
  </tr>
  <tr>
    <td rowspan="5">strual frequency for the past 6 months.</td>
    <td>HEENT: WNL</td>
    <td>Endometrial hyperplasia/malignancy</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Endometrial polyp</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Hyperthyroidism</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Hypothyroidism</td>
  </tr>
  <tr>
    <td></td>
    <td>GU: WNL</td>
    <td>Leiomyoma</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Office W/U TSH</td>
    <td>Office W/U 2D echocardiography</td>
    <td>Stop growth hormone when bone age &gt; 15 years</td>
  </tr>
  <tr>
    <td>FSH: T</td>
    <td>U/S—renal</td>
    <td>Audiogram every 3-5 years</td>
  </tr>
  <tr>
    <td>LH: T</td>
    <td>U/S—pelvis: Streaked ovaries</td>
    <td>Monitor blood pressure yearly</td>
  </tr>
  <tr>
    <td>Karyotyping: Consistent with Turner</td>
    <td>Skeletal survey: Short fourth metacarpal</td>
    <td>Liver and thyroid studies yearly</td>
  </tr>
  <tr>
    <td>syndrome</td>
    <td>Chem 13</td>
    <td>Monitor aortic root diameter every</td>
  </tr>
  <tr>
    <td>Lipid panel</td>
    <td>CBC</td>
    <td>3-5 years</td>
  </tr>
  <tr>
    <td>Fasting glucose</td>
    <td>UA</td>
    <td>Referral to support group for patients with</td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Lipid profile</td>
    <td>Turner syndrome</td>
  </tr>
  <tr>
    <td>Growth hormone therapy</td>
    <td>Hearing test</td>
    <td></td>
  </tr>
  <tr>
    <td>Estrogen + progestin</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Psychiatry/social work consult for</td>
    <td>Continue growth hormone therapy until</td>
    <td></td>
  </tr>
  <tr>
    <td>educational and psychosocial evaluations</td>
    <td>epiphysis is closed</td>
    <td></td>
  </tr>
  <tr>
    <td>Orthodontic evaluation</td>
    <td>Combination estrogen and progestin</td>
    <td></td>
  </tr>
  <tr>
    <td>Vitamin D supplementation</td>
    <td>Encourage weight-bearing exercises</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td></td>
    <td>Follow up in 6 months</td>
  </tr>
  <tr>
    <td>Urine pregnancy test</td>
    <td></td>
    <td>Counsel patient re: safe sex practices</td>
  </tr>
  <tr>
    <td colspan="3">TSH</td>
  </tr>
  <tr>
    <td colspan="3">CBC: Hypochromic microcytic anemia</td>
  </tr>
  <tr>
    <td colspan="3">Bleeding time</td>
  </tr>
  <tr>
    <td colspan="3">PT/PTT, INR</td>
  </tr>
  <tr>
    <td colspan="3">U/S—pelvis</td>
  </tr>
  <tr>
    <td colspan="3">Pap smear</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Iron sulfate</td>
  </tr>
  <tr>
    <td colspan="3">NSAIDs</td>
  </tr>
  <tr>
    <td>OCPs</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>|</td>
    <td>VS:T 36°C (97°F), BP 120/60, HR 80, RR 12</td>
    <td>Cervi</td>
  </tr>
  <tr>
    <td rowspan="8">. Her D.</td>
    <td>Gen: NAD</td>
    <td>infect</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL CV: WNL</td>
    <td>Ectop Mens</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: Suprapubic tenderness with no</td>
    <td>Spon</td>
  </tr>
  <tr>
    <td></td>
    <td>rebound or guarding</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Active bleeding from cervix, cervical</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>os open, 7-week-size uterus, mildly tender,</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>no cervical motion tenderness, no adnexal</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>masses or tenderness</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>60 yo F GO with a history of hypertension,</td>
    <td>Atrophic endometritis</td>
  </tr>
  <tr>
    <td>diabetes mellitus and infertility who had her</td>
    <td>Cervical cancer</td>
  </tr>
  <tr>
    <td>last menstrual period 10 years ago presents</td>
    <td>Endometrial cancer</td>
  </tr>
  <tr>
    <td rowspan="4">with mild vaginal bleeding for the last 2 days.</td>
    <td>Endometrial polyp</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>32 yo F G2P1011 presents with vaginal</td>
    <td>Cervical cancer</td>
  </tr>
  <tr>
    <td>bleeding after intercourse for the last month.</td>
    <td>Cervical polyp</td>
  </tr>
  <tr>
    <td>She has no history of abnormal Pap smears</td>
    <td>Cervicitis</td>
  </tr>
  <tr>
    <td>or STDs and has had the same partner for the</td>
    <td>Ectropion</td>
  </tr>
  <tr>
    <td>last 8 years. She uses OCPs.</td>
    <td>Vaginal cancer</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 3 weeks</td>
  </tr>
  <tr>
    <td>Urine pregnancy test: ©</td>
    <td>hcG</td>
    <td></td>
  </tr>
  <tr>
    <td>Quantitative serum B-hCG: 3000</td>
    <td>CBC</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC: Hemoglobin 9</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood type and screen, crossmatch</td>
    <td>Methylergonovine</td>
    <td></td>
  </tr>
  <tr>
    <td>Rh factor</td>
    <td>Doxycycline</td>
    <td></td>
  </tr>
  <tr>
    <td>U/S—pelvis: Intrauterine pregnancy sac,</td>
    <td>Anti-D immunoglobulin if Rh(D) ©</td>
    <td></td>
  </tr>
  <tr>
    <td>fetal pole, no fetal heart tones</td>
    <td>Counsel patient re: birth control</td>
    <td></td>
  </tr>
  <tr>
    <td>Gynecology consult</td>
    <td>Grief counseling</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Pelvic rest for 2 weeks</td>
    <td></td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>CXR</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>ECG</td>
    <td></td>
  </tr>
  <tr>
    <td>PT/PTT, INR</td>
    <td>CA-125</td>
    <td></td>
  </tr>
  <tr>
    <td>Bleeding time</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Pap smear</td>
    <td>Exploratory laparotomy</td>
    <td></td>
  </tr>
  <tr>
    <td>Endometrial biopsy: Poorly differentiated</td>
    <td>TAH-BSO</td>
    <td></td>
  </tr>
  <tr>
    <td>endometrioid adenocarcinoma</td>
    <td>Depending on staging, patient may</td>
    <td></td>
  </tr>
  <tr>
    <td>U/S—pelvis: 10-mm endometrial stripe</td>
    <td>benefit from adjuvant therapy (radiation vs</td>
    <td></td>
  </tr>
  <tr>
    <td>Gynecology consult</td>
    <td>chemotherapy vs hormonal therapy)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office</td>
    <td>W/U</td>
    <td>Office W/U</td>
    <td>Radical hysterectomy vs radiation therapy</td>
  </tr>
  <tr>
    <td>UA</td>
    <td></td>
    <td>Colposcopy</td>
    <td>+/— adjuvant chemoradiotherapy</td>
  </tr>
  <tr>
    <td>Urine</td>
    <td>hCG</td>
    <td>Cervical biopsy: Invasive squamous cell</td>
    <td></td>
  </tr>
  <tr>
    <td>Pap</td>
    <td>smear: HGSIL</td>
    <td>carcinoma of cervix</td>
    <td></td>
  </tr>
  <tr>
    <td>Pelvic:</td>
    <td>Visible cervical lesion</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="4">G&amp;C culture or PCR</td>
  </tr>
  <tr>
    <td colspan="4">Wet mount</td>
  </tr>
  <tr>
    <td></td>
    <td>Gynecology consult</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td></td>
    <td>VS: Afebrile, P 90, BP 120/64, RR 22, O, sat</td>
    <td>Accident proneness</td>
  </tr>
  <tr>
    <td>1 the</td>
    <td>95% room air</td>
    <td>Intimate partner violence</td>
  </tr>
  <tr>
    <td rowspan="8">sical use.</td>
    <td>Gen: Moderate distress with shallow</td>
    <td>Substance abuse</td>
  </tr>
  <tr>
    <td></td>
    <td>breathing</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>HEENT: 2.5-cm bruise on forehead; 2-cm bruise left cheek</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Chest/lungs: Severe tenderness on left fifth</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>and sixth ribs; CTA bilaterally</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>1 swelling</th>
    <th>VS:T 38°C (101°F), BP 140/95, HR 80, RR 18</th>
    <th>Cutaneous lupus eryt</th>
  </thead>
  <tr>
    <td>r her nasal</td>
    <td>Gen: Pallor, fatigue</td>
    <td>Dermatomyositis</td>
  </tr>
  <tr>
    <td>er expo-</td>
    <td>HEENT: Oral ulcers, malar erythema</td>
    <td>Drug reaction</td>
  </tr>
  <tr>
    <td>2uritic</td>
    <td>Lungs: CTA, pleural friction rub</td>
    <td>Mixed connective tis:</td>
  </tr>
  <tr>
    <td>algia, and</td>
    <td>CV: WNL</td>
    <td>Photosensitivity</td>
  </tr>
  <tr>
    <td>he says</td>
    <td>Abd: WNL</td>
    <td>Polymyositis</td>
  </tr>
  <tr>
    <td>om joint</td>
    <td>Ext: Maculopapular rash over arms and chest;</td>
    <td>Rheumatoid arthritis</td>
  </tr>
  <tr>
    <td>\ands,</td>
    <td>effusion in knees, wrists, and ankles</td>
    <td>SLE</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>fice W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 4 weeks with UA</td>
  </tr>
  <tr>
    <td>CBC: 1 hemoglobin</td>
    <td>Anti-dsDNA or antichromatin antibodies;</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>BMP</td>
    <td>anti-RNP antibodies; anti-Smith antibodies;</td>
    <td>Alcohol abstinence counseling</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td>anti-SS-A antibodies; anti-SS-B antibodies;</td>
    <td>Smoking cessation counseling</td>
  </tr>
  <tr>
    <td>ESR/CRP: T</td>
    <td>rheumatoid factor: ®</td>
    <td>Sunblock</td>
  </tr>
  <tr>
    <td>Serum ANA: ®</td>
    <td>Bone densitometry</td>
    <td></td>
  </tr>
  <tr>
    <td>UA: Proteinuria</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>Prednisone</td>
    <td></td>
  </tr>
  <tr>
    <td>Total complement: J C3 and C4</td>
    <td>NSAIDs</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Rheumatology consult</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="3">NSAIDs</td>
    <td>Nephrology consult</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Chloroquine or hydroxychloroquine</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ophthalmology consult if using</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo M with a history of diabetes mellitus</td>
    <td>VS:T 38°C (100.5°F), P 70, BP 120/60, RR 12</td>
    <td>Calf tear or pull</td>
  </tr>
  <tr>
    <td>sents with pain, swelling, and discolor-</td>
    <td>Gen: NAD</td>
    <td>Cellulitis</td>
  </tr>
  <tr>
    <td>on of his right leg for the last week. He</td>
    <td>Lungs: WNL</td>
    <td>Deep venous thrombosis</td>
  </tr>
  <tr>
    <td rowspan="5">lies any trauma.</td>
    <td>WNL</td>
    <td>Lymphedema</td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td>Osteomyelitis</td>
  </tr>
  <tr>
    <td></td>
    <td>+2 edema in right lower extremity;</td>
    <td>Popliteal (Baker) cyst</td>
  </tr>
  <tr>
    <td></td>
    <td>warmth, erythematous discoloration of</td>
    <td>Venous insufficiency</td>
  </tr>
  <tr>
    <td></td>
    <td>skin, 20-cm ulcer</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Two weeks later his leg is back to normal</td>
  </tr>
  <tr>
    <td>CBC: T WBC count</td>
    <td>Blood culture: ©</td>
    <td>Amoxicillin is discontinued after a course</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>Blood glucose: Controlled on insulin</td>
    <td>of 14 days</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td>regimen</td>
    <td></td>
  </tr>
  <tr>
    <td>U/S—left lower extremity: © for deep</td>
    <td>CBC: WBC downtrending</td>
    <td></td>
  </tr>
  <tr>
    <td>venous thrombosis</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>ESR</td>
    <td>Leg elevation</td>
    <td></td>
  </tr>
  <tr>
    <td>X-ray</td>
    <td>Switch to amoxicillin when patient is</td>
    <td></td>
  </tr>
  <tr>
    <td>Blood culture: Pending</td>
    <td>afebrile and symptoms improve (usually in</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>3-5 days)</td>
    <td></td>
  </tr>
  <tr>
    <td>IV ampicillin-sulbactam</td>
    <td>Discharge home</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>CPK, LDH: T</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>UA: @ for myoglobin</td>
    <td>Switch to alternative statin with less</td>
  </tr>
  <tr>
    <td>BMP</td>
    <td>Rx</td>
    <td>intrinsic muscle toxicity (pravastatin or</td>
  </tr>
  <tr>
    <td>TSH</td>
    <td>Discontinue simvastatin</td>
    <td>fluvastatin)</td>
  </tr>
  <tr>
    <td colspan="3">Serum CPK: T</td>
  </tr>
  <tr>
    <td colspan="3">LDH: T</td>
  </tr>
  <tr>
    <td colspan="3">Vitamin D level</td>
  </tr>
  <tr>
    <td colspan="3">EMG: Muscle injury</td>
  </tr>
  <tr>
    <td colspan="3">UA: Myoglobinuria</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Counsel patient re: medication side effects</td>
  </tr>
  <tr>
    <td>NSAIDs</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>VS:T 39°C (102°F), P 122, BP 138/82, RR</td>
  </tr>
  <tr>
    <td>O, sat 96% room air</td>
  </tr>
  <tr>
    <td>HEENT and neck: WNL</td>
  </tr>
  <tr>
    <td>Chest: Four vesicles on thoracic skin</td>
  </tr>
  <tr>
    <td>CV: WNL</td>
  </tr>
  <tr>
    <td>Abd: Three vesicles and 1 pustule on</td>
  </tr>
  <tr>
    <td>inal skin</td>
  </tr>
  <tr>
    <td>Ext: Knee joints are hot, swollen, and</td>
  </tr>
  <tr>
    <td>J ROM due to severe pain</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Child Protective Services</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Mandatory reporting of suspected child</td>
    <td>Evaluation of children sharing the</td>
  </tr>
  <tr>
    <td>PT/PTT</td>
    <td>abuse</td>
    <td>household with patient</td>
  </tr>
  <tr>
    <td>Chem 7</td>
    <td>Child Protective Services evaluation</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Posterior rib fractures</td>
    <td>Ventilator (if necessary)</td>
    <td></td>
  </tr>
  <tr>
    <td>Skeletal survey: Posterior rib fractures;</td>
    <td>IV fluids (NS)</td>
    <td></td>
  </tr>
  <tr>
    <td>obliquely oriented callus formation in right</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>femur</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CT—head: Short-length skull fractures;</td>
    <td colspan="3" rowspan="2">small subdural hemorrhages</td>
  </tr>
  <tr>
    <td colspan="3"></td>
  </tr>
  <tr>
    <td colspan="3">Ophthalmologic exam: Bilateral retinal</td>
  </tr>
  <tr>
    <td colspan="3">hemorrhages</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Admission to hospital</td>
  </tr>
  <tr>
    <td colspan="3">IV fluids (NS)</td>
  </tr>
  <tr>
    <td colspan="3">Neurosurgery consult</td>
  </tr>
  <tr>
    <td>Ventilator (if necessary)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>/U</td>
    <td>Follow up in 4 weeks</td>
  </tr>
  <tr>
    <td>ypochromic normocytic anemia,</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td rowspan="2">pocytosis</td>
    <td>Physical therapy</td>
  </tr>
  <tr>
    <td></td>
    <td>Occupational therapy</td>
  </tr>
  <tr>
    <td>-joints: Soft tissue swelling, juxta-</td>
    <td>Rest at home</td>
  </tr>
  <tr>
    <td>ar demineralization, joint space</td>
    <td>Exercise program</td>
  </tr>
  <tr>
    <td>jing, erosions in juxta-articular</td>
    <td>Splint extremity</td>
  </tr>
  <tr>
    <td>’</td>
    <td>Ophthalmologic consult if using</td>
  </tr>
  <tr>
    <td>jh titer</td>
    <td>hydroxychloroquine</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 2 weeks</td>
  </tr>
  <tr>
    <td>initially</td>
    <td>MRI—lumbar spine: Disc herniation at</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>L5-S1 level (MRI is not routinely ordered</td>
    <td>Rest at home</td>
  </tr>
  <tr>
    <td>Conservative treatment</td>
    <td>for a disk herniation; it is ordered if</td>
    <td>Physical therapy</td>
  </tr>
  <tr>
    <td>Pain control (NSAIDs, may consider a short</td>
    <td>conservative treatment fails)</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="4">course of opioids for severe pain)</td>
    <td></td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Conservative treatment</td>
    <td></td>
  </tr>
  <tr>
    <td>Orthopedic surgery consult (if conservative</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>treatment fails)</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th></th>
    <th>DUA</th>
  </thead>
  <tr>
    <td>1e ED because of</td>
    <td>VS:T 39°C (102°F), P 160, BP 77/50, RR 40,</td>
    <td>CNS fungal infection (i</td>
  </tr>
  <tr>
    <td>ting, and J oral</td>
    <td>O, sat 92% room air</td>
    <td>immunocompromised</td>
  </tr>
  <tr>
    <td>ay, his parents</td>
    <td>Gen: Irritable</td>
    <td>HIV infection (in immu</td>
  </tr>
  <tr>
    <td>101.5°F, and</td>
    <td>Lungs: Clear</td>
    <td>patients)</td>
  </tr>
  <tr>
    <td>e. The baby’s</td>
    <td>CV: Tachycardia; I/VI systolic murmur</td>
    <td>Meningitis (viral or bac</td>
  </tr>
  <tr>
    <td rowspan="3">grams, and he</td>
    <td></td>
    <td>Abd: WNL</td>
    <td>Osteomyelitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro/psych: Bulging fontanelle,</td>
    <td>Pneumonia</td>
  </tr>
  <tr>
    <td>J responsiveness</td>
    <td>Sepsis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th></th>
  </thead>
  <tr>
    <td>) because</td>
    <td>VS:T 39°C (102°F), P 160, BP 77/50, RR 40,</td>
    <td>Asthma</td>
  </tr>
  <tr>
    <td>ly Nose,</td>
    <td>O, sat 88% room air</td>
    <td>CHF</td>
  </tr>
  <tr>
    <td>g, and</td>
    <td>Gen: Irritable</td>
    <td>Cystic fibrosis</td>
  </tr>
  <tr>
    <td>tic mother</td>
    <td>Lungs: Tachypnea, intercostal retractions,</td>
    <td>Pneumonia</td>
  </tr>
  <tr>
    <td>yn during</td>
    <td>nasal flaring, expiratory wheezing, bilateral</td>
    <td>RSV bronchiolitis</td>
  </tr>
  <tr>
    <td>ematurely</td>
    <td>crackles</td>
    <td></td>
  </tr>
  <tr>
    <td>dira-</td>
    <td>CV: Tachycardia; continuous II/VI murmur</td>
    <td></td>
  </tr>
  <tr>
    <td>he has</td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td>nance</td>
    <td>Neuro/psych: Fontanelle is soft and flat;</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>irritable</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>EDW/U</td>
    <td>Ward W/U</td>
    <td>Follow up in 48 hours of discharge from</td>
  </tr>
  <tr>
    <td>CBC Chem 7:</td>
    <td>Serum glucose: 75 mg/dL Urine culture: ©</td>
    <td>hospital</td>
  </tr>
  <tr>
    <td>Hyponatremia Blood cultures</td>
    <td>Blood culture: ® for $</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td></td>
    <td>pneumoniae Ventilator</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR and culture</td>
    <td>(if necessary)</td>
    <td></td>
  </tr>
  <tr>
    <td>UA urine LP: Cell count, differential, bacterial culture,</td>
    <td>Rx IV fluids, (Dsy,NS)</td>
    <td></td>
  </tr>
  <tr>
    <td>viral PCR pending</td>
    <td>IV antibiotics x 10-14 days</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">ABG: Metabolic acidosis</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Admission to hospital</td>
  </tr>
  <tr>
    <td>Empiric IV antibiotics (ampicillin and</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>cefotaxime)</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">IV fluid bolus</td>
  </tr>
  <tr>
    <td>IV fluids with dextrose</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>EDW/U</td>
    <td>ICU W/U</td>
    <td>Follow up in 48 hours of discharge from</td>
  </tr>
  <tr>
    <td>CBC: WBC 14,000</td>
    <td>Serum glucose: 70 mg/dL</td>
    <td>hospital</td>
  </tr>
  <tr>
    <td>Blood culture</td>
    <td>Urine culture: ©</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td>Chem 7</td>
    <td>CXR: No change</td>
    <td></td>
  </tr>
  <tr>
    <td>CXR: Hyperinflation, bilateral patchy</td>
    <td>Blood culture: O</td>
    <td></td>
  </tr>
  <tr>
    <td>interstitial infiltrates, T pulmonary blood</td>
    <td>RSV PCR @</td>
    <td></td>
  </tr>
  <tr>
    <td>flow, prominent left atrium and ventricle</td>
    <td>Ventilator (if necessary)</td>
    <td></td>
  </tr>
  <tr>
    <td>UA and urine culture</td>
    <td>Echocardiogram: Patent ductus arteriosus</td>
    <td></td>
  </tr>
  <tr>
    <td>ABG: Hypoxemia</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>RSV PCR: Pending</td>
    <td>IV fluids (Ds,,NS)</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Supplemental O,</td>
    <td></td>
  </tr>
  <tr>
    <td>Admission to the ICU</td>
    <td>Nebulized albuterol (if effective)</td>
    <td></td>
  </tr>
  <tr>
    <td>Empiric IV antibiotics</td>
    <td>Cardiology consult</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">IV fluid bolus</td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td></td>
    <td>VS:T 40°C (104°F), P 134, BP 113/83,</td>
    <td>Complicated py</td>
  </tr>
  <tr>
    <td>Urgi-</td>
    <td>RR 31, O, sat 93% room air</td>
    <td>Infectious proc</td>
  </tr>
  <tr>
    <td>ue,</td>
    <td>Ophthalmology: Visual field defects, conjunc-</td>
    <td>Infective endoc</td>
  </tr>
  <tr>
    <td>\ for</td>
    <td>tival hemorrhage</td>
    <td>Intracranial infe</td>
  </tr>
  <tr>
    <td rowspan="6"></td>
    <td>Funduscopy: Abnormal spots</td>
    <td>Sepsis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: Regurgitant murmur</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: Petechiae on feet</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: CN Ill palsy</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo M presents with fever and altered</td>
    <td>Alcohol withdrawal</td>
  </tr>
  <tr>
    <td>ntal status 8 hours after undergoing a</td>
    <td>Cardiogenic shock</td>
  </tr>
  <tr>
    <td rowspan="6">erticular abscess drainage.</td>
    <td>Delirium</td>
  </tr>
  <tr>
    <td></td>
    <td>Hypovolemic shock</td>
  </tr>
  <tr>
    <td></td>
    <td>Septic shock</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>al period was</td>
    <td>VS:T 39°C (102°F), BP 75/30, HR 120</td>
    <td>Meningococcen</td>
  </tr>
  <tr>
    <td>vomiting,</td>
    <td>Gen: NAD</td>
    <td>Rocky Mountair</td>
  </tr>
  <tr>
    <td rowspan="5">)rash.</td>
    <td>Skin: Diffuse macular erythema; hyperemic</td>
    <td>Streptococcal te</td>
  </tr>
  <tr>
    <td></td>
    <td>mucous membranes</td>
    <td>Toxic shock sync</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Typhoid fever</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Menstrual flow; foul-smelling tampon</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>ED STAT</td>
    <td>ICU W/U</td>
    <td></td>
  </tr>
  <tr>
    <td>Supplemental O,</td>
    <td>Blood culture: O</td>
    <td></td>
  </tr>
  <tr>
    <td>IV fluids (NS)</td>
    <td>Urine culture: ©</td>
    <td></td>
  </tr>
  <tr>
    <td>Pelvic exam: Retained tampon identified</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>and removed</td>
    <td>Continue IV clindamycin and vancomycin</td>
    <td></td>
  </tr>
  <tr>
    <td>EDW/U</td>
    <td>Wound care</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">CBC with differential</td>
  </tr>
  <tr>
    <td colspan="3">Chem 14</td>
  </tr>
  <tr>
    <td colspan="3">UA</td>
  </tr>
  <tr>
    <td colspan="3">Urine culture: Pending</td>
  </tr>
  <tr>
    <td colspan="3">Blood culture: Pending</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">Admit to ICU</td>
  </tr>
  <tr>
    <td colspan="3">IV fluids (NS)</td>
  </tr>
  <tr>
    <td>Vasopressors (if necessary)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>0 yo F presents with a painless lump in</td>
    <td>VS: Afebrile, P 70, BP 110/50, RR 12</td>
    <td>Breast cancer</td>
  </tr>
  <tr>
    <td>er right breast. She first noted this lump</td>
    <td>Gen: NAD</td>
    <td>Fibroadenoma</td>
  </tr>
  <tr>
    <td rowspan="8">| month ago. There is no nipple discharge.</td>
    <td>Skin: WNL</td>
    <td>Fibrocystic disease</td>
  </tr>
  <tr>
    <td></td>
    <td>HEENT: WNL</td>
    <td>Mastitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lymph nodes: ©</td>
    <td>Papilloma</td>
  </tr>
  <tr>
    <td></td>
    <td>Breast: 3-cm, hard, immobile, nontender mass</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>with irregular borders; no nipple discharge</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>yo F complains of vaginal itching, painful</td>
    <td>VS: WNL</td>
    <td>Atrophic vaginitis</td>
  </tr>
  <tr>
    <td rowspan="7">ercourse, and a clear discharge.</td>
    <td>Gen: NAD</td>
    <td>Bacterial vaginosis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Candidal vaginitis</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Cervicitis (chlamydia, gonorrhea)</td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Vulvar erythema, thin and pale</td>
    <td>Trichomonal vaginitis</td>
  </tr>
  <tr>
    <td></td>
    <td>mucosa with areas of erythema, clear</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>discharge, mucosa bleeds easily during</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>exam</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PE</th>
    <th>[</th>
  </thead>
  <tr>
    <td>veeks’</td>
    <td>VS:T 37°C (99°F), P 96, BP 141/91, RR 26,</td>
    <td>Fetal death</td>
  </tr>
  <tr>
    <td>| battered-</td>
    <td>O, sat 93% room air</td>
    <td>Fetal sleep</td>
  </tr>
  <tr>
    <td>physician</td>
    <td>Gen: No jaundice</td>
    <td>Preeclampsia</td>
  </tr>
  <tr>
    <td>ements. She</td>
    <td>Eyes: Normal vision</td>
    <td>Pregnancy-inducec</td>
  </tr>
  <tr>
    <td>/normal and</td>
    <td>Lungs: No rales</td>
    <td></td>
  </tr>
  <tr>
    <td>8 weeks</td>
    <td>CV: No gallops or murmurs</td>
    <td></td>
  </tr>
  <tr>
    <td>e patient</td>
    <td>Pelvic: Fundal height in centimeters is</td>
    <td></td>
  </tr>
  <tr>
    <td>es and</td>
    <td>appropriate for gestational age; cephalic</td>
    <td></td>
  </tr>
  <tr>
    <td>|, or taking</td>
    <td>presentation; speculum exam reveals</td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">eceived a</td>
    <td>unripe cervix, no ferning, nitrazine OQ</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: Slight pedal edema</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Ward W/U</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>BMP</td>
    <td>UA: Protein 0.3 g/L/24 hrs; normal</td>
    <td>Obstetric consult</td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>sediment</td>
    <td></td>
  </tr>
  <tr>
    <td>UA: @ protein</td>
    <td>LFTs: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td>Random serum glucose</td>
    <td>Rx</td>
    <td></td>
  </tr>
  <tr>
    <td>Serum uric acid</td>
    <td>Monitor, continue BP cuff</td>
    <td></td>
  </tr>
  <tr>
    <td>Rx</td>
    <td>Fetal monitoring</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">Monitor, continue BP cuff</td>
  </tr>
  <tr>
    <td>Fetal monitoring</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>30 yo F presents for her regular checkup.</td>
    <td>VS: P 75, BP 160/90 (no difference in BP</td>
    <td>Cushing disease</td>
  </tr>
  <tr>
    <td>She denies any complaints but is concerned</td>
    <td>between both arms), RR 12</td>
    <td>Essential hypertension</td>
  </tr>
  <tr>
    <td>about her BP, as it has been high on both of</td>
    <td>Gen: WNL</td>
    <td>Hyperaldosteronism</td>
  </tr>
  <tr>
    <td rowspan="8">her previous visits over the past 2 months.</td>
    <td>HEENT: WNL</td>
    <td>Hyperthyroidism</td>
  </tr>
  <tr>
    <td></td>
    <td>Breast: WNL</td>
    <td>Renal artery stenosis</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>White coat hypertension</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Abd: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Ext: WNL</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Neuro: WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>6 yo Mis brought by his mother with con-</td>
    <td>Afebrile, P 80, BP 80/50, RR 14</td>
    <td>DIC</td>
  </tr>
  <tr>
    <td>tinuous oozing of blood from the site of</td>
    <td>NAD</td>
    <td>Hemophilia</td>
  </tr>
  <tr>
    <td>a tooth extraction he underwent 2 days</td>
    <td>WNL</td>
    <td>ITP</td>
  </tr>
  <tr>
    <td>ago. The bleeding initially stopped but</td>
    <td>HEENT: Blood oozing from site of extracted</td>
    <td>Liver disease</td>
  </tr>
  <tr>
    <td>restarted spontaneously a few hours later. His</td>
    <td>tooth</td>
    <td>TTP</td>
  </tr>
  <tr>
    <td>mother denies any history of epistaxis, easy</td>
    <td>Lungs: WNL</td>
    <td>Vitamin K deficiency</td>
  </tr>
  <tr>
    <td>bruising, petechiae, or bleeding per rectum.</td>
    <td>WNL</td>
    <td>von Willebrand disease</td>
  </tr>
  <tr>
    <td>The patient's mother has a brother with</td>
    <td>WNL</td>
    <td></td>
  </tr>
  <tr>
    <td>hemophilia.</td>
    <td>WNL</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>HX</th>
    <th>PE</th>
    <th>DDX</th>
  </thead>
  <tr>
    <td>7 yo F complains of pain during intercourse.</td>
    <td>VS: WNL</td>
    <td>Endometriosis</td>
  </tr>
  <tr>
    <td rowspan="7">he has a long history of painful periods.</td>
    <td>Gen: NAD</td>
    <td>Pelvic inflammatory disease</td>
  </tr>
  <tr>
    <td></td>
    <td>Lungs: WNL</td>
    <td>Vaginismus</td>
  </tr>
  <tr>
    <td></td>
    <td>CV: WNL</td>
    <td>Vaginitis</td>
  </tr>
  <tr>
    <td></td>
    <td>Pelvic: Normal vaginal walls, normal cervix,</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>mild cervical motion tenderness; uterus</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>tender, retroverted, and fixed; right adnexa</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>slightly enlarged and tender</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Office W/U</td>
    <td>Follow up in 1 month</td>
  </tr>
  <tr>
    <td>Lipid profile</td>
    <td>Consider workup for secondary</td>
    <td></td>
  </tr>
  <tr>
    <td>Chem 14</td>
    <td>hypertension given the patient's young</td>
    <td></td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>age (MRI/MRA renal arteries, urine</td>
    <td></td>
  </tr>
  <tr>
    <td>UA: +1 protein</td>
    <td>catecholamines, urine cortisol)</td>
    <td></td>
  </tr>
  <tr>
    <td colspan="3">ECG: LVH</td>
  </tr>
  <tr>
    <td colspan="3">Echocardiography: LVH</td>
  </tr>
  <tr>
    <td colspan="3">TSH</td>
  </tr>
  <tr>
    <td colspan="3">Rx</td>
  </tr>
  <tr>
    <td colspan="3">ACE inhibitor (eg, lisinopril)</td>
  </tr>
  <tr>
    <td colspan="3">Exercise program</td>
  </tr>
  <tr>
    <td>Low-sodium diet</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>CONTINUING MGMT F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>Console and reassure patient</td>
  </tr>
  <tr>
    <td>CBC</td>
    <td>Patient counseling</td>
  </tr>
  <tr>
    <td>Peripheral smear</td>
    <td>Family counseling</td>
  </tr>
  <tr>
    <td colspan="2">Bleeding time</td>
  </tr>
  <tr>
    <td colspan="2">PTT: Prolonged</td>
  </tr>
  <tr>
    <td colspan="2">PT, INR</td>
  </tr>
  <tr>
    <td colspan="2">Plasma factor VIII: 3%</td>
  </tr>
  <tr>
    <td colspan="2">Plasma factor IX</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">Factor Vill therapy</td>
  </tr>
  <tr>
    <td colspan="2">Genetics consult</td>
  </tr>
  <tr>
    <td>Counsel parents</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INITIAL MGMT</th>
    <th>F/U</th>
  </thead>
  <tr>
    <td>Office W/U</td>
    <td>If initial treatment with OCPs and</td>
  </tr>
  <tr>
    <td>Wet mount</td>
    <td>NSAIDs does not relieve pain, refer toa</td>
  </tr>
  <tr>
    <td>Chlamydia DNA probe</td>
    <td>gynecologist for a trial of GnRH analogs,</td>
  </tr>
  <tr>
    <td>Gonorrhea DNA probe</td>
    <td>progestins, or danazol.</td>
  </tr>
  <tr>
    <td>U/S—pelvis: Retroverted uterus of normal</td>
    <td>Follow up as needed</td>
  </tr>
  <tr>
    <td colspan="2">size; 2- X 3-cm cyst on right adnexa that</td>
  </tr>
  <tr>
    <td colspan="2">may represent a hemorrhagic corpus</td>
  </tr>
  <tr>
    <td colspan="2">luteum or endometrioma</td>
  </tr>
  <tr>
    <td colspan="2">Rx</td>
  </tr>
  <tr>
    <td colspan="2">NSAIDs</td>
  </tr>
  <tr>
    <td>OCPs</td>
    <td></td>
  </tr>
</table>
<table>
  <tr>
    <td>Ischemic Heart Disease</td>
    <td>30</td>
  </tr>
  <tr>
    <td>Valvular Disease</td>
    <td>32</td>
  </tr>
  <tr>
    <td>Heart Failure</td>
    <td>32</td>
  </tr>
  <tr>
    <td>SysToLic HEART FAILURE</td>
    <td>32</td>
  </tr>
  <tr>
    <td>Diastouic Heart FAILURE</td>
    <td>34</td>
  </tr>
  <tr>
    <td>Heart FAILURE RELATED TO VALVULAR DISEASE</td>
    <td>35</td>
  </tr>
  <tr>
    <td>Heart FAILure RELATED TO ARRHYTHMIAS.</td>
    <td>35</td>
  </tr>
  <tr>
    <td>Cardiomyopathy</td>
    <td>35</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Pericardial Disease</td>
    <td>35</td>
  </tr>
  <tr>
    <td>PERICARDITIS</td>
    <td>35</td>
  </tr>
  <tr>
    <td>PERICARDIAL EFFUSION AND CARDIAC TAMPONADE</td>
    <td>37</td>
  </tr>
  <tr>
    <td>Advanced Cardiac Evaluation</td>
    <td>38</td>
  </tr>
  <tr>
    <td>Hypertension</td>
    <td>38</td>
  </tr>
  <tr>
    <td>Aortic Dissection</td>
    <td>40</td>
  </tr>
  <tr>
    <td>Peripheral Vascular Disease</td>
    <td>43</td>
  </tr>
  <tr>
    <td>Hypercholesterolemia</td>
    <td>44</td>
  </tr>
  <tr>
    <td>Endocarditis</td>
    <td>46</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="3">Lert ANTERIOR Descenpine (LAD) ARTERY</th>
    <th rowspan="3">Lert CircumFLex ARTERY</th>
    <th rowspan="3">
      RicHt Coronary Artery/ Posterior DesceNDING ARTERY (RCA/PDA)
    </th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th></th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th></th>
  </thead>
  <tr>
    <td>Apex</td>
    <td>Lateral wall of LV</td>
    <td>Lateral wall of right ventricle (RV)</td>
  </tr>
  <tr>
    <td>Anterior wall of left</td>
    <td>Posterior wall of LV (20%)</td>
    <td>Posterior wall of LV (80%)</td>
  </tr>
  <tr>
    <td>ventricle (LV)</td>
    <td>Posterior one-third of IVS (20%)</td>
    <td>Posterior one-third of IVS (80%)</td>
  </tr>
  <tr>
    <td>Anterior two-thirds</td>
    <td></td>
    <td>SA node</td>
  </tr>
  <tr>
    <td>of interventricular</td>
    <td></td>
    <td>AV node</td>
  </tr>
  <tr>
    <td>septum (IVS)</td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Area OF INFARCT</th>
    <th>Coronary Artery INVOLVED</th>
    <th>Leaps with ST CHANGES</th>
  </thead>
  <tr>
    <td>Inferior wall (RV)</td>
    <td>RCA/PDA</td>
    <td>I, Ill, aVE</td>
  </tr>
  <tr>
    <td>Septum</td>
    <td>LAD</td>
    <td>V2, V3</td>
  </tr>
  <tr>
    <td>Lateral wall (LV)</td>
    <td>Left circumflex</td>
    <td>|, aVL, V5, V6</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Lesion</th>
    <th>Symptoms</th>
    <th>Exam</th>
    <th>TREATMENT</th>
    <th>Comments</th>
  </thead>
  <tr>
    <td>Mitral stenosis</td>
    <td>Symptoms of heart failure; hemoptysis; atrial fibrilla- tion (AF)</td>
    <td>
      Diastolic murmur best heard at = the apex; opening snap; usually does not
      radiate
    </td>
    <td>HR control, balloon valvulo- _ plasty, valve replacement</td>
    <td>—_ Usually caused by rheumatic fever</td>
  </tr>
  <tr>
    <td>Mitral regurgitation</td>
    <td>
      Has a long asymptomatic period; when severe or acute, presents with symp-
      toms of heart failure
    </td>
    <td>
      Blowing systolic murmur atthe apex, radiating to the axilla. The posterior
      leaflet may lead to a murmur along the sternal border
    </td>
    <td>
      _If acute, surgery is always required. For chronic mitral regurgitation,
      repair or replace the valve when symptomatic or if the ejec- tion fraction
      (EF) is &lt; 60%. Surgery is indicated in some patients with an EF &gt;
      60% (new AF, pulmonary hypertension)
    </td>
    <td>
      Long-standing regurgita- tion dilates the atrium, increasing the chance of
      AF
    </td>
  </tr>
  <tr>
    <td>Mitral valve prolapse</td>
    <td>
      Generally asymptomatic, although patients can complain of nonspecific
      symptoms such as pal- pitations or dyspnea; symptoms are unreliable
      indicators
    </td>
    <td>
      Midsystolic click; also murmur if mitral regurgitation is present (murmur
      increased by Valsalva maneuvers)
    </td>
    <td>Endocarditis prophylaxis is not required</td>
    <td>
      Questionable association with palpitations and panic attacks. The most
      common cause of mitral regurgitation
    </td>
  </tr>
  <tr>
    <td>Aortic stenosis</td>
    <td>Chest pain, syncope, heart failure, shortness of breath</td>
    <td>
      Harsh systolic crescendo- decrescendo murmur radiating to the carotids
      along the right sternal border. Signs of severe stenosis: a small and slow
      carotid upstroke (parvus et tardus), a late-peaking murmur, and a loss of
      clear S2
    </td>
    <td>
      Avoid overdiuresis; avoid —_- vasodilators such as nitrates and ACEls
      given fixed obstruction. Surgery, transcatheter valve replacement, or
      balloon __ valvuloplasty for all symp- tomatic patients
    </td>
    <td>Once symptoms appear, mortality is 50% at 3 years</td>
  </tr>
  <tr>
    <td>Aortic regurgitation</td>
    <td>
      Usually asymptomatic until advanced; then presents with symptoms of heart
      failure
    </td>
    <td>
      | Chronic: Soft, high-pitched diastolic murmur along the left sternal
      border. Radiates toward the apex. Wide pulse pressure and associated signs
      (eg, the Traube sign, Duroziez murmur) Acute: Low-pitched early dia-
    </td>
    <td>
      Afterload reduction with ACEls, hydralazine; valve replacement if symptom-
      atic or in the setting of a \EF
    </td>
    <td>
      Many cases are associated with aortic root disease, dissection, syphilis,
      anky- losing spondylitis, and Marfan syndrome
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Type</th>
    <th>AssociateD SYMPTOMS AND CONDITIONS</th>
    <th>DisTINGUISHING FEATURES</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Dilated</td>
    <td>
      Ischemia, tachycardia, hypertension, alcohol, and Chagas disease (in South
      America)
    </td>
    <td>
      If the offending source or stimulus is removed, alcoholic and
      tachycardia-induced cardiomy- opathies can be almost completely reversible
    </td>
    <td>
      ACEls, ARBs, B-blockers, and spironolactone; Digoxin can improve symptoms
      but does not improve mortality
    </td>
  </tr>
  <tr>
    <td>Restrictive</td>
    <td>
      Sarcoid, amyloid, hemochromatosis, cancer, and glycogen storage disease
    </td>
    <td>
      Echocardiography shows left ventricular hypertrophy (LVH), whereas ECG
      frequently shows low voltage. Biopsy is occasionally required to determine
      the cause
    </td>
    <td>
      Directed at the underlying cause and symptom management with diuretics
    </td>
  </tr>
  <tr>
    <td>Hypertrophic</td>
    <td>
      Genetically inherited in an autosomal dominant pattern; associated with
      sudden cardiac death
    </td>
    <td>
      Echocardiography may reveal a normalEF and an asymmetrically thickened
      ventricle
    </td>
    <td>Avoid inotropes, vasodilators, and excessive diuresis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>PERICARDITIS</th>
    <th>MI</th>
  </thead>
  <tr>
    <td>Clinical</td>
    <td>
      Pain improves with sitting up or leaning forward; sometimes pleuritic
    </td>
    <td>Pain is not alleviated or exacerbated by position</td>
  </tr>
  <tr>
    <td rowspan="5">ECG</td>
    <td>Diffuse ST-segment elevation, often</td>
    <td>ST-segment elevation is localized to</td>
  </tr>
  <tr>
    <td></td>
    <td>with upward concavity (see Figure 3-2);</td>
    <td>the distribution of coronary arteries,</td>
  </tr>
  <tr>
    <td></td>
    <td>PR-segment depression, particularly in the</td>
    <td>often with downward concavity;</td>
  </tr>
  <tr>
    <td></td>
    <td>limb leads; ST-T changes tend to normalize</td>
    <td>reciprocal ST depressions can be</td>
  </tr>
  <tr>
    <td></td>
    <td>more rapidly than those in MI</td>
    <td>present</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Mobpatity</th>
    <th>Pros</th>
    <th>Cons</th>
  </thead>
  <tr>
    <td>Treadmill</td>
    <td>Good for patients who can exercise lightly</td>
    <td>Lower sensitivity in women</td>
  </tr>
  <tr>
    <td rowspan="2">Dobutamine</td>
    <td>Good for patients who cannot</td>
    <td>_ Patients can feel poorly</td>
  </tr>
  <tr>
    <td></td>
    <td>exercise</td>
    <td>because of B-agonism</td>
  </tr>
  <tr>
    <td rowspan="3">Adenosine or dipyridamole (with nuclear imaging)</td>
    <td>Good for patients who cannot</td>
    <td>Can cause bronchospasm;</td>
  </tr>
  <tr>
    <td></td>
    <td>exercise</td>
    <td>use caution in patients with</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>asthma/COPD</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Mopatity</th>
    <th>Pros</th>
    <th>Cons</th>
  </thead>
  <tr>
    <td rowspan="4">ECG</td>
    <td>Inexpensive, fast</td>
    <td>Cannot localize the lesion; cannot use</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>with baseline ST-segment abnormalities</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>or LBBB; cannot use if the patient is on</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>digoxin</td>
  </tr>
  <tr>
    <td rowspan="2">Echocardiography</td>
    <td>Better than ECG in patients</td>
    <td>Quality is provider dependent, which</td>
  </tr>
  <tr>
    <td></td>
    <td>with LBBB; cheaper than nuclear imaging</td>
    <td>may limit the usefulness of images</td>
  </tr>
  <tr>
    <td>Radionuclide</td>
    <td>Localizes ischemia; localizes</td>
    <td>_ Expensive; usefulness can be limited</td>
  </tr>
  <tr>
    <td>tracer (thallium or</td>
    <td>infarcted tissue</td>
    <td>in extensive, multivessel CAD with</td>
  </tr>
  <tr>
    <td>technetium)</td>
    <td></td>
    <td>balanced ischemia in different regions</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Causes</th>
    <th>ExampLes</th>
  </thead>
  <tr>
    <td>Endocrine</td>
    <td>
      Cushing syndrome, Conn syndrome (aldosterone-producing tumor),
      hyperthyroidism, pheochromocytoma
    </td>
  </tr>
  <tr>
    <td>Renal</td>
    <td>
      Chronic kidney disease (CKD); renal artery stenosis (listen for an
      abdominal bruit)
    </td>
  </tr>
  <tr>
    <td>Medications</td>
    <td>OCPs, NSAIDs</td>
  </tr>
  <tr>
    <td rowspan="2">Other</td>
    <td>
      Fibromuscular dysplasia of the renal arteries and aortic coarctation (in
    </td>
  </tr>
  <tr>
    <td></td>
    <td>younger patients), obstructive sleep apnea, alcohol</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Commonty</th>
    <th></th>
    <th></th>
  </thead>
  <thead>
    <th>Usep CLasses</th>
    <th>Optima Use</th>
    <th>Main Apverse Errects</th>
  </thead>
  <tr>
    <td>Thiazide</td>
    <td>First line</td>
    <td>J Excretion of calcium and uric</td>
  </tr>
  <tr>
    <td>B-blockers</td>
    <td>Not recommended as a first line; useful in J EF, angina, and CAD</td>
    <td>Bradycardia, erectile dysfunction, bronchospasm in asthmatics</td>
  </tr>
  <tr>
    <td>ACEls</td>
    <td>
      First line, preferred over thiazides or CCBs in patients with CKD with or
      without diabetes, also useful in patients with J EF and in patients with
      diabetes with microalbuminuria
    </td>
    <td>Dry cough, angioedema, hyper- kalemia, acute kidney injury</td>
  </tr>
  <tr>
    <td>ARBs</td>
    <td>Same as ACEIs</td>
    <td>Hyperkalemia; do not cause cough associated with ACEls</td>
  </tr>
  <tr>
    <td>CCBs</td>
    <td>First line</td>
    <td>Lower extremity edema</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>MEDICATION</th>
    <th>Primary ErFect</th>
    <th>Apverse ErFects</th>
    <th>Comments</th>
  </thead>
  <tr>
    <td>HMG-CoA reductase</td>
    <td rowspan="4">LDL</td>
    <td rowspan="4">Hepatitis, myositis</td>
    <td>Potent LDL-lowering</td>
  </tr>
  <tr>
    <td rowspan="3">inhibitors (“statins”)</td>
    <td></td>
    <td></td>
    <td>medication; the only</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>medication to show a</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>mortality benefit</td>
  </tr>
  <tr>
    <td>Cholesterol absorp-</td>
    <td>LDL</td>
    <td>Generally well</td>
    <td>Introduced in 2003; no</td>
  </tr>
  <tr>
    <td>tion inhibitors</td>
    <td></td>
    <td>tolerated but can</td>
    <td>independent mortality</td>
  </tr>
  <tr>
    <td rowspan="3">(ezetimibe)</td>
    <td></td>
    <td></td>
    <td>cause diarrhea and</td>
    <td>benefit but improves</td>
  </tr>
  <tr>
    <td></td>
    <td>arthralgias</td>
    <td>cardiovascular outcomes</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>when added to statins in</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Fibrates (gemfibrozil)</td>
    <td>J Triglycerides, slightly T HDL</td>
    <td>Potentiates myositis with statins</td>
    <td></td>
  </tr>
  <tr>
    <td>Bile acid-binding resins</td>
    <td>LDL</td>
    <td>Bloating and cramping</td>
    <td>Many patients cannot tolerate GI adverse effects</td>
  </tr>
  <tr>
    <td rowspan="3">Nicotinic acid (niacin)</td>
    <td>LDL, T HDL</td>
    <td>Hepatitis, flushing</td>
    <td>Causes flushing, which</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>can be J by taking aspirin</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>beforehand</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>AcuTE</th>
    <th>SuBAcuTE</th>
    <th>Curture NEGATIVE</th>
    <th>NBTE (Marantic Enpocaroitis)</th>
    <th>Verrucous (LismaN-SAcks)</th>
  </thead>
  <tr>
    <td>Most commonly</td>
    <td>Viridans streptococci</td>
    <td>HACEK organisms?</td>
    <td>Thrombus formation on the valve</td>
    <td>Seen in lupus; vegetation is</td>
  </tr>
  <tr>
    <td rowspan="4">S aureus</td>
    <td>Enterococcus</td>
    <td>Coxiella burnetii</td>
    <td>seen in many cancers</td>
    <td>composed of fibrin, platelets,</td>
  </tr>
  <tr>
    <td></td>
    <td>Staphylococcus epidermidis</td>
    <td>Noncandidal fungi</td>
    <td></td>
    <td>immune complexes, and</td>
  </tr>
  <tr>
    <td></td>
    <td>Gram © rods</td>
    <td></td>
    <td></td>
    <td>inflammatory cells</td>
  </tr>
  <tr>
    <td></td>
    <td>Candida</td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>1.</td>
    <td>Microbiologic evidence</td>
    <td>Typical organisms isolated from two separate blood cultures:</td>
  </tr>
  <tr>
    <td rowspan="9"></td>
    <td rowspan="9">of IE</td>
    <td>Viridans streptococci, S aureus, HACEK organisms, or S bovis</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>OR</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Community-acquired enterococci in the absence of an</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>alternative 1° site of infection</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Persistently © blood cultures with other organisms:</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>At least two @ cultures drawn &gt;12 hours apart OR</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>All of three or a majority of four ® cultures, with the first</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>and last drawn &gt; 1 hour apart</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>One @ culture (or phase | IgG &gt; 1:800) for Coxiella burnetii</td>
  </tr>
  <tr>
    <td rowspan="6">2.</td>
    <td>Evidence of endocardial</td>
    <td>Echocardiogram showing one of the following:</td>
  </tr>
  <tr>
    <td></td>
    <td>involvement</td>
    <td>An oscillating intracardiac mass with no alternative</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>explanation</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>An abscess</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>New partial dehiscence of a prosthetic valve</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>New valvular regurgitation</td>
  </tr>
</table>
<table>
  <tr>
    <td></td>
    <td>alveolar-arterial (oxygen gradient)</td>
    <td></td>
    <td>anti-smooth muscle antibody</td>
  </tr>
  <tr>
    <td></td>
    <td>abdominal aortic aneurysm</td>
    <td></td>
    <td>aspartate aminotransferase</td>
  </tr>
  <tr>
    <td>ABC</td>
    <td>airway, breathing, circulation</td>
    <td></td>
    <td>acute tubular necrosis</td>
  </tr>
  <tr>
    <td>Abd</td>
    <td>abdominal</td>
    <td></td>
    <td>all-transretinoic acid</td>
  </tr>
  <tr>
    <td>ABG</td>
    <td>arterial blood gas</td>
    <td></td>
    <td>arteriovenous, atrioventricular</td>
  </tr>
  <tr>
    <td>ACA</td>
    <td>anterior cerebral artery</td>
    <td></td>
    <td>arteriovenous malformation</td>
  </tr>
  <tr>
    <td>ACE</td>
    <td>angiotensin-converting enzyme</td>
    <td></td>
    <td>atrioventricular nodal reentrant tac!</td>
  </tr>
  <tr>
    <td>ACEI</td>
    <td>angiotensin-converting enzyme inhibitor</td>
    <td></td>
    <td>abdominal x-ray</td>
  </tr>
  <tr>
    <td>ACh</td>
    <td>acetylcholine</td>
    <td></td>
    <td>zidovudine</td>
  </tr>
  <tr>
    <td>ACL</td>
    <td>anterior cruciate ligament</td>
    <td></td>
    <td>B-blocker</td>
  </tr>
  <tr>
    <td>ACLS</td>
    <td>advanced cardiac life support (protocol)</td>
    <td>BCG</td>
    <td>bacille Calmette-Guérin</td>
  </tr>
  <tr>
    <td>ACM</td>
    <td>Advanced Clinical Medicine</td>
    <td>BiPAP</td>
    <td>bilateral positive airway</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>pressure</td>
  </tr>
  <tr>
    <td>ACTH</td>
    <td>adrenocorticotropic hormone</td>
    <td>BMI</td>
    <td>body mass index</td>
  </tr>
  <tr>
    <td>ADA</td>
    <td>American Diabetes Association</td>
    <td>BMP</td>
    <td>basic metabolic panel</td>
  </tr>
  <tr>
    <td>ADH</td>
    <td>antidiuretic hormone</td>
    <td>BMT</td>
    <td>bone marrow transplantation</td>
  </tr>
  <tr>
    <td>ADHD</td>
    <td>attention-deficit/hyperactivity disorder</td>
    <td>BP</td>
    <td>blood pressure</td>
  </tr>
  <tr>
    <td>AF</td>
    <td>atrial fibrillation</td>
    <td>BPH</td>
    <td>benign prostatic hyperplasia</td>
  </tr>
  <tr>
    <td>AFB</td>
    <td>acid-fast bacillus</td>
    <td>BPP</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>biophysical profile</td>
  </tr>
  <tr>
    <td>AFI</td>
    <td>amniotic fluid index</td>
    <td>BS</td>
    <td>bowel sounds</td>
  </tr>
  <tr>
    <td>AFP</td>
    <td>a-fetoprotein</td>
    <td>BSA</td>
    <td>body surface area</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>AG</td>
    <td>anion</td>
    <td>BSO</td>
    <td>bilateral salpingo-oophorectomy</td>
  </tr>
  <tr>
    <td></td>
    <td>gap</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>AHI</td>
    <td>apnea-hypopnea index</td>
    <td>BUN</td>
    <td>blood urea</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>nitrogen</td>
  </tr>
  <tr>
    <td>AICD</td>
    <td>automatic implantable cardiac defibrillator</td>
    <td>CABG</td>
    <td>bypass</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>coronary artery graft</td>
  </tr>
  <tr>
    <td>AIDS</td>
    <td>acquired immunodeficiency syndrome</td>
    <td>CAD</td>
    <td>disease</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>coronary artery</td>
  </tr>
  <tr>
    <td>AKI</td>
    <td>acute kidney injury</td>
    <td>CAH</td>
    <td>congenital adrenal hyperplasia</td>
  </tr>
  <tr>
    <td>ALL</td>
    <td>acute lymphocytic leukemia</td>
    <td>CBC</td>
    <td>complete blood count</td>
  </tr>
  <tr>
    <td>ALS</td>
    <td>amyotrophic lateral sclerosis</td>
    <td>CBT</td>
    <td>cognitive-behavioral therapy</td>
  </tr>
  <tr>
    <td>ALT</td>
    <td>alanine aminotransferase</td>
    <td>CCB</td>
    <td>calcium channel blocker</td>
  </tr>
  <tr>
    <td>AMA</td>
    <td>antimitochondrial antibody</td>
    <td>CCP</td>
    <td>cyclic citrullinated peptide</td>
  </tr>
  <tr>
    <td>AML</td>
    <td>acute myelogenous leukemia</td>
    <td>CCS</td>
    <td>Computer-based Case Simulations</td>
  </tr>
  <tr>
    <td>ANA</td>
    <td>antinuclear antibody</td>
    <td>CD</td>
    <td>cluster of differentiation</td>
  </tr>
  <tr>
    <td>ANC</td>
    <td>absolute neutrophil count</td>
    <td>CEA</td>
    <td>carcinoembryonic antigen</td>
  </tr>
  <tr>
    <td>ANCA</td>
    <td>antineutrophil cytoplasmic antibody</td>
    <td>CF</td>
    <td>cystic fibrosis</td>
  </tr>
  <tr>
    <td>AP</td>
    <td>anteroposterior</td>
    <td>CGD</td>
    <td>chronic granulomatous disease</td>
  </tr>
  <tr>
    <td>APC</td>
    <td>activated protein C</td>
    <td>CH50</td>
    <td>total hemolytic complement</td>
  </tr>
  <tr>
    <td>APL</td>
    <td>acute promyelocytic leukemia</td>
    <td>Chem #</td>
    <td>chemistry panels</td>
  </tr>
  <tr>
    <td>ARB</td>
    <td>angiotensin receptor blocker</td>
    <td>Cl</td>
    <td>confidence interval</td>
  </tr>
  <tr>
    <td>ARDS</td>
    <td>
      acute respiratory distress s ======================================
      yndrome
    </td>
    <td>CIN</td>
    <td>Candidate Identification Number,</td>
  </tr>
  <tr>
    <td>ARR</td>
    <td>absolute risk reduction</td>
    <td></td>
    <td>intraepithelial neoplasia</td>
  </tr>
  <tr>
    <td>ART</td>
    <td>antiretroviral therapy</td>
    <td>Ck</td>
    <td>creatine kinase</td>
  </tr>
  <tr>
    <td>5-ASA</td>
    <td>5-aminosalicylic acid</td>
    <td>CKD</td>
    <td>chronic kidney disease</td>
  </tr>
  <tr>
    <td>ASCA</td>
    <td>anti-Saccharomyces cerevisiae antibody</td>
    <td>CK-MB</td>
    <td>creatine kinase-MB fraction</td>
  </tr>
  <tr>
    <td>ASCVD</td>
    <td>atherosclerotic cardiovascular disease</td>
    <td>CLL</td>
    <td>chronic lymphocytic leukemia</td>
  </tr>
  <tr>
    <td>ASD</td>
    <td>atrial septal defect</td>
    <td>CML</td>
    <td>chronic myelogenous leukemia</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>CMV</td>
    <td>cytomegalovirus</td>
    <td>ECT</td>
    <td>electroconvulsive therapy</td>
  </tr>
  <tr>
    <td>CN</td>
    <td>cranial nerve</td>
    <td></td>
    <td>emergency department, erectile dysfunc</td>
  </tr>
  <tr>
    <td>CNS</td>
    <td>central nervous system</td>
    <td>Q</td>
    <td>electroencephalography</td>
  </tr>
  <tr>
    <td>COBI</td>
    <td>cobicistat</td>
    <td>DTOMEAYD FRM Peo</td>
    <td>ejection fraction</td>
  </tr>
  <tr>
    <td>COMT</td>
    <td>catechol-O-methyltransferase</td>
    <td></td>
    <td>esophagogastroduodenoscopy</td>
  </tr>
  <tr>
    <td>COPD</td>
    <td>chronic obstructive pulmonary disease</td>
    <td>isa RY</td>
    <td>enterohemorrhagic E coli</td>
  </tr>
  <tr>
    <td>CPAP</td>
    <td>continuous positive airway pressure</td>
    <td>LISA PRR</td>
    <td>enzyme-linked immunosorbent assay</td>
  </tr>
  <tr>
    <td>CPK-MB</td>
    <td>creatine kinase-muscle/brain</td>
    <td></td>
    <td>erythema multiforme</td>
  </tr>
  <tr>
    <td>CPR</td>
    <td>cardiopulmonary resuscitation</td>
    <td>B2Ze R</td>
    <td>ear, nose, and throat</td>
  </tr>
  <tr>
    <td>CrCl</td>
    <td>creatinine clearance</td>
    <td></td>
    <td>extrapyramidal symptoms</td>
  </tr>
  <tr>
    <td>CRP</td>
    <td>C-reactive protein</td>
    <td>za</td>
    <td>estrogen receptor</td>
  </tr>
  <tr>
    <td>CRT</td>
    <td>cardiac resynchronization therapy</td>
    <td>RCP</td>
    <td>endoscopic retrograde</td>
  </tr>
  <tr>
    <td>CSA</td>
    <td>central sleep apnea</td>
    <td></td>
    <td>cholangiopancreatography</td>
  </tr>
  <tr>
    <td>CSF</td>
    <td>cerebrospinal fluid</td>
    <td>ESR</td>
    <td>erythrocyte sedimentation rate</td>
  </tr>
  <tr>
    <td>CST</td>
    <td>contraction stress test</td>
    <td>ESWL</td>
    <td>extracorporeal shock-wave lithotripsy</td>
  </tr>
  <tr>
    <td>CT</td>
    <td></td>
    <td>EtOH</td>
    <td>ethanol</td>
  </tr>
  <tr>
    <td></td>
    <td>computed tomography</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>CV</td>
    <td>cardiovascular</td>
    <td>EUS</td>
    <td>endoscopic ultrasound</td>
  </tr>
  <tr>
    <td>CVA</td>
    <td>costovertebral angle</td>
    <td>EVG</td>
    <td>elvitegravir</td>
  </tr>
  <tr>
    <td>CVID</td>
    <td>common variable immunodeficiency</td>
    <td>Ext</td>
    <td>extremities</td>
  </tr>
  <tr>
    <td>CXR</td>
    <td>chest x-ray</td>
    <td>FAP</td>
    <td>familial adenomatous polyposis</td>
  </tr>
  <tr>
    <td>D&amp;C</td>
    <td>dilation and curettage</td>
    <td>FAST</td>
    <td>focused abdominal sonography for traurr</td>
  </tr>
  <tr>
    <td>DBP</td>
    <td>diastolic blood</td>
    <td></td>
    <td>fractional excretion of sodium</td>
  </tr>
  <tr>
    <td></td>
    <td>pressure</td>
    <td>Fen</td>
    <td></td>
  </tr>
  <tr>
    <td>DCIS</td>
    <td>ductal carcinoma in situ</td>
    <td>Feurea</td>
    <td>fractional excretion of urea</td>
  </tr>
  <tr>
    <td>DDAVP</td>
    <td>desmopressin acetate</td>
    <td>FEV,</td>
    <td>forced expiratory volume in one second</td>
  </tr>
  <tr>
    <td>ddl</td>
    <td>didanosine</td>
    <td>FFP</td>
    <td>fresh frozen plasma</td>
  </tr>
  <tr>
    <td></td>
    <td>differential diagnosis</td>
    <td>FIP</td>
    <td>Foundations of Independent Practice</td>
  </tr>
  <tr>
    <td></td>
    <td>diethylstilbestrol</td>
    <td>FISH</td>
    <td>fluorescence in situ hybridization</td>
  </tr>
  <tr>
    <td></td>
    <td>dual-energy x-ray absorptiometry</td>
    <td>FNA</td>
    <td>fine-needle aspiration</td>
  </tr>
  <tr>
    <td></td>
    <td>direct fluorescent antibody</td>
    <td>FOBT</td>
    <td>fecal occult blood test</td>
  </tr>
  <tr>
    <td></td>
    <td>dehydroepiandrosterone</td>
    <td>FSH</td>
    <td>follicle-stimulating hormone</td>
  </tr>
  <tr>
    <td></td>
    <td>diabetes insipidus</td>
    <td>FSMB</td>
    <td>Federation of State Medical Boards</td>
  </tr>
  <tr>
    <td></td>
    <td>disseminated intravascular coagulation</td>
    <td>Fry</td>
    <td>free thyroxine</td>
  </tr>
  <tr>
    <td></td>
    <td>di istal interphalangeal (joint)</td>
    <td>FTA-ABS</td>
    <td>fluorescent treponemal antibody absorpt</td>
  </tr>
  <tr>
    <td>S</td>
    <td>iabetic ketoacidosis</td>
    <td>FTC</td>
    <td>emtricitabine</td>
  </tr>
  <tr>
    <td></td>
    <td>d</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>LCO</td>
    <td>d iffusing capacity of carbon monoxide</td>
    <td>FTT</td>
    <td>failure to thrive</td>
  </tr>
  <tr>
    <td>Zz Ky</td>
    <td>d iabetes mellitus</td>
    <td>5-FU</td>
    <td>5-fluorouracil</td>
  </tr>
  <tr>
    <td>MARD</td>
    <td>d isease-modifying antirheumatic drug</td>
    <td>F/U</td>
    <td>follow up</td>
  </tr>
  <tr>
    <td>ZZ</td>
    <td>d eoxyribonucleic acid</td>
    <td>FVC</td>
    <td>forced vital capacity</td>
  </tr>
  <tr>
    <td>VERS</td>
    <td>d o not resuscitate</td>
    <td>FWS</td>
    <td>fever without a source</td>
  </tr>
  <tr>
    <td></td>
    ======================================
    <td>d urable power of attorney</td>
    <td>G&amp;C</td>
    <td>gonorrhea and chlamydia (culture)</td>
  </tr>
  <tr>
    <td>Seeggg0gggggg00gy</td>
    <td>d ipeptidyl peptidase</td>
    <td>G6PD</td>
    <td>gluciose-6-phosphate dehydrogenase</td>
  </tr>
  <tr>
    <td>Zz</td>
    <td>d igital rectal examination</td>
    <td>GA</td>
    <td>gestational age</td>
  </tr>
  <tr>
    <td>De 226 Nilo</td>
    <td>d ouble-stranded DNA</td>
    <td>GAD</td>
    <td>generalized anxiety disorder</td>
  </tr>
  <tr>
    <td>n</td>
    <td>Diagnostic and Statistical Manual of Mental Fifth Edition</td>
    <td>GBM</td>
    <td>glomerular basement membrane B Guillain-Barré</td>
  </tr>
  <tr>
    <td>DTG</td>
    <td>Disorders, olutegravir</td>
    <td>GBS</td>
    <td>group Streptococcus, syndrome</td>
  </tr>
  <tr>
    <td>DTRs</td>
    <td>eep tendon reflexes</td>
    <td>GCS</td>
    <td>Glasgow Coma Scale</td>
  </tr>
  <tr>
    <td>DTs</td>
    <td>elirium tremens</td>
    <td>G-CSF</td>
    <td>granulocyte colony-stimulating factor</td>
  </tr>
  <tr>
    <td>DVT</td>
    <td>eep venous thrombosis</td>
    <td>GDPP</td>
    <td>gonadotropin-dependent precocious pub</td>
  </tr>
  <tr>
    <td>Dx</td>
    <td></td>
    <td>GERD</td>
    <td>reflux disease</td>
  </tr>
  <tr>
    <td></td>
    <td>diagnosis</td>
    <td></td>
    <td>gastroesophageal</td>
  </tr>
  <tr>
    <td>EBV</td>
    <td>virus</td>
    <td>GFR</td>
    <td>filtration rate</td>
  </tr>
  <tr>
    <td></td>
    <td>Epstein-Barr</td>
    <td></td>
    <td>glomerular</td>
  </tr>
  <tr>
    <td>ECFMG</td>
    <td>Educational Commission for Foreign Medical Graduates</td>
    <td>GGT GI</td>
    <td>gamma-glutamyl transferase gastrointestinal</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>GLP</th>
    <th>glucagon-like peptide</th>
    <th>CU</th>
    <th>intensive care unit</th>
  </thead>
  <tr>
    <td>GNR</td>
    <td>gram-negative rod</td>
    <td>E</td>
    <td>infective endocarditis</td>
  </tr>
  <tr>
    <td>GnRH</td>
    <td>gonadotropin-releasing hormone</td>
    <td>i</td>
    <td>immunoglobulin</td>
  </tr>
  <tr>
    <td>GTCS</td>
    <td>generalized tonic-clonic seizure</td>
    <td>M</td>
    <td>intramuscular</td>
  </tr>
  <tr>
    <td>GTD</td>
    <td>gestational trophoblastic disease</td>
    <td>MG</td>
    <td>international medical graduate</td>
  </tr>
  <tr>
    <td>GU</td>
    <td>genitourinary</td>
    <td>NH</td>
    <td>isoniazid</td>
  </tr>
  <tr>
    <td>H&amp;P</td>
    <td>history and physical</td>
    <td>NR</td>
    <td>International Normalized Ratio</td>
  </tr>
  <tr>
    <td>HAV</td>
    <td>hepatitis A virus</td>
    <td>NSTI</td>
    <td>integrase strand transfer inhibitor</td>
  </tr>
  <tr>
    <td>HbA).</td>
    <td>gylcated hemoglobin</td>
    <td>PT</td>
    <td>interpersonal psychotherapy</td>
  </tr>
  <tr>
    <td>HbH</td>
    <td>hemoglobin I</td>
    <td>TP</td>
    <td>idiopathic thrombocytopenic purp</td>
  </tr>
  <tr>
    <td>HBcAb</td>
    <td>hepatitis B core antibody</td>
    <td>UD</td>
    <td>intrauterine device</td>
  </tr>
  <tr>
    <td>HBeAg</td>
    <td>hepatitis B early antigen</td>
    <td>UGR</td>
    <td>intrauterine growth restriction</td>
  </tr>
  <tr>
    <td>HBIG</td>
    <td>hepatitis B immune globulin</td>
    <td>Vv</td>
    <td>intravenous</td>
  </tr>
  <tr>
    <td>HBsAb</td>
    <td>hepatitis B surface antibody</td>
    <td>VC</td>
    <td>inferior vena cava</td>
  </tr>
  <tr>
    <td>HBsAg</td>
    <td>al hepatitis B surface antigen</td>
    <td>VIG</td>
    <td>ntravenous immunoglobulin i</td>
  </tr>
  <tr>
    <td>HBV</td>
    <td>hepatitis B virus</td>
    <td>V p</td>
    <td>i</td>
  </tr>
  <tr>
    <td></td>
    <td>al</td>
    <td></td>
    <td>ntravenous pyelography</td>
  </tr>
  <tr>
    <td>HCC</td>
    <td>hepatocellular cancer 5</td>
    <td>VS</td>
    <td>nterventricular septum i</td>
  </tr>
  <tr>
    <td>hCG</td>
    <td>human chorionic gonadotropin</td>
    <td>IA</td>
    <td>juvenile idiopathic arthritis</td>
  </tr>
  <tr>
    <td>HCTZ</td>
    <td>hydrochlorothiazide</td>
    <td>VD</td>
    <td>jugular venous distention</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>p</td>
    <td></td>
  </tr>
  <tr>
    <td>HCV</td>
    <td>hepatitis C virus</td>
    <td>V</td>
    <td>jugular venous pressure</td>
  </tr>
  <tr>
    <td>H D</td>
    <td>disease</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>Huntington</td>
    <td></td>
    <td>potassium</td>
  </tr>
  <tr>
    <td>H DL</td>
    <td>high-density lipoprotein</td>
    <td>OH</td>
    <td>potassium hydroxide</td>
  </tr>
  <tr>
    <td>H DV</td>
    <td>hepatitis D virus</td>
    <td>UB</td>
    <td>idney, ureter, bladder (study)</td>
  </tr>
  <tr>
    <td>H KENT</td>
    <td>head, eyes, ears, nose, and throat</td>
    <td>LAD</td>
    <td>eft anterior descending (artery)</td>
  </tr>
  <tr>
    <td>H EV</td>
    <td>hepatitis F. virus</td>
    <td>LBBB</td>
    <td>eft bundle branch block</td>
  </tr>
  <tr>
    <td>H io</td>
    <td>heart failure</td>
    <td>LBP</td>
    <td>ow back</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>pain</td>
  </tr>
  <tr>
    <td>H FpEF</td>
    <td>heart failure with preserved ejection fraction</td>
    <td>LCIS</td>
    <td>obular carcinoma in situ</td>
  </tr>
  <tr>
    <td>HGSIL</td>
    <td>lesion</td>
    <td>LDH</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>high-grade squamous intraepithelial</td>
    <td></td>
    <td>actate dehydrogenase</td>
  </tr>
  <tr>
    <td>H IS</td>
    <td>hyperglycemic hyperosmolar state</td>
    <td>LDL</td>
    <td>ow-density lipoprotein</td>
  </tr>
  <tr>
    <td>H IV</td>
    <td>human herpesvirus</td>
    <td>LEEP</td>
    <td>oop electrosurgical excision proce</td>
  </tr>
  <tr>
    <td>5-HIAA</td>
    <td>5-hydroxyindoleacetic acid</td>
    <td>im</td>
    <td>ower esophageal sphincter</td>
  </tr>
  <tr>
    <td>H DA</td>
    <td>hepato-iminodiacetic acid (scan)</td>
    <td>LET</td>
    <td>iver function test</td>
  </tr>
  <tr>
    <td>H PAA</td>
    <td>Health Insurance Portability and</td>
    <td>LGSIL</td>
    <td>ow-grade squamous intraepithelia</td>
  </tr>
  <tr>
    <td></td>
    <td>Accountability Act</td>
    <td>LH</td>
    <td>hormone</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>uteinizing</td>
  </tr>
  <tr>
    <td>H H T Vv</td>
    <td>heparin-induced thrombocytopenia virus</td>
    <td>LKMA</td>
    <td>iver/kidney microsomal antibody eft lower</td>
  </tr>
  <tr>
    <td></td>
    <td>human immunodeficiency</td>
    <td>LLO</td>
    <td>quadrant</td>
  </tr>
  <tr>
    <td>HI LA</td>
    <td>human leukocyte antigen</td>
    <td>LMN</td>
    <td>ower motor neuron</td>
  </tr>
  <tr>
    <td>HMG-CoA</td>
    <td>hydroxymethylglutaryl coenzyme A</td>
    ======================================
    <td>LMP</td>
    <td>ast menstrual period</td>
  </tr>
  <tr>
    <td>HNPCC</td>
    <td>hereditary nonpolyposis colorectal cancer</td>
    <td>LMWH</td>
    <td>ow-molecular-weight heparin</td>
  </tr>
  <tr>
    <td>H 7</td>
    <td>hypothalamic-pituitary-adrenal (axis)</td>
    <td></td>
    <td>umbar puncture</td>
  </tr>
  <tr>
    <td>hpf</td>
    <td>high-power field</td>
    <td>LTBI</td>
    <td>atent tuberculosis infection</td>
  </tr>
  <tr>
    <td>H Vv</td>
    <td>human papillomavirus</td>
    <td>LUO</td>
    <td>eft upper quadrant</td>
  </tr>
  <tr>
    <td>H R</td>
    <td>neart rate</td>
    <td>LV</td>
    <td>eft ventricle</td>
  </tr>
  <tr>
    <td>H RIG</td>
    <td>human rabies immune globulin</td>
    <td>LVEF</td>
    <td>eft ventricular ejection fraction</td>
  </tr>
  <tr>
    <td>H RT</td>
    <td>hormone replacement therapy</td>
    <td>LVH</td>
    <td>eft ventricular hypertrophy</td>
  </tr>
  <tr>
    <td>HSP</td>
    <td>Henoch-Schénlein purpura</td>
    <td>MAC</td>
    <td>Mycobacterium avium complex</td>
  </tr>
  <tr>
    <td>HSV</td>
    <td>herpes simplex virus</td>
    <td>MAOI</td>
    <td>monoamine oxidase inhibitor</td>
  </tr>
  <tr>
    <td>5-HT</td>
    <td>5-hydroxytryptamine</td>
    <td>MAT</td>
    <td>multifocal atrial tachycardia</td>
  </tr>
  <tr>
    <td>HTLV</td>
    <td>human ‘T-cell lymphotropic virus</td>
    <td>MCA</td>
    <td>middle cerebral artery</td>
  </tr>
  <tr>
    <td>HUS</td>
    <td>hemolytic-uremic syndrome</td>
    <td>MCHC</td>
    <td>mean corpuscular hemoglobin cot</td>
  </tr>
  <tr>
    <td>HVA</td>
    <td>homovanillic acid</td>
    <td>MCI</td>
    <td>mild cognitive impairment</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>M DR</th>
    <th>multidrug-resistant</th>
    <th>PA</th>
    <th>osteroanterior</th>
  </thead>
  <tr>
    <td>M DRD</td>
    <td>Modification of Diet in Renal Disease</td>
    <td>PAC</td>
    <td>lasma aldosterone concentration, prematt</td>
  </tr>
  <tr>
    <td></td>
    <td>(equation)</td>
    <td></td>
    <td>atrial contraction</td>
  </tr>
  <tr>
    <td>M EN</td>
    <td>multiple endocrine neoplasia</td>
    <td>PAN</td>
    <td>olyarteritis nodosa</td>
  </tr>
  <tr>
    <td>MGUS</td>
    <td>monoclonal gammopathy of undetermined significance</td>
    <td>p-ANCA</td>
    <td>erinuclear antineutrophil cytoplasmic antibody</td>
  </tr>
  <tr>
    <td>M 1A-TP</td>
    <td>microhemagglutination assay for Treponema pallidum</td>
    <td>Paoz Paco</td>
    <td>
      artial pressure of oxygen in arterial blood artial of carbon dioxide in
      arteria
    </td>
  </tr>
  <tr>
    <td>M</td>
    <td>myocardial infarction</td>
    <td></td>
    <td>pressure blood</td>
  </tr>
  <tr>
    <td>M BG</td>
    <td>5 11_metaiodobenzylguanidine (scan)</td>
    <td>PAPP-A</td>
    <td>regnancy-associated plasma protein A</td>
  </tr>
  <tr>
    <td>M LF</td>
    <td>medial longitudinal fasciculus</td>
    <td>PCA</td>
    <td>osterior cerebral artery</td>
  </tr>
  <tr>
    <td>MMA</td>
    <td>methylmalonic acid</td>
    <td>PCL</td>
    <td>osterior cruciate ligament</td>
  </tr>
  <tr>
    <td>MMR</td>
    <td>measles, mumps, rubella (vaccine)</td>
    <td>Poco</td>
    <td>artial pressure of carbon dioxide</td>
  </tr>
  <tr>
    <td>MoM</td>
    <td>multiple of the</td>
    <td>PCOS</td>
    <td>olycystic ovarian syndrome</td>
  </tr>
  <tr>
    <td></td>
    <td>mean</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>M GN</td>
    <td>membranoproliferative glomerulonephritis</td>
    <td>PCP</td>
    <td>hencyclidine hydrochloride, Pneumocysti</td>
  </tr>
  <tr>
    <td>M RA</td>
    <td>magnetic resonance angiography</td>
    <td></td>
    <td>carinii (now jiroveci) pneumonia</td>
  </tr>
  <tr>
    <td>M RI</td>
    <td></td>
    <td>PCr</td>
    <td>lasma creatinine</td>
  </tr>
  <tr>
    <td></td>
    <td>magnetic resonance imaging</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>M RSA</td>
    <td>methicillin-resistant S aureus</td>
    <td>PCR</td>
    <td>olymerase chain reaction</td>
  </tr>
  <tr>
    <td>MS</td>
    <td>multiple sclerosis</td>
    <td>PCV</td>
    <td>olycythemia vera</td>
  </tr>
  <tr>
    <td>MSAFP</td>
    <td>maternal serum a-fetoprotein</td>
    <td>PCWP</td>
    <td>ulmonary capillary wedge pressure</td>
  </tr>
  <tr>
    <td>MTP</td>
    <td>metatarsophalangeal (joint)</td>
    <td>PD</td>
    <td>Parkinson disease</td>
  </tr>
  <tr>
    <td>MuSK</td>
    <td>muscle-specific kinase</td>
    <td>PDA</td>
    <td>atent ductus arteriosus, posterior descend:</td>
  </tr>
  <tr>
    <td colspan="4">MVA motor vehicle accident artery</td>
  </tr>
  <tr>
    <td>NAD</td>
    <td>no acute distress</td>
    <td>PDE-5a</td>
    <td>hosphodiesterase type 5a</td>
  </tr>
  <tr>
    <td>NBME</td>
    <td>National Board of Medical Examiners</td>
    <td>PE</td>
    <td>hysical examination, pulmonary embolisr</td>
  </tr>
  <tr>
    <td>NBT</td>
    <td>E nonbacterial thrombotic endocarditis</td>
    <td>PEA</td>
    <td>ulseless electrical</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>activity</td>
  </tr>
  <tr>
    <td>NCS</td>
    <td>nerve conduction study</td>
    <td>PEEP</td>
    <td>sitive end-expiratory</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>pressure</td>
  </tr>
  <tr>
    <td>NE</td>
    <td>norepinephrine</td>
    <td>PEG</td>
    <td>olyethylene glycol</td>
  </tr>
  <tr>
    <td>NEC</td>
    <td>enterocolitis</td>
    <td>PET</td>
    <td>ositron emission</td>
  </tr>
  <tr>
    <td></td>
    <td>necrotizing</td>
    <td></td>
    <td>tomography (scan)</td>
  </tr>
  <tr>
    <td>Neuro</td>
    <td>neurological</td>
    <td>PF</td>
    <td>latelet factor</td>
  </tr>
  <tr>
    <td>NG</td>
    <td>nasogastric</td>
    <td>PFT</td>
    <td>ulmonary function test</td>
  </tr>
  <tr>
    <td>NK</td>
    <td>natural killer (cells)</td>
    <td>PGF 4</td>
    <td>rostaglandin F2-a</td>
  </tr>
  <tr>
    <td>NMDA</td>
    <td>N-methyl-d-aspartate</td>
    <td>PI</td>
    <td>rotease inhibitor</td>
  </tr>
  <tr>
    <td>NNRTI</td>
    <td>non-nucleoside inhibitor</td>
    <td>PID</td>
    <td>disease</td>
  </tr>
  <tr>
    <td></td>
    <td>reverse transcriptase</td>
    <td></td>
    <td>elvic inflammatory</td>
  </tr>
  <tr>
    <td>NNT</td>
    <td>number needed to treat</td>
    <td>PIP</td>
    <td>roximal interphalangeal (joint)</td>
  </tr>
  <tr>
    <td>NPH</td>
    <td>neutral protamine Hagedorn (insulin)</td>
    <td>PIV</td>
    <td>arainfluenza virus</td>
  </tr>
  <tr>
    <td>NPO</td>
    <td>nil per os (nothing by mouth)</td>
    <td>PMI</td>
    <td>joint of maximal impulse</td>
  </tr>
  <tr>
    <td>NPV</td>
    <td>predictive value</td>
    <td>P ====================================== MN</td>
    <td>olymorphonuclear (leukocyte)</td>
  </tr>
  <tr>
    <td></td>
    <td>negative</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>NRTI</td>
    <td>nucleoside reverse transcriptase inhibitor</td>
    <td>PMR</td>
    <td>olymyalgia rheumatica</td>
  </tr>
  <tr>
    <td>NS</td>
    <td>normal saline</td>
    <td>PNa</td>
    <td>lasma sodium</td>
  </tr>
  <tr>
    <td>NSAID</td>
    <td>nonsteroidal anti-inflammatory drug</td>
    <td>PNH</td>
    <td>aroxysmal nocturnal hemoglobinuria</td>
  </tr>
  <tr>
    <td>NSCLC NST</td>
    <td>non-small cell lung cancer nonstress test</td>
    <td>PNS PO</td>
    <td>ripheral nervous system (by mouth)</td>
  </tr>
  <tr>
    <td>NSTEMI</td>
    <td>non-S'T-segment-elevation MI</td>
    <td>POC</td>
    <td>er os roduct of conception</td>
  </tr>
  <tr>
    <td>NTD</td>
    <td>neural tube defect</td>
    <td>Posm</td>
    <td>lasma osmolarity</td>
  </tr>
  <tr>
    <td>Oz</td>
    <td></td>
    <td>PPD</td>
    <td>urified derivative (of tuberculin)</td>
  </tr>
  <tr>
    <td>O&amp;P</td>
    <td>oxygen and</td>
    <td>PPI</td>
    <td>protein roton inhibitor</td>
  </tr>
  <tr>
    <td>OA</td>
    <td>ova parasites osteoarthritis</td>
    <td>PPROM</td>
    <td>pump of membranes</td>
  </tr>
  <tr>
    <td>OCD</td>
    <td>disorder</td>
    <td>PPV</td>
    <td>reterm premature rupture ositive value</td>
  </tr>
  <tr>
    <td>OCP</td>
    <td>obsessive-compulsive oral</td>
    <td>PR</td>
    <td>predictive</td>
  </tr>
  <tr>
    <td></td>
    <td>contraceptive pill</td>
    <td></td>
    <td>rogesterone receptor</td>
  </tr>
  <tr>
    <td>17-OHP OR</td>
    <td>17-hydroxyprogesterone odds ratio, operating</td>
    <td>PRA PRN</td>
    <td>lasma renin activity nata (as needed)</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>PT</td>
    <td>prothrombin time</td>
    <td>SMA</td>
    <td>superior mesenteric artery</td>
  </tr>
  <tr>
    <td>PTH</td>
    <td>parathyroid hormone</td>
    <td>SNRI</td>
    <td>serotonin-norepinephrine reuptake inh</td>
  </tr>
  <tr>
    <td>PTHrP</td>
    <td>parathyroid hormone-telated peptide</td>
    <td>SPEP</td>
    <td>serum protein electrophoresis</td>
  </tr>
  <tr>
    <td>PTSD</td>
    <td>posttraumatic stress disorder</td>
    <td>SPN</td>
    <td>solitary pulmonary nodule</td>
  </tr>
  <tr>
    <td>PTT</td>
    <td>partial thromboplastin time</td>
    <td>SQ</td>
    <td>subcutaneous</td>
  </tr>
  <tr>
    <td>PTU</td>
    <td>propylthiouracil</td>
    <td>SSRI</td>
    <td>selective serotonin reuptake inhibitor</td>
  </tr>
  <tr>
    <td>PUD</td>
    <td>peptic ulcer disease</td>
    <td>STD</td>
    <td>sexually transmitted disease</td>
  </tr>
  <tr>
    <td>PUVA</td>
    <td>psoralen and ultraviolet A</td>
    <td>STEMI</td>
    <td>ST-segment-elevation MI</td>
  </tr>
  <tr>
    <td>PVC</td>
    <td>premature ventricular contraction</td>
    <td>SVOz</td>
    <td>mixed venous oxygen saturation</td>
  </tr>
  <tr>
    <td>PVS</td>
    <td>persistent vegetative state</td>
    <td>SVR</td>
    <td>systemic vascular resistance</td>
  </tr>
  <tr>
    <td>RA</td>
    <td>rheumatoid arthritis</td>
    <td>SVT</td>
    <td>supraventricular tachycardia</td>
  </tr>
  <tr>
    <td>RAA</td>
    <td>renin-angiotensin-aldosterone (system)</td>
    <td></td>
    <td>triiodothyronine</td>
  </tr>
  <tr>
    <td>RAI</td>
    <td>radioactive iodine</td>
    <td></td>
    <td>hyroxine</td>
  </tr>
  <tr>
    <td>RAIU</td>
    <td>radioactive iodine uptake</td>
    <td></td>
    <td>‘otal abdominal hysterectomy</td>
  </tr>
  <tr>
    <td>RAL</td>
    <td>raltegravir</td>
    <td></td>
    <td>uberculosis</td>
  </tr>
  <tr>
    <td>RAST</td>
    <td></td>
    <td></td>
    <td>amivudine</td>
  </tr>
  <tr>
    <td></td>
    <td>radioallergosorbent testing</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>RBBB</td>
    <td>right bundle branch block</td>
    <td></td>
    <td>echnetium</td>
  </tr>
  <tr>
    <td>RBC</td>
    <td>red blood cell</td>
    <td>TCA</td>
    <td>tricyclic antidepressant</td>
  </tr>
  <tr>
    <td>RC</td>
    <td>reticulocyte count</td>
    <td>Td</td>
    <td>etanus and diphtheria toxoid</td>
  </tr>
  <tr>
    <td>RCA</td>
    <td>right coronary artery</td>
    <td>TdT</td>
    <td>erminal deoxynucleotidyl transferase</td>
  </tr>
  <tr>
    <td>RCT</td>
    <td>randomized controlled trial</td>
    <td>TEE</td>
    <td>ransesophageal echocardiography</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>stimula!</td>
  </tr>
  <tr>
    <td>RDS</td>
    <td>respiratory distress syndrome</td>
    <td>TENS</td>
    <td>ranscutaneous electrical nerve</td>
  </tr>
  <tr>
    <td>RDW</td>
    <td>red cell distribution width</td>
    <td>TGA</td>
    <td>ransposition of the great arteries</td>
  </tr>
  <tr>
    <td>REM</td>
    <td>rapid movement</td>
    <td>TIA</td>
    <td>ransient ischemic attack</td>
  </tr>
  <tr>
    <td></td>
    <td>eye</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>RF</td>
    <td>theumatoid factor</td>
    <td>TIBC</td>
    <td>otal iron-binding capacity</td>
  </tr>
  <tr>
    <td>RLO</td>
    <td>right lower quadrant</td>
    <td>TIG</td>
    <td>etanus immune globulin</td>
  </tr>
  <tr>
    <td>ROM</td>
    <td>rupture of membranes</td>
    <td>TIPS</td>
    <td>ransjugular intrahepatic portosystemic</td>
  </tr>
  <tr>
    <td>RPR</td>
    <td>rapid plasma reagin</td>
    <td>TLC</td>
    <td>otal lung capacity</td>
  </tr>
  <tr>
    <td>RR</td>
    <td>relative risk, respiratory rate</td>
    <td>TMP-SMX</td>
    <td>rimethoprim-sulfamethoxazole</td>
  </tr>
  <tr>
    <td>RRR</td>
    <td>regular rate and rhythm, relative risk</td>
    <td>TNE</td>
    <td>umor necrosis factor</td>
  </tr>
  <tr>
    <td></td>
    <td>reduction</td>
    <td>TNV</td>
    <td>enofovir</td>
  </tr>
  <tr>
    <td>RSV</td>
    <td>respiratory syncytial virus</td>
    <td>tPA</td>
    <td>issue plasminogen activator</td>
  </tr>
  <tr>
    <td>RTA</td>
    <td>renal tubular acidosis</td>
    <td>TPN</td>
    <td>otal parenteral nutrition</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>TPO</td>
    <td></td>
  </tr>
  <tr>
    <td>RUQ</td>
    <td>right upper quadrant</td>
    <td></td>
    <td>hyroperoxidase</td>
  </tr>
  <tr>
    <td>RV</td>
    <td>residual volume, right ventricle</td>
    <td>TRALI</td>
    <td>ransfusion-related acute lung injury</td>
  </tr>
  <tr>
    <td>RVH</td>
    <td>right ventricular hypertrophy</td>
    <td>TSH</td>
    <td>hyroid-stimulating hormone</td>
  </tr>
  <tr>
    <td>SA</td>
    <td>sinoatrial</td>
    <td>TSS</td>
    <td>‘oxic shock syndrome</td>
  </tr>
  <tr>
    <td>SAAG</td>
    <td>serum-ascites albumin gradient</td>
    <td>TSS-T</td>
    <td>‘oxic shock syndrome toxin</td>
  </tr>
  <tr>
    <td>SAB</td>
    <td>spontaneous abortion</td>
    <td>TTE</td>
    ======================================
    <td>ransthoracic echocardiography</td>
  </tr>
  <tr>
    <td>SAD</td>
    <td>seasonal affective disorder</td>
    <td>TTP</td>
    <td>hrombotic thrombocytopenic purpura</td>
  </tr>
  <tr>
    <td>SAH</td>
    <td>subarachnoid hemorrhage</td>
    <td>TURP</td>
    <td>transurethral resection of the prostate</td>
  </tr>
  <tr>
    <td>SBFT SBI</td>
    <td>small bowel follow-through serious bacterial infection</td>
    <td>Tx UA</td>
    <td>reatment</td>
  </tr>
  <tr>
    <td>SBP</td>
    <td>spontaneous bacterial peritonitis, systolic</td>
    <td>Vo</td>
    <td>urinalysis urine creatinine</td>
  </tr>
  <tr>
    <td></td>
    <td>blood pressure</td>
    <td>UIFE</td>
    <td>urine immunofixation electrophoresis</td>
  </tr>
  <tr>
    <td>SCID</td>
    <td>severe combined immunodeficiency</td>
    <td>UMN</td>
    <td>upper motor neuron</td>
  </tr>
  <tr>
    <td>SCLC</td>
    <td>small cell lung cancer</td>
    <td>Una</td>
    <td>urine sodium</td>
  </tr>
  <tr>
    <td>SERM SES</td>
    <td>selective estrogen receptor modulator socioeconomic</td>
    <td>Vosm UPEP</td>
    <td>urine osmolarity urine</td>
  </tr>
  <tr>
    <td>SIADH</td>
    <td>status syndrome of inappropriate secretion of</td>
    <td>URI</td>
    <td>protein electrophoresis upper respiratory tract infection</td>
  </tr>
  <tr>
    <td></td>
    <td>antidiuretic hormone</td>
    <td>UIS</td>
    <td>ultrasound</td>
  </tr>
  <tr>
    <td>SIDS</td>
    <td>sudden infant death syndrome</td>
    <td>USMLE</td>
    <td>United States Medical Licensing</td>
  </tr>
  <tr>
    <td>SIFE</td>
    <td>serum immunofixation electrophoresis</td>
    <td></td>
    <td>Examination</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>UTOX</td>
    <td>urine toxicology screen</td>
  </tr>
  <tr>
    <td>UV</td>
    <td>ultraviolet</td>
  </tr>
  <tr>
    <td>VCUG</td>
    <td>voiding cystourethrography</td>
  </tr>
  <tr>
    <td>VDRL</td>
    <td>Venereal Disease Research Laboratory</td>
  </tr>
  <tr>
    <td>VF</td>
    <td>ventricular fibrillation</td>
  </tr>
  <tr>
    <td>VIP</td>
    <td>vasoactive intestinal peptide</td>
  </tr>
  <tr>
    <td>VMA</td>
    <td>vanillylmandelic acid</td>
  </tr>
  <tr>
    <td>V/Q</td>
    <td>ventilation-perfusion (ratio)</td>
  </tr>
  <tr>
    <td>VRE</td>
    <td>vancomycin-resistant enterococcus</td>
  </tr>
  <tr>
    <td>VS</td>
    <td>vital signs</td>
  </tr>
</table>
<table>
  <tr>
    <td>THe 1° Survey</td>
  </tr>
  <tr>
    <td>THe 2° SuRVeY</td>
  </tr>
  <tr>
    <td>Management of Emergent Procedures</td>
  </tr>
  <tr>
    <td>Shock</td>
  </tr>
  <tr>
    <td>Orthopedic Injuries</td>
  </tr>
  <tr>
    <td>ANKLE INJURIES</td>
  </tr>
  <tr>
    <td>Knee INJURIES</td>
  </tr>
  <tr>
    <td>Hip INsuries</td>
  </tr>
  <tr>
    <td>ARM INJURIES</td>
  </tr>
  <tr>
    <td>OrTHoPeEDIC PEARLS.</td>
  </tr>
  <tr>
    <td>Common Dysrhythmias</td>
  </tr>
  <tr>
    <td>Advanced Cardiac Life Support</td>
  </tr>
  <tr>
    <td>UnstasLe BRADYCARDIA</td>
  </tr>
  <tr>
    <td>Carpiac ARREST</td>
  </tr>
  <tr>
    <td>TACHYCARDIA</td>
  </tr>
  <tr>
    <td>MyocarDIAL INFARCTION</td>
  </tr>
  <tr>
    <td>Toxicology</td>
  </tr>
  <tr>
    <td>ToxIDROMES</td>
  </tr>
  <tr>
    <td>Abdominal Pain</td>
  </tr>
  <tr>
    <td>Epicastric PAIN</td>
  </tr>
  <tr>
    <td>RLQ Pain</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Sexual Assault</td>
    <td>68</td>
  </tr>
  <tr>
    <td>Animal and Insect Bites</td>
    <td>68</td>
  </tr>
  <tr>
    <td>Tetanus</td>
    <td>69</td>
  </tr>
  <tr>
    <td>Anaphylaxis</td>
    <td>70</td>
  </tr>
  <tr>
    <td>Angioedema</td>
    <td></td>
  </tr>
  <tr>
    <td>Environmental Emergencies</td>
    <td>72</td>
  </tr>
  <tr>
    <td>CoLp EMERGENCIES</td>
    <td>72</td>
  </tr>
  <tr>
    <td>Heat EMERGENCIES</td>
    <td>73</td>
  </tr>
  <tr>
    <td>Burns</td>
    <td>73</td>
  </tr>
  <tr>
    <td>Electrical Injuries</td>
    <td>75</td>
  </tr>
  <tr>
    <td>Ophthalmology</td>
    <td>75</td>
  </tr>
  <tr>
    <td>OcuLar TRAUMA</td>
    <td>75</td>
  </tr>
  <tr>
    <td>ConJunctivitis</td>
    <td>76</td>
  </tr>
  <tr>
    <td>OTHER CONDITIONS OF THE EYE</td>
    <td>77</td>
  </tr>
  <tr>
    <td>Dental Emergencies</td>
    <td>77</td>
  </tr>
  <tr>
    <td>DeNTAL AVULSION</td>
    <td>77</td>
  </tr>
  <tr>
    <td>ManpiBuLar FRACTURE</td>
    <td>78</td>
  </tr>
  <tr>
    <td>Radiology and Other Diagnostic Testing</td>
    <td>78</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="2">Type</th>
    <th></th>
    <th></th>
    <th>Carpiac</th>
    <th></th>
    <th></th>
  </thead>
  <thead>
    <th></th>
    <th>Masor Causes</th>
    <th>PretoapD</th>
    <th>Output</th>
    <th>AFTERLOAD</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Hypovolemic</td>
    <td>— Trauma, blood loss, burns, dehydration</td>
    <td>Lj</td>
    <td>i</td>
    <td>T</td>
    <td>IV fluids: Crystalloid/blood</td>
  </tr>
  <tr>
    <td>Cardiogenic</td>
    <td>
      —_- MI, heart failure, arrhythmia, structural heart disease (eg, severe
      mitral regurgitation, ventricular septal defect)
    </td>
    <td>T</td>
    <td>L</td>
    <td>T</td>
    <td>
      Treat the cause and give vasopressors (dopamine; norepinephrine or
      dobutamine if necessary)
    </td>
  </tr>
  <tr>
    <td>Obstructive</td>
    <td>Tamponade, tension pneumothorax, pulmonary embolism (PE)</td>
    <td>Lort</td>
    <td>L</td>
    <td>T</td>
    <td>Tamponade: Pericardiocentesis PE: Fluids and thrombolytics</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="2">ToxiDROME Cholinergic</th>
    <th>Symptoms/Sicns</th>
    <th>Examples</th>
  </thead>
  <thead>
    <th></th>
    <th>
      DUMBELS: Diarrhea, Urination, Miosis, (Bronchorrhea Bronchospasm
      Bradycardia) Emesis, Lacrimation, Salivation
    </th>
    <th>
      Muscarine-containing mushrooms, organophosphates, pilocarpine,
      pyridostigmine
    </th>
  </thead>
  <tr>
    <td>Anticholinergic</td>
    <td>
      “Hot as a hare, red as a beet, dry as a bone, mad as a hatter, blind as a
      bat”: fever, skin flushing, dry mucous membranes, psychosis, mydriasis;
      also tachycardia and urinary retention
    </td>
    <td>
      Antihistamines, antipsychotics, atropine, Jimson weed, scopolamine,
      tricyclic antidepressants
    </td>
  </tr>
  <tr>
    <td>Opioid</td>
    <td>
      Triad of coma, respiratory depression, and miosis; also bradycardia,
      hypothermia, and diminished bowel sounds
    </td>
    <td>Heroin, morphine, oxycodone</td>
  </tr>
  <tr>
    <td>Sedative-hypnotic</td>
    <td>CNS depression, respiratory depression, and coma</td>
    <td>Alcohol, barbiturates, benzodiazepines</td>
  </tr>
  <tr>
    <td>Sympathomimetic</td>
    <td>
      Disorientation, panic, seizures, hypertension, tachycardia, and tachypnea
    </td>
    <td>Amphetamines, cocaine, PCP</td>
  </tr>
  <tr>
    <td>Extrapyramidal</td>
    <td>
      Parkinsonian symptoms: tremor, torticollis, trismus, rigidity, oculogyric
      crisis, opisthotonos, dysphonia, and dysphagia
    </td>
    <td>Haloperidol, metoclopramide, phenothiazines</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Bite Type</th>
    <th>Likety Orcanisms/Toxins</th>
    <th>TREATMENT</th>
  </thead>
  <tr>
    <td>Dog</td>
    <td>
      a-hemolytic streptococci, S aureus, Pasteurella multocida, and anaerobes
    </td>
    <td>
      — Amoxicillin/clavulanate or a first-generation cephalosporin +/— tetanus
      and rabies prophylaxis
    </td>
  </tr>
  <tr>
    <td>Cat</td>
    <td>P multocida (high rate of infection), anaerobes</td>
    <td>Amoxicillin/clavulanate +/— tetanus prophylaxis</td>
  </tr>
  <tr>
    <td>Human</td>
    <td>__ Polymicrobial. Viridans streptococci, Eikenella corrodens</td>
    <td>
      Second- or third-generation cephalosporins, dicloxacillin + penicillin,
      amoxicillin/clavulanate or clarithromycin +/— tetanus prophylaxis, HBV
      vaccine, hepatitis B immune globulin, and postexposure human HIV
      prophylaxis
    </td>
  </tr>
  <tr>
    <td>Rodent</td>
    <td>—Streptobacillus moniliformis, P multocida, Leptospira spp</td>
    <td>Penicillin VK or doxycycline</td>
  </tr>
  <tr>
    <td>Bat</td>
    <td>Rabies and other viruses</td>
    <td>Vaccination against rabies</td>
  </tr>
  <tr>
    <td>Snake</td>
    <td>
      Pseudomonas aeruginosa, Proteus spp, Bacteroides fragilis, Clostridium
      spp, venom
    </td>
    <td>
      | Antivenom as appropriate. Venomous snakes (eg, coral snake, pit viper,
      rattlesnake) do not require prophylactic antibiotics; ampicillin/sulbactam
      (or, alternatively, a fluoroquinolone or clindamycin + TMP-SMX) is given
      to combat the snake’s oral flora if infection develops Monitor for
      rhabdomyolysis, neurologic impairment, coagulopathy, and serum sickness
    </td>
  </tr>
  <tr>
    <td>Spider</td>
    <td>
      Venom (can cause tissue necrosis and/or rigid paralysis, depending on
      species)
    </td>
    <td>
      Antivenom as appropriate; otherwise supportive care (analgesics,
      antihistamines, wound irrigation/debridement) Tetanus prophylaxis
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th rowspan="2">History of ApsorBeD TETANUS Toxoip (Doses)</th>
    <th rowspan="2">Non-Tetanus-Prone Wounps To</th>
    <th colspan="2">Tetanus-Prone Wounps?*</th>
  </thead>
  <thead>
    <th></th>
    <th></th>
    <th>Tp</th>
    <th>TIG</th>
  </thead>
  <tr>
    <td>Unknown or &lt; 3 doses</td>
    <td>\</td>
    <td>V</td>
    <td>V</td>
  </tr>
  <tr>
    <td colspan="4">Three doses:</td>
  </tr>
  <tr>
    <td>Last dose = 5 years</td>
    <td></td>
    <td>V</td>
    <td></td>
  </tr>
  <tr>
    <td>Last dose = 10 years</td>
    <td>V</td>
    <td>V</td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>Severity oF Burn</th>
    <th>Tissue INVOLVEMENT</th>
    <th>Finpincs</th>
  </thead>
  <tr>
    <td>First degree</td>
    <td>Epidermis only</td>
    <td>Red and painful</td>
  </tr>
  <tr>
    <td>Second degree (superficial)</td>
    <td>Epidermis and superficial dermis</td>
    <td>Red, wet, and painful with blisters</td>
  </tr>
  <tr>
    <td>Second degree (deep)</td>
    <td>Epidermis and deep dermis</td>
    <td>White, dry, and painful</td>
  </tr>
  <tr>
    <td>Third degree</td>
    <td>Epidermis and entire dermis</td>
    <td>Charred/leathery, pearly white, and nontender</td>
  </tr>
  <tr>
    <td rowspan="2">Fourth degree</td>
    <td>Below the dermis to bone, muscle,</td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td>and fascia</td>
    <td></td>
  </tr>
</table>
<table>
  <tr>
    <td>Jiabetes Mellitus Tyee 1 Diabetes MeLuitus</td>
    <td>80 80</td>
  </tr>
  <tr>
    <td>Type 2 Diabetes MELLITus</td>
    <td>81</td>
  </tr>
  <tr>
    <td>Lonc-Term MANAGEMENT OF DiaBeTes MELLITUS</td>
    <td>82</td>
  </tr>
  <tr>
    <td>Diasetic KeTOAciDosis</td>
    <td>83</td>
  </tr>
  <tr>
    <td>HyPeRGLYCEMIC HYPEROSMOLAR STATE</td>
    <td>84</td>
  </tr>
  <tr>
    <td>Thyroid Disorders</td>
    <td>85</td>
  </tr>
  <tr>
    <td>1° HyPoTHyROIDISM</td>
    <td>85</td>
  </tr>
  <tr>
    <td>1° HYPERTHYROIDISM</td>
    <td>86</td>
  </tr>
  <tr>
    <td>2° HYPERTHYROIDISM</td>
    <td>87</td>
  </tr>
  <tr>
    <td>Tuyroip Nobutes</td>
    <td>88</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td>Hypercalcemia</td>
    <td>88</td>
  </tr>
  <tr>
    <td>Osteoporosis</td>
    <td>90</td>
  </tr>
  <tr>
    <td>Cushing Syndrome (Hypercortisolism)</td>
    <td></td>
  </tr>
  <tr>
    <td>Adrenal Insufficiency</td>
    <td>93</td>
  </tr>
  <tr>
    <td colspan="2">Hyperaldosteronism 95</td>
  </tr>
  <tr>
    <td>Prolactinoma</td>
    <td>95</td>
  </tr>
  <tr>
    <td>Acromegaly</td>
    <td>96</td>
  </tr>
  <tr>
    <td>Multiple Endocrine Neoplasia</td>
    <td>97</td>
  </tr>
  <tr>
    <td>PHEOCHROMOCYTOMA</td>
    <td>97</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Derenpent DM)</th>
    <th>Derenpent DM)</th>
  </thead>
  <tr>
    <td>Pathophysiology</td>
    <td>
      Failure of the pancreas to secrete insulin asa result of autoimmune
      destruction of B cells
    </td>
    <td>
      Insulin resistance and inadequate insulin secretion by the pancreas to
      compensate
    </td>
  </tr>
  <tr>
    <td>Incidence</td>
    <td>10%</td>
    <td>90%</td>
  </tr>
  <tr>
    <td>Age (exceptions are common)</td>
    <td>&lt; 30 years</td>
    <td>&gt; 40 years</td>
  </tr>
  <tr>
    <td>Association with obesity</td>
    <td>No</td>
    <td>Yes</td>
  </tr>
  <tr>
    <td>Common symptoms</td>
    <td>Polydipsia, polyuria, weight loss</td>
    <td>Usually asymptomatic, can cause fatigue, weight changes</td>
  </tr>
  <tr>
    <td>Diabetic ketoacidosis</td>
    <td>Common</td>
    <td>Rare</td>
  </tr>
  <tr>
    <td>Genetic predisposition</td>
    <td>Weak, polygenic</td>
    <td>Strong, polygenic</td>
  </tr>
  <tr>
    <td>Association with human leukocyte antigen (HLA) system</td>
    <td>Yes (HLA-DR3 and HLA-DR4)</td>
    <td>No</td>
  </tr>
  <tr>
    <td>Serum C-peptide</td>
    <td>J; Can be normal during the “honeymoon period”</td>
    <td>J Late in the disease</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>INSULIN</th>
    <th>Onset oF Action</th>
    <th>Duration oF AcTION</th>
    <th>Dosine ScHEDULE</th>
  </thead>
  <tr>
    <td colspan="4">Short acting:</td>
  </tr>
  <tr>
    <td>Aspart</td>
    <td>10-20 minutes</td>
    <td>1-3 hours</td>
    <td>3-4x daily, usually with</td>
  </tr>
  <tr>
    <td>Lispro</td>
    <td>5-10 minutes</td>
    <td>30-90 minutes</td>
    <td>meals</td>
  </tr>
  <tr>
    <td rowspan="4">Regular</td>
    <td>30-60 minutes</td>
    <td>5-8 hours</td>
    <td>3-4x daily, usually with</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>meals</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>Varies, usually twice</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>daily with NPH</td>
  </tr>
  <tr>
    <td colspan="4">Intermediate acting:</td>
  </tr>
  <tr>
    <td>NPH</td>
    <td>2-4 hours</td>
    <td>6-10 hours</td>
    <td>Usually twice daily with</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td>regular insulin</td>
  </tr>
  <tr>
    <td colspan="4">Long acting:</td>
  </tr>
  <tr>
    <td>Detemir</td>
    <td>2 hours</td>
    <td>20 hours</td>
    <td>Once or twice daily</td>
  </tr>
  <tr>
    <td>Glargine</td>
    <td>1-4 hours</td>
    <td>24 hours</td>
    <td>Once daily</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>MepIcaTion</th>
    <th>ExampLes</th>
    <th>Mecuanism oF ACTION</th>
    <th>Apverse ErFects</th>
    <th>COoNnTRAINDICATIONS</th>
  </thead>
  <tr>
    <td>Biguanides</td>
    <td>Metformin</td>
    <td>
      Inhibit hepatic gluconeogenesis, T glucose utilization, J insulin
      resistance, J postprandial glucose levels
    </td>
    <td>
      Lactic acidosis, diarrhea, GI discomfort, metallic taste, weight loss
    </td>
    <td>
      Renal insufficiency, any form of acidosis, liver disease, severe hypoxia
    </td>
  </tr>
  <tr>
    <td>Sulfonylureas</td>
    <td>
      First generation: Chlorpropamide Second generation: Glipizide, glyburide
    </td>
    <td>T Insulin secretion and T peripheral insulin sensitivity</td>
    <td>Hypoglycemia, weight gain, type IV hypersensitivity reactions</td>
    <td>Renal/liver disease</td>
  </tr>
  <tr>
    <td>Meglitinides</td>
    <td>Repaglinide</td>
    <td>
      Insulin secretion. (work like sulfonylureas by stimulating the release of
      insulin from the pancreas)
    </td>
    <td>Hypoglycemia</td>
    <td>Renal/liver disease</td>
  </tr>
  <tr>
    <td>a-Glucosidase inhibitors</td>
    <td>Acarbose</td>
    <td>
      Glucose absorption (L carbohy- drate absorption from the Gl tract, insulin
      demand)
    </td>
    <td>T Flatulence, GI discomfort, T liver function tests (LFTs)</td>
    <td>Renal/liver disease</td>
  </tr>
  <tr>
    <td>Thiazolidinediones (“‘glitazones”)</td>
    <td>Rosiglitazone, pioglitazone</td>
    <td>
      Insulin resistance, T glucose utilization (T insulin sensitization,
      hepatic gluconeogenesis and insulin receptor upregulation)
    </td>
    <td>Hepatocellular injury, anemia, pedal edema, heart failure (HF)</td>
    <td>Liver disease, HF (class _ III/IV), LFTs &gt; two times normal</td>
  </tr>
  <tr>
    <td>Glucagon-like peptide-1 (GLP-1) agonists</td>
    <td>Exenatide —_Liraglutide</td>
    <td>Postprandial glucose utilization</td>
    <td>Nausea, vomiting, weight loss, hypoglycemia</td>
    <td>Renal disease</td>
  </tr>
  <tr>
    <td>Dipeptidyl peptidase inhibitors</td>
    <td>Sitagliptin, vildagliptin</td>
    <td>Same as that of GLP-1 agonists</td>
    <td>Same as those of GLP-1 agonists</td>
    <td>Same as that of GLP-1 agonists</td>
  </tr>
  <tr>
    <td>SGLT2 inhibitors</td>
    <td>Canaglifozin</td>
    <td>J Renal glucose reabsorption</td>
    <td>Urinary tract infections, hypoglycemia</td>
    <td>Renal disease</td>
  </tr>
</table>
======================================
<table>
  <tr>
    <td rowspan="2">Neuropathy</td>
    <td>PRESENTATION</td>
    <td>Diacnosis</td>
    <td>ManaGement</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Primarily a symmetrical sensory polyneuropathy affecting the distal lower
      extremities; T the risk of diabetic foot ulcers (see Figure 5-1)
    </td>
    <td>Clinical</td>
    <td>
      Prevention is key, including daily self-inspection of feet and yearly foot
      exams. First-line treatment includes gabapentin or pregabalin and focuses
      on symptom relief
    </td>
  </tr>
  <tr>
    <td>Nephropathy</td>
    <td>
      Usually asymptomatic but may present with bilateral lower extremity edema
      from nephrotic syndrome
    </td>
    <td>
      Best initial test is yearly urine microalbumin. Definitive diagnosis is
      made by renal biopsy showing Kimmelstiel-Wilson lesions (not necessary in
      most cases)
    </td>
    <td>
      | ACEls and aggressive BP management (goal is &lt;130/80) can help prevent
      progression to end-stage renal disease
    </td>
  </tr>
  <tr>
    <td>Retinopathy</td>
    <td>Often asymptomatic; can also present with blurry vision</td>
    <td>
      Yearly dilated eye exam to look for prolifera- tive retinopathy with
      abnormal new blood vessels
    </td>
    <td>
      First line treatment: Laser therapy; 2nd line: Intravitreous injection of
      vascular endothelial growth factor inhibitor such as bevacizumab
    </td>
  </tr>
  <tr>
    <td>Atherosclerosis</td>
    <td>Manifestations vary but may present as MI or stroke</td>
    <td>May be diagnosed as CAD</td>
    <td>
      Treat hyperlipidemia with statins; implement aggressive management of risk
      factors (eg, hypertension obesity, smoking)
    </td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>HyPoTHyYROIDISM</th>
    <th>HyPERTHYROIDISM</th>
  </thead>
  <tr>
    <td>General</td>
    <td>Fatigue, lethargy</td>
    <td>Hyperactivity, nervousness, fatigue</td>
  </tr>
  <tr>
    <td>Temperature</td>
    <td>Cold intolerance</td>
    <td>Heat intolerance</td>
  </tr>
  <tr>
    <td>Gl</td>
    <td>Constipation leading to ileus; weight gain despite a poor appetite</td>
    <td>Diarrhea; weight loss despite a good appetite</td>
  </tr>
  <tr>
    <td>Cardiac</td>
    <td>Bradycardia, pericardial effusion, hyperlipidemia</td>
    <td>
      Tachycardia, atrial fibrillation, HF; systolic hypertension, T pulse
      pressure
    </td>
  </tr>
  <tr>
    <td>Neurologic</td>
    <td>Delayed deep tendon reflexes</td>
    <td>Fine resting tremor; apathetic hyperthyroidism (elderly)</td>
  </tr>
  <tr>
    <td>Menstruation</td>
    <td>Heavy</td>
    <td>Irregular, amenorrhea</td>
  </tr>
  <tr>
    <td>Dermatologic</td>
    <td>Dry, coarse skin; thinning hair; thin, brittle nails; myxedema</td>
    <td>Warm, sweaty skin; fine, oily hair; nail separation from matrix</td>
  </tr>
  <tr>
    <td>Other</td>
    <td>Arthralgias/myalgias</td>
    <td>Osteoporosis</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Graves Disease</th>
    <th>SuBacuTe THYROIDITIS</th>
    <th>HasHimoto THyroIpiTIs</th>
  </thead>
  <tr>
    <td>Etiology/ pathophysiology</td>
    <td>
      Antibody directed at TSH receptor; more prevalent in female patients
    </td>
    <td>Viral (possibly mumps or coxsackievirus)</td>
    <td>Autoimmune disorder</td>
  </tr>
  <tr>
    <td rowspan="5">Symptoms/exam</td>
    <td>Hyperthyroidism; diffuse, painless goiter</td>
    <td>Hyperthyroidism followed by hypothyroidism</td>
    <td>Occasionally presents</td>
  </tr>
  <tr>
    <td></td>
    <td>Proptosis (also called exophthalmos;</td>
    <td>Tender thyroid</td>
    <td>with hyperthyroidism</td>
  </tr>
  <tr>
    <td></td>
    <td>see Figure 5-2A), lid lag, diplopia,</td>
    <td>Malaise, upper respiratory tract symptoms,</td>
    <td>(hashitoxicosis) followed</td>
  </tr>
  <tr>
    <td></td>
    <td>conjunctival injection</td>
    <td>fever early on</td>
    <td>by hypothyroidism; pain-</td>
  </tr>
  <tr>
    <td></td>
    <td>Pretibial myxedema (see Figure 5-2B)</td>
    <td></td>
    <td>less thyroid enlargement</td>
  </tr>
  <tr>
    <td>Diagnosis</td>
    <td>T RAIU scan, @ thyroid-stimulating</td>
    <td>J RAIU scan, T erythrocyte sedimentation rate</td>
    <td>@ Anti-TPO antibody</td>
  </tr>
  <tr>
    <td></td>
    <td>immunoglobulin</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td rowspan="2">Disease-specific treatment</td>
    <td>
      Propylthiouracil, methimazole, thyroid ablation with "11, thyroidectomy
    </td>
    <td>NSAIDs for pain control, steroids for severe pain Self-limited</td>
    <td>Levothyroxine</td>
  </tr>
  <tr>
    <td></td>
    <td>
      Ophthalmopathy may require surgical decompression, steroids, or orbital
      radiation
    </td>
    <td></td>
    <td></td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>ACTH Depenpent</th>
    <th>ACTH InpEPENDENT</th>
  </thead>
  <tr>
    <td>Plasma cortisol</td>
    <td>T</td>
    <td>T</td>
  </tr>
  <tr>
    <td>Urinary cortisol</td>
    <td>T</td>
    <td>T</td>
  </tr>
  <tr>
    <td>ACTH</td>
    <td>T</td>
    <td>J or undetectable</td>
  </tr>
  <tr>
    <td rowspan="2">Source</td>
    <td>Pituitary (suppressible)</td>
    <td>Adenoma (J DHEA)</td>
  </tr>
  <tr>
    <td></td>
    <td>Ectopic (nonsuppressible)</td>
    <td>Carcinoma (T DHEA)</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th></th>
    <th>Appison Disease</th>
    <th>2° ADRENAL INSUFFICIENCY</th>
  </thead>
  <tr>
    <td>ACTH</td>
    <td>T</td>
    <td>L</td>
  </tr>
  <tr>
    <td>Cortisol after ACTH challenge</td>
    <td>L</td>
    <td>T</td>
  </tr>
  <tr>
    <td>Aldosterone</td>
    <td>i</td>
    <td>Normal</td>
  </tr>
  <tr>
    <td>Na</td>
    <td>i</td>
    <td>Normal or L</td>
  </tr>
  <tr>
    <td>K</td>
    <td>T</td>
    <td>Normal</td>
  </tr>
</table>
======================================
<table>
  <thead>
    <th>SYNDROME</th>
    <th>Type</th>
    <th>CHARACTERISTICS</th>
  </thead>
  <tr>
    <td rowspan="3">Wermer syndrome</td>
    <td>MEN 1</td>
    <td>Parathyroid hyperplasia</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Pancreatic islet cell tumor</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Pituitary adenoma</td>
  </tr>
  <tr>
    <td rowspan="8">Sipple syndrome</td>
    <td>MEN 2A</td>
    <td>Parathyroid hyperplasia</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Thyroid medullary cancer</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Pheochromocytoma</td>
  </tr>
  <tr>
    <td></td>
    <td>MEN 2B</td>
    <td>Thyroid medullary cancer</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Pheochromocytoma</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Mucocutaneous neuromas</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Ganglioneuromatosis of the colon</td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td>Marfan-like habitus</td>
  </tr>
</table>

